Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients

11178870 · 2021-11-23

Assignee

Inventors

Cpc classification

International classification

Abstract

Pyridine compounds of Formula (1) are provided: ##STR00001##
wherein R1, R2, X, Y and Het are defined. The pyridine compounds can be used to treat or prevent plant diseases.

Claims

1. A compound represented by Formula (1) ##STR03670## or a salt thereof wherein R1 represents a C1-C6 alkyl group optionally substituted with one substituent A, a C1-C6 haloalkyl group, or RaRbN— wherein Ra and Rb each independently represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group or Ra and Rb together with the nitrogen atom to which they are bonded form an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a homopiperidinyl group or an azocanyl group; R2 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally substituted with one substituent A, a C1-C6 haloalkyl group, a C2-C6 alkynyl group optionally substituted with one substituent A, a C1-C6 alkoxy group optionally substituted with one substituent A, or Rx1C(═O)— wherein Rx1 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— wherein Ra and Rb are the same as defined hereinabove; Het represents a pyridyl group, a thienyl group, a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms, the pyridyl group is optionally substituted with 0 to 4 substituents R3 with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent, the thienyl group is optionally substituted with 0 to 3 substituents R3 with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent, the pyrrolyl group, the pyrazolyl group, the imidazolyl group, the triazolyl group or the tetrazolyl group is each independently and optionally substituted with 0 to 4 substituents R3 with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent, the oxazolyl group is optionally substituted with 0 to 2 substituents R3 with the proviso that when two substituents R3 are present, each R3 represents an independent substituent, R3 represents a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with one substituent C, a C1-C6 haloalkyl group, a C1-C6 alkoxy group optionally substituted with one substituent C, RaRbN— wherein Ra and Rb each independently represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group or Ra and Rb together with the nitrogen atom to which they are bonded form an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a homopiperidinyl group or an azocanyl group, Rx1C(═O)— wherein Rx1 is the same as defined hereinabove, Rx2C(═O)N(Rx3)- wherein Rx2 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— wherein Ra and Rb are the same as defined hereinabove, Rx3 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group; Y represents a phenyl group, the phenyl group is substituted with R4 at the ortho position and further optionally substituted with 0 to 4 substituents R5 with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent, R4 represents a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with one substituent C, a C1-C6 haloalkyl group, or a C1-C6 alkoxy group optionally substituted with one substituent C, R5 represents a hydroxyl group, a cyano group, a halogen atom, a C1-C6 alkyl group optionally substituted with one substituent C, a C1-C6 alkoxy group optionally substituted with one substituent C, a C2-C6 alkenyloxy group optionally substituted with one substituent C, a C3-C6 alkynyloxy group optionally substituted with one substituent C, RaRbN— wherein Ra and Rb are the same as defined hereinabove, Rc-L- wherein Rc represents a C1-C6 alkyl group or a C1-C6 haloalkyl group and L represents S, SO or SO.sub.2, or Rx1C(═O)O— wherein Rx1 is the same as defined hereinabove; X represents an oxygen atom or a sulfur atom; a bond containing the broken line represents a double bond or a single bond; and the substituent A is at least one selected from the group consisting of a hydroxyl group, a cyano group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group, RaRbN— wherein Ra and Rb are the same as defined hereinabove and Rc-L- wherein Rc and L are the same as defined hereinabove; the substituent B is at least one selected from the group consisting of a cyano group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group and a C3-C8 cycloalkoxy group; the substituent C is at least one selected from the group consisting of a hydroxyl group, a cyano group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group, a C2-C6 alkoxyalkoxy group, RaRbN— wherein Ra and Rb are the same as defined hereinabove, Rc-L- wherein Rc and L are the same as defined hereinabove, Rx1C(═O)— wherein Rx1 is the same as defined hereinabove and a 3 to 6-membered ring group containing 1 to 2 oxygen atoms; the substituent D is at least one selected from the group consisting of a hydroxyl group, a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group which may be substituted with one substituent B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group and a C3-C8 cycloalkoxy group.

2. A compound represented by Formula (2) ##STR03671## or a salt thereof wherein R2 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally substituted with one substituent A, a C1-C6 haloalkyl group, a C2-C6 alkynyl group optionally substituted with one substituent A, a C1-C6 alkoxy group optionally substituted with one substituent A, or Rx1C(═O)— wherein Rx1 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— wherein Ra and Rb each independently represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group or Ra and Rb together with the nitrogen atom to which they are bonded form an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a homopiperidinyl group or an azocanyl group; Het represents a pyridyl group, a thienyl group, a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms, the pyridyl group is optionally substituted with 0 to 4 substituents R3 with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent, the thienyl group is optionally substituted with 0 to 3 substituents R3 with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent, the pyrrolyl group, the pyrazolyl group, the triazolyl group or the tetrazolyl group is each independently and optionally substituted with 0 to 4 substituents R3 with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent, the imidazolyl group is substituted with 1 to 3 substituents R3 with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent, the oxazolyl group is optionally substituted with 0 to 2 substituents R3 with the proviso that when two substituents R3 are present, each R3 represents an independent substituent, R3 represents a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with one substituent C, a C1-C6 haloalkyl group, a C1-C6 alkoxy group optionally substituted with one substituent C, RaRbN— wherein Ra and Rb each independently represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group or Ra and Rb together with the nitrogen atom to which they are bonded form an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a homopiperidinyl group or an azocanyl group, Rx1C(═O)— wherein Rx1 is the same as defined hereinabove, or Rx2C(═O)N(Rx3)- wherein Rx2 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— wherein Ra and Rb are the same as defined hereinabove, Rx3 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with one substituent B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group; Y represents a phenyl group, the phenyl group is substituted with R4 at the ortho position and further optionally substituted with 0 to 4 substituents R5 with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent, R4 represents a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with one substituent C, a C1-C6 haloalkyl group, or a C1-C6 alkoxy group optionally substituted with one substituent C, R5 represents a hydroxyl group, a cyano group, a halogen atom, a C1-C6 alkyl group optionally substituted with one substituent C, a C1-C6 alkoxy group optionally substituted with one substituent C, a C2-C6 alkenyloxy group optionally substituted with one substituent C, a C3-C6 alkynyloxy group optionally substituted with one substituent C, RaRbN— wherein Ra and Rb are the same as defined hereinabove, Rc-L- wherein Rc represents a C1-C6 alkyl group or a C1-C6 haloalkyl group and L represents S, SO or SO.sub.2, or Rx1C(═O)O— wherein Rx1 is the same as defined hereinabove; X represents an oxygen atom or a sulfur atom; and the substituent is at least one selected from the group consisting of a hydroxyl group, a cyano group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group, RaRbN— wherein Ra and Rb are the same as defined hereinabove) and Rc-L- wherein Rc and L are the same as defined hereinabove; the substituent B is at least one selected from the group consisting of a cyano group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group and a C3-C8 cycloalkoxy group; the substituent C is at least one selected from the group consisting of a hydroxyl group, a cyano group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group, a C2-C6 alkoxyalkoxy group, RaRbN— wherein Ra and Rb are the same as defined hereinabove, Rc-L- wherein Rc and L are the same as defined hereinabove), Rx1C(═O)— wherein Rx1 is the same as defined hereinabove and a 3 to 6-membered ring group containing 1 to 2 oxygen atoms; and the substituent D is at least one selected from the group consisting of a hydroxyl group, a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group which may be substituted with one substituent B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group and a C3-C8 cycloalkoxy group.

3. An agricultural and horticultural pest control agent containing the compound or a salt thereof according to claim 1 as an active ingredient.

4. An agricultural and horticultural fungicide containing the compound or a salt thereof according to claim 1 as an active ingredient.

5. A method for preventing and/or treating a plant disease, which comprises applying the agricultural and horticultural pest control agent according to claim 3 to a plant, a plant seed or a soil for plant cultivation.

6. A method for preventing and/or treating a plant disease, which comprises applying the agricultural and horticultural fungicides according to claim 4 to a plant, a plant seed or a soil for plant cultivation.

Description

DESCRIPTION OF EMBODIMENTS

(1) Hereinbelow, embodiments for carrying out the present invention will be described in detail.

(2) The terminologies used in the claims and the specification are understood in accordance with the definitions which are generally used in the art unless otherwise specified.

(3) In the present specification, the abbreviations used are explained below.

(4) DMF: N,N-dimethylformamide, THF: tetrahydrofuran, Me: methyl group, Et: ethyl group, Pr: propyl group, Bu: butyl group, Ac: acetyl group, Ph: phenyl group, Py: pyridyl group, Thio: thienyl group, Pyrrolyl: pyrrolyl group, Pyra: pyrazolyl group, Imida: imidazolyl group, Triazolyl: triazolyl group, Tetrazolyl: tetrazolyl group, Oxa: oxazolyl group, i: iso, sec: secondary, t: tertiary, ═: double bond and ≡: triple bond. In the columns in the tables, Pr and Bu used without any prefix indicate that the respective groups have a normal form.

(5) The definitions of the terminologies used in the present specification will be explained below.

(6) The expression Cx-Cy means that the number of carbon atoms that are possessed range from x to y. Here, x and y each represent an integer and are also understood to disclose all individual integers between x and y inclusive. For example, C1-C6 means that the number of carbon atoms that are possessed is 1, 2, 3, 4, 5 or 6; C2-C6 means that the number of carbon atoms that are possessed is 2, 3, 4, 5 or 6; C3-C8 means that the number of carbon atoms that are possessed is 3, 4, 5, 6, 7 or 8; C3-C6 means that the number of carbon atoms that are possessed is 3, 4, 5 or 6; and C1-C3 means that the number of carbon atoms that are possessed is 1, 2 or 3.

(7) The terms “optionally substituted” means it is to be substituted or unsubstituted. When this terms are used and a number of the substituent(s) is not clearly shown, the number of the substituent(s) indicates to be 1. On the other hand, for example, when a number of the substituent(s) is designated to as “optionally substituted with 0 to 6”, it is to be understood to disclose all individual integers between 0 to 6 inclusive. That is, it means that a number of substituent(s) is 0, 1, 2, 3, 4, 5 or 6. Similarly, “optionally substituted with 0 to 5” means that a number of substituent(s) is 0, 1, 2, 3, 4 or 5; “optionally substituted with 0 to 4” means that a number of substituent(s) is 0, 1, 2, 3 or 4; “optionally substituted with 0 to 3” means that a number of substituent(s) is 0, 1, 2 or 3; and “optionally substituted with 0 to 2” means that a number of substituent(s) of 0, 1 or 2.

(8) C1-C6 alkyl group may be a linear or branched and may include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a sec-butyl group, a t-butyl group, a pentyl group, an isopentyl group, a 2-methylbutyl group, a neopentyl group, a 1-ethylpropyl group, a hexyl group, a 4-methylpentyl group, a 3-methylpentyl group, a 2-methylpentyl group, a 1-methylpentyl group, a 3,3-dimethylbutyl group, a 2,2-dimethylbutyl group, a 1,1-dimethylbutyl group, a 1,2-dimethylbutyl group, a 1,3-dimethylbutyl group, a 2,3-dimethylbutyl group, a 2-ethylbutyl group, a 1-isopropylpropyl group, a 1,1,2-trimethylpropyl group, a, 1,2,2-trimethylpropyl group and the like.

(9) The halogen atom may include a fluorine atom, a chlorine atom, a bromine atom, an iodine atom and the like.

(10) The C1-C6 haloalkyl group represents a group resulting from the substitution of the above-mentioned C1l-C6 alkyl group with 1 or 2 or more halogen atoms in place of any hydrogen atom(s). When the group is substituted with two or more halogen atoms, these halogen atoms may be the same as or different from one another and the number of the substituents is not particularly limited as long as they can exist as a substituent. Specific examples of the C1-C6 haloalkyl group may include a monofluoromethyl group, a difluoromethyl group, a trifluoromethyl group, a monochloromethyl group, a monobromomethyl group, a monoiodomethyl group, a chlorodifluoromethyl group, a bromodifluoromethyl group, a 1-fluoroethyl group, a 2-fluoroethyl group, a 1,1-difluoroethyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 1,1,2,2-tetrafluoroethyl group, a pentafluoroethyl group, a 2,2,2-trichloroethyl group, a 3,3-difluoropropyl group, a 3,3,3-trifluoropropyl group, a heptafluoropropyl group, a heptafluoroisopropyl group, a 2,2,2-trifluoro-1-(trifluoromethyl)ethyl group, a nonafluorobutyl group, a nonafluoro-sec-butyl group, a 3,3,4,4,5,5,5-heptafluoropentyl group, a undecafluoropentyl group, a tridecafluorohexyl group and the like.

(11) The C3-C8 cycloalkyl group includes a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group and the like.

(12) The C2-C6 alkenyl group represents a linear or branched, unsaturated hydrocarbon group having 1 or 2 or more double bonds. When the group has geometric isomeric forms, the group may be either one of the E-isomer or the Z-isomer, or may be a mixture of the E-isomer and the Z-isomer in an appropriate ratio without limitation as long as the number of carbon atoms falls in the designated range. Specific examples of the C2-C6 alkenyl group may include a vinyl group, a 1-propenyl group, an allyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a 1-pentenyl group, a 2-pentenyl group, a 3-pentenyl group, a 4-pentenyl group, a 3-methyl-2-butenyl group, a 1-hexenyl group, a 2-hexenyl group, a 3-hexenyl group, a 4-hexenyl group, a 5-hexenyl group, a 4-methyl-3-pentenyl group, a 3-methyl-2-pentenyl group and the like.

(13) The C2-C6 haloalkenyl group represents a group resulting from the substitution of the above-mentioned C2-C6 alkenyl group with 1 or 2 or more halogen atoms in place of any hydrogen atom(s). When the group is substituted with two or more halogen atoms, these halogen atoms may be the same as or different from one another and the number of the substituents is not particularly limited as long as they can exist as a substituent. Specific examples of the C2-C6 haloalkenyl group may include a 2-fluorovinyl group, a 2,2-difluorovinyl group, a 2,2-dichlorovinyl group, a 3-fluoroallyl group, a 3,3-difluoroallyl group, a 3,3-dichloroallyl group, a 4,4-difluoro-3-butenyl group, a 5,5-difluoro-4-pentenyl group, a 6,6-difluoro-5-hexenyl group and the like.

(14) The C2-C6 alkynyl group represents a linear or branched, unsaturated hydrocarbon group having 1 or 2 or more triple bonds. Specific examples of the C2-C6 alkynyl group may include an ethynyl group, a 1-propynyl group, a propargyl group, a 1-butynyl group, a 2-butynyl group, a 3-butynyl group, a 1-pentynyl group, a 2-pentynyl group, a 3-pentynyl group, a 4-pentynyl group, a 1,1-dimethyl-2-propynyl group, a 1-hexynyl group, a 2-hexynyl group, a 3-hexynyl group, a 4-hexynyl group, a 5-hexynyl group and the like.

(15) The C2-C6 haloalkynyl group represents a group resulting from the substitution of the above-mentioned C2-C6 alkynyl group with 1 or 2 or more halogen atoms in place of any hydrogen atom(s). When the group is substituted with two or more halogen atoms, these halogen atoms may be the same as or different from one another and the number of the substituents is not particularly limited as long as they can exist as a substituent. Specific examples of the C2-C6 haloalkynyl group may include a 2-fluoroethynyl group, a 2-chloroethynyl group, a 2-bromoethynyl group, a 2-iodoethynyl group, a 3,3-difluoro-1-propynyl group, a 3-chloro-3,3-difluoro-1-propynyl group, a 3-bromo-3,3-difluoro-1-propynyl group, a 3,3,3-trifluoro-1-propynyl group, a 4,4-difluoro-1-butynyl group, a 4,4-difluoro-2-butynyl group, a 4-chloro-4,4-difluoro-1-butynyl group, a 4-chloro-4,4-difluoro-2-butynyl group, a 4-bromo-4,4-difluoro-1-butynyl group, a 4-bromo-4,4-difluoro-2-butynyl group, a 4,4,4-trifluoro-1-butynyl group, a 4,4,4-trifluoro-2-butynyl group, a 5,5-difluoro-3-pentynyl group, a 5-chloro-5,5-difluoro-3-pentynyl group, a 5-bromo-5,5-difluoro-3-pentynyl group, a 5,5,5-trifluoro-3-pentynyl group, a 6,6-difluoro-4-hexynyl group, a 6-chloro-6,6-difluoro-4-hexynyl group, a 6-bromo-6,6-difluoro-4-hexynyl group, a 6,6,6-trifluoro-4-hexynyl group and the like.

(16) The C1-C6 alkoxy group represents a combination of the above-mentioned C1-C6 alkyl group and an oxygen atom as a bonding site. Specific examples of the C1-C6 alkoxy group may include a methoxy group, an ethoxy group, a propyloxy group, an isopropyloxy group, a butoxy group, an isobutoxy group, a sec-butoxy group, a t-butoxy group, a pentyloxy group, an isopentyloxy group, a 1-methylbutoxy group, a 2-methylbutoxy group, a neopentyloxy group, a 1-ethylpropyloxy group, a 1,2-dimethylpropyloxy group, a hexyloxy group, a 1-methylpentyloxy group, a 2-methylpentyloxy group, a 3-methylpentyloxy group, a 4-methylpentyloxy group, a 1,1-dimethylbutoxy group, a 2,2-dimethylbutoxy group, a 3,3-dimethylbutoxy group, a 1,2-dimethylbutoxy group, a 1,3-dimethylbutoxy group, a 2,3-dimethylbutoxy group, a 2-ethylbutoxy group, a 1-isopropylpropyloxy group, a 1,1,2-trimethylpropyloxy group, a 1,2,2-trimethylpropyloxy group and the like.

(17) The C1-C6 haloalkoxy group represents a group resulting from the substitution of the above-mentioned C1-C6 alkoxy group with 1 or 2 or more halogen atoms in place of any hydrogen atom(s). When the group is substituted with two or more halogen atoms, these halogen atoms may be the same as or different from one another and the number of the substituents is not particularly limited as long as they can exist as a substituent. Specific examples of the C1-C6 haloalkoxy group may include a difluoromethoxy group, a trifluoromethoxy group, a chlorodifluoromethoxy group, a bromodifluoromethoxy group, a 2-fluoroethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 1,1,2,2-tetrafluoroethoxy group, a pentafluoroethoxy group, a 2,2,2-trichloroethoxy group, a 3,3-difluoropropyloxy group, a 3,3,3-trifluoropropyloxy group, a heptafluoropropyloxy group, a heptafluoroisopropyloxy group, a 2,2,2-trifluoro-1-(trifluoromethyl)-ethoxy group, a nonafluorobutoxy group, a nonafluoro-sec-butoxy group, a 3,3,4,4,5,5,5-heptafluoropentyloxy group, a undecafluoropentyloxy group, a tridecafluorohexyloxy group and the like.

(18) The C3-C8 cycloalkoxy group represents a combination of the above-mentioned C3-C8 cycloalkyl group and an oxygen atom as a bonding site. Specific examples of the C3-C8 cycloalkoxy group may include a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group, a cyclohexyloxy group, a cycloheptyloxy group, a cyclooctyloxy group and the like.

(19) The C2-C6 alkenyloxy group represents a combination of the above-mentioned C2-C6 alkenyl group and an oxygen atom as a bonding site. When the group has geometric isomeric forms, the group may be either one of the E-isomer or the Z-isomer, or may be a mixture of the E-isomer and the Z-isomer in an appropriate ratio without limitation as long as the number of carbon atoms falls in the designated range. Specific examples of the C2-C6 alkenyloxy group may include a vinyloxy group, a 1-propenyloxy group, an allyloxy group, a 1-butenyloxy group, a 2-butenyloxy group, a 3-butenyloxy group, a 1-pentenyloxy group, a 2-pentenyloxy group, a 3-pentenyloxy group, a 4-pentenyloxy group, a 3-methyl-2-butenyloxy group, a 1-hexenyloxy group, a 2-hexenyloxy group, a 3-hexenyloxy group, a 4-hexenyloxy group, a 5-hexenyloxy group, a 4-methyl-3-pentenyloxy group, a 3-methyl-2-pentenyloxy group and the like.

(20) The C2-C6 haloalkenyloxy group represents a group resulting from the substitution of the above-mentioned C2-C6 alkenyloxy group with 1 or 2 or more halogen atoms in place of any hydrogen atom(s). When the group is substituted with two or more halogen atoms, these halogen atoms may be the same as or different from one another and the number of the substituents is not particularly limited as long as they can exist as a substituent. Specific examples of the C2-C6 haloalkenyloxy group may include a 2-fluorovinyloxy group, a 2,2-difluorovinyloxy group, a 2,2-dichlorovinyloxy group, a 3-fluoroallyloxy group, a 3,3-difluoroallyloxy group, a 3,3-dichloroallyloxy group, a 4,4-difluoro-3-butenyloxy group, a 5,5-difluoro-4-pentenyloxy group, a 6,6-difluoro-5-hexenyloxy group and the like.

(21) The C3-C6 alkynyloxy group represents a combination of a C3-C6 alkynyl group belonging to the above-mentioned C2-C6 alkynyl group, and an oxygen atom as a bonding site. Specific examples of the C3-C6 alkynyloxy group may include a propargyloxy group, a 2-butynyloxy group, a 3-butynyloxy group, a 2-pentynyloxy group, a 3-pentynyloxy group, a 4-pentynyloxy group, a 1,1-dimethyl-2-propynyloxy group, a 2-hexynyloxy group, a 3-hexynyloxy group, a 4-hexynyloxy group, a 5-hexynyloxy group and the like.

(22) The C3-C6 haloalkynyloxy group represents a group resulting from the substitution of the above-mentioned C3-C6 alkynyloxy group with 1 or 2 or more halogen atoms in place of any hydrogen atom(s). When the group is substituted with two or more halogen atoms, these halogen atoms may be the same as or different from one another and the number of the substituents is not particularly limited as long as they can exist as a substituent. Specific examples of the C3-C6 haloalkynyloxy group may include a 1,1-difluoro-2-propynyloxy group, a 4,4-difluoro-2-butynyloxy group, a 4-chloro-4,4-difluoro-2-butynyloxy group, a 4-bromo-4,4-difluoro-2-butynyloxy group, a 4,4,4-trifluoro-2-butynyloxy group, a 5,5-difluoro-3-pentynyloxy group, a 5-chloro-5,5-difluoro-3-pentynyloxy group, a 5-bromo-5,5-difluoro-3-pentynyloxy group, a 5,5,5-trifluoro-3-pentynyloxy group, a 6,6-difluoro-4-hexynyloxy group, a 6-chloro-6,6-difluoro-4-hexynyloxy group, a 6-bromo-6,6-difluoro-4-hexynyloxy group, a 6,6,6-trifluoro-4-hexynyloxy group and the like.

(23) The C2-C6 alkoxyalkoxy group represents a group resulting from the substitution of a C1-C5 alkoxy group belonging to the above-mentioned C1-C6 alkoxy group with 1 or 2 or more C1-C5 alkoxy groups in place of any hydrogen atom(s). It is not particularly limited as long as the total number of the carbon atoms is within the range of the designated number of the carbon atoms. Specific examples of the C2-C6 alkoxyalkoxy group may include a methoxymethoxy group, an ethoxymethoxy group, a propyloxymethoxy group, isopropyloxymethoxy group, a methoxyethoxy group, ethoxyethoxy group, a propyloxyethoxy group, isopropyloxyethoxy group, a methoxypropyloxy group, an ethoxypropyloxy group, a propyloxypropyloxy group, an isopropyloxypropyloxy group and the like.

(24) The aryl group represents a cyclic aromatic substituent constituted by a hydrogen atom(s) and a carbon atom(s). Specific examples of the aryl group may include a phenyl group, a naphthyl group and the like.

(25) The heteroaryl group represents a cyclic aromatic substituent containing at least one hetero atom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as a constitutional atom of the ring. Specific examples of the heteroaryl group may include a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, a tetrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group, a thiadiazolyl group, furyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, oxazolyl group, an isoxazolyl group, a triazolyl group, an oxadiazolyl group, a thiadiazolyl group, tetrazolyl group and the like.

(26) The aryloxy group represents a combination of the above-mentioned aryl group and an oxygen atoms a bonding site. Specific examples of the aryloxy group may include a phenoxy group, a naphthyloxy group and the like.

(27) The heteroaryloxy group represents a combination of the above-mentioned heteroaryl group and an oxygen atoms a bonding site. Specific examples of the heteroaryloxy group may include a pyridyloxy group, a pyridazinyloxy group, a pyrimidinyloxy group, a pyrazinyloxy group, a triazinyloxy group, a tetrazinyloxy group, a thienyloxy group, a thiazolyloxy group, an isothiazolyloxy group, a thiadiazolyloxy group, a furyloxy group, a pyrrolyloxy group, an imidazolyloxy group, a pyrazolyloxy group, an oxazolyloxy group, an isoxazolyloxy group, a triazolyloxy group, an oxadiazolyloxy group, a thiadiazolyloxy group, a tetrazolyloxy group and the like.

(28) The aralkyloxy group represents a combination of an aralkyl group resulting from the substitution of the C1-C3 alkyl group with an aryl group such as a phenyl group, a naphthyl group and the like in place of hydrogen atom(s), and an oxygen atom as a bonding site. Specific examples of the aralkyloxy group may include a benzyloxy group, a phenethyloxy group, a phenylpropyloxy group, a naphthalenylmethoxy group, a naphthalenylethoxy group, a naphthalenylpropoxy group and the like.

(29) Specific examples of the 3 to 6 membered ring group containing 1 to 2 oxygen atoms may include a 1,2-epoxyethanyl group, an oxetanyl group, a oxolanyl group, an oxanyl group, a 1,3-dioxolanyl group, a 1,3-dioxanyl group, a 1,4-dioxanyl group and the like.

(30) The pyridone compound of the present invention include those compounds represented by Formula (1) below and salts thereof.

(31) ##STR00019##

(32) In the following, Formula (1) will be described.

(33) R1 in Formula (1) is a hydroxyl group, a cyano group, a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) A, a C2-C6 alkenyl group optionally substituted with substituent(s) A, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) A, a C2-C6 haloalkynyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) A, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) A, a C2-C6 alkenyloxy group optionally substituted with substituent(s) A, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) A, a C3-C6 haloalkynyloxy group or RaRbN— (wherein Ra and Rb each independently represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group or Ra and Rb together with the nitrogen atom to which they are bonded form an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a homopiperidinyl group or an azocanyl group).

(34) Above all, R1 is preferably a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C2-C6 alkenyl group optionally substituted with substituent(s) A, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) A, a C2-C6 haloalkynyl group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove);

(35) R1 is particularly preferably a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove);

(36) and R1 is further preferably a C1-C6 alkyl group, a C1-C6 haloalkyl group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove).

(37) In R1 of Formula (1), a hydroxyl group and a cyano group are contained.

(38) The C1-C6 alkyl group of the “C1-C6 alkyl group optionally substituted with substituent(s) A” in R1 of Formula (1) is the same as defined hereinabove and preferably a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group or an isobutyl group, further preferably a methyl group, an ethyl group or a propyl group and particularly preferably a methyl group or an ethyl group. When it has the substituent(s) A, the C1-C6 alkyl group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(39) The “C1-C6 haloalkyl group” in R1 of Formula (1) is the same as defined hereinabove, preferably a 2-fluoroethyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 3,3-difluoropropyl group or a 3,3,3-trifluoropropyl group, further preferably a 2-fluoroethyl group, a 2,2-difluoroethyl group or a 2,2,2-trifluoroethyl group and particularly preferably a 2,2-difluoroethyl group or a 2,2,2-trifluoroethyl group.

(40) The C3-C8 cycloalkyl group of the “C3-C8 cycloalkyl group optionally substituted with substituent(s) A” in R1 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyl group, a cyclobutyl group, a cyclopentyl group or a cyclohexyl group and further preferably a cyclopropyl group or a cyclobutyl group. When it has the substituent(s) A, the C3-C8 cycloalkyl group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(41) The C2-C6 alkenyl group of the “C2-C6 alkenyl group optionally substituted with substituent(s) A” in R1 of Formula (1) is the same as defined hereinabove, preferably a vinyl group, a 1-propenyl group or an allyl group and further preferably a vinyl group or an allyl group. When it has the substituent(s) A, the C2-C6 alkenyl group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(42) The “C2-C6 haloalkenyl group” in R1 of Formula (1) is the same as defined hereinabove, preferably a 2-fluorovinyl group, a 2,2-difluorovinyl group, a 3-fluoroallyl group or a 3,3-difluoroallyl group and further preferably a 2-fluorovinyl group or a 2,2-difluorovinyl group.

(43) The C2-C6 alkynyl group of “C2-C6 alkynyl group optionally substituted with substituent(s) A” in R1 of Formula (1) is the same as defined hereinabove, preferably a propargyl group, a 2-butynyl group or a 3-butynyl group and further preferably a propargyl group. When it has the substituent(s) A, the C2-C6 alkynyl group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(44) The “C2-C6 haloalkynyl group” in R1 of Formula (1) is the same as defined hereinabove, preferably 4,4-difluoro-2-butynyl group, a 4-chloro-4,4-difluoro-2-butynyl group, a 4-bromo-4,4-difluoro-2-butynyl group or a 4,4,4-trifluoro-2-butynyl group, further preferably a 4,4-difluoro-2-butynyl group or a 4,4,4-trifluoro-2-butynyl group.

(45) The C1-C6 alkoxy group of “C1-C6 alkoxy group optionally substituted with substituent(s) A” in R1 of Formula (1) is the same as defined hereinabove, preferably a methoxy group, an ethoxy group, a propyloxy group, an isopropyloxy group, a butoxy group or an isobutoxy group and further preferably a methoxy group or an ethoxy group.

(46) When it has the substituent(s) A, the C1-C6 alkoxy group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(47) The “C1-C6 haloalkoxy group” in R1 of Formula (1) is the same as defined hereinabove, preferably a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 3,3-difluoropropyloxy group or a 3,3,3-trifluoropropyloxy group and further preferably a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group or a 2,2,2-trifluoroethoxy group.

(48) The C3-C8 cycloalkoxy group of the “C3-C8 cycloalkoxy group optionally substituted with substituent(s) A” in R1 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group or a cyclohexyloxy group and further preferably a cyclopropyloxy group or a cyclobutoxy group. When it has the substituent(s) A, the C3-C8 cycloalkoxy group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(49) The C2-C6 alkenyloxy group of the “C2-C6 alkenyloxy group optionally substituted with substituent(s) A” in R1 of Formula (1) is the same as defined hereinabove, preferably a vinyloxy group, a 1-propenyloxy group or an allyloxy group and further preferably an allyloxy group. When it has the substituent(s) A, a hydrogen atom in the C2-C6 alkenyloxy group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(50) The “C2-C6 haloalkenyloxy group” in R1 of Formula (1) is the same as defined hereinabove, preferably a 2-fluorovinyloxy group, a 2,2-difluorovinyloxy group, a 3-fluoroallyloxy group or a 3,3-difluoroallyloxy group and further preferably a 2-fluorovinyloxy group or a 2,2-difluorovinyloxy group.

(51) The C3-C6 alkynyloxy group of the “C3-C6 alkynyloxy group optionally substituted with substituent(s) A” in R1 of Formula (1) is the same as defined hereinabove, preferably a propargyloxy group, a 2-butynyloxy group or a 3-butynyloxy group and further preferably a propargyloxy group. When it has the substituent(s) A, a hydrogen atom of the C3-C6 alkynyloxy group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(52) The “C3-C6 haloalkynyloxy group” in R1 of Formula (1) is the same as defined hereinabove, preferably a 4,4-difluoro-2-butynyloxy group, a 4-chloro-4,4-difluoro-2-butynyloxy group, a 4-bromo-4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group and further preferably a 4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group.

(53) Each term of the “RaRbN—” (wherein Ra and Rb each independently represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group or Ra and Rb together with the nitrogen atom to which they are bonded form an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a homopiperidinyl group or an azocanyl group.) in R1 of Formula (1) is the same as defined hereinabove. Incidentally, with regard to the “C1-C6 alkyl group optionally substituted with substituent(s) B”, when it has the substituent(s) B, the C1-C6 alkyl group is optionally substituted with the substituent(s) B in place of hydrogen atom(s). Ra and Rb are each preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a pyrrolidinyl group or a piperidinyl group and further preferably a hydrogen atom or a C1-C6 alkyl group optionally substituted with substituent(s) B. The “RaRbN—” is preferably an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group, further preferably an amino group, a methylamino group, a dimethylamino group, an ethylmethylamino group or a diethylamino group and particularly preferably an amino group, a methylamino group or a dimethylamino group.

(54) R2 in Formula (1) represents a hydrogen atom, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) A, a C2-C6 alkenyl group optionally substituted with substituent(s) A, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) A, a C2-C6 haloalkynyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) A, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) A, a C2-C6 alkenyloxy group optionally substituted with substituent(s) A, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) A, a C3-C6 haloalkynyloxy group, Rc-L- (wherein Rc represents a C1-C6 alkyl group or a C1-C6 haloalkyl group and L represents S, SO or SO.sub.2.) or Rx1C(═O)— (wherein Rx1 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove)).

(55) Above all, R2 is preferably a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) A, a C2-C6 haloalkynyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) A, a C1-C6 haloalkoxy group, a C2-C6 alkenyloxy group optionally substituted with substituent(s) A, a C3-C6 alkynyloxy group optionally substituted with substituent(s) A, Rc-L- (wherein Rc and L are the same as defined hereinabove.) or Rx1C(═O)— (wherein Rx1 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove));

(56) R2 is particularly preferably a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) A, a C1-C6 alkoxy group optionally substituted with substituent(s) A or Rx1C(═O)— (wherein Rx1 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove));

(57) and R2 is further preferably a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) A or a C1-C6 alkoxy group optionally substituted with substituent(s) A.

(58) In R2 of Formula (1), a hydrogen atom and a nitro group are contained.

(59) The halogen atom in R2 of Formula (1) is the same as defined hereinabove, preferably a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.

(60) The C1-C6 alkyl group of the “C1-C6 alkyl group optionally substituted with substituent(s) A” in R2 of Formula (1) is the same as defined hereinabove, preferably a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group or an isobutyl group, further preferably a methyl group or an ethyl group and particularly preferably a methyl group. When it has the substituent(s) A, the C1-C6 alkyl group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(61) The “C1-C6 haloalkyl group” in R2 of Formula (1) is the same as defined hereinabove, preferably a difluoromethyl group, a trifluoromethyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 3,3-difluoropropyl group or a 3,3,3-trifluoropropyl group, further preferably a difluoromethyl group, a trifluoromethyl group, a 2,2-difluoroethyl group or a 2,2,2-trifluoroethyl group and particularly preferably a difluoromethyl group or a trifluoromethyl group.

(62) The C3-C8 cycloalkyl group of the “C3-C8 cycloalkyl group optionally substituted with substituent(s) A” in R2 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyl group, a cyclobutyl group, a cyclopentyl group or a cyclohexyl group, and further preferably a cyclopropyl group or a cyclobutyl group. When it has the substituent(s) A, the C3-C8 cycloalkyl group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(63) The C2-C6 alkenyl group of the “C2-C6 alkenyl group optionally substituted with substituent(s) A” in R2 of Formula. (1) is the same as defined hereinabove, preferably a vinyl group, a 1-propenyl group, an allyl group, a 1-butenyl group, a 2-butenyl group or a 3-butenyl group and further preferably a vinyl group, a 1-propenyl group or an allyl group. When it has the substituent(s) A, the C2-C6 alkenyl group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(64) The “C2-C6 haloalkenyl group” in R2 of Formula (1) is the same as defined hereinabove, preferably a 2-fluorovinyl group, a 2,2-difluorovinyl group, a 2,2-dichlorovinyl group, a 3-fluoroallyl group, a 3,3-difluoroallyl group or a 3,3-dichloroallyl group and further preferably a 2-fluorovinyl group or a 2,2-difluorovinyl group.

(65) The C2-C6 alkynyl group of the “C2-C6 alkynyl group optionally substituted with substituent(s) A” in R2 of Formula (1) is the same as defined hereinabove, preferably an ethynyl group, a 1-propynyl group, a propargyl group, a 1-butynyl group, a 2-butynyl group or a 3-butynyl group, further preferably an ethynyl group, a 1-propynyl group or a propargyl group and particularly preferably an ethynyl group. When it has the substituent(s) A, the C2-C6 alkynyl group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(66) The “C2-C6 haloalkynyl group” in R2 of Formula (1) is the same as defined hereinabove, preferably a 3,3-difluoro-1-propynyl group, a 3,3,3-trifluoro-1-propynyl group, a 4,4-difluoro-1-butynyl group, a 4,4-difluoro-2-butynyl group, a 4,4,4-trifluoro-1-butynyl group or a 4,4,4-trifluoro-2-butynyl group and further preferably a 3,3-difluoro-1-propynyl group or a 3,3,3-trifluoro-1-propynyl group.

(67) The C1-C6 alkoxy group of the “C1-C6 alkoxy group optionally substituted with substituent(s) A” in R2 of Formula (1) is the same as defined hereinabove, preferably a methoxy group, an ethoxy group, a propyloxy group, an isopropyloxy group, a butoxy group or an isobutoxy group, further preferably a methoxy group, an ethoxy group, a propyloxy group or an isopropyloxy group and particularly preferably a methoxy group. When it has the substituent(s) A, the C1-C6 alkoxy group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(68) The “C1-C6 haloalkoxy group” in R2 of Formula (1) is the same as defined hereinabove, preferably a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 3,3-difluoropropyloxy group or a 3,3,3-trifluoropropyloxy group and further preferably a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group or a 2,2,2-trifluoroethoxy group.

(69) The C3-C8 cycloalkoxy group of the “C3-C8 cycloalkoxy group optionally substituted with substituent(s) A” in R2 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group or a cyclohexyloxy group and further preferably a cyclopropyloxy group or a cyclobutoxy group. When it has the substituent(s) A, the C3-C8 cycloalkoxy group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(70) The C2-C6 alkenyloxy group of the “C2-C6 alkenyloxy group optionally substituted with substituent(s) A” in R2 of Formula (1) is the same as defined hereinabove, preferably a vinyloxy group, a 1-propenyloxy group, an allyloxy group, a 1-butenyloxy group, a 2-butenyloxy group or a 3-butenyloxy group and further preferably a vinyloxy group, a 1-propenyloxy group or an allyloxy group. When it has the substituent(s) A, the C2-C6 alkenyloxy group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(71) The “C2-C6 haloalkenyloxy group” in R2 of Formula (1) is the same as defined hereinabove and is a 2-fluorovinyloxy group, a 2,2-difluorovinyloxy group, a 2,2-dichlorovinyloxy group, a 3-fluoroallyloxy group, a 3,3-difluoroallyloxy group or a 3,3-dichloroallyloxy group, further preferably a 2-fluorovinyloxy group or a 2,2-difluorovinyloxy group.

(72) The C3-C6 alkynyloxy group of the “C3-C6 alkynyloxy group optionally substituted with substituent(s) A” in R2 of Formula (1) is the same as defined hereinabove, preferably a propargyloxy group, a 2-butynyloxy group or a 3-butynyloxy group and further preferably a propargyloxy group. When it has the substituent(s) A, the C3-C6 alkynyloxy group is optionally substituted with the substituent(s) A in place of hydrogen atom(s).

(73) The “C3-C6 haloalkynyloxy group” in R2 of Formula (1) is the same as defined hereinabove, preferably a 4,4-difluoro-2-butynyloxy group, a 4-chloro-4,4-difluoro-2-butynyloxy group, a 4-bromo-4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group and further preferably a 4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group.

(74) Each term of the “Rc-L-” (wherein Rc represents a C1-C6 alkyl group or a C1-C6 haloalkyl group and L represents S, SO or SO.sub.2.) in R2 of Formula (1) is the same as defined hereinabove. The “Rc-L-” is preferably a methylthio group, a methanesulfinyl group, a methanesulfonyl group, a trifluoromethylthio group, a trifluoromethanesulfinyl group or a trifluoromethanesulfonyl group and further preferably a methylthio group, a methanesulfinyl group or a methanesulfonyl group.

(75) Each term of the “Rx1C(═O)—” (wherein Rx1 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove)) in R2 of Formula (1) is the same as defined hereinabove. Incidentally, with regard to the “C1-C6 alkyl group optionally substituted with substituent(s) B”, when it has the substituent(s) B, the C1-C6 alkyl group is optionally substituted with the substituent(s) B in place of hydrogen atom(s). The Rx1 is preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or C1-C6 alkoxy group, further preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B or C1-C6 alkoxy group and particularly preferably a hydrogen atom. The “Rx1C(═O)—” is a formyl group, an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a propionyl group, a difluoroacetyl group, a trifluoroacetyl group, a cyclopropancarbonyl group, a methoxycarbonyl group, an ethoxycarbonyl group, a 2,2-difluoroethoxycarbonyl group, a 2,2,2-trifluoroethoxycarbonyl group, a 3,3,3-trifluoropropyloxycarbonyl group, a cyclopropyloxycarbonyl group, an aminocarbonyl group, a methylaminocarbonyl group, an ethylaminocarbonyl group, a (methoxymethyl)aminocarbonyl group, a (2-methoxyethyl)aminocarbonyl group, a (cyanomethyl)aminocarbonyl group, a (2-cyanoethyl)aminocarbonyl group, a dimethylaminocarbonyl group, an ethylmethylaminocarbonyl group, a diethylaminocarbonyl group, a (methoxymethyl)methylaminocarbonyl group, a (2-methoxyethyl)-methylaminocarbonyl group, a (cyanomethyl)methylaminocarbonyl group, a (2-cyanoethyl)methylaminocarbonyl group, a 2,2-difluoroethylaminocarbonyl group, a 2,2,2-trifluoroethylaminocarbonyl group, a cyclopropylaminocarbonyl group, a (cyclopropyl)methylaminocarbonyl group, a pyrrolidinylcarbonyl group, a piperidinylcarbonyl group and the like. The “Rx1C(═O)—” is preferably a formyl group, an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a propionyl group, a difluoroacetyl group, a trifluoroacetyl group, a methoxycarbonyl group or an ethoxycarbonyl group, further preferably a formyl group, an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a methoxycarbonyl group or an ethoxycarbonyl group and particularly preferably a formyl group.

(76) In Formula (1), Het represents a 5 to 6-membered heterocyclic group or the 8 to 10-membered heterocyclic group.

(77) The 5 to 6-membered heterocyclic group or the 8 to 10-membered heterocyclic group is optionally substituted with 0 to 6 substituents R3 (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent).

(78) Specific examples of the 5 to 6-membered heterocyclic group may include a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, a tetrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group, a thiadiazolyl group, a thiatriazolyl group, a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, a pentazolyl group, a furyl group, an oxazolyl group or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms and the like.

(79) Specific examples of the 8 to 10-membered heterocyclic group may include an indolyl group, an isoindolyl group, an indazolyl group, a benzimidazolyl group, a benzotriazolyl group, a benzofuryl group, an isobenzofuryl group, a benzoxazolyl group, a benzothienyl group, benzothiazolyl group, a benzisothiazolyl group, a benzothiadiazolyl group, an indolidinyl group, an imidazopyridyl group, a pyrazolopyridyl group, a triazolopyridyl group, a pyrrolopyrimidinyl group, an imidazopyrimidinyl group, a pyrazolopyrimidinyl group, a triazolopyrimidinyl group, a pyrrolopyrazinyl group, an imidazopyrazinyl group, a pyrazolopyrazinyl group, a triazolopyrazinyl group, a quinolyl group, an isoquinolyl group, a cinnolyl group, a phthalazinyl group, a quinoxalynyl group, a quinazolynyl group or a naphthylidinyl group and the like.

(80) Above all, Het is preferably a 5 to 6-membered heterocyclic group, and is specifically preferably a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, a tetrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group, a thiadiazolyl group, a thiatriazolyl group, a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, a pentazolyl group, a furyl group, an oxazolyl group or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms; and

(81) Het is particularly preferably a pyridyl group, a thienyl group, a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group or a 3 to 6-membered ring, group containing 1 to 2 oxygen atoms.

(82) Het is further preferably a pyridyl group, a thienyl group, a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, an oxazolyl group or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms.

(83) The pyridyl group, the pyridazinyl group, the pyrimidinyl group, the pyrazinyl group, the triazinyl group or the tetrazinyl group is optionally substituted with 0 to 4 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(84) The thienyl group, the thiazolyl group, the isothiazolyl group, the thiadiazolyl group or the thiatriazolyl group is optionally substituted with 0 to 3 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(85) The pyrrolyl group, the pyrazolyl group, the imidazolyl group, the triazolyl group, the tetrazolyl group or the pentazolyl group is optionally substituted with 0 to 4 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(86) The furyl group or the oxazolyl group is optionally substituted with 0 to 3 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(87) The indolyl group, the isoindolyl group, the indazolyl group, the benzimidazolyl group or the benzotriazolyl group is optionally substituted with 0 to 6 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(88) The benzofuryl group, the isobenzofuryl group or the benzoxazolyl group is optionally substituted with 0 to 5 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(89) The benzothienyl group, the benzothiazolyl group, the benzisothiazolyl group or the benzothiadiazolyl group is optionally substituted with 0 to 5 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(90) The indolidinyl group, the imidazopyridyl group, the pyrazolopyridyl group or the triazolopyridyl group is optionally substituted with 0 to 6 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(91) The pyrrolopyrimidinyl group, the imidazopyrimidinyl group, the pyrazolopyrimidinyl group, the triazolopyrimidinyl group, the pyrrolopyrazinyl group, the imidazopyrazinyl group, the pyrazolopyrazinyl group or the triazolopyrazinyl group is optionally substituted with 0 to 5 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(92) The quinolyl group, the isoquinolyl group, the cinnolyl group, the phthalazinyl group, the quinoxalynyl group, the quinazolynyl group or the naphthylidinyl group is optionally substituted with 0 to 6 substituents R3. (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent.)

(93) R3 represents a hydroxyl group, a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) C, a C2-C6 haloalkynyl group, a CL-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, a C3-C6 haloalkynyloxy group, an aryl group optionally substituted with substituent(s) D, a heteroaryl group optionally substituted with substituent(s) D, an aryloxy group optionally substituted with substituent(s) D, a heteroaryloxy group optionally substituted with substituent(s) D, an aralkyloxy group optionally substituted with substituent(s) D, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove),

(94) Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove), Rx1C(═O)O— (wherein Rx1 is the same as defined hereinabove), Rx2C(═O)N(Rx3)- (wherein Rx2 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rx3 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group), Rx4Rx5C═N—O— (wherein Rx4 and Rx5 each independently represent a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove)) or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms.

(95) Above all, R3 is preferably a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 alkynyl group optionally substituted with substituent(s) C, a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove), Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove), Rx1C(═O)O— (wherein Rx1 is the same as defined hereinabove.) or Rx2C(═O)N(Rx3)- (wherein Rx2 and Rx3 are the same as defined hereinabove); R3 is particularly preferably a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) C, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove.) or Rx2C(═O)N(Rx3)- (wherein Rx2 and Rx3 are the same as defined hereinabove);

(96) and R3 is further preferably a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) C, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), or Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove).

(97) In R3 of Formula (1), a hydroxyl group, a cyano group and a nitro group are contained.

(98) The halogen atom in R3 of Formula (1) is the same as defined hereinabove, preferably a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.

(99) The C1-C6 alkyl group of the “C1-C6 alkyl group optionally substituted with substituent(s) C” in R3 of Formula (I) is the same as defined hereinabove, preferably a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group or an isobutyl group, further preferably a methyl group, an ethyl group or a propyl group and particularly preferably a methyl group. When it has the substituent(s) C, the C1-C6 alkyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(100) The “C1-C6 haloalkyl group” in R3 of Formula (1) is the same as defined hereinabove, preferably a monofluoromethyl group, a monochloromethyl group, a monobromomethyl group, a difluoromethyl group, a trifluoromethyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 3,3-difluoropropyl group or a 3,3,3-trifluoropropyl group, further preferably a monobromomethyl group, a difluoromethyl group, a trifluoromethyl group, a 2,2-difluoroethyl group or a 2,2,2-trifluoroethyl group and particularly preferably monobromomethyl group, a difluoromethyl group or a trifluoromethyl group.

(101) The C3-C8 cycloalkyl group of the “C3-C8 cycloalkyl group optionally substituted with substituent(s) C” in R3 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyl group, a cyclobutyl group, a cyclopentyl group or a cyclohexyl group, further preferably a cyclopropyl group or a cyclobutyl group. When it has the substituent(s) C, the C3-C8 cycloalkyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(102) The C2-C6 alkenyl group of the “C2-C6 alkenyl group optionally substituted with substituent(s) C” in R3 of Formula (1) is the same as defined hereinabove, preferably a vinyl group, a 1-propenyl group, an allyl group, a 1-butenyl group, a 2-butenyl group or a 3-butenyl group and further preferably a vinyl group, a 1-propenyl group or an allyl group. When it has the substituent(s) C, the C2-C6 alkenyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(103) The “C2-C6 haloalkenyl group” in R3 of Formula (1) is the same as defined hereinabove, preferably a 2-fluorovinyl group, a 2,2-difluorovinyl group, a 2,2-dichlorovinyl group, a 3-fluoroallyl group, a 3,3-difluoroallyl group or a 3,3-dichloroallyl group and further preferably a 2-fluorovinyl group or a 2,2-difluorovinyl group.

(104) The C2-C6 alkynyl group of the “C2-C6 alkynyl group optionally substituted with substituent(s) C” in R3 of Formula (1) is the same as defined hereinabove, preferably an ethynyl group, a 1-propynyl group, a propargyl group, a 1-butynyl group, a 2-butynyl group or a 3-butynyl group and further preferably an ethynyl group, a 1-propynyl group or a propargyl group. When it has the substituent(s) C, the C2-C6 alkynyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(105) The “C2-C6 haloalkynyl group” in R3 of Formula (1) is the same as defined hereinabove, preferably a 3,3-difluoro-1-propynyl group, a 3,3,3-trifluoro-1-propynyl group, a 4,4-difluoro-1-butynyl group, a 4,4-difluoro-2-butynyl group, a 4,4,4-trifluoro-1-butynyl group or a 4,4,4-trifluoro-2-butynyl group and further preferably a 3,3-difluoro-1-propynyl group or a 3,3,3-trifluoro-1-propynyl group.

(106) The C1-C6 alkoxy group of the “C1-C6 alkoxyl group optionally substituted with substituent(s) C” in R3 of Formula (1) is the same as defined hereinabove, preferably a methoxy group, an ethoxy group, a propyloxy group, an isopropyloxy group, a butoxy group or an isobutoxy group, further preferably a methoxy group, an ethoxy group, a propyloxy group or an isopropyloxy group and particularly preferably a methoxy group. When it has the substituent(s) C, the C1-C6 alkoxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(107) The “C1-C6 haloalkoxy group” in R3 of Formula (1) is the same as defined hereinabove, preferably a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 3,3-difluoropropyloxy group or a 3,3,3-trifluoropropyloxy group and further preferably a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group or a 2,2,2-trifluoroethoxy group.

(108) The C3-C8 cycloalkoxy group of the “C3-C8 cycloalkoxy group optionally substituted with substituent(s) C” in R3 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group or a cyclohexyloxy group and further preferably a cyclopropyloxy group or a cyclobutoxy group. When it has the substituent(s) C, the C3-C8 cycloalkoxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(109) The C2-C6 alkenyloxy group of the “C2-C6 alkenyloxy group optionally substituted with substituent(s) C” in R3 of Formula (1) is the same as defined hereinabove, preferably a vinyloxy group, a 1-propenyloxy group, an allyloxy group, a 1-butenyloxy group, a 2-butenyloxy group or a 3-butenyloxy group and further preferably a vinyloxy group, a 1-propenyloxy group or an allyloxy group. When it has the substituent(s) C, the C2-C6 alkenyloxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(110) The “C2-C6 haloalkenyloxy group” in R3 of Formula (1) is the same as defined hereinabove, preferably a 2-fluorovinyloxy group, a 2,2-difluorovinyloxy group, a 2,2-dichlorovinyloxy group, a 3-fluoroallyloxy group, a 3,3-difluoroallyloxy group or a 3,3-dichloroallyloxy group and further preferably a 2-fluorovinyloxy group or a 2,2-difluorovinyloxy group.

(111) The C3-C6 alkynyloxy group of the “C3-C6 alkynyloxy group optionally substituted with substituent(s) C” in R3 of Formula (1) is the same as defined hereinabove, preferably a propargyloxy group, a 2-butynyloxy group or a 3-butynyloxy group and further preferably a propargyloxy group. When it has the substituent(s) C, the C3-C6 alkynyloxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(112) The “C3-C6 haloalkynyloxy group” in R3 of Formula (1) is the same as defined hereinabove, preferably a 4,4-difluoro-2-butynyloxy group, a 4-chloro-4,4-difluoro-2-butynyloxy group, a 4-bromo-4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group and further preferably a 4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group.

(113) The aryl group of the “aryl group optionally substituted with substituent(s) D” in R3 of Formula (1) is the same as defined hereinabove, preferably phenyl group. When it has the substituent(s) D, the aryl group is optionally substituted with the substituent(s) D in place of hydrogen(s).

(114) The heteroaryl group of the “heteroaryl group optionally substituted with substituent(s) D” in R3 of Formula (1) is the same as defined hereinabove, preferably a pyridyl group, a pyrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group, furyl group, an imidazolyl group, a pyrazolyl group, oxazolyl group, an isoxazolyl group, a triazolyl group, an oxadiazolyl group or a tetrazolyl group and further preferably a pyridyl group, an imidazolyl group, a pyrazolyl group, triazolyl group or a tetrazolyl group. When it has the substituent(s) D, the heteroaryl group is optionally substituted with the substituent(s) D in place of hydrogen(s).

(115) The aryloxy group of the “aryloxy group optionally substituted with substituent(s) D” in R3 of Formula (1) is the same as defined hereinabove, preferably a phenoxy group or a naphthyloxy group and further preferably a phenoxy group. When it has the substituent(s) D, the aryloxy group is optionally substituted with the substituent(s) D in place of hydrogen atom(s).

(116) The heteroaryloxy group of the “heteroaryloxy group optionally substituted with substituent(s) D” in R3 of Formula (1) is the same as defined hereinabove, preferably a pyridyloxy group, a pyridazinyloxy group, a pyrimidinyloxy group, a pyrazinyloxy group, a pyrazolyloxy group, a triazinyloxy group, a tetrazinyloxy group, a thienyloxy group, a thiazolyloxy group, an isothiazolyloxy group or a thiadiazolyloxy group and further preferably a pyridyloxy group, a pyridazinyloxy group, a pyrimidinyloxy group, a pyrazinyloxy group or a pyrazolyloxy group. When it has the substituent(s) D, the heteroaryloxy group is optionally substituted with the substituent(s) D in place of hydrogen atom(s).

(117) The aralkyloxy group of the “aralkyloxy group optionally substituted with substituent(s) D” in R3 of Formula (1) is the same as defined hereinabove, preferably a benzyloxy group, a phenethyloxy group or a phenylpropyloxy group and further preferably a benzyloxy group or a phenethyloxy group. When it has the substituent(s) D, the aralkyloxy group is optionally substituted with the substituent(s) D in place of hydrogen atom(s).

(118) Ra and Rb of “RaRbN—” in R3 of Formula (1) are the same as defined hereinabove. Ra and Rb are each preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, pyrrolidinyl group or a piperidinyl group and further preferably a hydrogen atom or a C1-C6 alkyl group optionally substituted with substituent(s) B. The “RaRbN—” is preferably an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group, further preferably an amino group, a methylamino group, a dimethylamino group, an ethylmethylamino group or a diethylamino group and particularly preferably an amino group, a methylamino group or a dimethylamino group.

(119) Rc and L of “Rc-L-” in R3 of Formula (1) are the same as defined hereinabove. The “Rc-L-” is preferably a methylthio group, a methanesulfinyl group, a methanesulfonyl group, a trifluoromethylthio group, a trifluoromethanesulfinyl group or a trifluoromethanesulfonyl group and further preferably a methylthio group, a methanesulfinyl group or a methanesulfonyl group.

(120) Rx1 of “Rx1C(═O)—” in R3 of Formula (1) is the same as defined hereinabove. Rx1 is preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or C1-C6 alkoxy group, further preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B or C1-C6 alkoxy group and particularly preferably a hydrogen atom. The “Rx1C(═O)—” is preferably a formyl group, an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a propionyl group, a difluoroacetyl group, a trifluoroacetyl group, a cyclopropancarbonyl group, a methoxycarbonyl group, an ethoxycarbonyl group, a 2,2-difluoroethoxycarbonyl group, a 2,2,2-trifluoroethoxycarbonyl group, a 3,3,3-trifluoropropyloxycarbonyl group, a cyclopropyloxycarbonyl group, an aminocarbonyl group, a methylaminocarbonyl group, an ethylaminocarbonyl group, a (methoxymethyl)aminocarbonyl group, a (2-methoxyethyl)aminocarbonyl group, a (cyanomethyl)aminocarbonyl group, a (2-cyanoethyl)aminocarbonyl group, a dimethylaminocarbonyl group, an ethylmethylaminocarbonyl group, a diethylaminocarbonyl group, a (methoxymethyl)methylaminocarbonyl group, a (2-methoxyethyl)methylaminocarbonyl group, a (cyanomethyl)methylaminocarbonyl group, a (2-cyanoethyl)methylaminocarbonyl group, a 2,2-difluoroethylaminocarbonyl group, a 2,2,2-trifluoroethylaminocarbonyl group, a cyclopropylaminocarbonyl group, a (cyclopropyl)methylaminocarbonyl group, a pyrrolidinylcarbonyl group or a piperidinylcarbonyl group, further preferably a formyl group, an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a propionyl group, a difluoroacetyl group, a trifluoroacetyl group, a methoxycarbonyl group, an ethoxycarbonyl group and particularly preferably a formyl group or an ethoxycarbonyl group.

(121) Rx1 of “Rx1C(═O)O—” in R3 of Formula (1) is the same as defined hereinabove. The “Rx1C(═O)O—” is preferably a formyloxy group, an acetyloxy group, a methoxyacetyloxy group, a cyanoacetyloxy group, a propionyloxy group, a difluoroacetyloxy group, a trifluoroacetyloxy group, a cyclopropancarbonyloxy group, a methoxycarbonyloxy group, an ethoxycarbonyloxy group, a 2,2-difluoroethoxycarbonyloxy group, a 2,2,2-trifluoroethoxycarbonyloxy group, a 3,3,3-trifluoropropyloxycarbonyloxy group, a cyclopropyloxycarbonyloxy group, an aminocarbonyloxy group, a methylaminocarbonyloxy group, an ethylaminocarbonyloxy group, a (methoxymethyl)aminocarbonyloxy group, a (2-methoxyethyl)aminocarbonyloxy group, a (cyanomethyl)aminocarbonyloxy group, a (2-cyanoethyl)aminocarbonyloxy group, a dimethylaminocarbonyloxy group, an ethylmethylaminocarbonyloxy group, a diethylaminocarbonyloxy group, a (methoxymethyl)methylaminocarbonyloxy group, a (2-methoxyethyl)methylaminocarbonyloxy group, a (cyanomethyl)methylamino-carbonyloxy group, a (2-cyanoethyl)methylaminocarbonyloxy group, a 2,2-difluoroethylaminocarbonyloxy group, a 2,2,2-trifluoroethylaminocarbonyloxy group, a cyclopropylaminocarbonyloxy group, a (cyclopropyl)methylaminocarbonyloxy group, a pyrrolidinylcarbonyloxy group or a piperidinylcarbonyloxy group and further preferably a formyloxy group, an acetyloxy group or a trifluoroacetyloxy group.

(122) Each term of “Rx2C(═O)N(Rx3)-” (wherein Rx2 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rx3 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group.) in R3 of Formula (1) is the same as defined hereinabove. Incidentally, with regard to the “C1-C6 alkyl group optionally substituted with substituent(s) B”, when it has the substituent(s) B, the C1-C6 alkyl group is optionally substituted with the substituent(s) B in place of hydrogen atom(s). The Rx2 is preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C1-C6 alkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove.) and further preferably a C1-C6 alkyl group optionally substituted with substituent(s) B. The Rx3 is preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B or C1-C6 haloalkyl group and further preferably a hydrogen atom. Specific examples of the Rx2 is preferably a hydrogen atom, a methyl group, a methoxymethyl group, a cyanomethyl group, an ethyl group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a methoxy group, an ethoxy group, a 2,2-difluoroethoxy, a 2,2,2-trifluoroethoxy group, a cyclopropyloxy group, an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group, further preferably a hydrogen atom, a methyl group, a methoxymethyl group, a cyanomethyl group, a difluoromethyl group, a trifluoromethyl group, a methoxy group, an ethoxy group, an amino group, a dimethylamino group, an ethylmethylamino group or a diethylamino group and particularly preferably a methyl group. Also, specific examples of the Rx3 is preferably a hydrogen atom, a methyl group, a methoxymethyl group, an ethoxymethyl group, a cyanomethyl group, an ethyl group, a 2-methoxyethyl group, a 2-ethoxyethyl group, a 2-cyanoethyl group, a propyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group or a cyclopropyl group, further preferably a hydrogen atom, a methyl group, a methoxymethyl group, a cyanomethyl group, an ethyl group, a 2-methoxyethyl group, a 2,2-difluoroethyl group or a 2,2,2-trifluoroethyl group and particularly preferably a hydrogen atom. Further, the “Rx2C(═O)N(Rx3)-” is preferably an acetylamide group, a 2,2,2-trifluoroacetylamide group, a methylcarbamate group or an ethylcarbamate group and further preferably an acetylamide group.

(123) Each term of the “Rx4Rx5C═N—O—” (wherein Rx4 and Rx5 each independently represent a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove)) in R3 of Formula (1) is the same as defined hereinabove. Incidentally, with regard to the “C1-C6 alkyl group optionally substituted with substituent(s) B”, when it has the substituent(s) B, the C1-C6 alkyl group is optionally substituted with the substituent(s) B in place of hydrogen atom(s).

(124) Rx4 and Rx5 are each preferably a methyl group, an ethyl group, a propyl group, an isopropyl group, a trifluoromethyl group, a 2,2,2-trifluoroethyl group, a cyclopropyl group, a cyclopentyl group, a cyclohexyl group, a methoxy group, an ethoxy group, isopropyloxy group, a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group and further preferably a methyl group, an ethyl group, a trifluoromethyl group, a 2,2,2-trifluoroethyl group, a methoxy group, an ethoxy group, a 2,2,2-trifluoroethoxy group, a dimethylamino group, an ethylmethylamino group or a diethylamino group.

(125) The “3 to 6 membered ring group containing 1 to 2 oxygen atoms” in R3 of Formula (1) is the same as defined hereinabove, preferably an oxolanyl group, an oxanyl group, a 1,3-dioxolanyl group or a 1,3-dioxanyl group and further preferably a 1,3-dioxolanyl group or a 1,3-dioxanyl group.

(126) In the following, Het in Formula (1) will be described in detail.

(127) A) When Het is a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group or tetrazinyl group, Het represents a partial structure represented by Formula (a)

(128) ##STR00020##
(wherein R3 is the same as defined hereinabove and “na” represents an integer of 0 to 4).

(129) G1, G2, G3, G4 and G5 in Formula (a) are each independent and represent a carbon atom or a nitrogen atom. With the proviso that at least one among G1, G2, G3, G4 and G5 is a nitrogen atom. Preferred G1, G2, G3, G4 and G5 are that any one of G1, G2, G3, G4 and G5 is a nitrogen atom. That is, it is a pyridyl group.

(130) “na” in Formula (a) represents an integer of 0 to 4.

(131) When “na” in Formula (a) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(132) Specific examples of the partial structures of Formula (a) are illustrated below.

(133) ##STR00021## ##STR00022##

(134) Among the partial structures of Formula (a), preferable specific examples are shown below.

(135) ##STR00023##

(136) Among the partial structures of Formula (a), more preferable specific examples are shown below.

(137) ##STR00024##

(138) Among the partial structures of Formula (a), particularly preferable specific examples are shown below.

(139) ##STR00025##

(140) B) When Het is a thienyl group, a thiazolyl group, an isothiazolyl group, a thiadiazolyl group or a thiatriazolyl group, Het represents a partial structure represented by Formula (b-1)

(141) ##STR00026##
or Formula (b-2)

(142) ##STR00027##
(wherein R3 is the same as defined hereinabove and “nb” represents an integer of 0 to 3).

(143) G6, G7 and G8 in Formula (b-1) and Formula (b-2) are each independent and represent a carbon atom or a nitrogen atom.

(144) “nb” in Formula (b-1) and Formula (b-2) represents an integer of 0 to 3.

(145) When “nb” in Formula (b-1) and Formula (b-2) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(146) Specific examples of the partial structure of Formula (b-1) are shown below.

(147) ##STR00028##

(148) Among the partial structures of Formula (b-1), preferable specific examples are shown below.

(149) ##STR00029##

(150) Among the partial structures of Formula (b-1), more preferable specific examples are shown below.

(151) ##STR00030##

(152) Specific examples of the partial structure of Formula (b-2) are shown below.

(153) ##STR00031##

(154) Among the partial structures of Formula (b-2), preferable specific examples are shown below.

(155) ##STR00032##

(156) Among the partial structures of Formula (b-2), more preferable specific examples are shown below.

(157) ##STR00033##

(158) C) When Het is a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group or a pentazolyl group, Het represents a partial structure represented by

(159) ##STR00034##
(wherein R3 is the same as defined hereinabove and “nc” represents an integer of 0 to 4).

(160) G9, G10, G11 and G12 in Formula (c-1), Formula (c-2) and Formula (c-3) are each independent and represent a carbon atom or a nitrogen atom.

(161) “nc” in Formula (c-1), Formula (c-2) and Formula (c-3) represents an integer of 0 to 4.

(162) When “nc” in Formula (c-1), Formula (c-2) and Formula (c-3) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(163) Specific examples of the partial structure of Formula (c-1) are shown below.

(164) ##STR00035##

(165) Among the partial structures of Formula (c-1), preferable specific examples are shown below.

(166) ##STR00036##

(167) Among the partial structures of Formula (c-1), more preferable specific examples are shown below.

(168) ##STR00037##

(169) Among the partial structures of Formula (c-1), particularly preferable specific examples are shown below.

(170) ##STR00038##

(171) Specific examples of the partial structure of Formula (c-2) are shown below.

(172) ##STR00039##

(173) Among the partial structures of Formula (c-2), preferable specific examples are shown below.

(174) ##STR00040##

(175) Among the partial structures of Formula (c-2), more preferable specific examples are shown below.

(176) ##STR00041##

(177) Among the partial structures of Formula (c-2), particularly preferable specific examples are shown below.

(178) ##STR00042##

(179) Specific examples of the partial structure of Formula (c-3) are shown below.

(180) ##STR00043##

(181) Among the partial structures of Formula (c-3), preferable specific examples are shown below.

(182) ##STR00044##

(183) Among the partial structures of Formula (c-3), more preferable specific examples are shown below.

(184) ##STR00045##

(185) Among the partial structures of Formula (c-3), particularly preferable specific examples are shown below.

(186) ##STR00046##

(187) D) When Het is a furyl group or an oxazolyl group, Het represents a partial structure represented by Formula (d-1)

(188) ##STR00047##
or Formula (d-2)

(189) ##STR00048##
(wherein R3 is the same as defined hereinabove and “nd” represents an integer of 0 to 3).

(190) G13 and G14 in Formula (d-1) and Formula (d-2) are each independent and represent a carbon atom or a nitrogen atom.

(191) “nd” in Formula (d-1) and Formula (d-2) represents an integer of 0 to 3.

(192) When “nd” in Formula (d-1) and Formula (d-2) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(193) Specific examples of the partial structure of Formula (d-1) are shown below.

(194) ##STR00049##

(195) Among the partial structures of Formula (d-1), preferable specific examples are shown below.

(196) ##STR00050##

(197) Among the partial structures of Formula (d-1), more preferable specific examples are shown below.

(198) ##STR00051##

(199) Specific examples of the partial structure of Formula (d-2) are shown below.

(200) ##STR00052##

(201) Among the partial structures of Formula (d-2), preferable specific examples are shown below.

(202) ##STR00053##

(203) E) When Het is an indolyl group, an isoindolyl group, an indazolyl group, a benzimidazolyl group or a benzotriazolyl group, Het represents a partial structure represented by Formula (e-1)

(204) ##STR00054##
or Formula (e-2)

(205) ##STR00055##
(wherein R3 is the same as defined hereinabove and “ne” represents an integer of 0 to 6).

(206) G15 and G16 in Formula (e-1) and Formula (e-2) are each independent and represent a carbon atom or a nitrogen atom.

(207) “ne” in Formula (e-1) and Formula (e-2) represents an integer of 0 to 6.

(208) When “ne” in Formula (e-1) and Formula (e-2) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(209) Specific examples of the partial structure of Formula (e-1) are shown below.

(210) ##STR00056## ##STR00057##

(211) Specific examples of the partial structure of Formula (e-2) are shown below.

(212) ##STR00058##

(213) F) when Het is a benzofuryl group, an isobenzofuryl group or a benzoxazolyl group, Het represents a partial structure represented by Formula (f-1)

(214) ##STR00059##
or Formula (f-2)

(215) ##STR00060##
(wherein R3 is the same as defined hereinabove and “nf” represents an integer of 0 to 5).

(216) G17 in Formula (f-1) represents a carbon atom or a nitrogen atom.

(217) “nf” in Formula (f-1) and Formula (f-2) represents an integer of 0 to 5.

(218) When “nf” in Formula (f-1) and Formula (f-2) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(219) Specific examples of the partial structure of Formula (f-1) are shown below.

(220) ##STR00061##

(221) Specific examples of the partial structure of Formula (f-2) are shown below.

(222) ##STR00062##

(223) G) When Het is a benzothienyl group, benzothiazolyl group, a benzisothiazolyl group or a benzothiadiazolyl group, Het represents a partial structure represented by Formula (g-1)

(224) ##STR00063##
or Formula (g-2)

(225) ##STR00064##
(wherein R3 is the same as defined hereinabove and “ng” represents an integer of 0 to 5).

(226) G18 and G19 in Formula (g-1) and Formula (g-2) are each independent and represent a carbon atom or a nitrogen atom.

(227) “ng” in Formula (g-1) and Formula (g-2) represents an integer of 0 to 5.

(228) When “ng” in Formula (g-1) and Formula (g-2) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(229) Specific examples of the partial structure of Formula (g-1) are shown below.

(230) ##STR00065## ##STR00066##

(231) Specific examples of the partial structure of Formula (g-2) are shown below.

(232) ##STR00067##

(233) H) When Het is an indolidinyl group, an imidazopyridyl group, a pyrazolopyridyl group or a triazolopyridyl group, Het represents a partial structure represented by Formula (h-1)

(234) ##STR00068##
(wherein R3 is the same as defined hereinabove and “nh” represents an integer of 0 to 6).

(235) G20, G21 and G22 in Formula (h-1) are each independent and represent a carbon atom or a nitrogen atom.

(236) “nh” in Formula (h-1) represents an integer of 0 to 6.

(237) When “nh” in Formula (h-1) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(238) Specific examples of the partial structure of Formula (h-1) are shown below.

(239) ##STR00069## ##STR00070## ##STR00071## ##STR00072##

(240) I) When Het is a pyrrolopyrimidinyl group, an imidazopyrimidinyl group, a pyrazolopyrimidinyl group, a triazolopyrimidinyl group, a pyrrolopyrazinyl group, an imidazopyrazinyl group, a pyrazolopyrazinyl group or a triazolopyrazinyl group, Het represents a partial structure represented by

(241) ##STR00073##
(wherein R3 is the same as defined hereinabove and “ni” represents an integer of 0 to 5).

(242) G23, G24 and G25 in Formula (i-1), Formula (i-2) and Formula (i-3) are each independent and represent a carbon atom or a nitrogen atom.

(243) “ni” in Formula (i-1), Formula (i-2) and Formula (i-3) represents an integer of 0 to 5.

(244) When “ni” in Formula (i-1), Formula (i-2) and Formula (i-3) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(245) Specific examples of the partial structure of Formula (i-1) are shown below.

(246) ##STR00074## ##STR00075## ##STR00076##

(247) Specific examples of the partial structure of Formula (i-2) are shown below.

(248) ##STR00077## ##STR00078## ##STR00079## ##STR00080##

(249) Specific examples of the partial structure of Formula (i-3) are shown below.

(250) ##STR00081## ##STR00082## ##STR00083##

(251) J) When Het is a quinolyl group, an isoquinolyl group, a cinnolyl group, a phthalazinyl group, a quinoxalynyl group, a quinazolynyl group or a naphthylidinyl group, Het represents a partial structure represented by Formula (j-1)

(252) ##STR00084##
or Formula (j-2)

(253) ##STR00085##
(wherein R3 is the same as defined hereinabove and “nj” represents an integer of 0 to 6).

(254) G26, G27, G28 and G29 in Formula (j-1) and Formula (j-2) are each independent and represent a carbon atom or a nitrogen atom. With the proviso that at least one among G26, G27, G28 and G29 is a nitrogen atom. Preferred G26, G27, G28 and G29 are that any one of G26, G27, G28 and G29 is a nitrogen atom. That is, it is a quinolyl group.

(255) “nj” in Formula (j-1) and Formula (j-2) represents an integer of 0 to 6.

(256) When “nj” in Formula (j-1) and Formula (j-2) is 2 or more, the two or more substituents R3 are independent of one another and may be selected appropriately to be the same as or different from one another.

(257) Specific examples of the partial structures of Formula (j-1) are illustrated below.

(258) ##STR00086## ##STR00087## ##STR00088##

(259) Specific examples of the partial structures of Formula (j-2) are illustrated below.

(260) ##STR00089##

(261) N) When. Het is the “3 to 6 membered ring group containing 1 to 2 oxygen atoms”, Het represents a 1,2-epoxyethanyl group, an oxetanyl group, a oxolanyl group, an oxanyl group, a 1,3-dioxolanyl group, a 1,3-dioxanyl group or a 1,4-dioxanyl group. Above all, an oxolanyl group, an oxanyl group, a 1,3-dioxolanyl group, a 1,3-dioxanyl group or a 1,4-dioxanyl group is preferable, and in particular, a 1,3-dioxolanyl group or a 1,3-dioxanyl group is preferable.

(262) Y in Formula (1) represents a phenyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, a tetrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group or a thiadiazolyl group. Above all, a phenyl group or a pyridyl group is preferable, and in particular, a phenyl group is preferable.

(263) The phenyl group is substituted with R4 at an ortho position and is further optionally substituted with 0 to 4 substituents R5. (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent.)

(264) the pyridyl group, the pyridazinyl group, the pyrimidinyl group, the pyrazinyl group, the triazinyl group or the tetrazinyl group is substituted with R4 at an ortho position and is further optionally substituted with 0 to 3 substituents R5. (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent.)

(265) the thienyl group, the thiazolyl group, the isothiazolyl group or the thiadiazolyl group is substituted with R4 at an ortho position and is further optionally substituted with 0 to 2 substituents R5. (with the proviso that when two substituents R5 are present, each R5 represents an independent substituent.)

(266) R4 in Formula (1) represents a hydroxyl group, a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) C, a C2-C6 haloalkynyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, a C3-C6 haloalkynyloxy group, an aryl group optionally substituted with substituent(s) D, a heteroaryl group optionally substituted with substituent(s) D, an aryloxy group optionally substituted with substituent(s) D, a heteroaryloxy group optionally substituted with substituent(s) D, an aralkyloxy group optionally substituted with substituent(s) D, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove), Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove), Rx1C(═O)O— (wherein Rx1 is the same as defined hereinabove), Rx2C(═O)N(Rx3)- (wherein Rx2 and Rx3 are the same as defined hereinabove), Rx4Rx5C═N—O— (wherein Rx4 and Rx5 are the same as defined hereinabove.) or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms.

(267) Above all, R4 is preferably a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) C or C1-C6 haloalkoxy group;

(268) R4 is particularly preferably a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group or a C1-C6 alkoxyl group optionally substituted with substituent(s) C;

(269) and R4 is further preferably a cyano group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group or a C1-C6 alkoxyl group optionally substituted with substituent(s) C.

(270) In R4 of Formula (1), a hydroxyl group, a cyano group and a nitro group are contained.

(271) The halogen atom in R4 of Formula (1) is the same as defined hereinabove, preferably a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, and further preferably a fluorine atom, a chlorine atom or a bromine atom.

(272) The C1-C6 alkyl group of the “C1-C6 alkyl group optionally substituted with substituent(s) C” in R4 of Formula (1) is the same as defined hereinabove, preferably a methyl group, an ethyl group, a propyl group or an isopropyl group, further preferably a methyl group, an ethyl group or a propyl group, and particularly preferably a methyl group or an ethyl group. When it has the substituent(s) C, the C1-C6 alkyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(273) The “C1-C6 haloalkyl group” in R4 of Formula (1) is the same as defined hereinabove, preferably a difluoromethyl group, a trifluoromethyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 3,3-difluoropropyl group or a 3,3,3-trifluoropropyl group, further preferably a difluoromethyl group or a trifluoromethyl group, and particularly preferably a trifluoromethyl group.

(274) The C3-C8 cycloalkyl group of the “C3-C8 cycloalkyl group optionally substituted with substituent(s) C” in R4 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyl group, a cyclobutyl group, a cyclopentyl group or a cyclohexyl group, and further preferably a cyclopropyl group or a cyclobutyl group. When it has the substituent(s) C, the C3-C8 cycloalkyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(275) The C2-C6 alkenyl group of the “C2-C6 alkenyl group optionally substituted with substituent(s) C” in R4 of Formula (1) is the same as defined hereinabove, preferably a vinyl group, a 1-propenyl group, an allyl group, a 1-butenyl group, a 2-butenyl group or a 3-butenyl group, and further preferably a vinyl group. When it has the substituent(s) C, the C2-C6 alkenyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(276) The “C2-C6 haloalkenyl group” in R4 of Formula (1) is the same as defined hereinabove, preferably a 2-fluorovinyl group, a 2,2-difluorovinyl group, a 2,2-dichlorovinyl group, a 3-fluoroallyl group, a 3,3-difluoroallyl group or a 3,3-dichloroallyl group, and further preferably a 2-fluorovinyl group or a 2,2-difluorovinyl group.

(277) The C2-C6 alkynyl group of the “C2-C6 alkynyl group optionally substituted with substituent(s) C” in R4 of Formula (1) is the same as defined hereinabove, preferably an ethynyl group, a 1-propynyl group or a propargyl group, and further preferably a ethynyl group. When it has the substituent(s) C, the C2-C6 alkynyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(278) The “C2-C6 haloalkynyl group” in R4 of Formula (1) is the same as defined hereinabove, preferably a 3,3-difluoro-1-propynyl group, a 3,3,3-trifluoro-1-propynyl group, a 4,4-difluoro-1-butynyl group, a 4,4-difluoro-2-butynyl group, a 4,4,4-trifluoro-1-butynyl group or a 4,4,4-trifluoro-2-butynyl group, and further preferably a 3,3-difluoro-1-propynyl group or a 3,3,3-trifluoro-1-propynyl group.

(279) The C1-C6 alkoxy group of the “C1-C6 alkoxyl group optionally substituted with substituent(s) C” in R4 of Formula (1) is the same as defined hereinabove, preferably a methoxy group, an ethoxy group, a propyloxy group or an isopropyloxy group, further preferably a methoxy group or an ethoxy group, and particularly preferably a methoxy group. When it has the substituent(s) C, the C1-C6 alkoxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(280) The “C1-C6 haloalkoxy group” in R4 of Formula (1) is the same as defined hereinabove, preferably a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 3,3-difluoropropyloxy group or a 3,3,3-trifluoropropyloxy group, and further preferably a difluoromethoxy group or a trifluoromethoxy group.

(281) The C3-C8 cycloalkoxy group of the “C3-C8 cycloalkoxy group optionally substituted with substituent(s) C” in R4 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group or a cyclohexyloxy group, and further preferably a cyclopropyloxy group or a cyclobutoxy group. When it has the substituent(s) C, the C3-C8 cycloalkoxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(282) The C2-C6 alkenyloxy group of the “C2-C6 alkenyloxy group optionally substituted with substituent(s) C” in R4 of Formula (1) is the same as defined hereinabove, preferably a vinyloxy group, a 1-propenyloxy group or an allyloxy group, and further preferably an allyloxy group. When it has the substituent(s) C, the C2-C6 alkenyloxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(283) The “C2-C6 haloalkenyloxy group” in R4 of Formula (1) is the same as defined hereinabove, preferably a 2-fluorovinyloxy group, a 2,2-difluorovinyloxy group, a 2,2-dichlorovinyloxy group, a 3-fluoroallyloxy group, a 3,3-difluoroallyloxy group or a 3,3-dichloroallyloxy group, and further preferably a 2-fluorovinyloxy group or a 2,2-difluorovinyloxy group.

(284) The C3-C6 alkynyloxy group of the “C3-C6 alkynyloxy group optionally substituted with substituent(s) C” in R4 of Formula (1) is the same as defined hereinabove, preferably a propargyloxy group, a 2-butynyloxy group or a 3-butynyloxy group, and further preferably a propargyloxy group. When it has the substituent(s) C, the C3-C6 alkynyloxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(285) The “C3-C6 haloalkynyloxy group” in R4 of Formula (1) is the same as defined hereinabove, preferably a 4,4-difluoro-2-butynyloxy group, a 4-chloro-4,4-difluoro-2-butynyloxy group, a 4-bromo-4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group, and further preferably a 4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group.

(286) The aryl group of the “aryl group optionally substituted with substituent(s) D” in R4 of Formula (1) is the same as defined hereinabove, and preferably a phenyl group. When it has the substituent(s) D, the aryl group is optionally substituted with the substituent(s) D in place of hydrogen(s).

(287) The heteroaryl group of the “heteroaryl group optionally substituted with substituent(s) D” in R4 of Formula (1) is the same as defined hereinabove, preferably a pyridyl group, a pyrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group, furyl group, an imidazolyl group, a pyrazolyl group, oxazolyl group, an isoxazolyl group, a triazolyl group, an oxadiazolyl group or a tetrazolyl group, and further preferably a pyridyl group, an imidazolyl group, a pyrazolyl group, triazolyl group or a tetrazolyl group. When it has the substituent(s) D, the heteroaryl group is optionally substituted with the substituent(s) D in place of hydrogen(s).

(288) The aryloxy group of the “aryloxy group optionally substituted with substituent(s) D” in R4 of Formula (1) is the same as defined hereinabove, preferably a phenoxy group or a naphthyloxy group, and further preferably a phenoxy group. When it has the substituent(s) D, the aryloxy group is optionally substituted with the substituent(s) D in place of hydrogen atom(s).

(289) The heteroaryloxy group of the “heteroaryloxy group optionally substituted with substituent(s) D” in R4 of Formula (1) is the same as defined hereinabove, preferably a pyridyloxy group, a pyridazinyloxy group, a pyrimidinyloxy group, a pyrazinyloxy group, a pyrazolyloxy group, a triazinyloxy group, a tetrazinyloxy group, a thienyloxy group, a thiazolyloxy group, an isothiazolyloxy group or a thiadiazolyloxy group, and further preferably a pyridyloxy group, a pyridazinyloxy group, a pyrimidinyloxy group, a pyrazinyloxy group or a pyrazolyloxy group. When it has the substituent(s) D, the heteroaryloxy group is optionally substituted with the substituent(s) D in place of hydrogen atom(s).

(290) The aralkyloxy group of the “aralkyloxy group optionally substituted with substituent(s) D” in R4 of Formula (1) is the same as defined hereinabove, preferably a benzyloxy group, a phenethyloxy group or a phenylpropyloxy group, and further preferably a benzyloxy group. When it has the substituent(s) D, the aralkyloxy group is optionally substituted with the substituent(s) D in place of hydrogen atom(s).

(291) Ra and Rb of “RaRbN—” in R4 of Formula (1) are the same as defined hereinabove. The “RaRbN—” is preferably an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group, and further preferably an amino group, a dimethylamino group, an ethylmethylamino group or a diethylamino group.

(292) Rc and L of the “Rc-L-” in R4 of Formula (1) is the same as defined hereinabove. The “Rc-L-” is preferably a methylthio group, a methanesulfinyl group, a methanesulfonyl group, a trifluoromethylthio group, a trifluoromethanesulfinyl group or a trifluoromethanesulfonyl group, and further preferably a methylthio group, a methanesulfinyl group or a methanesulfonyl group.

(293) Rx1 of the “Rx1C(═O)—” in R4 of Formula (1) is the same as defined hereinabove. The “Rx1C(═O)—” is preferably an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a propionyl group, a difluoroacetyl group, a trifluoroacetyl group, a cyclopropancarbonyl group, a methoxycarbonyl group, an ethoxycarbonyl group, a 2,2-difluoroethoxycarbonyl group, a 2,2,2-trifluoroethoxycarbonyl group, a 3,3,3-trifluoropropyloxycarbonyl group, a cyclopropyloxycarbonyl group, an aminocarbonyl group, a methylaminocarbonyl group, an ethylaminocarbonyl group, a (methoxymethyl)aminocarbonyl group, a (2-methoxyethyl)aminocarbonyl group, a (cyanomethyl)aminocarbonyl group, a (2-cyanoethyl)aminocarbonyl group, a dimethyl-aminocarbonyl group, an ethylmethylaminocarbonyl group, a diethylaminocarbonyl group, a (methoxymethyl)methylaminocarbonyl group, a (2-methoxyethyl)methylaminocarbonyl group, a (cyanomethyl)methylaminocarbonyl group, a (2-cyanoethyl)methylaminocarbonyl group, a 2,2-difluoroethylaminocarbonyl group, a 2,2,2-trifluoroethylaminocarbonyl group, a cyclopropylaminocarbonyl group, a (cyclopropyl)methylaminocarbonyl group, a pyrrolidinylcarbonyl group or a piperidinylcarbonyl group, and further preferably an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a difluoroacetyl group, a trifluoroacetyl group, a methoxycarbonyl group, an ethoxycarbonyl group, an aminocarbonyl group, a dimethylaminocarbonyl group, an ethylmethylaminocarbonyl group or a diethylaminocarbonyl group.

(294) Rx1 of “Rx1C(═O)O—” in R4 of Formula (1) is the same as defined hereinabove. The “Rx1C(═O)O—” is preferably an acetyloxy group, a methoxyacetyloxy group, a cyanoacetyloxy group, a propionyloxy group, a difluoroacetyloxy group, a trifluoroacetyloxy group, a cyclopropancarbonyloxy group, a methoxycarbonyloxy group, an ethoxycarbonyloxy group, a 2,2-difluoroethoxycarbonyloxy group, a 2,2,2-trifluoroethoxycarbonyloxy group, a 3,3,3-trifluoropropyloxycarbonyloxy group, a cyclopropyloxycarbonyloxy group, an aminocarbonyloxy group, a methylaminocarbonyloxy group, an ethylaminocarbonyloxy group, a (methoxymethyl)-aminocarbonyloxy group, a (2-methoxyethyl)aminocarbonyloxy group, a (cyano-methyl)aminocarbonyloxy group, a (2-cyanoethyl)aminocarbonyloxy group, a dimethylaminocarbonyloxy group, an ethylmethylaminocarbonyloxy group, a diethylaminocarbonyloxy group, a (methoxymethyl)methylaminocarbonyloxy group, a (2-methoxyethyl)methylaminocarbonyloxy group, a (cyanomethyl)methylamino-carbonyloxy group, a (2-cyanoethyl)methylaminocarbonyloxy group, a 2,2-difluoroethylaminocarbonyloxy group, a 2,2,2-trifluoroethylaminocarbonyloxy group, a cyclopropylaminocarbonyloxy group, a (cyclopropyl)methylaminocarbonyloxy group, a pyrrolidinylcarbonyloxy group or a piperidinylcarbonyloxy group, further preferably an acetyloxy group, a methoxyacetyloxy group, a cyanoacetyloxy group, a difluoroacetyloxy group, a trifluoroacetyloxy group, a methoxycarbonyloxy group, an ethoxycarbonyloxy group, an aminocarbonyloxy group, a dimethylaminocarbonyloxy group, an ethylmethylaminocarbonyloxy group or a diethylaminocarbonyloxy group.

(295) Each term of “Rx2C(═O)N(Rx3)-” (wherein Rx2 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rx3 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group.) in R4 of Formula (1) is the same as defined hereinabove. Incidentally, with regard to the “C1-C6 alkyl group optionally substituted with substituent(s) B”, when it has the substituent(s) B, the C1-C6 alkyl group is optionally substituted with the substituent(s) B in place of hydrogen atom(s). The Rx2 is preferably a hydrogen atom, a methyl group, a methoxymethyl group, a cyanomethyl group, an ethyl group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a methoxy group, an ethoxy group, a 2,2-difluoroethoxy, a 2,2,2-trifluoroethoxy group, a cyclopropyloxy group, an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group, and further preferably a hydrogen atom, a methyl group, a methoxymethyl group, a cyanomethyl group, a difluoromethyl group, a trifluoromethyl group, a methoxy group, an ethoxy group, an amino group, a dimethylamino group, an ethylmethylamino group or a diethylamino group. Also, the Rx3 is preferably a hydrogen atom, a methyl group, a methoxymethyl group, an ethoxymethyl group, a cyanomethyl group, an ethyl group, a 2-methoxyethyl group, a 2-ethoxyethyl group, a 2-cyanoethyl group, a propyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group or a cyclopropyl group, and further preferably a hydrogen atom, a methyl group, a methoxymethyl group, a cyanomethyl group, an ethyl group, a 2-methoxyethyl group, a 2,2-difluoroethyl group or a 2,2,2-trifluoroethyl group.

(296) Each term in the “Rx4Rx5C═N—O—” (wherein Rx4 and Rx5 each independently represent a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove)) in R4 of Formula (1) is the same as defined hereinabove. Incidentally, with regard to the “C1-C6 alkyl group optionally substituted with substituent(s) B”, when it has the substituent(s) B, the C1-C6 alkyl group is optionally substituted with the substituent(s) B in place of hydrogen atom(s).

(297) Rx4 and Rx5 are each preferably a methyl group, an ethyl group, a propyl group, an isopropyl group, a trifluoromethyl group, a 2,2,2-trifluoroethyl group, a cyclopropyl group, a cyclopentyl group, a cyclohexyl group, a methoxy group, an ethoxy group, isopropyloxy group, a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group, and further preferably a methyl group, an ethyl group, a trifluoromethyl group, a 2,2,2-trifluoroethyl group, a methoxy group, an ethoxy group, a 2,2,2-trifluoroethoxy group, a dimethylamino group, an ethylmethylamino group or a diethylamino group.

(298) The “3 to 6 membered ring group containing 1 to 2 oxygen atoms” in R4 of Formula (1) is the same as defined hereinabove, preferably an oxolanyl group, an oxanyl group, a 1,3-dioxolanyl group or a 1,3-dioxanyl group, and further preferably a 1,3-dioxolanyl group or a 1,3-dioxanyl group.

(299) R5 in Formula (1) is defined the same as R4 described hereinabove. That is, it represents a hydroxyl group, a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) C, a C2-C6 haloalkynyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, a C3-C6 haloalkynyloxy group, an aryl group optionally substituted with substituent(s) D, a heteroaryl group optionally substituted with substituent(s) D, an aryloxy group optionally substituted with substituent(s) D, a heteroaryloxy group optionally substituted with substituent(s) D, an aralkyloxy group optionally substituted with substituent(s) D, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove), Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove), Rx C(═O)O— (wherein Rx1 is the same as defined hereinabove), Rx2C(═O)N(Rx3)- (wherein Rx2 and Rx3 are the same as defined hereinabove), Rx4Rx5C═N—O— (wherein Rx4 and Rx5 are the same as defined hereinabove.) or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms.

(300) Above all, R5 is preferably a hydroxyl group, a cyano group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 alkynyl group optionally substituted with substituent(s) C, a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove.) or Rx1C(═O)O— (wherein Rx1 is the same as defined hereinabove);

(301) R5 is particularly preferably a hydroxyl group, a cyano group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove.) or Rx1C(═O)O— (wherein Rx1 is the same as defined hereinabove);

(302) and R5 is further preferably a hydroxyl group, a cyano group, a halogen atom, a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove.) or Rx1C(═O)O— (wherein Rx1 is the same as defined hereinabove).

(303) In R5 of Formula (1), a hydroxyl group, a cyano group and a nitro group are contained.

(304) The halogen atom in R5 of Formula (1) is the same as defined hereinabove, preferably a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, and further preferably a fluorine atom or an iodine atom.

(305) The C1-C6 alkyl group of the “C1-C6 alkyl group optionally substituted with substituent(s) C” in R5 of Formula (1) is the same as defined hereinabove, preferably a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group or an isobutyl group, further preferably a methyl group or an ethyl group. When it has the substituent(s) C, the C1-C6 alkyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(306) The “C1-C6 haloalkyl group” in R5 of Formula (1) is the same as defined hereinabove, preferably a difluoromethyl group, a trifluoromethyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 3,3-difluoropropyl group or a 3,3,3-trifluoropropyl group, and further preferably a difluoromethyl group, a trifluoromethyl group, a 2,2-difluoroethyl group or a 2,2,2-trifluoroethyl group.

(307) The C3-C8 cycloalkyl group of the “C3-C8 cycloalkyl group optionally substituted with substituent(s) C” in R5 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyl group, a cyclobutyl group, a cyclopentyl group or a cyclohexyl group, and further preferably a cyclopropyl group or a cyclobutyl group. When it has the substituent(s) C, the C3-C8 cycloalkyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(308) The C2-C6 alkenyl group in the “C2-C6 alkenyl group optionally substituted with substituent(s) C” in R5 of Formula (1) is the same as defined hereinabove, preferably a vinyl group, a 1-propenyl group, an allyl group, a 1-butenyl group, a 2-butenyl group or a 3-butenyl group, and further preferably a vinyl group, a 1-propenyl group or an allyl group. When it has the substituent(s) C, C2-C6 alkenyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(309) The “C2-C6 haloalkenyl group” in R5 of Formula (1) is the same as defined hereinabove, preferably a 2-fluorovinyl group, a 2,2-difluorovinyl group, a 2,2-dichlorovinyl group, a 3-fluoroallyl group, a 3,3-difluoroallyl group or a 3,3-dichloroallyl group, and further preferably a 2-fluorovinyl group or a 2,2-difluorovinyl group.

(310) The C2-C6 alkynyl group of the “C2-C6 alkynyl group optionally substituted with substituent(s) C” in R5 of Formula (1) is the same as defined hereinabove, preferably an ethynyl group, a 1-propynyl group, a propargyl group, a 1-butynyl group, a 2-butynyl group or a 3-butynyl group, and further preferably an ethynyl group, a 1-propynyl group or a propargyl group. When it has the substituent(s) C, the C2-C6 alkynyl group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(311) The “C2-C6 haloalkynyl group” in R5 of Formula (1) is the same as defined hereinabove, preferably a 3,3-difluoro-1-propynyl group, a 3,3,3-trifluoro-1-propynyl group, a 4,4-difluoro-1-butynyl group, a 4,4-difluoro-2-butynyl group, a 4,4,4-trifluoro-1-butynyl group or a 4,4,4-trifluoro-2-butynyl group, and further preferably a 3,3-difluoro-1-propynyl group or a 3,3,3-trifluoro-1-propynyl group.

(312) The C1-C6 alkoxy group in the “C1-C6 alkoxyl group optionally substituted with substituent(s) C” in R5 of Formula (1) is the same as defined hereinabove, preferably a methoxy group, an ethoxy group, a propyloxy group, an isopropyloxy group, a butoxy group or an isobutoxy group, further preferably a methoxy group, an ethoxy group, a propyloxy group or an isopropyloxy group, and particularly preferably a methoxy group or an ethoxy group. When it has the substituent(s) C, the C1-C6 alkoxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s). The substituent(s) C is preferably a cyano group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C2-C6 alkoxyalkoxy group, Rc-L- (wherein Rc and L are the same as defined hereinabove), Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove.) or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms, and further preferably a cyano group, a C1-C6 alkoxy group or Rc-L- (wherein Rc and L are the same as defined hereinabove). The C1-C6 alkoxy group substituted with the substituent(s) C is preferably a cyanomethoxy group, a cyanoethoxy group, a methoxymethoxy group, a methoxyethoxy group, an ethoxymethoxy group or an ethoxyethoxy group, further preferably a cyanomethoxy group, a methoxymethoxy group or a methoxyethoxy group, and particularly preferably a methoxymethoxy group or a methoxyethoxy group.

(313) The “C1-C6 haloalkoxy group” in R5 of Formula (1) is the same as defined hereinabove, preferably a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 3,3-difluoropropyloxy group or a 3,3,3-trifluoropropyloxy group, and further preferably a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group or a 2,2,2-trifluoroethoxy group.

(314) The C3-C8 cycloalkoxy group of the “C3-C8 cycloalkoxy group optionally substituted with substituent(s) C” in R5 of Formula (1) is the same as defined hereinabove, preferably a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group or a cyclohexyloxy group, and further preferably a cyclopropyloxy group or a cyclobutoxy group. When it has the substituent(s) C, the C3-C8 cycloalkoxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(315) The C2-C6 alkenyloxy group of the “C2-C6 alkenyloxy group optionally substituted with substituent(s) C” in R5 of Formula (1) is the same as defined hereinabove, preferably a vinyloxy group, a 1-propenyloxy group, an allyloxy group, a 1-butenyloxy group, a 2-butenyloxy group or a 3-butenyloxy group, further preferably a vinyloxy group, a 1-propenyloxy group or an allyloxy group, and particularly preferably an allyloxy group. When it has the substituent(s) C, the C2-C6 alkenyloxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(316) The “C2-C6 haloalkenyloxy group” in R5 of Formula (1) is the same as defined hereinabove, preferably a 2-fluorovinyloxy group, a 2,2-difluorovinyloxy group, a 2,2-dichlorovinyloxy group, a 3-fluoroallyloxy group, a 3,3-difluoroallyloxy group or a 3,3-dichloroallyloxy group, and further preferably a 2-fluorovinyloxy group or a 2,2-difluorovinyloxy group.

(317) The C3-C6 alkynyloxy group of the “C3-C6 alkynyloxy group optionally substituted with substituent(s) C” in R5 of Formula (1) is the same as defined hereinabove, preferably a propargyloxy group, a 2-butynyloxy group or a 3-butynyloxy group, further preferably a propargyloxy group or a 2-butynyloxy group, and particularly preferably a propargyloxy group. When it has the substituent(s) C, the C3-C6 alkynyloxy group is optionally substituted with the substituent(s) C in place of hydrogen atom(s).

(318) The “C3-C6 haloalkynyloxy group” in R5 of Formula (1) is the same as defined hereinabove, preferably a 4,4-difluoro-2-butynyloxy group, a 4-chloro-4,4-difluoro-2-butynyloxy group, a 4-bromo-4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group, and further preferably a 4,4-difluoro-2-butynyloxy group or a 4,4,4-trifluoro-2-butynyloxy group.

(319) The aryl group of the “aryl group optionally substituted with substituent(s) D” in R5 of Formula (1) is the same as defined hereinabove, and preferably a phenyl group. When it has, the substituent(s) D, the aryl group is optionally substituted with the substituent(s) D in place of hydrogen(s).

(320) The heteroaryl group of the “heteroaryl group optionally substituted with substituent(s) D” in R5 of Formula (1) is the same as defined hereinabove, preferably a pyridyl group, a pyrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group, furyl group, an imidazolyl group, a pyrazolyl group, oxazolyl group, an isoxazolyl group, a triazolyl group, an oxadiazolyl group or a tetrazolyl group, and further preferably a pyridyl group, an imidazolyl group, a pyrazolyl group, triazolyl group or a tetrazolyl group. When it has the substituent(s) D, the heteroaryl group is optionally substituted with the substituent(s) D in place of hydrogen(s).

(321) The aryloxy group of the “aryloxy group optionally substituted with substituent(s) D” in R5 of Formula (1) is the same as defined hereinabove, preferably a phenoxy group or a naphthyloxy group, and further preferably a phenoxy group. When it has the substituent(s) D, the aryloxy group is optionally substituted with the substituent(s) D in place of hydrogen atom(s).

(322) The heteroaryloxy group of the “heteroaryloxy group optionally substituted with substituent(s) D” in R5 of Formula (1) is the same as defined hereinabove, preferably a pyridyloxy group, a pyridazinyloxy group, a pyrimidinyloxy group, a pyrazinyloxy group, a pyrazolyloxy group, a triazinyloxy group, a tetrazinyloxy group, a thienyloxy group, a thiazolyloxy group, an isothiazolyloxy group or a thiadiazolyloxy group, and further preferably a pyridyloxy group, a pyridazinyloxy group, a pyrimidinyloxy group, a pyrazinyloxy group or a pyrazolyloxy group. When it has the substituent(s) D, the heteroaryloxy group is optionally substituted with the substituent(s) D in place of hydrogen atom(s).

(323) The aralkyloxy group of the “aralkyloxy group optionally substituted with substituent(s) D” in R5 of Formula (1) is the same as defined hereinabove, preferably a benzyloxy group, a phenethyloxy group or a phenylpropyloxy group, and further preferably a benzyloxy group or a phenethyloxy group. When it has the substituent(s) D, the aralkyloxy group is optionally substituted with the substituent(s) D in place of hydrogen atom(s).

(324) Ra and Rb of the “RaRbN—” in R5 of Formula (1) are the same as defined hereinabove. Ra and Rb are each preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, pyrrolidinyl group or a piperidinyl group, and further preferably a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a pyrrolidinyl group or a piperidinyl group. The “RaRbN—” is-preferably an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group, further preferably an amino group, a methylamino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a pyrrolidinyl group or a piperidinyl group, and particularly preferably a methylamino group, a pyrrolidinyl group or a piperidinyl group.

(325) Rc and L of the “Rc-L-” in R5 of Formula (1) is the same as defined hereinabove. The Rc is preferably a C1-C6 alkyl group. The L is preferably S. The “Rc-L-” is preferably a methylthio group, a methanesulfinyl group, a methanesulfonyl group, a trifluoromethylthio group, a trifluoromethanesulfinyl group or a trifluoromethanesulfonyl group, further preferably a methylthio group, a methanesulfinyl group or a methanesulfonyl group, and particularly preferably a methylthio group.

(326) Rx1 in the “Rx1C(═O)—” in R5 of Formula (1) is the same as defined hereinabove. The “Rx1C(═O)—” is preferably an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a propionyl group, a difluoroacetyl group, a trifluoroacetyl group, a cyclopropancarbonyl group, a methoxycarbonyl group, an ethoxycarbonyl group, a 2,2-difluoroethoxycarbonyl group, a 2,2,2-trifluoroethoxycarbonyl group, a 3,3,3-trifluoropropyloxycarbonyl group, a cyclopropyloxycarbonyl group, an aminocarbonyl group, a methylaminocarbonyl group, an ethylaminocarbonyl group, a (methoxymethyl)aminocarbonyl group, a (2-methoxyethyl)aminocarbonyl group, a (cyanomethyl)aminocarbonyl group, a (2-cyanoethyl)aminocarbonyl group, a dimethylaminocarbonyl group, an ethylmethylaminocarbonyl group, a diethylaminocarbonyl group, a (methoxymethyl)methylaminocarbonyl group, a (2-methoxyethyl)methylaminocarbonyl group, a (cyanomethyl)methylaminocarbonyl group, a (2-cyanoethyl)methylaminocarbonyl group, a 2,2-difluoroethylaminocarbonyl group, a 2,2,2-trifluoroethylaminocarbonyl group, a cyclopropylaminocarbonyl group, a (cyclopropyl)methylaminocarbonyl group, a pyrrolidinylcarbonyl group or a piperidinylcarbonyl group, and further preferably an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a difluoroacetyl group, a trifluoroacetyl group, a methoxycarbonyl group, an ethoxycarbonyl group, an aminocarbonyl group, a dimethylaminocarbonyl group, an ethylmethylaminocarbonyl group or a diethylaminocarbonyl group.

(327) Rx1 of the “Rx1C(═O)O—” in R5 of Formula (1) is the same as defined hereinabove. The Rx1 is preferably a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove), further preferably a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C1-C6 alkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove), and particularly preferably a C1-C6 alkyl group optionally substituted with substituent(s) B. The “Rx1C(═O)O—” is preferably an acetyloxy group, a methoxyacetyloxy group, a cyanoacetyloxy group, a propionyloxy group, a difluoroacetyloxy group; a trifluoroacetyloxy group, a cyclopropancarbonyloxy group, a methoxycarbonyloxy group, an ethoxycarbonyloxy group, a 2,2-difluoroethoxycarbonyloxy group, a 2,2,2-trifluoroethoxycarbonyloxy group, a 3,3,3-trifluoropropyloxycarbonyloxy group, a cyclopropyloxycarbonyloxy group, an aminocarbonyloxy group, a methylaminocarbonyloxy group, an ethylaminocarbonyloxy group, a (methoxymethyl)aminocarbonyloxy group, a (2-methoxyethyl)aminocarbonyloxy group, a (cyanomethyl)aminocarbonyloxy group, a (2-cyanoethyl)aminocarbonyloxy group, a dimethylaminocarbonyloxy group, an ethylmethylaminocarbonyloxy group, a diethylaminocarbonyloxy group, a (methoxy-methyl)methylaminocarbonyloxy group, a (2-methoxyethyl)methylaminocarbonyloxy group, a (cyanomethyl)methylaminocarbonyloxy group, a (2-cyanoethyl)methylamino-carbonyloxy group, a 2,2-difluoroethylaminocarbonyloxy group, a 2,2,2-trifluoroethylaminocarbonyloxy group, a cyclopropylaminocarbonyloxy group, a (cyclopropyl)methylaminocarbonyloxy group, a pyrrolidinylcarbonyloxy group or a piperidinylcarbonyloxy group, further preferably an acetyloxy group, a methoxyacetyloxy group, a cyanoacetyloxy group, a difluoroacetyloxy group, a trifluoroacetyloxy group, a methoxycarbonyloxy group, an ethoxycarbonyloxy group, an aminocarbonyloxy group, a dimethylaminocarbonyloxy group, an ethylmethylaminocarbonyloxy group or a diethylaminocarbonyloxy group, and particularly preferably an acetyloxy group.

(328) Each term of the “Rx2C(═O)N(Rx3)-” (wherein Rx2 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rx3 represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group.) in R5 of Formula (1) is the same as defined hereinabove. Incidentally, with regard to the “C1-C6 alkyl group optionally substituted with substituent(s) B”, when it has the substituent(s) B, the C1-C6 alkyl group is optionally substituted with the substituent(s) B in place of hydrogen atom(s). The Rx2 is preferably a hydrogen atom, a methyl group, a methoxymethyl group, a cyanomethyl group, an ethyl group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a methoxy group, an ethoxy group, a 2,2-difluoroethoxy, a 2,2,2-trifluoroethoxy group, a cyclopropyloxy group, an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group, further preferably a hydrogen atom, a methyl group, a methoxymethyl group, a cyanomethyl group, a difluoromethyl group, a trifluoromethyl group, a methoxy group, an ethoxy group, an amino group, a dimethylamino group, an ethylmethylamino group or a diethylamino group. Also, Rx3 is preferably a hydrogen atom, a methyl group, a methoxymethyl group, an ethoxymethyl group, a cyanomethyl group, an ethyl group, a 2-methoxyethyl group, a 2-ethoxyethyl group, a 2-cyanoethyl group, a propyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group or a cyclopropyl group, and further preferably a hydrogen atom, a methyl group, a methoxymethyl group, a cyanomethyl group, an ethyl group, a 2-methoxyethyl group, a 2,2-difluoroethyl group or a 2,2,2-trifluoroethyl group.

(329) Each term of the “Rx4Rx5C═N—O—” (wherein Rx4 and Rx5 each independently represent a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group or RaRbN— (wherein Ra and Rb are the same as defined hereinabove)) in R5 of Formula (1) is the same as defined hereinabove. Incidentally, with regard to the “C1-C6 alkyl group optionally substituted with substituent(s) B”, when it has the substituent(s) B, the C1-C6 alkyl group is optionally substituted with the substituent(s) B in place of hydrogen atom(s).

(330) Rx4 and Rx5 are each preferably a methyl group, an ethyl group, a propyl group, an isopropyl group, a trifluoromethyl group, a 2,2,2-trifluoroethyl group, a cyclopropyl group, a cyclopentyl group, a cyclohexyl group, a methoxy group, an ethoxy group, isopropyloxy group, a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group or a piperidinyl group, and further preferably a methyl group, an ethyl group, a trifluoromethyl group, a 2,2,2-trifluoroethyl group, a methoxy group, an ethoxy group, a 2,2,2-trifluoroethoxy group, a dimethylamino group, an ethylmethylamino group or a diethylamino group.

(331) The “3 to 6 membered ring group containing 1 to 2 oxygen atoms in R5 of Formula (1) is the same as defined hereinabove, preferably an oxolanyl group, an oxanyl group, a 1,3-dioxolanyl group or a 1,3-dioxanyl group, and further preferably a 1,3-dioxolanyl group or a 1,3-dioxanyl group.

(332) In the following, Y in Formula (1) will be described in detail.

(333) A) When Y is a phenyl group, Y represents a partial structure represented by Formula (k)

(334) ##STR00090##
(wherein R4 and R5 is the same as defined hereinabove and “ma” represents an integer of 0 to 4).

(335) “ma” in Formula (k) represents an integer of 0 to 4.

(336) When “ma” of Formula (k) is 2 or more, the two or more substituents R5 are independent of one another and may be optionally selected to be the same as or different from one another.

(337) In the present specification, when Y is a phenyl group, the ortho position indicates the position in the phenyl group at which there is the substituent R4 as illustrated in Formula (k).

(338) The phenyl group in which the substituent R4 is positioned at the ortho position constitutes the characteristics of the present invention.

(339) Preferred combination of the substituents of Formula (k) is a 2-R4-phenyl group, a 2-R4-6-R5-phenyl group, a 2-R4-4-R5-phenyl group, a 2-R4-4-R5-6-R5-phenyl group, a 2-R4-3-R5-phenyl group or a 2-R4-3-R5-4-R5-6-R5-phenyl group, and more preferred combination of the substituents is a 2-R4-phenyl group, a 2-R4-6-R5-phenyl group, a 2-R4-4-R5-phenyl group, a 2-R4-4-R5-6-R5-phenyl group or a 2-R4-3-R5-4-R5-6-R5-phenyl group. Here, for example, the “2-R4-6-R5-phenyl group” indicates a di-substituted phenyl group having the substituent R4 at the 2-position and the substituent R5 at the 6-position, and the same applies hereinafter.

(340) B) When Y is a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group or tetrazinyl group, Y represents a partial structure represented by Formula (L)

(341) ##STR00091##
(wherein R4, R5 are the same as defined hereinabove and “mb” represents an integer of 0 to 3).

(342) G30, G31, G32 and G33 in Formula (L) are each independent and represent a carbon atom or a nitrogen atom. With the proviso that at least one among G30, G31, G32 and G33 is a nitrogen atom. Preferred G30, G31, G32 and G33 are that any one of G30, G31, G32 and G33 is a nitrogen atom. That is, it is a pyridyl group.

(343) “mb” in Formula (L) represents an integer of 0 to 3.

(344) When “mb” of Formula (L) is 2 or more, the two or more substituents R5 are independent of one another and may be optionally selected to be the same as or different from one another.

(345) In the present specification, when Y is a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group or a tetrazinyl group, the ortho position indicates the position in the 6-membered ring at which there is the substituent R4 as illustrated in Formula (L).

(346) Specific examples of the partial structures represented by Formula (L) are illustrated below.

(347) ##STR00092##

(348) The pyridyl group, the pyridazinyl group, the pyrimidinyl group, the pyrazinyl group, the triazinyl group or the tetrazinyl group in which the substituent R4 is positioned at the ortho position constitute the characteristics of the present invention.

(349) Preferred specific examples of Formula (L) are a 3-R4-pyridin-2-yl group, a 3-R4-5-R5-pyridin-2-yl group, a 2-R4-pyridin-3-yl group, a 2-R4-4-R5-pyridin-3-yl group, a 2-R4-6-R5-pyridin-3-yl group, a 2-R4-4-R5-6-R5-pyridin-3-yl group, a 4-R4-pyridin-3-yl group, a 4-R4-2-R5-pyridin-3-yl group, a 4-R4-6-R5-pyridin-3-yl group, a 4-R4-2-R5-6-R5-pyridin-3-yl group, a 3-R4-pyridin-4-yl group or a 3-R4-5-R5-pyridin-4-yl group.

(350) C) When Y is a thienyl group, a thiazolyl group, an isothiazolyl group or a thiadiazolyl group, Y represents a partial structure represented by

(351) ##STR00093##

(352) ##STR00094##
or

(353) ##STR00095##
(wherein R4 and R5 are the same as defined hereinabove and “mc” represents an integer of 0 to 2).

(354) G34 and G35 in Formula (m-1), Formula (m-2) and Formula (m-3) are each independent and represent a carbon atom or a nitrogen atom.

(355) “mc” in Formula (m-1), Formula (m-2) and Formula (m-3) represents an integer of 0 to 2.

(356) When “mc” in Formula (m-1), Formula (m-2) and Formula (m-3) is 2, the two substituents R5 are independent of one another and may be optionally selected to be the same as or different from one another.

(357) In the present specification, when Y is a thienyl group, a thiazolyl group, an isothiazolyl group or a thiadiazolyl group, the ortho position indicates the position in the 5-membered ring at which there is the subsistent R4 as illustrated in Formula (m-1), Formula (m-2) and Formula (m-3).

(358) Specific examples of the partial structures represented by Formula (m-1) are illustrated below.

(359) ##STR00096##

(360) Specific examples of the partial structures represented by Formula (m-2) are illustrated below.

(361) ##STR00097##

(362) Specific examples of the partial structures represented by Formula (m-3) are illustrated below.

(363) ##STR00098##

(364) The thienyl group, the thiazolyl group, the isothiazolyl group or the thiadiazolyl group in which the substituent R4 is positioned at the ortho position constitute the characteristics of the present invention.

(365) X in Formula (1) represents an oxygen atom or a sulfur atom. Preferable X is an oxygen atom.

(366) A bond containing the broken line in Formula (1) represents the portion represented by

(367) [Chem. 80]

(368) The bond containing the broken line in Formula (1) represents a double bond or a single bond.

(369) When the bond containing the a broken line in Formula (1) is a double bond, the compound represented by Formula (1a)

(370) ##STR00099##
(wherein R1, R2, Het, X and Y are the same as defined in Formula (1)) or a salt thereof is represented.

(371) When the bond containing the broken line in Formula (1) is a single bond, the compound represented by Formula (1b)

(372) ##STR00100##
(wherein R1, R2, Het, X and Y are the same as defined in Formula (1).) or a salt thereof is represented.

(373) When R2 in Formula (1b) is a substituent other than hydrogen, the compound is either one of the R-isomer or the S-isomer, or a mixture of the R-isomer and the S-isomer with an optional ratio.

(374) The “substituent(s) A” in Formula (1) represents at least one kind selected from the group consisting of a hydroxyl group, a cyano group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group, RaRbN— (wherein Ra and Rb are the same as defined hereinabove.) and Rc-L- (wherein Rc and L are the same as defined hereinabove).

(375) Above all, the substituent(s) A is preferably a cyano group, a C1-C6 alkoxy group or Rc-L- (wherein Rc and L are the same as defined hereinabove), and

(376) particularly preferably a cyano group or a C1-C6 alkoxy group.

(377) Preferred specific examples of the substituent(s) A may include a hydroxyl group; a cyano group;

(378) a cyclopropyl group, a cyclobutyl group, a cyclopentyl group and a cyclohexyl group as the C3-C8 cycloalkyl group;

(379) a methoxy group, an ethoxy group, a propyloxy group and an isopropyloxy group as the C1-C6 alkoxy group;

(380) a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 3,3-difluoropropyloxy group and a 3,3,3-trifluoro-propyloxy group as the C1-C6 haloalkoxy group;

(381) a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group and a cyclohexyloxy group as the C3-C8 cycloalkoxy group;

(382) an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)-amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group and a piperidinyl group as the RaRbN— (wherein Ra and Rb are the same as defined hereinabove);
and a methylthio group, a methanesulfinyl group, a methanesulfonyl group, a trifluoromethylthio group, a trifluoromethanesulfinyl group and a trifluoromethanesulfonyl group as the Rc-L- (wherein Rc and L are the same as defined hereinabove).

(383) More preferred specific examples of the substituent(s) A may include a hydroxyl group; a cyano group;

(384) a cyclopropyl group and a cyclobutyl group as the C3-C8 cycloalkyl group,

(385) a methoxy group and an ethoxy group as the C1-C6 alkoxy group,

(386) a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group and a 2,2,2-trifluoroethoxy group as the C1-C6 haloalkoxy group,

(387) a cyclopropyloxy group and a cyclobutoxy group as the C3-C8 cycloalkoxy group,

(388) a dimethylamino group, an ethylmethylamino group and a diethylamino group as the RaRbN— (wherein Ra and Rb are the same as defined hereinabove),

(389) and a methylthio group, a methanesulfinyl group and a methanesulfonyl group as the Rc-L- (wherein Rc and L are the same as defined hereinabove).

(390) The “substituent(s) B” in Formula (1) represents at least one kind selected from the group consisting of a cyano group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group and a C3-C8 cycloalkoxy group.

(391) Above all, the substituent(s) B is preferably a cyano group or a C1-C6 alkoxy group.

(392) Preferred specific examples of the substituent(s) B may include a cyano group; a methoxy group, an ethoxy group, a propyloxy group and an isopropyloxy group as the C1-C6 alkoxy group;

(393) a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 3,3-difluoropropyloxy group and a 3,3,3-trifluoro-propyloxy group as the C1-C6 haloalkoxy group;

(394) and a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group and a cyclohexyloxy group as the C3-C8 cycloalkoxy group.

(395) More preferred specific examples of the substituent(s) B may include a cyano group;

(396) a methoxy group and an ethoxy group as the C1-C6 alkoxy group;

(397) a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group and a 2,2,2-trifluoroethoxy group as the C1-C6 haloalkoxy group;

(398) and a cyclopropyloxy group and a cyclobutoxy group as the C3-C8 cycloalkoxy group.

(399) The “substituent(s) C” in Formula (1) represents at least one kind selected from the group consisting of a hydroxyl group, a cyano group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group, a C2-C6 alkoxyalkoxy group, RaRbN— (wherein Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove), Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove.) and a 3 to 6-membered ring group containing 1 to 2 oxygen atoms;

(400) above all, the substituent(s) C is preferably a cyano group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group, a C2-C6 alkoxyalkoxy group, Rc-L- (wherein Rc and L are the same as defined hereinabove), Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove.) or a 3 to 6-membered ring group containing 1 to 2 oxygen atoms, and

(401) particularly preferably a cyano group, a C1-C6 alkoxy group or Rc-L- (wherein Rc and L are the same as defined hereinabove).

(402) Preferred specific examples of the substituent(s) C may include a hydroxyl group; a cyano group;

(403) a cyclopropyl group, a cyclobutyl group, a cyclopentyl group and a cyclohexyl group as the C3-C8 cycloalkyl group;

(404) a methoxy group, an ethoxy group, a propyloxy group, an isopropyloxy group, a butoxy group, an isobutoxy group and a t-butoxy group as the C1-C6 alkoxy group;

(405) a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 3,3-difluoropropyloxy group and a 3,3,3-trifluoro-propyloxy group as the C1-C6 haloalkoxy group;

(406) a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group and a cyclohexyloxy group as the C3-C8 cycloalkoxy group;

(407) a methoxymethoxy group, an ethoxymethoxy group, a methoxyethoxy group, an ethoxyethoxy group and a methoxypropyloxy group as the C2-C6 alkoxyalkoxy group;

(408) an amino group, a methylamino group, an ethylamino group, a (methoxymethyl)amino group, a (2-methoxyethyl)amino group, a (cyanomethyl)amino group, a (2-cyanoethyl)-amino group, a dimethylamino group, an ethylmethylamino group, a diethylamino group, a (methoxymethyl)methylamino group, a (2-methoxyethyl)methylamino group, a (cyanomethyl)methylamino group, a (2-cyanoethyl)methylamino group, a 2,2-difluoroethylamino group, a 2,2,2-trifluoroethylamino group, a cyclopropylamino group, a (cyclopropyl)methylamino group, a pyrrolidinyl group and a piperidinyl group as the RaRbN— (wherein Ra and Rb are the same as defined hereinabove);
a methylthio group, a methanesulfinyl group, a methanesulfonyl group, a trifluoromethylthio group, a trifluoromethanesulfinyl group and a trifluoromethanesulfonyl group as the Rc-L- (wherein Rc and L are the same as defined hereinabove);
a formyl group, an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a propionyl group, a difluoroacetyl group, a trifluoroacetyl group, a cyclopropancarbonyl group, a methoxycarbonyl group, an ethoxycarbonyl group, a 2,2-difluoroethoxycarbonyl group, a 2,2,2-trifluoroethoxycarbonyl group, a 3,3,3-trifluoropropyloxycarbonyl group, a cyclopropyloxycarbonyl group, an aminocarbonyl group, a methylaminocarbonyl group, an ethylaminocarbonyl group, a (methoxymethyl)-aminocarbonyl group, a (2-methoxyethyl)aminocarbonyl group, a (cyanomethyl)-aminocarbonyl group, a (2-cyanoethyl)aminocarbonyl group, a dimethylaminocarbonyl group, an ethylmethylaminocarbonyl group, a diethylaminocarbonyl group, a (methoxymethyl)methylaminocarbonyl group, a (2-methoxyethyl)methylaminocarbonyl group, a (cyanomethyl)methylaminocarbonyl group, a (2-cyanoethyl)methylaminocarbonyl group, a 2,2-difluoroethylaminocarbonyl group, a 2,2,2-trifluoroethylaminocarbonyl group, a cyclopropylaminocarbonyl group, a (cyclopropyl)methylaminocarbonyl group, a pyrrolidinylcarbonyl group and a piperidinylcarbonyl group as the Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove);
and an oxolanyl group, an oxanyl group, a 1,3-dioxolanyl group and a 1,3-dioxanyl group as the 3 to 6 membered ring group containing 1 to 2 oxygen atoms.

(409) More preferred specific examples of the substituent(s) C may include a hydroxyl group; a cyano group;

(410) a cyclopropyl group and a cyclobutyl group as the C3-C8 cycloalkyl group;

(411) a methoxy group and an ethoxy group as the C1-C6 alkoxy group;

(412) a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group and a 2,2,2-trifluoroethoxy group as the C1-C6 haloalkoxy group;

(413) a cyclopropyloxy group and a cyclobutoxy group as the C3-C8 cycloalkoxy group;

(414) a methoxymethoxy group, an ethoxymethoxy group, a methoxyethoxy group and an ethoxyethoxy group as the C2-C6 alkoxyalkoxy group;

(415) a dimethylamino group, an ethylmethylamino group and a diethylamino group as the RaRbN— (wherein Ra and Rb are the same as defined hereinabove);

(416) a methylthio group, a methanesulfinyl group and a methanesulfonyl group as the Rc-L- (wherein Rc and L are the same as defined hereinabove);

(417) a formyl group, an acetyl group, a methoxyacetyl group, a cyanoacetyl group, a difluoroacetyl group, a trifluoroacetyl group, a methoxycarbonyl group, an ethoxycarbonyl group, an aminocarbonyl group, a dimethylaminocarbonyl group, an ethylmethylaminocarbonyl group and a diethylaminocarbonyl group as the Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove);
and a 1,3-dioxolanyl group and a 1,3-dioxanyl group as the 3 to 6-membered ring group containing 1 to 2 oxygen atoms.

(418) The “substituent(s) D” in Formula (1) represents at least one kind selected from the group consisting of a hydroxyl group, a cyano group, a nitro group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group, a C1-C6 alkoxy group, C1-C6 haloalkoxy group and a C3-C8 cycloalkoxy group.

(419) Above all, the substituent(s) D is preferably a cyano group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group, a C1-C6 alkoxy group or C1-C6 haloalkoxy group.

(420) Preferred specific examples of the substituent(s) D may include a hydroxyl group; a cyano group; a nitro group;

(421) a fluorine atom, a chlorine atom, a bromine atom and an iodine atom as the halogen atom;

(422) a methyl group, a methoxymethyl group, an ethoxymethyl group, a cyanomethyl group, an ethyl group, a 2-methoxyethyl group, a 2-ethoxyethyl group, a 2-cyanoethyl group, a propyl group, an isopropyl group, a butyl group and an isobutyl group as the C1-C6 alkyl group optionally substituted with substituent(s) B;
a difluoromethyl group, a trifluoromethyl group, a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 3,3-difluoropropyl group and a 3,3,3-trifluoropropyl group as the C1-C6 haloalkyl group;
a cyclopropyl group, a cyclobutyl group, a cyclopentyl group and a cyclohexyl group as the C3-C8 cycloalkyl group;
a methoxy group, an ethoxy group, a propyloxy group, an isopropyloxy group, a butoxy group, an isobutoxy group and a t-butoxy group as the C1-C6 alkoxy group;
a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group, a 2,2,2-trifluoroethoxy group, a 3,3-difluoropropyloxy group and a 3,3,3-trifluoropropyloxy group as the C1-C6 haloalkoxy group;
and a cyclopropyloxy group, a cyclobutoxy group, a cyclopentyloxy group and a cyclohexyloxy group as the C3-C8 cycloalkoxy group.

(423) More preferred specific examples of the substituent(s) D may include a hydroxyl group; a cyano group; a nitro group;

(424) a fluorine atom, a chlorine atom and a bromine atom as the halogen atom;

(425) a methyl group, a methoxymethyl group, an ethoxymethyl group, a cyanomethyl group, an ethyl group, a 2-methoxyethyl group, a 2-ethoxyethyl group and a 2-cyanoethyl group as the C1-C6 alkyl group optionally substituted with substituent(s) B; a difluoromethyl group, a trifluoromethyl group, a 2,2-difluoroethyl group and a 2,2,2-trifluoroethyl group as the C1-C6 haloalkyl group;
a cyclopropyl group and a cyclobutyl group as the C3-C8 cycloalkyl group;
a methoxy group, an ethoxy group, a propyloxy group and an isopropyloxy group as the C1-C6 alkoxy group;
a difluoromethoxy group, a trifluoromethoxy group, a 2,2-difluoroethoxy group and a 2,2,2-trifluoroethoxy group as the C1-C6 haloalkoxy group;
and a cyclopropyloxy group and a cyclobutoxy group as the C3-C8 cycloalkoxy group.

(426) The compound represented by Formula (1) may have one or two axial chirality. A ratio of the isomers at this time is a single isomer or a mixture of isomers with an optional ratio, and is not particularly limited.

(427) The compound represented by Formula (1) may contain an asymmetric atom. A ratio of the isomers at this time is a single isomer or a mixture of isomers with an optional ratio, and is not particularly limited.

(428) The compound represented by Formula (1) may contain geometric isomers. A ratio of the isomers at this time is a single isomer or a mixture of isomers with an optional ratio, and is not particularly limited.

(429) The compound represented by Formula (1) may form a salt. There may be exemplified salts formed with acids such as hydrochloric acid, sulfuric acid, acetic acid, fumaric acid and maleic acid, and salts formed with metals such as sodium, potassium and calcium, but these salts are not particularly limited as long as they are usable as agricultural and horticultural fungicides.

(430) All the scope of the compounds obtainable by optionally combining the preferable scope in R1, R2, Het, R3, Y, R4, R5, X, the bond containing the broken line, the substituent(s) A, the substituent(s) B, the substituent(s) C and the substituent(s) D explained hereinabove are also to be described herein as a scope of Formula (1) of the present invention or its production intermediate compounds.

(431) Next, specific compounds of the present invention are shown by combinations of the structural formulae P-1 to P-77 illustrated in Table 1 (wherein X in Table 1 is an oxygen atom or a sulfur atom, a bond containing a broken line represents a double bond or a single bond), the structural formulae (Y-1 to Y-408) of Y illustrated in Table 2 (wherein Y is the same as defined hereinabove), and the structural formulae (Het-1 to Het-2880) of Het illustrated in Table 3 (wherein Het is the same as defined hereinabove). Those compounds are only illustrative and the scope of the present invention is not limited to these compounds.

(432) TABLE-US-00001 TABLE 1 01embedded image P-1 02embedded image P-2 03embedded image P-3 04embedded image P-4 05embedded image P-5 06embedded image P-6 07embedded image P-7 08embedded image P-8 09embedded image P-9 0embedded image P-10 embedded image P-11 embedded image P-12 embedded image P-13 embedded image P-14 embedded image P-15 embedded image P-16 embedded image P-17 embedded image P-18 embedded image P-19 0embedded image P-20 embedded image P-21 embedded image P-22 embedded image P-23 embedded image P-24 embedded image P-25 embedded image P-26 embedded image P-27 embedded image P-28 embedded image P-29 0embedded image P-30 embedded image P-31 embedded image P-32 embedded image P-33 embedded image P-34 embedded image P-35 embedded image P-36 embedded image P-37 embedded image P-38 embedded image P-39 0embedded image P-40 embedded image P-41 embedded image P-42 embedded image P-43 embedded image P-44 embedded image P-45 embedded image P-46 embedded image P-47 embedded image P-48 embedded image P-49 0embedded image P-50 embedded image P-51 embedded image P-52 embedded image P-53 embedded image P-54 embedded image P-55 embedded image P-56 embedded image P-57 embedded image P-58 embedded image P-59 0embedded image P-60 embedded image P-61 embedded image P-62 embedded image P-63 embedded image P-64 embedded image P-65 embedded image P-66 embedded image P-67 embedded image P-68 embedded image P-69 0embedded image P-70 embedded image P-71 embedded image P-72 embedded image P-73 embedded image P-74 embedded image P-75 embedded image P-76 embedded image P-77

(433) TABLE-US-00002 TABLE 2 embedded image Y-1 embedded image Y-2 0embedded image Y-3 embedded image Y-4 embedded image Y-5 embedded image Y-6 embedded image Y-7 embedded image Y-8 embedded image Y-9 embedded image Y-10 embedded image Y-11 embedded image Y-12 0embedded image Y-13 embedded image Y-14 embedded image Y-15 embedded image Y-16 embedded image Y-17 embedded image Y-18 embedded image Y-19 embedded image Y-20 embedded image Y-21 embedded image Y-22 00embedded image Y-23 01embedded image Y-24 02embedded image Y-25 03embedded image Y-26 04embedded image Y-27 05embedded image Y-28 06embedded image Y-29 07embedded image Y-30 08embedded image Y-31 09embedded image Y-32 0embedded image Y-33 embedded image Y-34 embedded image Y-35 embedded image Y-36 embedded image Y-37 embedded image Y-38 embedded image Y-39 embedded image Y-40 embedded image Y-41 embedded image Y-42 0embedded image Y-43 embedded image Y-44 embedded image Y-45 embedded image Y-46 embedded image Y-47 embedded image Y-48 embedded image Y-49 embedded image Y-50 embedded image Y-51 embedded image Y-52 0embedded image Y-53 embedded image Y-54 embedded image Y-55 embedded image Y-56 embedded image Y-57 embedded image Y-58 embedded image Y-59 embedded image Y-60 embedded image Y-61 embedded image Y-62 0embedded image Y-63 embedded image Y-64 embedded image Y-65 embedded image Y-66 embedded image Y-67 embedded image Y-68 embedded image Y-69 embedded image Y-70 embedded image Y-71 embedded image Y-72 0embedded image Y-73 embedded image Y-74 embedded image Y-75 embedded image Y-76 embedded image Y-77 embedded image Y-78 embedded image Y-79 embedded image Y-80 embedded image Y-81 embedded image Y-82 0embedded image Y-83 embedded image Y-84 embedded image Y-85 embedded image Y-86 embedded image Y-87 embedded image Y-88 embedded image Y-89 embedded image Y-90 embedded image Y-91 embedded image Y-92 0embedded image Y-93 embedded image Y-94 embedded image Y-95 embedded image Y-96 embedded image Y-97 embedded image Y-98 embedded image Y-99 embedded image Y-100 embedded image Y-101 embedded image Y-102 0embedded image Y-103 embedded image Y-104 embedded image Y-105 embedded image Y-106 embedded image Y-107 embedded image Y-108 embedded image Y-109 embedded image Y-110 embedded image Y-111 embedded image Y-112 0embedded image Y-113 embedded image Y-114 embedded image Y-115 embedded image Y-116 embedded image Y-117 embedded image Y-118 embedded image Y-119 embedded image Y-120 embedded image Y-121 embedded image Y-122 00embedded image Y-123 01embedded image Y-124 02embedded image Y-125 03embedded image Y-126 04embedded image Y-127 05embedded image Y-128 06embedded image Y-129 07embedded image Y-130 08embedded image Y-131 09embedded image Y-132 0embedded image Y-133 embedded image Y-134 embedded image Y-135 embedded image Y-136 embedded image Y-137 embedded image Y-138 embedded image Y-139 embedded image Y-140 embedded image Y-141 embedded image Y-142 0embedded image Y-143 embedded image Y-144 embedded image Y-145 embedded image Y-146 embedded image Y-147 embedded image Y-148 embedded image Y-149 embedded image Y-150 embedded image Y-151 embedded image Y-152 0embedded image Y-153 embedded image Y-154 embedded image Y-155 embedded image Y-156 embedded image Y-157 embedded image Y-158 embedded image Y-159 embedded image Y-160 embedded image Y-161 embedded image Y-162 0embedded image Y-163 embedded image Y-164 embedded image Y-165 embedded image Y-166 embedded image Y-167 embedded image Y-168 embedded image Y-169 embedded image Y-170 embedded image Y-171 embedded image Y-172 0embedded image Y-173 embedded image Y-174 embedded image Y-175 embedded image Y-176 embedded image Y-177 embedded image Y-178 embedded image Y-179 embedded image Y-180 embedded image Y-181 embedded image Y-182 0embedded image Y-183 embedded image Y-184 embedded image Y-185 embedded image Y-186 embedded image Y-187 embedded image Y-188 embedded image Y-189 embedded image Y-190 embedded image Y-191 embedded image Y-192 0embedded image Y-193 embedded image Y-194 embedded image Y-195 embedded image Y-196 embedded image Y-197 embedded image Y-198 embedded image Y-199 embedded image Y-200 embedded image Y-201 embedded image Y-202 0embedded image Y-203 embedded image Y-204 embedded image Y-205 embedded image Y-206 embedded image Y-207 embedded image Y-208 embedded image Y-209 embedded image Y-210 embedded image Y-211 embedded image Y-212 0embedded image Y-213 embedded image Y-214 embedded image Y-215 embedded image Y-216 embedded image Y-217 embedded image Y-218 embedded image Y-219 embedded image Y-220 embedded image Y-221 embedded image Y-222 00embedded image Y-223 01embedded image Y-224 02embedded image Y-225 03embedded image Y-226 04embedded image Y-227 05embedded image Y-228 06embedded image Y-229 07embedded image Y-230 08embedded image Y-231 09embedded image Y-232 0embedded image Y-233 embedded image Y-234 embedded image Y-235 embedded image Y-236 embedded image Y-237 embedded image Y-238 embedded image Y-239 embedded image Y-240 embedded image Y-241 embedded image Y-242 0embedded image Y-243 embedded image Y-244 embedded image Y-245 embedded image Y-246 embedded image Y-247 embedded image Y-248 embedded image Y-249 embedded image Y-250 embedded image Y-251 embedded image Y-252 0embedded image Y-253 embedded image Y-254 embedded image Y-255 embedded image Y-256 embedded image Y-257 embedded image Y-258 embedded image Y-259 embedded image Y-260 embedded image Y-261 embedded image Y-262 0embedded image Y-263 embedded image Y-264 embedded image Y-265 embedded image Y-266 embedded image Y-267 embedded image Y-268 embedded image Y-269 embedded image Y-270 embedded image Y-271 embedded image Y-272 0embedded image Y-273 embedded image Y-274 embedded image Y-275 embedded image Y-276 embedded image Y-277 embedded image Y-278 embedded image Y-279 embedded image Y-280 embedded image Y-281 embedded image Y-282 0embedded image Y-283 embedded image Y-284 embedded image Y-285 embedded image Y-286 embedded image Y-287 embedded image Y-288 embedded image Y-289 embedded image Y-290 embedded image Y-291 embedded image Y-292 0embedded image Y-293 embedded image Y-294 embedded image Y-295 embedded image Y-296 embedded image Y-297 embedded image Y-298 embedded image Y-299 embedded image Y-300 embedded image Y-301 embedded image Y-302 0embedded image Y-303 embedded image Y-304 embedded image Y-305 embedded image Y-306 embedded image Y-307 embedded image Y-308 embedded image Y-309 embedded image Y-310 embedded image Y-311 embedded image Y-312 0embedded image Y-313 embedded image Y-314 embedded image Y-315 embedded image Y-316 embedded image Y-317 embedded image Y-318 embedded image Y-319 embedded image Y-320 embedded image Y-321 embedded image Y-322 00embedded image Y-323 01embedded image Y-324 02embedded image Y-325 03embedded image Y-326 04embedded image Y-327 05embedded image Y-328 06embedded image Y-329 07embedded image Y-330 08embedded image Y-331 09embedded image Y-332 0embedded image Y-333 embedded image Y-334 embedded image Y-335 embedded image Y-336 embedded image Y-337 embedded image Y-338 embedded image Y-339 embedded image Y-340 embedded image Y-341 embedded image Y-342 0embedded image Y-343 embedded image Y-344 embedded image Y-345 embedded image Y-346 embedded image Y-347 embedded image Y-348 embedded image Y-349 embedded image Y-350 embedded image Y-351 embedded image Y-352 0embedded image Y-353 embedded image Y-354 embedded image Y-355 embedded image Y-356 embedded image Y-357 embedded image Y-358 embedded image Y-359 embedded image Y-360 embedded image Y-361 embedded image Y-362 0embedded image Y-363 embedded image Y-364 embedded image Y-365 embedded image Y-366 embedded image Y-367 embedded image Y-368 embedded image Y-369 embedded image Y-370 embedded image Y-371 embedded image Y-372 0embedded image Y-373 embedded image Y-374 embedded image Y-375 embedded image Y-376 embedded image Y-377 embedded image Y-378 embedded image Y-379 embedded image Y-380 embedded image Y-381 embedded image Y-382 0embedded image Y-383 embedded image Y-384 embedded image Y-385 embedded image Y-386 embedded image Y-387 embedded image Y-388 embedded image Y-389 embedded image Y-390 embedded image Y-391 embedded image Y-392 0embedded image Y-393 embedded image Y-394 embedded image Y-395 embedded image Y-396 embedded image Y-397 embedded image Y-398 embedded image Y-399 embedded image Y-400 embedded image Y-401 embedded image Y-402 0embedded image Y-403 embedded image Y-404 embedded image Y-405 embedded image Y-406 embedded image Y-407 embedded image Y-408

(434) TABLE-US-00003 TABLE 3 embedded image Het-1 embedded image Het-2 embedded image Het-3 embedded image Het-4 0embedded image Het-5 embedded image Het-6 embedded image Het-7 embedded image Het-8 embedded image Het-9 embedded image Het-10 embedded image Het-11 embedded image Het-12 embedded image Het-13 embedded image Het-14 00embedded image Het-15 01embedded image Het-16 02embedded image Het-17 03embedded image Het-18 04embedded image Het-19 05embedded image Het-20 06embedded image Het-21 07embedded image Het-22 08embedded image Het-23 09embedded image Het-24 0embedded image Het-25 embedded image Het-26 embedded image Het-27 embedded image Het-28 embedded image Het-29 embedded image Het-30 embedded image Het-31 embedded image Het-32 embedded image Het-33 embedded image Het-34 0embedded image Het-35 embedded image Het-36 embedded image Het-37 embedded image Het-38 embedded image Het-39 embedded image Het-40 embedded image Het-41 embedded image Het-42 embedded image Het-43 embedded image Het-44 0embedded image Het-45 embedded image Het-46 embedded image Het-47 embedded image Het-48 embedded image Het-49 embedded image Het-50 embedded image Het-51 embedded image Het-52 embedded image Het-53 embedded image Het-54 0embedded image Het-55 embedded image Het-56 embedded image Het-57 embedded image Het-58 embedded image Het-59 embedded image Het-60 embedded image Het-61 embedded image Het-62 embedded image Het-63 embedded image Het-64 0embedded image Het-65 embedded image Het-66 embedded image Het-67 embedded image Het-68 embedded image Het-69 embedded image Het-70 embedded image Het-71 embedded image Het-72 embedded image Het-73 embedded image Het-74 0embedded image Het-75 embedded image Het-76 embedded image Het-77 embedded image Het-78 embedded image Het-79 embedded image Het-80 embedded image Het-81 embedded image Het-82 embedded image Het-83 embedded image Het-84 0embedded image Het-85 embedded image Het-86 embedded image Het-87 embedded image Het-88 embedded image Het-89 embedded image Het-90 embedded image Het-91 embedded image Het-92 embedded image Het-93 embedded image Het-94 0embedded image Het-95 embedded image Het-96 embedded image Het-97 embedded image Het-98 embedded image Het-99 embedded image Het-100 embedded image Het-101 embedded image Het-102 embedded image Het-103 embedded image Het-104 0embedded image Het-105 embedded image Het-106 embedded image Het-107 embedded image Het-108 embedded image Het-109 embedded image Het-110 embedded image Het-111 embedded image Het-112 embedded image Het-113 embedded image Het-114 00embedded image Het-115 01embedded image Het-116 02embedded image Het-117 03embedded image Het-118 04embedded image Het-119 05embedded image Het-120 06embedded image Het-121 07embedded image Het-122 08embedded image Het-123 09embedded image Het-124 0embedded image Het-125 embedded image Het-126 embedded image Het-127 embedded image Het-128 embedded image Het-129 embedded image Het-130 embedded image Het-131 embedded image Het-132 embedded image Het-133 embedded image Het-134 0embedded image Het-135 embedded image Het-136 embedded image Het-137 embedded image Het-138 embedded image Het-139 embedded image Het-140 embedded image Het-141 embedded image Het-142 embedded image Het-143 embedded image Het-144 0embedded image Het-145 embedded image Het-146 embedded image Het-147 embedded image Het-148 embedded image Het-149 embedded image Het-150 embedded image Het-151 embedded image Het-152 embedded image Het-153 embedded image Het-154 0embedded image Het-155 embedded image Het-156 embedded image Het-157 embedded image Het-158 embedded image Het-159 embedded image Het-160 embedded image Het-161 embedded image Het-162 embedded image Het-163 embedded image Het-164 0embedded image Het-165 embedded image Het-166 embedded image Het-167 embedded image Het-168 embedded image Het-169 embedded image Het-170 embedded image Het-171 embedded image Het-172 embedded image Het-173 embedded image Het-174 0embedded image Het-175 embedded image Het-176 embedded image Het-177 embedded image Het-178 embedded image Het-179 embedded image Het-180 embedded image Het-181 embedded image Het-182 embedded image Het-183 embedded image Het-184 0embedded image Het-185 embedded image Het-186 embedded image Het-187 embedded image Het-188 embedded image Het-189 embedded image Het-190 embedded image Het-191 embedded image Het-192 embedded image Het-193 embedded image Het-194 0embedded image Het-195 embedded image Het-196 embedded image Het-197 embedded image Het-198 embedded image Het-199 embedded image Het-200 embedded image Het-201 embedded image Het-202 embedded image Het-203 embedded image Het-204 0embedded image Het-205 embedded image Het-206 embedded image Het-207 embedded image Het-208 embedded image Het-209 embedded image Het-210 embedded image Het-211 embedded image Het-212 embedded image Het-213 embedded image Het-214 00embedded image Het-215 01embedded image Het-216 02embedded image Het-217 03embedded image Het-218 04embedded image Het-219 05embedded image Het-220 06embedded image Het-221 07embedded image Het-222 08embedded image Het-223 09embedded image Het-224 0embedded image Het-225 embedded image Het-226 embedded image Het-227 embedded image Het-228 embedded image Het-229 embedded image Het-230 embedded image Het-231 embedded image Het-232 embedded image Het-233 embedded image Het-234 0embedded image Het-235 embedded image Het-236 embedded image Het-237 embedded image Het-238 embedded image Het-239 embedded image Het-240 embedded image Het-241 embedded image Het-242 embedded image Het-243 embedded image Het-244 0embedded image Het-245 embedded image Het-246 embedded image Het-247 embedded image Het-248 embedded image Het-249 embedded image Het-250 embedded image Het-251 embedded image Het-252 embedded image Het-253 embedded image Het-254 0embedded image Het-255 embedded image Het-256 embedded image Het-257 embedded image Het-258 embedded image Het-259 embedded image Het-260 embedded image Het-261 embedded image Het-262 embedded image Het-263 embedded image Het-264 0embedded image Het-265 embedded image Het-266 embedded image Het-267 embedded image Het-268 embedded image Het-269 embedded image Het-270 embedded image Het-271 embedded image Het-272 embedded image Het-273 embedded image Het-274 0embedded image Het-275 embedded image Het-276 embedded image Het-277 embedded image Het-278 embedded image Het-279 embedded image Het-280 embedded image Het-281 embedded image Het-282 embedded image Het-283 embedded image Het-284 0embedded image Het-285 embedded image Het-286 embedded image Het-287 embedded image Het-288 embedded image Het-289 embedded image Het-290 embedded image Het-291 embedded image Het-292 embedded image Het-293 embedded image Het-294 0embedded image Het-295 embedded image Het-296 embedded image Het-297 embedded image Het-298 embedded image Het-299 embedded image Het-300 embedded image Het-301 embedded image Het-302 embedded image Het-303 embedded image Het-304 0embedded image Het-305 embedded image Het-306 embedded image Het-307 embedded image Het-308 embedded image Het-309 embedded image Het-310 embedded image Het-311 embedded image Het-312 embedded image Het-313 embedded image Het-314 00embedded image Het-315 01embedded image Het-316 02embedded image Het-317 03embedded image Het-318 04embedded image Het-319 05embedded image Het-320 06embedded image Het-321 07embedded image Het-322 08embedded image Het-323 09embedded image Het-324 0embedded image Het-325 embedded image Het-326 embedded image Het-327 embedded image Het-328 embedded image Het-329 embedded image Het-330 embedded image Het-331 embedded image Het-332 embedded image Het-333 embedded image Het-334 0embedded image Het-335 embedded image Het-336 embedded image Het-337 embedded image Het-338 embedded image Het-339 embedded image Het-340 embedded image Het-341 embedded image Het-342 embedded image Het-343 embedded image Het-344 0embedded image Het-345 embedded image Het-346 embedded image Het-347 embedded image Het-348 embedded image Het-349 embedded image Het-350 embedded image Het-351 embedded image Het-352 embedded image Het-353 embedded image Het-354 0embedded image Het-355 embedded image Het-356 embedded image Het-357 embedded image Het-358 embedded image Het-359 embedded image Het-360 embedded image Het-361 embedded image Het-362 embedded image Het-363 embedded image Het-364 0embedded image Het-365 embedded image Het-366 embedded image Het-367 embedded image Het-368 embedded image Het-369 embedded image Het-370 embedded image Het-371 embedded image Het-372 embedded image Het-373 embedded image Het-374 0embedded image Het-375 embedded image Het-376 embedded image Het-377 embedded image Het-378 embedded image Het-379 embedded image Het-380 embedded image Het-381 embedded image Het-382 embedded image Het-383 embedded image Het-384 0embedded image Het-385 embedded image Het-386 embedded image Het-387 embedded image Het-388 embedded image Het-389 embedded image Het-390 embedded image Het-391 embedded image Het-392 embedded image Het-393 embedded image Het-394 0embedded image Het-395 embedded image Het-396 embedded image Het-397 embedded image Het-398 embedded image Het-399 embedded image Het-400 embedded image Het-401 embedded image Het-402 embedded image Het-403 embedded image Het-404 0embedded image Het-405 embedded image Het-406 embedded image Het-407 embedded image Het-408 embedded image Het-409 embedded image Het-410 embedded image Het-411 embedded image Het-412 embedded image Het-413 embedded image Het-414 000embedded image Het-415 001embedded image Het-416 002embedded image Het-417 003embedded image Het-418 004embedded image Het-419 005embedded image Het-420 006embedded image Het-421 007embedded image Het-422 008embedded image Het-423 009embedded image Het-424 010embedded image Het-425 011embedded image Het-426 012embedded image Het-427 013embedded image Het-428 014embedded image Het-429 015embedded image Het-430 016embedded image Het-431 017embedded image Het-432 018embedded image Het-433 019embedded image Het-434 020embedded image Het-435 021embedded image Het-436 022embedded image Het-437 023embedded image Het-438 024embedded image Het-439 025embedded image Het-440 026embedded image Het-441 027embedded image Het-442 028embedded image Het-443 029embedded image Het-444 030embedded image Het-445 031embedded image Het-446 032embedded image Het-447 033embedded image Het-448 034embedded image Het-449 035embedded image Het-450 036embedded image Het-451 037embedded image Het-452 038embedded image Het-453 039embedded image Het-454 040embedded image Het-455 041embedded image Het-456 042embedded image Het-457 043embedded image Het-458 044embedded image Het-459 045embedded image Het-460 046embedded image Het-461 047embedded image Het-462 048embedded image Het-463 049embedded image Het-464 050embedded image Het-465 051embedded image Het-466 052embedded image Het-467 053embedded image Het-468 054embedded image Het-469 055embedded image Het-470 056embedded image Het-471 057embedded image Het-472 058embedded image Het-473 059embedded image Het-474 060embedded image Het-475 061embedded image Het-476 062embedded image Het-477 063embedded image Het-478 064embedded image Het-479 065embedded image Het-480 066embedded image Het-481 067embedded image Het-482 068embedded image Het-483 069embedded image Het-484 070embedded image Het-485 071embedded image Het-486 072embedded image Het-487 073embedded image Het-488 074embedded image Het-489 075embedded image Het-490 076embedded image Het-491 077embedded image Het-492 078embedded image Het-493 079embedded image Het-494 080embedded image Het-495 081embedded image Het-496 082embedded image Het-497 083embedded image Het-498 084embedded image Het-499 085embedded image Het-500 086embedded image Het-501 087embedded image Het-502 088embedded image Het-503 089embedded image Het-504 090embedded image Het-505 091embedded image Het-506 092embedded image Het-507 093embedded image Het-508 094embedded image Het-509 095embedded image Het-510 096embedded image Het-511 097embedded image Het-512 098embedded image Het-513 099embedded image Het-514 00embedded image Het-515 01embedded image Het-516 02embedded image Het-517 03embedded image Het-518 04embedded image Het-519 05embedded image Het-520 06embedded image Het-521 07embedded image Het-522 08embedded image Het-523 09embedded image Het-524 0embedded image Het-525 embedded image Het-526 embedded image Het-527 embedded image Het-528 embedded image Het-529 embedded image Het-530 embedded image Het-531 embedded image Het-532 embedded image Het-533 embedded image Het-534 0embedded image Het-535 embedded image Het-536 embedded image Het-537 embedded image Het-538 embedded image Het-539 embedded image Het-540 embedded image Het-541 embedded image Het-542 embedded image Het-543 embedded image Het-544 0embedded image Het-545 embedded image Het-546 embedded image Het-547 embedded image Het-548 embedded image Het-549 embedded image Het-550 embedded image Het-551 embedded image Het-552 embedded image Het-553 embedded image Het-554 0embedded image Het-555 embedded image Het-556 embedded image Het-557 embedded image Het-558 embedded image Het-559 embedded image Het-560 embedded image Het-561 embedded image Het-562 embedded image Het-563 embedded image Het-564 0embedded image Het-565 embedded image Het-566 embedded image Het-567 embedded image Het-568 embedded image Het-569 embedded image Het-570 embedded image Het-571 embedded image Het-572 embedded image Het-573 embedded image Het-574 0embedded image Het-575 embedded image Het-576 embedded image Het-577 embedded image Het-578 embedded image Het-579 embedded image Het-580 embedded image Het-581 embedded image Het-582 embedded image Het-583 embedded image Het-584 0embedded image Het-585 embedded image Het-586 embedded image Het-587 embedded image Het-588 embedded image Het-589 embedded image Het-590 embedded image Het-591 embedded image Het-592 embedded image Het-593 embedded image Het-594 0embedded image Het-595 embedded image Het-596 embedded image Het-597 embedded image Het-598 embedded image Het-599 embedded image Het-600 embedded image Het-601 embedded image Het-602 embedded image Het-603 embedded image Het-604 0embedded image Het-605 embedded image Het-606 embedded image Het-607 embedded image Het-608 embedded image Het-609 embedded image Het-610 embedded image Het-611 embedded image Het-612 embedded image Het-613 embedded image Het-614 00embedded image Het-615 01embedded image Het-616 02embedded image Het-617 03embedded image Het-618 04embedded image Het-619 05embedded image Het-620 06embedded image Het-621 07embedded image Het-622 08embedded image Het-623 09embedded image Het-624 0embedded image Het-625 embedded image Het-626 embedded image Het-627 embedded image Het-628 embedded image Het-629 embedded image Het-630 embedded image Het-631 embedded image Het-632 embedded image Het-633 embedded image Het-634 0embedded image Het-635 embedded image Het-636 embedded image Het-637 embedded image Het-638 embedded image Het-639 embedded image Het-640 embedded image Het-641 embedded image Het-642 embedded image Het-643 embedded image Het-644 0embedded image Het-645 embedded image Het-646 embedded image Het-647 embedded image Het-648 embedded image Het-649 embedded image Het-650 embedded image Het-651 embedded image Het-652 embedded image Het-653 embedded image Het-654 0embedded image Het-655 embedded image Het-656 embedded image Het-657 embedded image Het-658 embedded image Het-659 embedded image Het-660 embedded image Het-661 embedded image Het-662 embedded image Het-683 embedded image Het-664 0embedded image Het-665 embedded image Het-666 embedded image Het-667 embedded image Het-688 embedded image Het-669 embedded image Het-670 embedded image Het-671 embedded image Het-672 embedded image Het-673 embedded image Het-674 0embedded image Het-675 embedded image Het-676 embedded image Het-677 embedded image Het-678 embedded image Het-679 embedded image Het-680 embedded image Het-681 embedded image Het-682 embedded image Het-683 embedded image Het-684 0embedded image Het-685 embedded image Het-686 embedded image Het-687 embedded image Het-688 embedded image Het-689 embedded image Het-690 embedded image Het-691 embedded image Het-692 embedded image Het-693 embedded image Het-694 0embedded image Het-695 embedded image Het-696 embedded image Het-697 embedded image Het-698 embedded image Het-699 embedded image Het-700 embedded image Het-701 embedded image Het-702 embedded image Het-703 embedded image Het-704 0embedded image Het-705 embedded image Het-706 embedded image Het-707 embedded image Het-708 embedded image Het-709 embedded image Het-710 embedded image Het-711 embedded image Het-712 embedded image Het-713 embedded image Het-714 00embedded image Het-715 01embedded image Het-716 02embedded image Het-717 03embedded image Het-718 04embedded image Het-719 05embedded image Het-720 06embedded image Het-721 07embedded image Het-722 08embedded image Het-723 09embedded image Het-724 0embedded image Het-725 embedded image Het-726 embedded image Het-727 embedded image Het-728 embedded image Het-729 embedded image Het-730 embedded image Het-731 embedded image Het-732 embedded image Het-733 embedded image Het-734 0embedded image Het-735 embedded image Het-736 embedded image Het-737 embedded image Het-738 embedded image Het-739 embedded image Het-740 embedded image Het-741 embedded image Het-742 embedded image Het-743 embedded image Het-744 0embedded image Het-745 embedded image Het-746 embedded image Het-747 embedded image Het-748 embedded image Het-749 embedded image Het-750 embedded image Het-751 embedded image Het-752 embedded image Het-753 embedded image Het-754 0embedded image Het-755 embedded image Het-756 embedded image Het-757 embedded image Het-758 embedded image Het-759 embedded image Het-760 embedded image Het-761 embedded image Het-762 embedded image Het-763 embedded image Het-764 0embedded image Het-765 embedded image Het-766 embedded image Het-767 embedded image Het-768 embedded image Het-769 embedded image Het-770 embedded image Het-771 embedded image Het-772 embedded image Het-773 embedded image Het-774 0embedded image Het-775 embedded image Het-776 embedded image Het-777 embedded image Het-778 embedded image Het-779 embedded image Het-780 embedded image Het-781 embedded image Het-782 embedded image Het-783 embedded image Het-784 0embedded image Het-785 embedded image Het-786 embedded image Het-787 embedded image Het-788 embedded image Het-789 embedded image Het-790 embedded image Het-791 embedded image Het-792 embedded image Het-793 embedded image Het-794 0embedded image Het-795 embedded image Het-796 embedded image Het-797 embedded image Het-798 embedded image Het-799 embedded image Het-800 embedded image Het-801 embedded image Het-802 embedded image Het-803 embedded image Het-804 0embedded image Het-805 embedded image Het-806 embedded image Het-807 embedded image Het-808 embedded image Het-809 embedded image Het-810 embedded image Het-811 embedded image Het-812 embedded image Het-813 embedded image Het-814 00embedded image Het-815 01embedded image Het-816 02embedded image Het-817 03embedded image Het-818 04embedded image Het-819 05embedded image Het-820 06embedded image Het-821 07embedded image Het-822 08embedded image Het-823 09embedded image Het-824 0embedded image Het-825 embedded image Het-826 embedded image Het-827 embedded image Het-828 embedded image Het-829 embedded image Het-830 embedded image Het-831 embedded image Het-832 embedded image Het-833 embedded image Het-834 0embedded image Het-835 embedded image Het-836 embedded image Het-837 embedded image Het-838 embedded image Het-839 embedded image Het-840 embedded image Het-841 embedded image Het-842 embedded image Het-843 embedded image Het-844 0embedded image Het-845 embedded image Het-846 embedded image Het-847 embedded image Het-848 embedded image Het-849 embedded image Het-850 embedded image Het-851 embedded image Het-852 embedded image Het-853 embedded image Het-854 0embedded image Het-855 embedded image Het-856 embedded image Het-857 embedded image Het-858 embedded image Het-859 embedded image Het-860 embedded image Het-881 embedded image Het-862 embedded image Het-863 embedded image Het-864 0embedded image Het-865 embedded image Het-866 embedded image Het-887 embedded image Het-868 embedded image Het-869 embedded image Het-870 embedded image Het-871 embedded image Het-872 embedded image Het-873 embedded image Het-874 0embedded image Het-875 embedded image Het-876 embedded image Het-877 embedded image Het-878 embedded image Het-879 embedded image Het-880 embedded image Het-881 embedded image Het-882 embedded image Het-883 embedded image Het-884 0embedded image Het-885 embedded image Het-886 embedded image Het-887 embedded image Het-888 embedded image Het-889 embedded image Het-890 embedded image Het-891 embedded image Het-892 embedded image Het-893 embedded image Het-894 0embedded image Het-895 embedded image Het-896 embedded image Het-897 embedded image Het-898 embedded image Het-899 embedded image Het-900 embedded image Het-901 embedded image Het-902 embedded image Het-903 embedded image Het-904 0embedded image Het-905 embedded image Het-906 embedded image Het-907 embedded image Het-908 embedded image Het-909 embedded image Het-910 embedded image Het-911 embedded image Het-912 embedded image Het-913 embedded image Het-914 00embedded image Het-915 01embedded image Het-916 02embedded image Het-917 03embedded image Het-918 04embedded image Het-919 05embedded image Het-920 06embedded image Het-921 07embedded image Het-922 08embedded image Het-923 09embedded image Het-924 0embedded image Het-925 embedded image Het-926 embedded image Het-927 embedded image Het-928 embedded image Het-929 embedded image Het-930 embedded image Het-931 embedded image Het-932 embedded image Het-933 embedded image Het-934 0embedded image Het-935 embedded image Het-936 embedded image Het-937 embedded image Het-938 embedded image Het-939 embedded image Het-940 embedded image Het-941 embedded image Het-942 embedded image Het-943 embedded image Het-944 0embedded image Het-945 embedded image Het-946 embedded image Het-947 embedded image Het-948 embedded image Het-949 embedded image Het-950 embedded image Het-951 embedded image Het-952 embedded image Het-953 embedded image Het-954 0embedded image Het-955 embedded image Het-956 embedded image Het-957 embedded image Het-958 embedded image Het-959 embedded image Het-960 embedded image Het-961 embedded image Het-982 embedded image Het-983 embedded image Het-964 0embedded image Het-965 embedded image Het-966 embedded image Het-967 embedded image Het-968 embedded image Het-969 embedded image Het-970 embedded image Het-971 embedded image Het-972 embedded image Het-973 embedded image Het-974 0embedded image Het-975 embedded image Het-976 embedded image Het-977 embedded image Het-978 embedded image Het-979 embedded image Het-980 embedded image Het-981 embedded image Het-982 embedded image Het-983 embedded image Het-984 0embedded image Het-985 embedded image Het-986 embedded image Het-987 embedded image Het-988 embedded image Het-989 embedded image Het-990 embedded image Het-991 embedded image Het-992 embedded image Het-993 embedded image Het-994 0embedded image Het-995 embedded image Het-996 embedded image Het-997 embedded image Het-998 embedded image Het-999 embedded image Het-1000 embedded image Het-1001 embedded image Het-1002 embedded image Het-1003 embedded image Het-1004 0embedded image Het-1005 embedded image Het-1006 embedded image Het-1007 embedded image Het-1008 embedded image Het-1009 embedded image Het-1010 embedded image Het-1011 embedded image Het-1012 embedded image Het-1013 embedded image Het-1014 00embedded image Het-1015 01embedded image Het-1016 02embedded image Het-1017 03embedded image Het-1018 04embedded image Het-1019 05embedded image Het-1020 06embedded image Het-1021 07embedded image Het-1022 08embedded image Het-1023 09embedded image Het-1024 0embedded image Het-1025 embedded image Het-1026 embedded image Het-1027 embedded image Het-1028 embedded image Het-1029 embedded image Het-1030 embedded image Het-1031 embedded image Het-1032 embedded image Het-1033 embedded image Het-1034 0embedded image Het-1035 embedded image Het-1036 embedded image Het-1037 embedded image Het-1038 embedded image Het-1039 embedded image Het-1040 embedded image Het-1041 embedded image Het-1042 embedded image Het-1043 embedded image Het-1044 0embedded image Het-1045 embedded image Het-1046 embedded image Het-1047 embedded image Het-1048 embedded image Het-1049 embedded image Het-1050 embedded image Het-1051 embedded image Het-1052 embedded image Het-1053 embedded image Het-1054 0embedded image Het-1055 embedded image Het-1056 embedded image Het-1057 embedded image Het-1058 embedded image Het-1059 embedded image Het-1060 embedded image Het-1061 embedded image Het-1062 embedded image Het-1063 embedded image Het-1064 0embedded image Het-1065 embedded image Het-1066 embedded image Het-1067 embedded image Het-1068 embedded image Het-1069 embedded image Het-1070 embedded image Het-1071 embedded image Het-1072 embedded image Het-1073 embedded image Het-1074 0embedded image Het-1075 embedded image Het-1076 embedded image Het-1077 embedded image Het-1078 embedded image Het-1079 embedded image Het-1080 embedded image Het-1081 embedded image Het-1082 embedded image Het-1083 embedded image Het-1084 0embedded image Het-1085 embedded image Het-1086 embedded image Het-1087 embedded image Het-1088 embedded image Het-1089 embedded image Het-1090 embedded image Het-1091 embedded image Het-1092 embedded image Het-1093 embedded image Het-1094 0embedded image Het-1095 embedded image Het-1096 embedded image Het-1097 embedded image Het-1098 embedded image Het-1099 embedded image Het-1100 embedded image Het-1101 embedded image Het-1102 embedded image Het-1103 embedded image Het-1104 0embedded image Het-1105 embedded image Het-1106 embedded image Het-1107 embedded image Het-1108 embedded image Het-1109 embedded image Het-1110 embedded image Het-1111 embedded image Het-1112 embedded image Het-1113 embedded image Het-1114 00embedded image Het-1115 01embedded image Het-1116 02embedded image Het-1117 03embedded image Het-1118 04embedded image Het-1119 05embedded image Het-1120 06embedded image Het-1121 07embedded image Het-1122 08embedded image Het-1123 09embedded image Het-1124 0embedded image Het-1125 embedded image Het-1126 embedded image Het-1127 embedded image Het-1128 embedded image Het-1129 embedded image Het-1130 embedded image Het-1131 embedded image Het-1132 embedded image Het-1133 embedded image Het-1134 0embedded image Het-1135 embedded image Het-1136 embedded image Het-1137 embedded image Het-1138 embedded image Het-1139 embedded image Het-1140 embedded image Het-1141 embedded image Het-1142 embedded image Het-1143 embedded image Het-1144 0embedded image Het-1145 embedded image Het-1146 embedded image Het-1147 embedded image Het-1148 embedded image Het-1149 embedded image Het-1150 embedded image Het-1151 embedded image Het-1152 embedded image Het-1153 embedded image Het-1154 0embedded image Het-1155 embedded image Het-1156 embedded image Het-1157 embedded image Het-1158 embedded image Het-1159 embedded image Het-1160 embedded image Het-1161 embedded image Het-1162 embedded image Het-1163 embedded image Het-1164 0embedded image Het-1165 embedded image Het-1166 embedded image Het-1167 embedded image Het-1168 embedded image Het-1169 embedded image Het-1170 embedded image Het-1171 embedded image Het-1172 embedded image Het-1173 embedded image Het-1174 0embedded image Het-1175 embedded image Het-1176 embedded image Het-1177 embedded image Het-1178 embedded image Het-1179 embedded image Het-1180 embedded image Het-1181 embedded image Het-1182 embedded image Het-1183 embedded image Het-1184 0embedded image Het-1185 embedded image Het-1186 embedded image Het-1187 embedded image Het-1188 embedded image Het-1189 embedded image Het-1190 embedded image Het-1191 embedded image Het-1192 embedded image Het-1193 embedded image Het-1194 0embedded image Het-1195 embedded image Het-1196 embedded image Het-1197 embedded image Het-1198 embedded image Het-1199 embedded image Het-1200 embedded image Het-1201 embedded image Het-1202 embedded image Het-1203 embedded image Het-1204 0embedded image Het-1205 embedded image Het-1206 embedded image Het-1207 embedded image Het-1208 embedded image Het-1209 embedded image Het-1210 embedded image Het-1211 embedded image Het-1212 embedded image Het-1213 embedded image Het-1214 00embedded image Het-1215 01embedded image Het-1216 02embedded image Het-1217 03embedded image Het-1218 04embedded image Het-1219 05embedded image Het-1220 06embedded image Het-1221 07embedded image Het-1222 08embedded image Het-1223 09embedded image Het-1224 0embedded image Het-1226 embedded image Het-1226 embedded image Het-1227 embedded image Het-1228 embedded image Het-1229 embedded image Het-1230 embedded image Het-1231 embedded image Het-1232 embedded image Het-1233 embedded image Het-1234 0embedded image Het-1235 embedded image Het-1236 embedded image Het-1237 embedded image Het-1238 embedded image Het-1239 embedded image Het-1240 embedded image Het-1241 embedded image Het-1242 embedded image Het-1243 embedded image Het-1244 0embedded image Het-1245 embedded image Het-1246 embedded image Het-1247 embedded image Het-1248 embedded image Het-1249 embedded image Het-1250 embedded image Het-1251 embedded image Het-1252 embedded image Het-1253 embedded image Het-1254 0embedded image Het-1255 embedded image Het-1256 embedded image Het-1257 embedded image Het-1258 embedded image Het-1259 embedded image Het-1260 embedded image Het-1261 embedded image Het-1262 embedded image Het-1263 embedded image Het-1264 0embedded image Het-1265 embedded image Het-1266 embedded image Het-1267 embedded image Het-1268 embedded image Het-1269 embedded image Het-1270 embedded image Het-1271 embedded image Het-1272 embedded image Het-1273 embedded image Het-1274 0embedded image Het-1275 embedded image Het-1276 embedded image Het-1277 embedded image Het-1278 embedded image Het-1279 embedded image Het-1280 embedded image Het-1281 embedded image Het-1282 embedded image Het-1283 embedded image Het-1284 0embedded image Het-1285 embedded image Het-1286 embedded image Het-1287 embedded image Het-1288 embedded image Het-1289 embedded image Het-1290 embedded image Het-1291 embedded image Het-1292 embedded image Het-1293 embedded image Het-1294 0embedded image Het-1295 embedded image Het-1296 embedded image Het-1297 embedded image Het-1298 embedded image Het-1299 embedded image Het-1300 embedded image Het-1301 embedded image Het-1302 embedded image Het-1303 embedded image Het-1304 0embedded image Het-1305 embedded image Het-1306 embedded image Het-1307 embedded image Het-1308 embedded image Het-1309 embedded image Het-1310 embedded image Het-1311 embedded image Het-1312 embedded image Het-1313 embedded image Het-1314 00embedded image Het-1315 01embedded image Het-1316 02embedded image Het-1317 03embedded image Het-1318 04embedded image Het-1319 05embedded image Het-1320 06embedded image Het-1321 07embedded image Het-1322 08embedded image Het-1323 09embedded image Het-1324 0embedded image Het-1325 embedded image Het-1326 embedded image Het-1327 embedded image Het-1328 embedded image Het-1329 embedded image Het-1330 embedded image Het-1331 embedded image Het-1332 embedded image Het-1333 embedded image Het-1334 0embedded image Het-1335 embedded image Het-1336 embedded image Het-1337 embedded image Het-1338 embedded image Het-1339 embedded image Het-1340 embedded image Het-1341 embedded image Het-1342 embedded image Het-1343 embedded image Het-1344 0embedded image Het-1345 embedded image Het-1346 embedded image Het-1347 embedded image Het-1348 embedded image Het-1349 embedded image Het-1350 embedded image Het-1351 embedded image Het-1352 embedded image Het-1353 embedded image Het-1354 0embedded image Het-1355 embedded image Het-1356 embedded image Het-1357 embedded image Het-1358 embedded image Het-1359 embedded image Het-1360 embedded image Het-1361 embedded image Het-1362 embedded image Het-1363 embedded image Het-1364 0embedded image Het-1365 embedded image Het-1366 embedded image Het-1367 embedded image Het-1368 embedded image Het-1369 embedded image Het-1370 embedded image Het-1371 embedded image Het-1372 embedded image Het-1373 embedded image Het-1374 0embedded image Het-1375 embedded image Het-1376 embedded image Het-1377 embedded image Het-1378 embedded image Het-1379 embedded image Het-1380 embedded image Het-1381 embedded image Het-1382 embedded image Het-1383 embedded image Het-1384 0embedded image Het-1385 embedded image Het-1386 embedded image Het-1387 embedded image Het-1388 embedded image Het-1389 embedded image Het-1390 embedded image Het-1391 embedded image Het-1392 embedded image Het-1393 embedded image Het-1394 0embedded image Het-1395 embedded image Het-1396 embedded image Het-1397 embedded image Het-1398 embedded image Het-1399 embedded image Het-1400 embedded image Het-1401 embedded image Het-1402 embedded image Het-1403 embedded image Het-1404 0embedded image Het-1405 embedded image Het-1406 embedded image Het-1407 embedded image Het-1408 embedded image Het-1409 embedded image Het-1410 embedded image Het-1411 embedded image Het-1412 embedded image Het-1413 embedded image Het-1414 000embedded image Het-1415 001embedded image Het-1416 002embedded image Het-1417 003embedded image Het-1418 004embedded image Het-1419 005embedded image Het-1420 006embedded image Het-1421 007embedded image Het-1422 008embedded image Het-1423 009embedded image Het-1424 010embedded image Het-1425 011embedded image Het-1426 012embedded image Het-1427 013embedded image Het-1428 014embedded image Het-1429 015embedded image Het-1430 016embedded image Het-1431 017embedded image Het-1432 018embedded image Het-1433 019embedded image Het-1434 020embedded image Het-1435 021embedded image Het-1436 022embedded image Het-1437 023embedded image Het-1438 024embedded image Het-1439 025embedded image Het-1440 026embedded image Het-1441 027embedded image Het-1442 028embedded image Het-1443 029embedded image Het-1444 030embedded image Het-1445 031embedded image Het-1446 032embedded image Het-1447 033embedded image Het-1448 034embedded image Het-1449 035embedded image Het-1450 036embedded image Het-1451 037embedded image Het-1452 038embedded image Het-1453 039embedded image Het-1454 040embedded image Het-1455 041embedded image Het-1456 042embedded image Het-1457 043embedded image Het-1458 044embedded image Het-1459 045embedded image Het-1460 046embedded image Het-1461 047embedded image Het-1462 048embedded image Het-1463 049embedded image Het-1464 050embedded image Het-1465 051embedded image Het-1466 052embedded image Het-1467 053embedded image Het-1468 054embedded image Het-1469 055embedded image Het-1470 056embedded image Het-1471 057embedded image Het-1472 058embedded image Het-1473 059embedded image Het-1474 060embedded image Het-1475 061embedded image Het-1476 062embedded image Het-1477 063embedded image Het-1478 064embedded image Het-1479 065embedded image Het-1480 066embedded image Het-1481 067embedded image Het-1482 068embedded image Het-1483 069embedded image Het-1484 070embedded image Het-1485 071embedded image Het-1486 072embedded image Het-1487 073embedded image Het-1488 074embedded image Het-1489 075embedded image Het-1490 076embedded image Het-1491 077embedded image Het-1492 078embedded image Het-1493 079embedded image Het-1494 080embedded image Het-1495 081embedded image Het-1496 082embedded image Het-1497 083embedded image Het-1498 084embedded image Het-1499 085embedded image Het-1500 086embedded image Het-1501 087embedded image Het-1502 088embedded image Het-1503 089embedded image Het-1504 090embedded image Het-1505 091embedded image Het-1506 092embedded image Het-1507 093embedded image Het-1508 094embedded image Het-1509 095embedded image Het-1510 096embedded image Het-1511 097embedded image Het-1512 098embedded image Het-1513 099embedded image Het-1514 00embedded image Het-1515 01embedded image Het-1516 02embedded image Het-1517 03embedded image Het-1518 04embedded image Het-1519 05embedded image Het-1520 06embedded image Het-1521 07embedded image Het-1522 08embedded image Het-1523 09embedded image Het-1524 0embedded image Het-1525 embedded image Het-1526 embedded image Het-1527 embedded image Het-1528 embedded image Het-1529 embedded image Het-1530 embedded image Het-1531 embedded image Het-1532 embedded image Het-1533 embedded image Het-1534 0embedded image Het-1535 embedded image Het-1536 embedded image Het-1537 embedded image Het-1538 embedded image Het-1539 embedded image Het-1540 embedded image Het-1541 embedded image Het-1542 embedded image Het-1543 embedded image Het-1544 0embedded image Het-1545 embedded image Het-1546 embedded image Het-1547 embedded image Het-1548 embedded image Het-1549 embedded image Het-1550 embedded image Het-1551 embedded image Het-1552 embedded image Het-1553 embedded image Het-1554 0embedded image Het-1555 embedded image Het-1556 embedded image Het-1557 embedded image Het-1558 embedded image Het-1559 embedded image Het-1560 embedded image Het-1561 embedded image Het-1562 embedded image Het-1563 embedded image Het-1564 0embedded image Het-1565 embedded image Het-1566 embedded image Het-1567 embedded image Het-1568 embedded image Het-1569 embedded image Het-1570 embedded image Het-1571 embedded image Het-1572 embedded image Het-1573 embedded image Het-1574 0embedded image Het-1575 embedded image Het-1576 embedded image Het-1577 embedded image Het-1578 embedded image Het-1579 embedded image Het-1580 embedded image Het-1581 embedded image Het-1582 embedded image Het-1583 embedded image Het-1584 0embedded image Het-1585 embedded image Het-1586 embedded image Het-1587 embedded image Het-1588 embedded image Het-1589 embedded image Het-1590 embedded image Het-1591 embedded image Het-1592 embedded image Het-1593 embedded image Het-1594 0embedded image Het-1595 embedded image Het-1596 embedded image Het-1597 embedded image Het-1598 embedded image Het-1599 embedded image Het-1600 embedded image Het-1601 embedded image Het-1602 embedded image Het-1603 embedded image Het-1604 0embedded image Het-1605 embedded image Het-1606 embedded image Het-1607 embedded image Het-1608 embedded image Het-1609 embedded image Het-1610 embedded image Het-1611 embedded image Het-1612 embedded image Het-1613 embedded image Het-1614 00embedded image Het-1615 01embedded image Het-1616 02embedded image Het-1617 03embedded image Het-1618 04embedded image Het-1619 05embedded image Het-1620 06embedded image Het-1621 07embedded image Het-1622 08embedded image Het-1623 09embedded image Het-1624 0embedded image Het-1625 embedded image Het-1626 embedded image Het-1627 embedded image Het-1628 embedded image Het-1629 embedded image Het-1630 embedded image Het-1631 embedded image Het-1632 embedded image Het-1633 embedded image Het-1634 0embedded image Het-1635 embedded image Het-1636 embedded image Het-1637 embedded image Het-1638 embedded image Het-1639 embedded image Het-1640 embedded image Het-1641 embedded image Het-1642 embedded image Het-1643 embedded image Het-1644 0embedded image Het-1645 embedded image Het-1646 embedded image Het-1647 embedded image Het-1648 embedded image Het-1649 embedded image Het-1650 embedded image Het-1651 embedded image Het-1652 embedded image Het-1653 embedded image Het-1654 0embedded image Het-1655 embedded image Het-1656 embedded image Het-1657 embedded image Het-1658 embedded image Het-1659 embedded image Het-1660 embedded image Het-1661 embedded image Het-1662 embedded image Het-1683 embedded image Het-1684 0embedded image Het-1665 embedded image Het-1666 embedded image Het-1667 embedded image Het-1668 embedded image Het-1669 embedded image Het-1670 embedded image Het-1671 embedded image Het-1672 embedded image Het-1673 embedded image Het-1674 0embedded image Het-1675 embedded image Het-1676 embedded image Het-1677 embedded image Het-1678 embedded image Het-1679 embedded image Het-1680 embedded image Het-1681 embedded image Het-1682 embedded image Het-1683 embedded image Het-1684 0embedded image Het-1685 embedded image Het-1686 embedded image Het-1687 embedded image Het-1688 embedded image Het-1689 embedded image Het-1690 embedded image Het-1691 embedded image Het-1692 embedded image Het-1693 embedded image Het-1694 0embedded image Het-1695 embedded image Het-1696 embedded image Het-1697 embedded image Het-1698 embedded image Het-1699 embedded image Het-1700 embedded image Het-1701 embedded image Het-1702 embedded image Het-1703 embedded image Het-1704 0embedded image Het-1705 embedded image Het-1706 embedded image Het-1707 embedded image Het-1708 embedded image Het-1709 embedded image Het-1710 embedded image Het-1711 embedded image Het-1712 embedded image Het-1713 embedded image Het-1714 00embedded image Het-1715 01embedded image Het-1716 02embedded image Het-1717 03embedded image Het-1718 04embedded image Het-1719 05embedded image Het-1720 06embedded image Het-1721 07embedded image Het-1722 08embedded image Het-1723 09embedded image Het-1724 0embedded image Het-1725 embedded image Het-1726 embedded image Het-1727 embedded image Het-1728 embedded image Het-1729 embedded image Het-1730 embedded image Het-1731 embedded image Het-1732 embedded image Het-1733 embedded image Het-1734 0embedded image Het-1735 embedded image Het-1736 embedded image Het-1737 embedded image Het-1738 embedded image Het-1739 embedded image Het-1740 embedded image Het-1741 embedded image Het-1742 embedded image Het-1743 embedded image Het-1744 0embedded image Het-1745 embedded image Het-1746 embedded image Het-1747 embedded image Het-1748 embedded image Het-1749 embedded image Het-1750 embedded image Het-1751 embedded image Het-1752 embedded image Het-1753 embedded image Het-1754 0embedded image Het-1755 embedded image Het-1756 embedded image Het-1757 embedded image Het-1758 embedded image Het-1759 embedded image Het-1760 embedded image Het-1761 embedded image Het-1762 embedded image Het-1763 embedded image Het-1764 0embedded image Het-1765 embedded image Het-1766 embedded image Het-1767 embedded image Het-1768 embedded image Het-1769 embedded image Het-1770 embedded image Het-1771 embedded image Het-1772 embedded image Het-1773 embedded image Het-1774 0embedded image Het-1775 embedded image Het-1776 embedded image Het-1777 embedded image Het-1778 embedded image Het-1779 embedded image Het-1780 embedded image Het-1781 embedded image Het-1782 embedded image Het-1783 embedded image Het-1784 0embedded image Het-1785 embedded image Het-1786 embedded image Het-1787 embedded image Het-1788 embedded image Het-1789 embedded image Het-1790 embedded image Het-1791 embedded image Het-1792 embedded image Het-1793 embedded image Het-1794 0embedded image Het-1795 embedded image Het-1796 embedded image Het-1797 embedded image Het-1798 embedded image Het-1799 embedded image Het-1800 embedded image Het-1801 embedded image Het-1802 embedded image Het-1803 embedded image Het-1804 0embedded image Het-1805 embedded image Het-1806 embedded image Het-1807 embedded image Het-1808 embedded image Het-1809 embedded image Het-1810 embedded image Het-1811 embedded image Het-1812 embedded image Het-1813 embedded image Het-1814 00embedded image Het-1815 01embedded image Het-1816 02embedded image Het-1817 03embedded image Het-1818 04embedded image Het-1819 05embedded image Het-1820 06embedded image Het-1821 07embedded image Het-1822 08embedded image Het-1823 09embedded image Het-1824 0embedded image Het-1825 embedded image Het-1826 embedded image Het-1827 embedded image Het-1828 embedded image Het-1829 embedded image Het-1830 embedded image Het-1831 embedded image Het-1832 embedded image Het-1833 embedded image Het-1834 0embedded image Het-1835 embedded image Het-1836 embedded image Het-1837 embedded image Het-1838 embedded image Het-1839 embedded image Het-1840 embedded image Het-1841 embedded image Het-1842 embedded image Het-1843 embedded image Het-1844 0embedded image Het-1845 embedded image Het-1846 embedded image Het-1847 embedded image Het-1848 embedded image Het-1849 embedded image Het-1850 embedded image Het-1851 embedded image Het-1852 embedded image Het-1853 embedded image Het-1854 0embedded image Het-1855 embedded image Het-1856 embedded image Het-1857 embedded image Het-1858 embedded image Het-1859 embedded image Het-1860 embedded image Het-1861 embedded image Het-1862 embedded image Het-1863 embedded image Het-1864 0embedded image Het-1865 embedded image Het-1866 embedded image Het-1887 embedded image Het-1868 embedded image Het-1869 embedded image Het-1870 embedded image Het-1871 embedded image Het-1872 embedded image Het-1873 embedded image Het-1874 0embedded image Het-1875 embedded image Het-1876 embedded image Het-1877 embedded image Het-1878 embedded image Het-1879 embedded image Het-1880 embedded image Het-1881 embedded image Het-1882 embedded image Het-1883 embedded image Het-1884 0embedded image Het-1885 embedded image Het-1886 embedded image Het-1887 embedded image Het-1888 embedded image Het-1889 embedded image Het-1890 embedded image Het-1891 embedded image Het-1892 embedded image Het-1893 embedded image Het-1894 0embedded image Het-1895 embedded image Het-1896 embedded image Het-1897 embedded image Het-1898 embedded image Het-1899 embedded image Het-1900 embedded image Het-1901 embedded image Het-1902 embedded image Het-1903 embedded image Het-1904 0embedded image Het-1905 embedded image Het-1906 embedded image Het-1907 embedded image Het-1908 embedded image Het-1909 embedded image Het-1910 embedded image Het-1911 embedded image Het-1912 embedded image Het-1913 embedded image Het-1914 00embedded image Het-1915 01embedded image Het-1916 02embedded image Het-1917 03embedded image Het-1918 04embedded image Het-1919 05embedded image Het-1920 06embedded image Het-1921 07embedded image Het-1922 08embedded image Het-1923 09embedded image Het-1924 0embedded image Het-1925 embedded image Het-1926 embedded image Het-1927 embedded image Het-1928 embedded image Het-1929 embedded image Het-1930 embedded image Het-1931 embedded image Het-1932 embedded image Het-1933 embedded image Het-1934 0embedded image Het-1935 embedded image Het-1936 embedded image Het-1937 embedded image Het-1938 embedded image Het-1939 embedded image Het-1940 embedded image Het-1941 embedded image Het-1942 embedded image Het-1943 embedded image Het-1944 0embedded image Het-1945 embedded image Het-1946 embedded image Het-1947 embedded image Het-1948 embedded image Het-1949 embedded image Het-1950 embedded image Het-1951 embedded image Het-1952 embedded image Het-1953 embedded image Het-1954 0embedded image Het-1955 embedded image Het-1956 embedded image Het-1957 embedded image Het-1958 embedded image Het-1959 embedded image Het-1960 embedded image Het-1961 embedded image Het-1962 embedded image Het-1963 embedded image Het-1964 0embedded image Het-1965 embedded image Het-1966 embedded image Het-1967 embedded image Het-1968 embedded image Het-1969 embedded image Het-1970 embedded image Het-1971 embedded image Het-1972 embedded image Het-1973 embedded image Het-1974 0embedded image Het-1975 embedded image Het-1976 embedded image Het-1977 embedded image Het-1978 embedded image Het-1979 embedded image Het-1980 embedded image Het-1981 embedded image Het-1982 embedded image Het-1983 embedded image Het-1984 0embedded image Het-1985 embedded image Het-1986 embedded image Het-1987 embedded image Het-1988 embedded image Het-1989 embedded image Het-1990 embedded image Het-1991 embedded image Het-1992 embedded image Het-1993 embedded image Het-1994 0embedded image Het-1995 embedded image Het-1996 embedded image Het-1997 embedded image Het-1998 embedded image Het-1999 embedded image Het-2000 embedded image Het-2001 embedded image Het-2002 embedded image Het-2003 embedded image Het-2004 0embedded image Het-2005 embedded image Het-2006 embedded image Het-2007 embedded image Het-2008 embedded image Het-2009 embedded image Het-2010 embedded image Het-2011 embedded image Het-2012 embedded image Het-2013 embedded image Het-2014 00embedded image Het-2015 01embedded image Het-2016 02embedded image Het-2017 03embedded image Het-2018 04embedded image Het-2019 05embedded image Het-2020 06embedded image Het-2021 07embedded image Het-2022 08embedded image Het-2023 09embedded image Het-2024 0embedded image Het-2025 embedded image Het-2026 embedded image Het-2027 embedded image Het-2028 embedded image Het-2029 embedded image Het-2030 embedded image Het-2031 embedded image Het-2032 embedded image Het-2033 embedded image Het-2034 0embedded image Het-2035 embedded image Het-2036 embedded image Het-2037 embedded image Het-2038 embedded image Het-2039 embedded image Het-2040 embedded image Het-2041 embedded image Het-2042 embedded image Het-2043 embedded image Het-2044 0embedded image Het-2045 embedded image Het-2046 embedded image Het-2047 embedded image Het-2048 embedded image Het-2049 embedded image Het-2050 embedded image Het-2051 embedded image Het-2052 embedded image Het-2053 embedded image Het-2054 0embedded image Het-2055 embedded image Het-2056 embedded image Het-2057 embedded image Het-2058 embedded image Het-2059 embedded image Het-2060 embedded image Het-2061 embedded image Het-2062 embedded image Het-2063 embedded image Het-2064 0embedded image Het-2065 embedded image Het-2066 embedded image Het-2067 embedded image Het-2068 embedded image Het-2069 embedded image Het-2070 embedded image Het-2071 embedded image Het-2072 embedded image Het-2073 embedded image Het-2074 0embedded image Het-2075 embedded image Het-2076 embedded image Het-2077 embedded image Het-2078 embedded image Het-2079 embedded image Het-2080 embedded image Het-2081 embedded image Het-2082 embedded image Het-2083 embedded image Het-2084 0embedded image Het-2085 embedded image Het-2086 embedded image Het-2087 embedded image Het-2088 embedded image Het-2089 embedded image Het-2090 embedded image Het-2091 embedded image Het-2092 embedded image Het-2093 embedded image Het-2094 0embedded image Het-2095 embedded image Het-2096 embedded image Het-2097 embedded image Het-2098 embedded image Het-2099 embedded image Het-2100 embedded image Het-2101 embedded image Het-2102 embedded image Het-2103 embedded image Het-2104 0embedded image Het-2105 embedded image Het-2106 embedded image Het-2107 embedded image Het-2108 embedded image Het-2109 embedded image Het-2110 embedded image Het-2111 embedded image Het-2112 embedded image Het-2113 embedded image Het-2114 00embedded image Het-2115 01embedded image Het-2116 02embedded image Het-2117 03embedded image Het-2118 04embedded image Het-2119 05embedded image Het-2120 06embedded image Het-2121 07embedded image Het-2122 08embedded image Het-2123 09embedded image Het-2124 0embedded image Het-2125 embedded image Het-2126 embedded image Het-2127 embedded image Het-2128 embedded image Het-2129 embedded image Het-2130 embedded image Het-2131 embedded image Het-2132 embedded image Het-2133 embedded image Het-2134 0embedded image Het-2135 embedded image Het-2136 embedded image Het-2137 embedded image Het-2138 embedded image Het-2139 embedded image Het-2140 embedded image Het-2141 embedded image Het-2142 embedded image Het-2143 embedded image Het-2144 0embedded image Het-2145 embedded image Het-2146 embedded image Het-2147 embedded image Het-2148 embedded image Het-2149 embedded image Het-2150 embedded image Het-2151 embedded image Het-2152 embedded image Het-2153 embedded image Het-2154 0embedded image Het-2155 embedded image Het-2156 embedded image Het-2157 embedded image Het-2158 embedded image Het-2159 embedded image Het-2160 embedded image Het-2161 embedded image Het-2162 embedded image Het-2163 embedded image Het-2164 0embedded image Het-2165 embedded image Het-2166 embedded image Het-2167 embedded image Het-2168 embedded image Het-2169 embedded image Het-2170 embedded image Het-2171 embedded image Het-2172 embedded image Het-2173 embedded image Het-2174 0embedded image Het-2175 embedded image Het-2176 embedded image Het-2177 embedded image Het-2178 embedded image Het-2179 embedded image Het-2180 embedded image Het-2181 embedded image Het-2182 embedded image Het-2183 embedded image Het-2184 0embedded image Het-2185 embedded image Het-2186 embedded image Het-2187 embedded image Het-2188 embedded image Het-2189 embedded image Het-2190 embedded image Het-2191 embedded image Het-2192 embedded image Het-2193 embedded image Het-2194 0embedded image Het-2195 embedded image Het-2196 embedded image Het-2197 embedded image Het-2198 embedded image Het-2199 embedded image Het-2200 embedded image Het-2201 embedded image Het-2202 embedded image Het-2203 embedded image Het-2204 0embedded image Het-2205 embedded image Het-2206 embedded image Het-2207 embedded image Het-2208 embedded image Het-2209 embedded image Het-2210 embedded image Het-2211 embedded image Het-2212 embedded image Het-2213 embedded image Het-2214 00embedded image Het-2215 01embedded image Het-2216 02embedded image Het-2217 03embedded image Het-2218 04embedded image Het-2219 05embedded image Het-2220 06embedded image Het-2221 07embedded image Het-2222 08embedded image Het-2223 09embedded image Het-2224 0embedded image Het-2225 embedded image Het-2226 embedded image Het-2227 embedded image Het-2228 embedded image Het-2229 embedded image Het-2230 embedded image Het-2231 embedded image Het-2232 embedded image Het-2233 embedded image Het-2234 0embedded image Het-2235 embedded image Het-2236 embedded image Het-2237 embedded image Het-2238 embedded image Het-2239 embedded image Het-2240 embedded image Het-2241 embedded image Het-2242 embedded image Het-2243 embedded image Het-2244 0embedded image Het-2245 embedded image Het-2246 embedded image Het-2247 embedded image Het-2248 embedded image Het-2249 embedded image Het-2250 embedded image Het-2251 embedded image Het-2252 embedded image Het-2253 embedded image Het-2254 0embedded image Het-2255 embedded image Het-2256 embedded image Het-2257 embedded image Het-2258 embedded image Het-2259 embedded image Het-2260 embedded image Het-2261 embedded image Het-2262 embedded image Het-2263 embedded image Het-2264 0embedded image Het-2265 embedded image Het-2266 embedded image Het-2267 embedded image Het-2268 embedded image Het-2269 embedded image Het-2270 embedded image Het-2271 embedded image Het-2272 embedded image Het-2273 embedded image Het-2274 0embedded image Het-2275 embedded image Het-2276 embedded image Het-2277 embedded image Het-2278 embedded image Het-2279 embedded image Het-2280 embedded image Het-2281 embedded image Het-2282 embedded image Het-2283 embedded image Het-2284 0embedded image Het-2285 embedded image Het-2286 embedded image Het-2287 embedded image Het-2288 embedded image Het-2289 embedded image Het-2290 embedded image Het-2291 embedded image Het-2292 embedded image Het-2293 embedded image Het-2294 0embedded image Het-2295 embedded image Het-2296 embedded image Het-2297 embedded image Het-2298 embedded image Het-2299 embedded image Het-2300 embedded image Het-2301 embedded image Het-2302 embedded image Het-2303 embedded image Het-2304 0embedded image Het-2305 embedded image Het-2306 embedded image Het-2307 embedded image Het-2308 embedded image Het-2309 embedded image Het-2310 embedded image Het-2311 embedded image Het-2312 embedded image Het-2313 embedded image Het-2314 00embedded image Het-2315 01embedded image Het-2316 02embedded image Het-2317 03embedded image Het-2318 04embedded image Het-2319 05embedded image Het-2320 06embedded image Het-2321 07embedded image Het-2322 08embedded image Het-2323 09embedded image Het-2324 0embedded image Het-2325 embedded image Het-2326 embedded image Het-2327 embedded image Het-2328 embedded image Het-2329 embedded image Het-2330 embedded image Het-2331 embedded image Het-2332 embedded image Het-2333 embedded image Het-2334 0embedded image Het-2335 embedded image Het-2336 embedded image Het-2337 embedded image Het-2338 embedded image Het-2339 embedded image Het-2340 embedded image Het-2341 embedded image Het-2342 embedded image Het-2343 embedded image Het-2344 0embedded image Het-2345 embedded image Het-2346 embedded image Het-2347 embedded image Het-2348 embedded image Het-2349 embedded image Het-2350 embedded image Het-2351 embedded image Het-2352 embedded image Het-2353 embedded image Het-2354 0embedded image Het-2355 embedded image Het-2356 embedded image Het-2357 embedded image Het-2358 embedded image Het-2359 embedded image Het-2360 embedded image Het-2361 embedded image Het-2362 embedded image Het-2363 embedded image Het-2364 0embedded image Het-2365 embedded image Het-2366 embedded image Het-2367 embedded image Het-2368 embedded image Het-2369 embedded image Het-2370 embedded image Het-2371 embedded image Het-2372 embedded image Het-2373 embedded image Het-2374 0embedded image Het-2375 embedded image Het-2376 embedded image Het-2377 embedded image Het-2378 embedded image Het-2379 embedded image Het-2380 embedded image Het-2381 embedded image Het-2382 embedded image Het-2383 embedded image Het-2384 0embedded image Het-2385 embedded image Het-2386 embedded image Het-2387 embedded image Het-2388 embedded image Het-2389 embedded image Het-2390 embedded image Het-2391 embedded image Het-2392 embedded image Het-2393 embedded image Het-2394 0embedded image Het-2395 embedded image Het-2396 embedded image Het-2397 embedded image Het-2398 embedded image Het-2399 embedded image Het-2400 embedded image Het-2401 embedded image Het-2402 embedded image Het-2403 embedded image Het-2404 0embedded image Het-2405 embedded image Het-2406 embedded image Het-2407 embedded image Het-2408 embedded image Het-2409 embedded image Het-2410 embedded image Het-2411 embedded image Het-2412 embedded image Het-2413 embedded image Het-2414 000embedded image Het-2415 001embedded image Het-2416 002embedded image Het-2417 003embedded image Het-2418 004embedded image Het-2419 005embedded image Het-2420 006embedded image Het-2421 007embedded image Het-2422 008embedded image Het-2423 009embedded image Het-2424 010embedded image Het-2425 011embedded image Het-2426 012embedded image Het-2427 013embedded image Het-2428 014embedded image Het-2429 015embedded image Het-2430 016embedded image Het-2431 017embedded image Het-2432 018embedded image Het-2433 019embedded image Het-2434 020embedded image Het-2435 021embedded image Het-2436 022embedded image Het-2437 023embedded image Het-2438 024embedded image Het-2439 025embedded image Het-2440 026embedded image Het-2441 027embedded image Het-2442 028embedded image Het-2443 029embedded image Het-2444 030embedded image Het-2445 031embedded image Het-2446 032embedded image Het-2447 033embedded image Het-2448 034embedded image Het-2449 035embedded image Het-2450 036embedded image Het-2451 037embedded image Het-2452 038embedded image Het-2453 039embedded image Het-2454 040embedded image Het-2455 041embedded image Het-2456 042embedded image Het-2457 043embedded image Het-2458 044embedded image Het-2459 045embedded image Het-2460 046embedded image Het-2461 047embedded image Het-2462 048embedded image Het-2463 049embedded image Het-2464 050embedded image Het-2465 051embedded image Het-2466 052embedded image Het-2467 053embedded image Het-2468 054embedded image Het-2469 055embedded image Het-2470 056embedded image Het-2471 057embedded image Het-2472 058embedded image Het-2473 059embedded image Het-2474 060embedded image Het-2475 061embedded image Het-2476 062embedded image Het-2477 063embedded image Het-2478 064embedded image Het-2479 065embedded image Het-2480 066embedded image Het-2481 067embedded image Het-2482 068embedded image Het-2483 069embedded image Het-2484 070embedded image Het-2485 071embedded image Het-2486 072embedded image Het-2487 073embedded image Het-2488 074embedded image Het-2489 075embedded image Het-2490 076embedded image Het-2491 077embedded image Het-2492 078embedded image Het-2493 079embedded image Het-2494 080embedded image Het-2495 081embedded image Het-2496 082embedded image Het-2497 083embedded image Het-2498 084embedded image Het-2499 085embedded image Het-2500 086embedded image Het-2501 087embedded image Het-2502 088embedded image Het-2503 089embedded image Het-2504 090embedded image Het-2505 091embedded image Het-2506 092embedded image Het-2507 093embedded image Het-2508 094embedded image Het-2509 095embedded image Het-2510 096embedded image Het-2511 097embedded image Het-2512 098embedded image Het-2513 099embedded image Het-2514 00embedded image Het-2515 01embedded image Het-2516 02embedded image Het-2517 03embedded image Het-2518 04embedded image Het-2519 05embedded image Het-2520 06embedded image Het-2521 07embedded image Het-2522 08embedded image Het-2523 09embedded image Het-2524 0embedded image Het-2525 embedded image Het-2526 embedded image Het-2527 embedded image Het-2528 embedded image Het-2529 embedded image Het-2530 embedded image Het-2531 embedded image Het-2532 embedded image Het-2533 embedded image Het-2534 0embedded image Het-2535 embedded image Het-2536 embedded image Het-2537 embedded image Het-2538 embedded image Het-2539 embedded image Het-2540 embedded image Het-2541 embedded image Het-2542 embedded image Het-2543 embedded image Het-2544 0embedded image Het-2545 embedded image Het-2546 embedded image Het-2547 embedded image Het-2548 embedded image Het-2549 embedded image Het-2550 embedded image Het-2551 embedded image Het-2552 embedded image Het-2553 embedded image Het-2554 0embedded image Het-2555 embedded image Het-2556 embedded image Het-2557 embedded image Het-2558 embedded image Het-2559 embedded image Het-2560 embedded image Het-2561 embedded image Het-2562 embedded image Het-2563 embedded image Het-2564 0embedded image Het-2565 embedded image Het-2566 embedded image Het-2567 embedded image Het-2568 embedded image Het-2569 embedded image Het-2570 embedded image Het-2571 embedded image Het-2572 embedded image Het-2573 embedded image Het-2574 0embedded image Het-2575 embedded image Het-2576 embedded image Het-2577 embedded image Het-2578 embedded image Het-2579 embedded image Het-2580 embedded image Het-2581 embedded image Het-2582 embedded image Het-2583 embedded image Het-2584 0embedded image Het-2585 embedded image Het-2586 embedded image Het-2587 embedded image Het-2588 embedded image Het-2589 embedded image Het-2590 embedded image Het-2591 embedded image Het-2592 embedded image Het-2593 embedded image Het-2594 0embedded image Het-2595 embedded image Het-2596 embedded image Het-2597 embedded image Het-2598 embedded image Het-2599 embedded image Het-2600 embedded image Het-2601 embedded image Het-2602 embedded image Het-2603 embedded image Het-2604 0embedded image Het-2605 embedded image Het-2606 embedded image Het-2607 embedded image Het-2608 embedded image Het-2609 embedded image Het-2610 embedded image Het-2611 embedded image Het-2612 embedded image Het-2613 embedded image Het-2614 00embedded image Het-2615 01embedded image Het-2616 02embedded image Het-2617 03embedded image Het-2618 04embedded image Het-2619 05embedded image Het-2620 06embedded image Het-2621 07embedded image Het-2622 08embedded image Het-2623 09embedded image Het-2624 0embedded image Het-2625 embedded image Het-2626 embedded image Het-2627 embedded image Het-2628 embedded image Het-2629 embedded image Het-2630 embedded image Het-2631 embedded image Het-2632 embedded image Het-2633 embedded image Het-2634 0embedded image Het-2635 embedded image Het-2636 embedded image Het-2637 embedded image Het-2638 embedded image Het-2639 embedded image Het-2640 embedded image Het-2641 embedded image Het-2642 embedded image Het-2643 embedded image Het-2644 0embedded image Het-2645 embedded image Het-2646 embedded image Het-2647 embedded image Het-2648 embedded image Het-2649 embedded image Het-2650 embedded image Het-2651 embedded image Het-2652 embedded image Het-2653 embedded image Het-2654 0embedded image Het-2655 embedded image Het-2656 embedded image Het-2657 embedded image Het-2658 embedded image Het-2659 embedded image Het-2660 embedded image Het-2661 embedded image Het-2662 embedded image Het-2663 embedded image Het-2664 0embedded image Het-2665 embedded image Het-2666 embedded image Het-2667 embedded image Het-2668 embedded image Het-2669 embedded image Het-2670 embedded image Het-2671 embedded image Het-2672 embedded image Het-2673 embedded image Het-2674 0embedded image Het-2675 embedded image Het-2676 embedded image Het-2677 embedded image Het-2678 embedded image Het-2679 embedded image Het-2680 embedded image Het-2681 embedded image Het-2682 embedded image Het-2683 embedded image Het-2684 0embedded image Het-2685 embedded image Het-2686 embedded image Het-2687 embedded image Het-2688 embedded image Het-2689 embedded image Het-2690 embedded image Het-2691 embedded image Het-2692 embedded image Het-2693 embedded image Het-2694 0embedded image Het-2695 embedded image Het-2696 embedded image Het-2697 embedded image Het-2698 embedded image Het-2699 embedded image Het-2700 embedded image Het-2701 embedded image Het-2702 embedded image Het-2703 embedded image Het-2704 0embedded image Het-2705 embedded image Het-2706 embedded image Het-2707 embedded image Het-2708 embedded image Het-2709 embedded image Het-2710 embedded image Het-2711 embedded image Het-2712 embedded image Het-2713 embedded image Het-2714 00embedded image Het-2715 01embedded image Het-2716 02embedded image Het-2717 03embedded image Het-2718 04embedded image Het-2719 05embedded image Het-2720 06embedded image Het-2721 07embedded image Het-2722 08embedded image Het-2723 09embedded image Het-2724 0embedded image Het-2725 embedded image Het-2726 embedded image Het-2727 embedded image Het-2728 embedded image Het-2729 embedded image Het-2730 embedded image Het-2731 embedded image Het-2732 embedded image Het-2733 embedded image Het-2734 0embedded image Het-2735 embedded image Het-2736 embedded image Het-2737 embedded image Het-2738 embedded image Het-2739 embedded image Het-2740 embedded image Het-2741 embedded image Het-2742 embedded image Het-2743 embedded image Het-2744 0embedded image Het-2745 embedded image Het-2746 embedded image Het-2747 embedded image Het-2748 embedded image Het-2749 embedded image Het-2750 embedded image Het-2751 embedded image Het-2752 embedded image Het-2753 embedded image Het-2754 0embedded image Het-2755 embedded image Het-2756 embedded image Het-2757 embedded image Het-2758 embedded image Het-2759 embedded image Het-2760 embedded image Het-2761 embedded image Het-2762 embedded image Het-2763 embedded image Het-2764 0embedded image Het-2765 embedded image Het-2766 embedded image Het-2767 embedded image Het-2768 embedded image Het-2769 embedded image Het-2770 embedded image Het-2771 embedded image Het-2772 embedded image Het-2773 embedded image Het-2774 0embedded image Het-2775 embedded image Het-2776 embedded image Het-2777 embedded image Het-2778 embedded image Het-2779 embedded image Het-2780 embedded image Het-2781 embedded image Het-2782 embedded image Het-2783 embedded image Het-2784 0embedded image Het-2785 embedded image Het-2786 embedded image Het-2787 embedded image Het-2788 embedded image Het-2789 embedded image Het-2790 embedded image Het-2791 embedded image Het-2792 embedded image Het-2793 embedded image Het-2794 0embedded image Het-2795 embedded image Het-2796 embedded image Het-2797 embedded image Het-2798 embedded image Het-2799 embedded image Het-2800 embedded image Het-2801 embedded image Het-2802 embedded image Het-2803 embedded image Het-2804 0embedded image Het-2805 embedded image Het-2806 embedded image Het-2807 embedded image Het-2808 embedded image Het-2809 embedded image Het-2810 embedded image Het-2811 embedded image Het-2812 embedded image Het-2813 embedded image Het-2814 00embedded image Het-2815 01embedded image Het-2816 02embedded image Het-2817 03embedded image Het-2818 04embedded image Het-2819 05embedded image Het-2820 06embedded image Het-2821 07embedded image Het-2822 08embedded image Het-2823 09embedded image Het-2824 0embedded image Het-2825 embedded image Het-2826 embedded image Het-2827 embedded image Het-2828 embedded image Het-2829 embedded image Het-2830 embedded image Het-2831 embedded image Het-2832 embedded image Het-2833 embedded image Het-2834 0embedded image Het-2835 embedded image Het-2836 embedded image Het-2837 embedded image Het-2838 embedded image Het-2839 embedded image Het-2840 embedded image Het-2841 embedded image Het-2842 embedded image Het-2843 embedded image Het-2844 0embedded image Het-2845 embedded image Het-2846 embedded image Het-2847 embedded image Het-2848 embedded image Het-2849 embedded image Het-2850 embedded image Het-2851 embedded image Het-2852 embedded image Het-2853 embedded image Het-2854 0embedded image Het-2855 embedded image Het-2856 embedded image Het-2857 embedded image Het-2858 embedded image Het-2859 embedded image Het-2860 embedded image Het-2861 embedded image Het-2862 embedded image Het-2863 embedded image Het-2864 0embedded image Het-2865 embedded image Het-2866 embedded image Het-2867 embedded image Het-2868 embedded image Het-2869 embedded image Het-2870 embedded image Het-2871 embedded image Het-2872 embedded image Het-2873 embedded image Het-2874 0embedded image Het-2875 embedded image Het-2876 embedded image Het-2877 embedded image Het-2878 embedded image Het-2879 embedded image Het-2880

(435) In the following, examples of the methods for producing the compounds represented by Formula (1) will be illustrated. The methods for producing the compounds of the present invention are not limited to Production Method A to Production Method AJ.

(436) [Production Method A]

(437) ##STR03466##

(438) In the formula, R7 represents a hydrogen atom, a hydroxyl group, a cyano group, a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) A, a C2-C6 alkenyl group optionally substituted with substituent(s) A, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) A, a C2-C6 haloalkynyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) A, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) A, a C2-C6 alkenyloxy group optionally substituted with substituent(s) A, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) A, a C3-C6 haloalkynyloxy group or RaRbN— (wherein Ra and Rb each independently represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group or Ra and Rb together with the nitrogen atom to which they are bonded form an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a homopiperidinyl group or an azocanyl group), R6 represents a hydrogen atom or a C1-C6 alkyl group, and R2, Het, X and Y are the same as defined hereinabove.

(439) Production Method A is a method for obtaining a compound represented by Formula (1b-a) including a compound of the present invention and a production intermediate of a compound of the present invention, and includes reacting a compound represented by Formula (3) with R7NH.sub.2 in the presence of an acid.

(440) The R7NH.sub.2 used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method. The R7NH.sub.2 may be a material which forms a salt with an acidic compound such as hydrochloric acid and acetic acid, and is not particularly limited as long as the target reaction proceeds.

(441) The R7NH.sub.2 used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (3), and is not particularly limited as long as the target reaction proceeds, and is preferably 1 equivalent or more and 200 equivalents or less.

(442) The acids used in the present reaction may be exemplified by an inorganic acid such as hydrochloric acid, sulfuric acid and the like, and an organic acid such as acetic acid, methanesulfonic acid, p-toluenesulfonic acid and the like, and is not particularly limited as long as the target reaction proceeds, and preferably acetic acid. In addition, when a salt of the R7NH.sub.2 and the acidic compound is used, use of the acid is not essential.

(443) An amount of the acid used in the present reaction may be 1 equivalent or more relative to the R7NH.sub.2, and is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 200 equivalents or less. In addition, when the acid to be used is a liquid, it is possible to use it as a solvent.

(444) A solvent may be used in the present reaction, but it is not essential.

(445) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include acidic solvents such as acetic acid and methanesulfonic acid, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, alcohol solvents such as methanol, ethanol and isopropanol, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio. As the solvents, among others, acidic solvents are preferably mentioned, and acetic acid is more preferably mentioned.

(446) An amount of the solvent used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight to 200 times by weight relative to the amount of the compound represented by Formula (3).

(447) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 50° C. or higher and 180° C. or lower or a boiling point of the solvent or lower.

(448) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio.

(449) The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(450) The reaction mixture obtained above which contains the compound represented by Formula (1b-a) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(451) The reaction mixture obtained above which contains the compound represented by Formula (1b-a) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(452) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1b-a) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(453) According to Production Method A, a compound represented by Formula (2) which can be produced when R7 in a compound represented by Formula (1b-a) represents a hydrogen atom can be a useful production intermediate for obtaining a compound represented by Formula (1b) among the compounds of the present invention.

(454) Specific examples of the production intermediate represented by Formula (2) are shown by combinations of the structural formulae (I-1 to I-12) illustrated in Table 4, Y illustrated in Table 2, Het illustrated in Table 3, and X which is an oxygen atom or a sulfur atom. These compounds are only illustrative, and the present invention is not limited by these.

(455) [Table 4]

(456) TABLE-US-00004 TABLE 4 embedded image I-1 embedded image I-2 embedded image I-3 0embedded image I-4 embedded image I-5 embedded image I-6 embedded image I-7 embedded image I-8 embedded image I-9 embedded image I-10 embedded image I-11 embedded image I-12

(457) A method for obtaining Formula (1b) of the present invention by utilizing the compound represented by Formula (2) as a production intermediate is described.

(458) [Production Method B]

(459) ##STR03479##

(460) In the formula, Lv represents a leaving group such as a methanesulfonyl group, a trifluoromethanesulfonyl group, a p-toluenesulfonyl group or a halogen atom, and R1, R2, Het, X and Y are the same as defined hereinabove.

(461) Production Method B is a method for obtaining a compound represented by Formula (1b), and is a production method which comprises reacting a production intermediate represented by Formula (2) with R1-Lv in the presence of a base in a solvent.

(462) The R1-Lv to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method.

(463) An amount of the R1-Lv to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (2), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(464) The base to be used in the present reaction may be exemplified by inorganic bases such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate and sodium hydride, which is not particularly limited as long as the target reaction proceeds.

(465) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (2), which is not particularly limited as long as the target reaction proceeds, preferably 1 equivalent or more and 10 equivalents or less.

(466) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, alcohol solvents such as methanol, ethanol and isopropanol, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, sulfur solvents such as dimethylsulfoxide and sulforane, ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, and the like.

(467) These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(468) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (2).

(469) A temperature to carry out the present reaction is not particularly limited as long, as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(470) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(471) The reaction mixture obtained above which contains the compound represented by Formula (1b) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(472) The reaction mixture obtained above which contains the compound represented by Formula (1b) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(473) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1b) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(474) [Production Method C]

(475) ##STR03480##

(476) In the formula, SR represents a sulfurizing agent, and R1, R2, Het and Y are the same as defined hereinabove.

(477) Production Method C is a production method for obtaining a compound represented by Formula (1b-c) which belongs to the compounds represented by Formula (1b), and is a production method which comprises reacting a compound represented by Formula (1b-b) and a sulfurizing agent (SR) in a solvent.

(478) An example of the sulfurizing agent to be used in the present reaction may include Lawesson's reagent (2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulfide) and the like.

(479) An amount of the sulfurizing agent to be used in the present reaction may be 0.5 equivalent or more relative to a compound represented by Formula (1b-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(480) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(481) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1b-b).

(482) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 50° C. or higher and 180° C. or lower or a boiling point of the solvent or lower.

(483) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired. Also, in the present reaction, the liquid separating operation is not essential.

(484) The reaction mixture obtained above which contains the compound represented by Formula (1b-c) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(485) The reaction mixture obtained above which contains the compound represented by Formula (1b-c) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(486) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1b-c) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(487) [Production Method D]

(488) ##STR03481##

(489) In the formula, R2a represents a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) A, a C2-C6 alkenyl group optionally substituted with substituent(s) A, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) A or C2-C6 haloalkynyl group, and R1, Het, Lv, X and Y are the same as defined hereinabove.

(490) Production Method D is a synthetic method of a compound represented by Formula (1b-e), which belongs to the compounds represented by Formula (1b), wherein R2a is a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) A, a C2-C6 alkenyl group optionally substituted with substituent(s) A, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) A or a C2-C6 haloalkynyl group, and is a production method which comprises reacting a compound represented by Formula (1b-d) and R2a-Lv in the presence of a base in a solvent.

(491) The R2a-Lv to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method.

(492) An amount of the R2a-Lv to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1b-d), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 1.8 equivalents or less.

(493) The base to be used in the present reaction may be exemplified by metal hydrides such as sodium hydride, organolithiums such as methyllithium, butyllithium, sec-butyllithium, t-butyllithium and hexyllithium, metal amides such as lithium diisopropylamide, hexamethyldisilazane lithium, hexamethyldisilazane sodium and hexamethyldisilazane potassium.

(494) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1b-d), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(495) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(496) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1b-d).

(497) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −80° C. or higher and 100° C. or lower or a boiling point of the solvent or lower.

(498) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane and chloroform, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(499) The reaction mixture obtained above which contains the compound represented by Formula (1b-e) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(500) The reaction mixture obtained above which contains the compound represented by Formula (1b-e) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(501) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1b-e) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(502) [Production Method E]

(503) ##STR03482##

(504) In the formula, Ox represents an oxidizing agent, and R1, R2, Het, X and Y are the same as defined hereinabove.

(505) Production Method E is a method for obtaining a compound represented by Formula (1a), and is a production method which comprises reacting a compound represented by Formula (1b) and an oxidizing agent (Ox) in a solvent.

(506) The oxidizing agent to be used in the present reaction may include metal oxides such as manganese dioxide, benzoquinones such as 2,3-dichloro-5,6-dicyano-p-benzoquinone, a combination of a radical initiator such as azobisisobutyronitrile, 2,2′-azobis(4-methoxy-2,4-dimethylvaleryonitrile) and benzoyl peroxide, and a halogenating agent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, 1,3-dichloro-5,5-dimethylhydantoin, 1,3-dibromo-5,5-dimethylhydantoin and 1,3-diiodo-5,5-dimethylhydantoin.

(507) In the following, a method in which the oxidizing agent is a metal oxide will be described.

(508) An amount of the oxidizing agent to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1b), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 200 equivalents or less.

(509) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(510) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1b).

(511) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(512) As a post treatment after the reaction; it is possible to remove undissolved metal by filtration. Further, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents, such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired. Also, in the present reaction, the liquid separating operation is not essential.

(513) The reaction mixture obtained above which contains the compound represented by Formula (1a) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(514) The reaction mixture obtained above which contains the compound represented by Formula (1a) may be distilled off under reduced pressure to remove the solvent as long as the compound is not decomposed.

(515) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(516) In the following, a method in which the oxidizing agent is a benzoquinone will be described.

(517) An amount of the oxidizing agent to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1b), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 20 equivalents or less.

(518) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(519) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1b).

(520) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(521) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired. Also, in the present reaction, the liquid separating operation is not essential.

(522) The reaction mixture obtained above which contains the compound represented by Formula (1a) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(523) The reaction mixture obtained above which contains the compound represented by Formula (1a) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(524) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(525) In the following, a method in which the oxidizing agent is a combination of a radical initiator and a halogenating agent will be described.

(526) Each amount of the radical initiator and the halogenating agent to be used in the present reaction is 0.01 equivalent or more and 1.0 equivalent or more relative to the compound represented by Formula (1b), respectively, and is not particularly limited as long as the target reaction proceeds. The radical initiator is preferably 0.01 equivalent or more and 1 equivalent or less, and the halogenating agent is 1 equivalent or more and 3 equivalents or less.

(527) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include halogenated benzene solvents such as chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(528) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1b).

(529) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 20° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(530) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane and chloroform, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(531) The reaction mixture obtained above which contains the compound represented by Formula (1a) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(532) The reaction mixture obtained above which contains the compound represented by Formula (1a) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(533) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(534) [Production Method F]

(535) ##STR03483##

(536) In the formula, R2b represents a halogen atom, HalR represents a halogenating agent, and R1, Het, X and Y are the same as defined hereinabove.

(537) Production Method F is a production method for obtaining a compound represented by Formula (1a-b), which belongs to the compounds represented by Formula (1a), wherein R2b represents a halogen atom, and is a production method which comprises reacting a compound represented by Formula (1a-a) and a halogenating agent (HalR) in a solvent.

(538) The halogenating agent to be used in the present reaction may include Selectfluor (N-fluoro-N′-triethylenediamine bis(tetrafluoroborate)), N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, 1,3-dichloro-5,5-dimethylhydantoin, 1,3-dibromo-5,5-dimethylhydantoin, 1,3-diiodo-5,5-dimethylhydantoin, bromine, iodine and the like.

(539) An amount of the halogenating agent to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1a-a), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less. If the amount of the halogenating agent including hydantoin is 0.5 equivalent or more, it is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 5 equivalents or less.

(540) When the halogenating agent to be used in the present reaction is an iodinating agent, an acid including an inorganic acid such as hydrochloric acid, sulfuric acid or the like, or an organic acid such as acetic acid, trifluoroacetic acid, methanesulfonic acid, trifluoromethanesulfonic acid or the like may be added.

(541) An amount of the acid to be used when the halogenating agent to be used in the present reaction is the iodinating agent may be 0.01 equivalent or more relative to the compound represented by Formula (1a-a), which is not particularly limited as long as the target reaction proceeds, and preferably 0.1 equivalent or more and 3 equivalents or less.

(542) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include acidic solvents such as sulfuric acid, acetic acid, trifluoroacetic acid, methanesulfonic acid and trifluoromethanesulfonic acid, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, alcohol solvents such as methanol, ethanol and isopropanol, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, and the like.

(543) These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(544) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1a-a).

(545) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(546) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution, is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(547) The reaction mixture obtained above which contains the compound represented by Formula (1a-b) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(548) The reaction mixture obtained above which contains the compound represented by Formula (1a-b) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(549) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a-b) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(550) [Production Method G]

(551) ##STR03484##

(552) In the formula, J represents an oxygen atom or a sulfur atom, when J is an oxygen atom, R2c represents a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) A, a C2-C6 alkenyl group optionally substituted with substituent(s) A, a C2-C6 haloalkenyl group, a C3-C6 alkynyl group optionally substituted with substituent(s) A or a C3-C6 haloalkynyl group, when J is a sulfur atom, R2c represents a C1-C6 alkyl group or a C1-C6 haloalkyl group, Q represents a hydrogen atom or a metal, and R1, Het, R2b, X and Y are the same as defined hereinabove.

(553) Production Method G is a synthetic method of a compound represented by Formula (1a-c), which belongs to the compounds represented by Formula (1a), wherein J represents an oxygen atom or a sulfur atom, when J is an oxygen atom, R2c represents a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) A, a C2-C6 alkenyl group optionally substituted with substituent(s) A, a C2-C6 haloalkenyl group, a C3-C6 alkynyl group optionally substituted with substituent(s) A or a C3-C6 haloalkynyl group, and when J is a sulfur atom, R2c represents a C1-C6 alkyl group or a C1-C6 haloalkyl group, and is a production method which comprises a coupling reaction wherein a compound represented by Formula (1a-b) and R2c-J-Q are reacted in the presence of a transition metal and a base in a solvent.

(554) Among the compounds represented by Formula (1a-b), preferable R2b is a chlorine atom, a bromine atom or an iodine atom.

(555) The R2c-J-Q to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method. Preferable Q is a hydrogen atom or an alkali metal such as sodium, potassium and the like.

(556) An amount of the R2c-J-Q to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1a-b), and is not particularly limited as long as the target reaction proceeds. When Q is a hydrogen atom, it can be also used as a solvent.

(557) The transition metal to be used in the present reaction may have a ligand, and may include palladiums such as palladium acetate, [1,1′-bis(diphenylphosphine)ferrocene]palladium dichloride, tris(dibenzylideneacetone)dipalladium, tetrakis(triphenylphosphine)palladium, bis(triphenylphosphine)palladium dichloride and the like.

(558) An amount of the transition metal to be used in the present reaction may be 0.001 equivalent or more and 1 equivalent or less relative to the compound represented by Formula (1a-b), and is not particularly limited as long as the target reaction proceeds.

(559) In order to proceed the present reaction efficiently, a phosphine ligand such as triphenylphosphine, 1,1′-bis(diphenylphosphine)ferrocene, 2-dicyclohexylphosphino-2′4′6′-triisopropylbiphenyl, 2-di-t-butylphosphino-2′4′6′-triisopropylbiphenyl and the like may be added.

(560) An amount of the phosphine ligand to be used in the present reaction may be 0.001 equivalent or more and 1 equivalent or less relative to the compound represented by Formula (1a-b), and is not particularly limited as long as the target reaction proceeds.

(561) The base to be used in the present reaction may include inorganic bases such as sodium carbonate, potassium carbonate and cesium carbon and organic bases such as triethylamine, tributylamine and diisopropylethylamine.

(562) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1a-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 50 equivalents or less.

(563) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include alcohol solvents represented by R2c-J-H (wherein R2c is the same as defined hereinabove, and J is an oxygen atom), ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, and benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, and the like.

(564) These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(565) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1a-b).

(566) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 30° C. or higher and 200° C. or lower or a boiling point of the solvent or lower.

(567) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired. In addition, it is also possible to remove insoluble materials by subjecting to filtration operation but it is not essential.

(568) The reaction mixture obtained above which contains the compound represented by Formula (1a-c) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(569) The reaction mixture obtained above which contains the compound represented by Formula (1a-c) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(570) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a-c) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(571) [Production Method H]

(572) ##STR03485##

(573) In the formula, R2d represents a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) A, a C2-C6 alkenyl group optionally substituted with substituent(s) A or a C2-C6 haloalkenyl group, R2d-B represents organic boronic acids, and R1, Het, R2b, X and Y are the same as defined hereinabove.

(574) Production Method H is a synthetic method of a compound represented by Formula (1a-d), which belongs to the compounds represented by Formula (1a), wherein R2d is a C1-C6 alkyl group optionally substituted with substituent(s) A, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) A, a C2-C6 alkenyl group optionally substituted with substituent(s) A or a C2-C6 haloalkenyl group, and is a production method which comprises Suzuki-Miyaura coupling wherein a compound represented by Formula (1a-b) and an organic boronic acid (R2d-B) are reacted in the presence of a transition metal and a base in a solvent.

(575) In Formula (1a-b), preferable R2b is a chlorine atom, a bromine atom or an iodine atom.

(576) The R2d-B to be used in the present reaction represents organic boronic acids such as an organic boronic acid, organic boronic acid ester and the like, and can be obtained as a commercially available product or produced by a conventionally known method.

(577) An amount of the R2d-B to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1a-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(578) The transition metal to be used in the present reaction may be palladium, nickel, ruthenium and the like, which may have a ligand(s). It may preferably include palladiums such as palladium acetate, [1,1′-bis(diphenylphosphine)ferrocene]palladium dichloride, tris(dibenzylideneacetone)dipalladium, tetrakis(triphenylphosphine)palladium, bis(triphenylphosphine)palladium dichloride and the like.

(579) An amount of the transition metal to be used in the present reaction may be 0.001 equivalent or more and 1 equivalent or less relative to the compound represented by Formula (1a-b), and is not particularly limited as long as the target reaction proceeds.

(580) In order to proceed the reaction efficiently, a phosphine ligand such as triphenylphosphine, tricyclohexylphosphine and the like may be added.

(581) An amount of the phosphine ligand to be used in the present reaction may be 0.001 equivalent or more and 1 equivalent or less relative to the compound represented by Formula (1a-b), and is not particularly limited as long as the target reaction proceeds.

(582) The base to be used in the present reaction may include inorganic bases such as sodium carbonate, potassium carbonate, cesium carbonate and tripotassium phosphate, and metal alkoxides such as sodium methoxide, sodium ethoxide and potassium t-butoxide.

(583) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1a-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 50 equivalents or less.

(584) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include water solvent, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(585) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1a-b).

(586) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 30° C. or higher and 200° C. or lower or a boiling point of the solvent or lower.

(587) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired. In addition, it is also possible to remove insoluble materials by subjecting to filtration operation but it is not essential.

(588) The reaction mixture obtained above which contains the compound represented by Formula (1a-d) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(589) The reaction mixture obtained above which contains the compound represented by Formula (1a-d) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(590) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a-d) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(591) [Production Method I]

(592) ##STR03486##

(593) In the formula, R2e represents a C2-C6 alkynyl group optionally substituted with substituent(s) A or a C2-C6 haloalkynyl group, and R1, Het, R2b, X and Y are the same as defined hereinabove.

(594) Production Method I is a synthetic method of a compound represented by Formula (1a-e), among the compounds represented by Formula (1a), wherein R2e is a C2-C6 alkynyl group optionally substituted with substituent(s) A or a C2-C6 haloalkynyl group, and is a production method which comprises Sonogashira coupling wherein a compound represented by (1a-b) and a terminal-alkyne compound are reacted in the presence of a transition metal and a base in a solvent.

(595) In Formula (1a-b), preferable R2b is a chlorine atom, a bromine atom or an iodine atom.

(596) The terminal-alkyne compound to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method. In addition, as the terminal-alkyne compound, trimethylsilylacetylene may be also used. In such a case, after introducing trimethylsilylethynyl group into the compound represented by Formula (1a-b), desilylation is required to be carried out.

(597) With regard to the desilylation, it may be carried out with reference to Non-Patent Documents such as Journal of the American Chemical Society, vol. 131, No. 2, pp. 634-643 (2009) and Journal of Organometallic Chemistry, vol. 696, No. 25, pp. 4039-4045 (2011).

(598) An amount of the terminal-alkyne compound to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1a-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(599) The transition metal to be used in the present reaction may have a ligand, and may include palladiums such as palladium acetate, [1,1′-bis(diphenyl-phosphine)ferrocene]palladium dichloride, tris(dibenzylideneacetone)dipalladium, tetrakis(triphenylphosphine)palladium, bis(triphenylphosphine)palladium dichloride and the like. In addition, coppers such as copper chloride, copper bromide, copper iodate and the like may also be used simultaneously.

(600) With regard to an amount of the transition metal to be used in the present reaction, palladiums and coppers each may be used in 0.001 equivalent or more relative to the compound represented by Formula (1a-b), and is not particularly limited as long as the target reaction proceeds. Preferable amounts thereof are each 0.001 equivalent or more and 1 equivalent or less.

(601) The base to be used in the present reaction may include organic amines such as triethylamine, tributylamine, isopropylamine, diethylamine, diisopropylamine and diisopropylethylamine, inorganic bases such as sodium carbonate, potassium carbonate and cesium carbonate and the like.

(602) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1a-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 50 equivalents or less. In addition, the organic bases which is in a liquid state can be also used as a solvent.

(603) In order to proceed the reaction efficiently, a phosphine ligand such as tri-t-butyl phosphine, 2-dicyclohexylphosphino-2′4′6′-triisopropylbiphenyl and the like may be added, but this is not essential.

(604) An amount of the phosphine ligand to be used in the present reaction may be 0.001 equivalent or more and 1 equivalent or less relative to the compound represented by Formula (1a-b), and is not particularly limited as long as the target reaction proceeds.

(605) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, an organic amine solvent such as triethylamine, tributylamine, isopropylamine, diethylamine, diisopropylamine and diisopropylethylamine, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(606) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1a-b).

(607) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(608) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired. In addition, it is also possible to remove insoluble materials by subjecting to filtration operation but it is not essential.

(609) The reaction mixture obtained above which contains the compound represented by Formula (1a-e) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(610) The reaction mixture obtained above which contains the compound represented by Formula (1a-e) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(611) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a-e) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(612) [Production Method J]

(613) ##STR03487##

(614) In the formula, Rya represents a C1-C6 alkoxy group, Het1 represents a 5 to 6-membered heterocyclic group or the 8 to 10-membered heterocyclic group, the 5 to 6-membered heterocyclic group or the 8 to 10-membered heterocyclic group is optionally substituted with 0 to 5 substituents R3 (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent), and R1, R2, X, Y and the broken line are the same as defined hereinabove.

(615) Production Method J is a synthetic method of a compound represented by Formula (1-b) having a hydroxyl group which belongs to the compounds represented by Formula (1), and is a production method which comprises reacting a compound represented by Formula (1-a) wherein Rya is a C1-C6 alkoxy group and an acid in a solvent.

(616) The acid to be used in the present reaction may include boron halides such as boron trichloride and boron tribromide.

(617) An amount of the acid to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-a), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(618) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, nitrile solvents such as acetonitrile, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(619) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1-a).

(620) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −80° C. or higher and 100° C. or lower or a boiling point of the solvent or lower.

(621) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(622) The reaction mixture obtained above which contains the compound represented by Formula (1-b) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(623) The reaction mixture obtained above which contains the compound represented by Formula (1-b) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(624) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-b) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(625) [Production Method K]

(626) ##STR03488##

(627) In the formula, Ryb represents a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, a C3-C6 alkynyl group optionally substituted with substituent(s) C, a C3-C6 haloalkynyl group, an aryl group optionally substituted with substituent(s) D, a heteroaryl group optionally substituted with substituent(s) D, an aralkyl group optionally substituted with substituent(s) D or Rx1C(═O)—, and Lv, R1, R2, Het1, Rx1, X, Y and the broken line are the same as defined hereinabove.

(628) Production Method K is a synthetic method of a compound represented by Formula (1-c), which belongs to the compounds represented by Formula (1), wherein Ryb-O— represents a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, a C3-C6 haloalkynyloxy group, an aryloxy group optionally substituted with substituent(s) D, a heteroaryloxy group optionally substituted with substituent(s) D, an aralkyloxy group optionally substituted with substituent(s) D or Rx1C(═O)O— (Rx1 is the same as defined hereinabove), and is a production method which comprises reacting a compounds represented by Formula (1-b) and Ryb-Lv in the presence of a base in a solvent.

(629) The Ryb-Lv to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method.

(630) The Ryb-Lv to be used in the present reaction may be 1 equivalent or more relative to the compounds represented by Formula (i-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(631) The base to be used in the present reaction may be exemplified by inorganic bases such as sodium carbonate, potassium carbonate, cesium carbonate and sodium hydride, and organic bases such as triethylamine, tributylamine, diisopropylethylamine, pyridine, 4-dimethylaminopyridine, collidine and lutidine, and is not particularly limited as long as the target reaction proceeds.

(632) The base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(633) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, alcohol solvents such as methanol, ethanol and isopropanol, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, sulfur solvents such as dimethylsulfoxide and sulforane, ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(634) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1-b).

(635) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −20° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(636) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(637) The reaction mixture obtained above which contains the compound represented by Formula (1-c) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(638) The reaction mixture obtained above which contains the compound represented by Formula (1-c) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(639) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-c) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(640) [Production Method L].

(641) ##STR03489##

(642) In the formula, Ya represents a phenyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, a tetrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group or a thiadiazolyl group, wherein when the phenyl group is substituted with the Rya at the ortho-position, the group is further optionally substituted with 0 to 4 substituents R5 (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent), and when R4 is positioned at the ortho-position, the group is further optionally substituted with 0 to 3 substituents R5 (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent), and when the pyridyl group, the pyrazinyl group, the pyrimidinyl group, the pyridazinyl group, the a triazinyl group or the tetrazinyl group is substituted with the Rya at the ortho-position, the group is further optionally substituted with 0 to 3 substituents R5 (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent), and when R4 is positioned at the ortho-position, the group is further optionally substituted with 0 to 2 substituents R5 (with the proviso that when two substituents R5 are present, each R5 represents an independent substituent), and R1, R2, Rya, X, Het and the broken line are the same as defined hereinabove.

(643) Production Method L is a synthetic method of a compound represented by Formula (1-e) having a hydroxyl group at Y which belongs to the compounds represented by Formula (1), and is a production method which comprises reacting a compound represented by Formula (1-d) and an acid in a solvent.

(644) By using the compound represented by Formula (1-d) in place of the compound represented by Formula (1-a) in Production Method J, Production Method L can be carried out in accordance with Production Method J.

(645) [Production Method M]

(646) ##STR03490##

(647) In the formula, Yb represents a phenyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, a tetrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group or a thiadiazolyl group, wherein when the phenyl group is substituted with a hydroxyl group at the ortho-position, the group is further optionally substituted with 0 to 4 substituents R5 (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent), and when R4 is positioned at the ortho-position, the group is further optionally substituted with 0 to 3 substituents R5 (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent), and when the pyridyl group, the pyrazinyl group, the pyrimidinyl group, the pyridazinyl group, the a triazinyl group or the tetrazinyl group is substituted with hydroxyl group at the ortho-position, the group is further optionally substituted with 0 to 3 substituents R5 (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent), and when R4 is positioned at the ortho-position, the group is further optionally substituted with 0 to 2 substituents R5 (with the proviso that when two substituents R5 are present, each R5 represents an independent substituent), and Lv, R1, R2, Het, Ryb, X and the broken line are the same as defined hereinabove. The hydroxyl group in the compound represented by Formula (1-e) and the Ryb-O— in the compound represented by Formula (1-f) represent a substituent corresponding to either of R4 or R5, or each other's substituents.

(648) Production Method M is a synthetic method of a compound represented by Formula (1-f) which belongs to the compounds represented by Formula (1), and is a production method which comprises reacting a compound represented by Formula (1-e) and Ryb-Lv in the presence of a base in a solvent.

(649) By using the compound represented by Formula (1-e) in place of the compound represented by Formula (1-b) in Production Method K, Production Method M can be carried out in accordance with Production Method K.

(650) [Production Method N]

(651) ##STR03491##

(652) In the formula, Ryc represents a halogen atom, Ryd represents a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, an aryl group optionally substituted with substituent(s) D or a heteroaryl group optionally substituted with substituent(s) D, Het2 represents a 5 to 6-membered heterocyclic group or a 8 to 10-membered heterocyclic group, the 5 to 6-membered heterocyclic group or the 8 to 10-membered heterocyclic group is optionally substituted with 0 to 5 substituents R3 (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent), Ryd-B represents an organic boronic acid, and R1, R2, X, Y and the broken line are the same as defined hereinabove.

(653) Production Method N is a synthetic method of a compound represented by Formula (1-h), which belongs to the compounds represented by Formula (1), wherein Ryd is a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, an aryl group optionally substituted with substituent(s) D or a heteroaryl group optionally substituted with substituent(s) D, and is a production method which comprises Suzuki-Miyaura coupling wherein a compound represented by Formula (1-g) and an organic boronic acid (Ryd-B) are reacted in the presence of a transition metal and a base in a solvent.

(654) In the compound represented by Formula (1-g), preferable Ryc is a chlorine atom, a bromine atom or an iodine atom.

(655) The Ryd-B to be used in the present reaction represents organic boronic acids such as an organic boronic acid and an organic boronic acid ester, and can be obtained as a commercially available product or produced by a conventionally known method.

(656) By using the compound represented by Formula (1-g) and Ryd-B in place of the compound represented by Formula (1a-b) and R2d-B in Production Method H, respectively, Production Method N can be carried out in accordance with Production Method H.

(657) [Production Method O]

(658) ##STR03492##

(659) In the formula, Yc represents a phenyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, a tetrazinyl group, a thienyl group, a thiazolyl group, an isothiazolyl group or a thiadiazolyl group, wherein when the phenyl group is substituted with Ryc at the ortho-position, the group is further optionally substituted with 0 to 4 substituents R5 (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent), and when R4 is positioned at the ortho-position, the group is further optionally substituted with 0 to 3 substituents R5 (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent), and when the pyridyl group, the pyrazinyl group, the pyrimidinyl group, the pyridazinyl group, the a triazinyl group or the tetrazinyl group is substituted with Ryc at the ortho-position, the group is further optionally substituted with 0 to 3 substituents R5 (with the proviso that when two or more substituents R5 are present, each R5 represents an independent substituent), and when R4 is positioned at the ortho-position, the group is further optionally substituted with 0 to 2 substituents R5 (with the proviso that when two substituents R5 are present, each R5 represents an independent substituent), and Ryc, Ryd, Ryd-B, R1, R2, X, Het and the broken line are the same as defined hereinabove. The Ryc in the compound represented by Formula (1-i) and the Ryd in the compound represented by Formula (1-j) represent a substituent corresponding to either of R4 or R5, or each other's substituents.

(660) Production Method O is a synthetic method of a compound represented by Formula (1-j) which belongs to the compounds represented by Formula (1), and is a production method which comprises Suzuki-Miyaura coupling wherein a compound represented by Formula (1-i) and an organic boronic acid (Ryd-B) are reacted in the presence of a transition metal and a base in a solvent.

(661) In the compounds represented by Formula (1-i), preferable Ryc is a chlorine atom, a bromine atom or an iodine atom.

(662) By using the compound represented by Formula (1-i) and Ryd-B in place of the compound represented by Formula (1a-b) and R2d-B in Production Method H, respectively, Production Method O can be carried out in accordance with Production Method H.

(663) [Production Method P]

(664) ##STR03493##

(665) In the formula, Rye represents a C2-C6 alkynyl group optionally substituted with substituent(s) C or a C2-C6 haloalkynyl group, and Ryc, R1, R2, X, Y, Het2 and the broken line are the same as defined hereinabove.

(666) Production Method P is a synthetic method of a compound represented by Formula (1-k), which belongs to the compounds represented by Formula (1), wherein Rye is a C2-C6 alkynyl group optionally substituted with substituent(s) C or a C2-C6 haloalkynyl group, and is a production method which comprises Sonogashira coupling wherein a compound represented by Formula (1-g) and a terminal-alkyne compound are reacted in the presence of a transition metal and a base in a solvent.

(667) Among the compounds represented by Formula (1-g), preferable Ryc is a chlorine atom, a bromine atom or an iodine atom.

(668) By using the compound represented by Formula (1-g) in place of the compound represented by Formula (1a-b) in Production Method I, Production Method P can be carried out in accordance with Production Method I.

(669) [Production Method Q]

(670) ##STR03494##

(671) In the formula, Ryc, Rye, R1, R2, X, Yc, Het and the broken line are the same as defined hereinabove. The Ryc in the compound represented by Formula (1-i) and the Rye in the compound represented by Formula (1-1) represent a substituent corresponding to either of R4 or R5, or each other's substituents.

(672) Production Method Q is a synthetic method of a compound represented by Formula (1-1) which belongs to the compounds represented by Formula (1), and is a production method which comprises Sonogashira coupling wherein a compound represented by Formula (1-i) and a terminal-alkyne compound are reacted in the presence of a transition metal and a base in a solvent.

(673) In the compound represented by Formula (1-i), preferable Ryc is a chlorine atom, a bromine atom or an iodine atom.

(674) By using the compound represented by Formula (1-i) in place of the compound represented by Formula (1a-b) in Production Method I, Production Method Q can be carried out in accordance with Production Method I.

(675) [Production Method R]

(676) ##STR03495##

(677) In the formula, Ryf represents a halogen atom, Het3 represents a 5 to 6-membered heterocyclic group or a 8 to 10-membered heterocyclic group, the 5 to 6-membered heterocyclic group or the 8 to 10-membered heterocyclic group is optionally substituted with 0 to 5 substituents R3 (with the proviso that when two or more substituents R3 are present, each R3 represents an independent substituent), and HalR, R1, R2, X, Y and the broken line are the same as defined hereinabove.

(678) Production Method R is a production method of a compound represented by Formula (1-n), which belongs to the compounds represented by Formula (1), wherein Ryf is a halogen atom, and is a production method which comprises reacting a compound represented by Formula (1-m) and a halogenating agent (HalR) in a solvent.

(679) A base or a radical initiator may be added to the present reaction. It may be optionally set so that the target reaction proceeds.

(680) In the following, a method of reacting a compound represented by Formula (1-m) and a halogenating agent (HalR) in a solvent will be described.

(681) The halogenating agent to be used in the present reaction may include Selectfluor (N-fluoro-N′-triethylenediamine bis(tetrafluoroborate)), N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, 1,3-dichloro-5,5-dimethylhydantoin, 1,3-dibromo-5,5-dimethylhydantoin, 1,3-diiodo-5,5-dimethylhydantoin, bromine, iodine and the like,

(682) An amount of the halogenating agent to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-m), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less. If the amount of the halogenating agent including hydantoin is 0.5 equivalent or more, it is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 5 equivalents or less.

(683) When the halogenating agent to be used in the present reaction is an iodinating agent, an acid including an inorganic acid such as hydrochloric acid, sulfuric acid or the like, or an organic acid such as acetic acid, trifluoroacetic acid, methanesulfonic acid, trifluoromethanesulfonic acid or the like may be added.

(684) An amount of the acid to be used when the halogenating agent to be used in the present reaction is the iodinating agent may be 0.01 equivalent or more relative to the compound represented by Formula (1-m), which is not particularly limited as long as the target reaction proceeds, and preferably 0.1 equivalent or more and 3 equivalents or less.

(685) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include acidic solvents such as sulfuric acid, acetic acid, trifluoroacetic acid, methanesulfonic acid and trifluoromethanesulfonic acid, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, alcohol solvents such as methanol, ethanol and isopropanol, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, and the like.

(686) These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(687) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1-m).

(688) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(689) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(690) The reaction mixture obtained above which contains the compound represented by Formula (1-n) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(691) The reaction mixture obtained above which contains the compound represented by Formula (1-n) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(692) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-n) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(693) In the following, a method of reacting a compound represented by Formula (1-m) and a halogenating agent (HalR) in the presence of a base in a solvent will be described.

(694) The halogenating agent to be used in the present reaction may include Selectfluor (N-fluoro-N′-triethylenediamine bis(tetrafluoroborate)), N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, 1,3-dichloro-5,5-dimethylhydantoin, 1,3-dibromo-5,5-dimethylhydantoin, 1,3-diiodo-5,5-dimethylhydantoin, hexachloro-ethane, bromine, iodine and the like.

(695) An amount of the halogenating agent to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-m), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less. If the amount of the halogenating agent including hydantoin is 0.5 equivalent or more, it is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 5 equivalents or less.

(696) The base to be used in the present reaction may be exemplified by metal hydrides such as sodium hydride, organolithiums such as methyllithium, butyllithium, sec-butyllithium, t-butyllithium and hexyllithium, metal amides such as lithium diisopropylamide, hexamethyldisilazane lithium, hexamethyldisilazane sodium and hexamethyldisilazane potassium, and it is not particularly limited as long as the target reaction proceeds.

(697) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-m), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(698) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(699) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1-m).

(700) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −80° C. or higher and 100° C. or lower or a boiling point of the solvent or lower.

(701) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur, atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane and chloroform, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(702) The reaction mixture obtained above which contains the compound represented by Formula (1-n) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(703) The reaction mixture obtained above which contains the compound represented by Formula (1-n) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(704) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-n) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(705) In the following, a method of reacting a compound represented by Formula (1-m), a halogenating agent (HalR) and a radical initiator in a solvent will be described.

(706) The radical initiator to be used in the present reaction may include azobisisobutyronitrile, 2,2′-azobis(4-methoxy-2,4-dimethylvaleryonitrile), benzoyl peroxide and the like.

(707) An amount of the radical initiator to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0.01 equivalent or more and 1.0 equivalent or less relative to the compound represented by Formula (1-m).

(708) The halogenating agent to be used in the present reaction may include N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, 1,3-dichloro-5,5-dimethylhydantoin, 1,3-dibromo-5,5-dimethylhydantoin, 1,3-diiodo-5,5-dimethylhydantoin and the like.

(709) An amount of the halogenating agent to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-m), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 1.8 equivalents or less.

(710) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include halogenated benzene solvents such as chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(711) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1-m).

(712) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 20° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(713) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane and chloroform, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(714) The reaction mixture obtained above which contains the compound represented by Formula (1-n) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(715) The reaction mixture obtained above which contains the compound represented by Formula (1-n) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(716) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-n) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(717) [Production Method S]

(718) ##STR03496##

(719) In the formula, Ryg represents a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, a C3-C6 haloalkynyloxy group, a heteroaryl group optionally substituted with substituent(s) D, an aryloxy group optionally substituted with substituent(s) D, a heteroaryloxy group optionally substituted with substituent(s) D, an aralkyloxy group optionally substituted with substituent(s) D, RaRbN— (here, Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove.) or Rx4Rx5C═N—O— (here, Rx4 and Rx5 are the same as defined hereinabove), and R1, R2, Ryc, Het, X, Yc, Q and the broken line are the same as defined hereinabove. The Ryc in the compound represented by Formula (1-i) and the Ryg in the compound represented by Formula (1-o) represent a substituent corresponding to either of R4 or R5, or each other's substituents.

(720) Production Method S is a method of obtaining a compound represented by Formula (1-o), which belongs to the compounds represented by Formula (1) wherein Ryg is a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, a C3-C6 haloalkynyloxy group, a heteroaryl group optionally substituted with substituent(s) D, an aryloxy group optionally substituted with substituent(s) D, a heteroaryloxy group optionally substituted with substituent(s) D, an aralkyloxy group optionally substituted with substituent(s) D, RaRbN— (here, Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove.) or Rx4Rx5C═N—O— (here, Rx4 and Rx5 are the same as defined hereinabove), and is a production method which comprises reacting a compound represented by Formula (1-i) and Ryg-Q in the presence of a base in a solvent.

(721) In the compounds represented by Formula (1-i), preferable Ryc is a fluorine atom, a chlorine atom or a bromine atom.

(722) The Ryg-Q to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method. Preferable Q is a hydrogen atom or an alkali metal such as sodium, potassium and the like.

(723) An amount of the Ryg-Q to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-i), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 30 equivalents or less. Also, when Q represents a hydrogen atom, it may be used as a solvent.

(724) The base to be used in the present reaction is preferably inorganic bases such as sodium carbonate, potassium carbonate, cesium carbonate and sodium hydride. In addition, when Q is an alkali metal, use of the base is not essential.

(725) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-i), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 30 equivalents or less.

(726) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include alcohol solvents represented by Ryg-H (wherein Ryg is the same as defined hereinabove), ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents, such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, sulfur solvents such as dimethylsulfoxide and sulforane, ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(727) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1-i).

(728) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(729) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(730) The reaction mixture obtained above which contains the compound represented by Formula (1-o) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(731) The reaction mixture obtained above which contains the compound represented by Formula (1-o) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(732) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-o) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(733) [Production Method T]

(734) ##STR03497##

(735) In the formula, p represents an integer of 1 to 2, and R1, R2, X, Y and the broken line are the same as defined hereinabove.

(736) Production Method T is a synthetic method of a compound represented by Formula (1-p), which belongs to atoms among the compounds represented by Formula (1) wherein Het is a 3 to 6-membered ring group containing 1 to 2 oxygen, and is a production method which comprises reacting a compound represented by Formula (4) and a glycol in the presence of an acid in a solvent.

(737) The compound represented by Formula (4) to be used in the present reaction can be obtained with reference to Reference Examples.

(738) The acid to be used in the present reaction may be exemplified by an inorganic acid such as hydrochloric acid and sulfuric acid, and an organic acid such as p-toluenesulfonic acid and the like, which is not particularly limited as long as the target reaction proceeds.

(739) An amount of the acid to be used in the present reaction may be 0.01 equivalent or more relative to the compound represented by Formula (4), which is not particularly limited as long as the target reaction proceeds, and preferably 0.1 equivalent or more and 1 equivalent or less.

(740) The glycols to be used in the present reaction may be exemplified by ethylene glycol and propylene glycol, and can be obtained as commercially available products or produced by a conventionally known method.

(741) An amount of the glycols to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (4), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 30 equivalent or less.

(742) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(743) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 1 time by weight or more and 200 times by weight or less relative to the compound represented by Formula (4).

(744) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −80° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(745) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(746) The reaction mixture obtained above which contains the compound represented by Formula (1-p) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(747) The reaction mixture obtained above which contains the compound represented by Formula (1-p) may be distilled off under reduced pressure to remove the solvent as long as the compound is not decomposed.

(748) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-p) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(749) [Production Method U]

(750) ##STR03498##

(751) In the formula, Ryh represents a hydrogen atom, a hydroxyl group, a cyano group, a halogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) C, a C2-C6 haloalkynyl group, an aryl group optionally substituted with substituent(s) D, a heteroaryl group optionally substituted with substituent(s) D, an aryloxy group optionally substituted with substituent(s) D, a heteroaryloxy group optionally substituted with substituent(s) D, an aralkyloxy group optionally substituted with substituent(s) D, Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove.) or Rx1C(═O)O— (wherein Rx1 is the same as defined hereinabove), Ryi represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) C, a C2-C6 haloalkynyl group, an aryl group optionally substituted with substituent(s) D or a heteroaryl group optionally substituted with substituent(s) D, and R1, R2, X, Y and the broken line are the same as defined hereinabove.

(752) The production method U is a synthetic method of a compound represented by Formula (I-q) and a compound represented by Formula (1-r) which belong to the compounds represented by Formula (1), and is a production method which comprises reacting a compound represented by Formula (4-a) and NH2NH-Ryi in a solvent.

(753) A ratio of the compound represented by Formula (1-q) and the compound represented by Formula (1-r) may be either one, thereof alone or a mixture thereof with an optional ratio, which is not particularly limited.

(754) The compound represented by Formula (4-a) to be used in the present reaction can be obtained with reference to Reference Examples.

(755) The NH.sub.2NH-Ryi to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method. The NH.sub.2NH-Ryi may form a salt with an acidic compound such as hydrochloric acid and acetic acid, and is not particularly limited as long as the target reaction proceeds.

(756) An amount of the NH.sub.2NH-Ryi to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (4-a), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 30 equivalents or less.

(757) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include alcohol solvents such as methanol, ethanol, propanol and butanol, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, sulfur solvents such as dimethylsulfoxide and sulforane, ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(758) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (4-a).

(759) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(760) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(761) The reaction mixture obtained above which contains the compound represented by Formula (1-q) and the compound represented by Formula (1-r) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(762) The reaction mixture obtained above which contains the compound represented by Formula (1-q) and the compound represented by Formula (1-r) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(763) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-q) and the compound represented by Formula (1-r) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(764) [Production Method V]

(765) ##STR03499##

(766) In the formula, La represents S, Lb represents SO or SO.sub.2, and Ox′ represents an oxidizing agent.

(767) The production method V is a production method of a compounds represented by Formula (Lb), which belongs to in the compounds represented by Formula (1) represented by the formula (1) wherein Lb contained in R2, R3, R4, R5, substituent(s) A and substituent(s) C is SO or SO.sub.2, and is a production method which comprises reacting a compound represented by Formula (La), which belongs to the compounds represented by Formula (1) wherein La contained in R2, R3, R4, R5, substituent(s) A and substituent(s) C is S and an oxidizing agent (Ox′) in a solvent.

(768) The oxidizing agent to be used in the present reaction may include a peroxide such as aqueous hydrogen peroxide, meta-chloroperbenzoic acid and the like. In addition, a transition metal such as sodium tungstate may be added.

(769) An amount of the oxidizing agent to be used in the present reaction may be usually 1.0 equivalent or more and 1.2 equivalents or less relative to the compound represented by Formula (La) when SO is produced, and is usually 2 equivalents or more and 10 equivalents or less when SO.sub.2 is produced. In addition, when the transition metal is to be added, it is usually used in 0.001 equivalent or more and 1 equivalent or less.

(770) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include water solvent, an acidic solvent such as acetic acid, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, nitrile solvents such as acetonitrile, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(771) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (La).

(772) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −10° C. or higher and 120° C. or lower or a boiling point of the solvent or lower.

(773) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like.

(774) In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(775) The reaction mixture obtained above which contains the compound represented by Formula (Lb) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(776) The reaction mixture obtained above which contains the compound represented by Formula (Lb) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(777) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (Lb) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(778) Next, a synthetic method of the compound represented by Formula (3) described in Production Method A will be described.

(779) [Production Method W]

(780) ##STR03500##

(781) In the formula, R2, R6, Het, X and Y are the same as defined hereinabove.

(782) The production method W is a production method of a production intermediate represented by the compound of Formula (3), and is a production method which comprises reacting a compound represented by Formula (5) and a compound represented by Formula (6) in the presence of a base in a solvent.

(783) The compound represented by Formula (5) to be used in the present reaction can be synthesized in accordance with Reference Examples. In addition, it can be synthesized with reference to Green Chemistry, vol. 41, pp. 580-585, The Journal of Organic Chemistry, vol. 65, No. 20, pp. 6458-6461 (2000) or U.S. Pat. No. 5,922,718.

(784) The compound represented by Formula (6) to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method.

(785) An amount of the compound represented by Formula (6) to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (5), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 3 equivalents or less.

(786) The base to be used in the present reaction may include inorganic bases such as sodium carbonate, potassium carbonate, cesium carbonate and tripotassium phosphate, or metal alkoxides such as sodium methoxide, sodium ethoxide and potassium t-butoxide.

(787) The base to be used in the present reaction can be carried out with a catalytic amount, which is not particularly limited as long as the target reaction proceeds, and preferably 0.01 equivalent or more and 3 equivalents or less relative to the compound represented by Formula (5).

(788) The solvents to be used in the present reaction may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, sulfur solvents such as dimethylsulfoxide and sulforane, ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(789) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (5).

(790) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −50° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(791) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(792) The reaction mixture obtained above which contains the compound represented by Formula (3) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(793) The reaction mixture obtained above which contains the compound represented by Formula (3) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(794) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (3) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(795) [Production Method X]

(796) ##STR03501##

(797) In the formula, R6a represents a C1-C6 alkyl group, and R2, Het, X and Y are the same as defined hereinabove.

(798) Production Method X is a production method of a production intermediate represented by Formula (3b) which belongs to the compounds represented by Formula (3), and is a production method which comprises reacting a compound represented by Formula (3a) under acidic conditions or basic conditions in a solvent.

(799) First, the reaction under acidic conditions will be described.

(800) The acid to be used in the present reaction may be exemplified by inorganic acids such as hydrochloric acid, hydrobromic acid and phosphoric acid, and organic acids such as acetic acid, methanesulfonic acid, p-toluenesulfonic acid and trifluoroacetic acid. It is not particularly limited as long as the target reaction proceeds.

(801) An amount of the acid to be used in the present reaction may be a catalytic amount, which is not particularly limited as long as the target reaction proceeds, and preferably 0.01 equivalent or more relative to the compound represented by Formula (3a). In addition, with regard to a liquid state acid, it is also possible to use it as a solvent.

(802) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include water solvent, acidic solvents such as acetic acid and methanesulfonic acid, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, alcohol solvents such as methanol, ethanol and isopropanol, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(803) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (3a).

(804) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 180° C. or lower or a boiling point of the solvent or lower.

(805) Next, the reaction under basic conditions will be described.

(806) The base to be used in the present reaction may be exemplified by inorganic bases such as lithium hydroxide, sodium hydroxide and potassium hydroxide, and is not particularly limited as long as the target reaction proceeds.

(807) The base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (3a), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 30 equivalents or less.

(808) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include water solvent, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, alcohol solvents such as methanol, ethanol and isopropanol, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(809) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (3a).

(810) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −20° C. or higher and 180° C. or lower or a boiling point of the solvent or lower.

(811) A post treatment after the reaction can be carried out in the same way as the reaction under acidic conditions and the reaction under basic conditions. It is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, and a saline solution can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(812) The reaction mixture obtained above which contains the compound represented by Formula (3b) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(813) The reaction mixture obtained above which contains the compound represented by Formula (3b) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(814) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (3b) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(815) The compound represented by Formula (3b) contains an isomer represented by Formula (3b′)

(816) ##STR03502##
(wherein R2, Het, X and Y are the same as defined hereinabove).

(817) The compound represented by Formula (3b′) can be handled similar to the compound represented by Formula (3b), and Production Method A can be applied.

(818) Also, the compound represented by Formula (3b′) contains an asymmetric carbon, and a mixed ratio of the isomers may be a single isomer alone or a mixture with an optional ratio. Further, it may be a mixture of the compound represented by Formula (3b) and the compound represented by Formula (3b′), and a mixed ratio of the isomers may be a single isomer alone or a mixture with an optional ratio.

(819) [Production Method Y]

(820) ##STR03503##

(821) In the formula, Ryj represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) C, a C2-C6 haloalkynyl group, an aryl group optionally substituted with substituent(s) D or a heteroaryl group optionally substituted with substituent(s) D, and R1, R2, X, Y and the broken line are the same as defined hereinabove.

(822) Production Method Y is a synthetic method of a compound represented by Formula (1-s) which belongs to the compounds represented by Formula (1), and is a production method which comprises reacting a compound represented by Formula (4) and a compound represented by Formula (7) in the presence of a base in a solvent.

(823) The compound represented by Formula (4) to be used in the present reaction can be obtained with reference to Reference Examples.

(824) The compound represented by Formula (7) to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method.

(825) An amount of the compound represented by Formula (7) to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (4), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 10 equivalents or less.

(826) The base to be used in the present reaction may be exemplified by inorganic bases such as sodium hydride, lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate and tripotassium phosphate, and metal alkoxides such as sodium methoxide, sodium ethoxide and potassium t-butoxide, and is not particularly limited as long as the target reaction proceeds.

(827) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (4), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 10 equivalents or less.

(828) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include alcohol solvents such as methanol, ethanol, propanol and butanol, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, sulfur solvents such as dimethylsulfoxide and sulforane, ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(829) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (4).

(830) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(831) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(832) The reaction mixture obtained above which contains the compound represented by Formula (1-s) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(833) The reaction mixture obtained above which contains the compound represented by Formula (1-s) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(834) The reaction mixture, obtained after distillation of the solvent which contains the compound represented by Formula (1-s) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(835) [Production Method Z]

(836) ##STR03504##

(837) In the formula, Ryk represents a hydrogen atom, a cyano group, a nitro group, a C1-C6 alkyl group optionally substituted with substituent(s) C, a C1-C6 haloalkyl group, a C3-C8 cycloalkyl group optionally substituted with substituent(s) C, a C2-C6 alkenyl group optionally substituted with substituent(s) C, a C2-C6 haloalkenyl group, a C2-C6 alkynyl group optionally substituted with substituent(s) C, a C2-C6 haloalkynyl group, a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group or Rx1C(═O)— (wherein Rx1 is the same as defined hereinabove), and R1, R2, Ryj, X, Y and the broken line are the same as defined hereinabove.

(838) The production method Z is a synthetic method of a compound represented by Formula (1-t) which belongs to the compounds represented by Formula (1), and is a production method which comprises reacting a compound represented by Formula (8) and a compound represented by Formula (7) in the presence of a base in a solvent.

(839) The compound represented by Formula (8) to be used in the present reaction can be obtained with reference to Reference Examples. The compound represented by Formula (8) contains geometric isomers, a mixed ratio of the isomers may be a single isomer alone or a mixture with an optional ratio, and is not particularly limited as long as the target reaction proceeds.

(840) The compound represented by Formula (7) to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method.

(841) An amount of the compound represented by Formula (7) to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (8), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 10 equivalents or less.

(842) The base to be used in the present reaction may be exemplified by inorganic bases such as sodium hydride, lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate and tripotassium phosphate, and metal alkoxides such as sodium methoxide, sodium ethoxide and potassium t-butoxide, and is not particularly limited as long as the target reaction proceeds.

(843) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (8), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 10 equivalents or less.

(844) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include alcohol solvents such as methanol, ethanol, propanol and butanol, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, sulfur solvents such as dimethylsulfoxide and sulforane, ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(845) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (8).

(846) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(847) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(848) The reaction mixture obtained above which contains the compound represented by Formula (1-t) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(849) The reaction mixture obtained above which contains the compound represented by Formula (1-t) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(850) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-t) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(851) [Production Method AA]

(852) ##STR03505##

(853) In the formula, R1, Het, R2b, X and Y are the same as defined hereinabove.

(854) Production Method AA is a synthetic method of a compound represented by Formula (1a-f) having a trifluoromethyl group which belongs to the compounds represented by Formula (1a), and is a production method which comprises reacting a compound represented by Formula (1a-b) and methyl difluoro(fluorosulfonyl)acetate in the presence of a transition metal.

(855) In the compound represented by Formula (1a-b), preferable R2b is a chlorine atom, a bromine atom or an iodine atom.

(856) Methyl difluoro(fluorosulfonyl)acetate to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method.

(857) An amount of methyl difluoro(fluorosulfonyl)acetate to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1a-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 50 equivalents or less.

(858) The transition metal to be used in the present reaction is copper and the like. It is preferably copper bromide, copper iodide and the like.

(859) An amount of the transition metal to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1a-b), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 50 equivalents or less.

(860) In order to proceed the reaction efficiently, an additive such as ethyldiisopropylamine and hexamethylphosphoric triamide, but it is not essential.

(861) An amount of the additive to be used in the present reaction may be 50 equivalents or less relative to the compound represented by Formula (1a-b), and is not particularly limited as long as the target reaction proceeds.

(862) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, sulfur solvents such as dimethylsulfoxide and sulforane, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(863) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1a-b).

(864) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(865) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which ammonia, potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(866) The reaction mixture obtained above which contains the compound represented by Formula (1a-f) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(867) The reaction mixture obtained above which contains the compound represented by Formula (1a-f) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(868) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a-f) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(869) [Production Method AB]

(870) ##STR03506##

(871) In the formula, R1, R2, Ryc, Ryg, Het2, X, Y, Q and the broken line are the same as defined hereinabove.

(872) Production Method AB is a method of obtaining a compound represented by Formula (1-u), which belongs to the compounds represented by Formula (1), wherein Ryg is a C1-C6 alkoxy group optionally substituted with substituent(s) C, a C1-C6 haloalkoxy group, a C3-C8 cycloalkoxy group optionally substituted with substituent(s) C, a C2-C6 alkenyloxy group optionally substituted with substituent(s) C, a C2-C6 haloalkenyloxy group, a C3-C6 alkynyloxy group optionally substituted with substituent(s) C, a C3-C6 haloalkynyloxy group, a heteroaryl group optionally substituted with substituent(s) D, an aryloxy group optionally substituted with substituent(s) D, a heteroaryloxy group optionally substituted with substituent(s) D, an aralkyloxy group optionally substituted with substituent(s) D, RaRbN— (here, Ra and Rb are the same as defined hereinabove), Rc-L- (wherein Rc and L are the same as defined hereinabove.) or Rx4Rx5C═N—O— (here, Rx4 and Rx5 are the same as defined hereinabove), and is a production method which comprises reacting a compound represented by Formula (1-g) and Ryg-Q in the presence of a base in a solvent.

(873) In the compound represented by Formula (1-g), preferable Ryc is a fluorine atom, a chlorine atom or a bromine atom.

(874) The Ryg-Q to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method. Preferable Q is a hydrogen atom or an alkali metal such as sodium, potassium and the like.

(875) An amount of the Ryg-Q to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-g), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 30 equivalents or less. Also, when Q represents a hydrogen atom, it may be used as a solvent.

(876) The base to be used in the present reaction is preferably inorganic bases such as sodium carbonate, potassium carbonate, cesium carbonate and sodium hydride. Also, when the Q is an alkali metal, then use of the base is not essential.

(877) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (1-g), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 30 equivalents or less.

(878) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include alcohol solvents represented by Ryg-H (wherein Ryg is the same as defined hereinabove), ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, sulfur solvents such as dimethylsulfoxide and sulforane, ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(879) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1-g).

(880) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(881) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride; hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(882) The reaction mixture obtained above which contains the compound represented by Formula (1-u) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(883) The reaction mixture obtained above which contains the compound represented by Formula (1-u) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(884) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1-u) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(885) [Production Method AC]

(886) ##STR03507##

(887) In the formula, R2f represents a halogen atom, and HalR, R1, Het, X and Y are the same as defined hereinabove.

(888) Production Method AC is a method of obtaining a compound represented by Formula (1a-h), which belongs to the compounds represented by Formula (1a), wherein R2f is a halogen atom, and is a production method which comprises reacting a compound represented by Formula (1a-g) using a radical initiator and a halogenating agent (HalR) in a solvent.

(889) In Formula (1a-h), preferable R2f is a chlorine atom, a bromine atom or an iodine atom.

(890) The radical initiator to be used in the present reaction may include azobisisobutyronitrile, 2,2′-azobis(4-methoxy-2,4-dimethylvaleryonitrile), benzoyl peroxide and the like.

(891) An amount of the radical initiator to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0.01 equivalent or more and 1.0 equivalent or less relative to the compound represented by Formula (1a-g).

(892) The halogenating agent to be used in the present reaction may include N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, 1,3-dichloro-5,5-dimethylhydantoin, 1,3-dibromo-5,5-dimethylhydantoin, 1,3-diiodo-5,5-dimethylhydantoin and the like.

(893) An amount of the halogenating agent to be used in the present reaction may be 2 equivalents or more relative to the compound represented by Formula (1a-g), which is not particularly limited as long as the target reaction proceeds, and is usually 2 equivalents or more and 2.8 equivalents or less.

(894) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include halogenated benzene solvents such as chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(895) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1a-g).

(896) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 20° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(897) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane and chloroform, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(898) The reaction mixture obtained above which contains the compound represented by Formula (1a-h) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(899) The reaction mixture obtained above which contains the compound represented by Formula (1a-h) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(900) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a-h) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(901) [Production Method AD]

(902) ##STR03508##

(903) In the formula, R1, R2f, Het, X and Y are the same as defined hereinabove.

(904) Production Method AD is a method of obtaining a compound represented by Formula (1a-i) which belongs to the compounds represented by Formula (1a), and is a production method which comprises hydrolyzing a compound represented by Formula (1a-h) in the presence of water in a solvent.

(905) In Formula (1a-h), preferable R2f is a chlorine atom, a bromine atom or an iodine atom.

(906) In the present reaction, water is essential. Also, in order to proceed the present reaction smoothly, silver nitrate may be used.

(907) When an amount of water to be used in the present reaction is 1 equivalent or more relative to the compound represented by Formula (1a-h), it is not limited as long as the target reaction proceeds. In addition, water can be used as a solvent.

(908) When an amount of the silver nitrate to be used in the present reaction is 2 equivalents or more relative to the compound represented by Formula (1a-h), it is not limited as long as the target reaction proceeds, and it is usually 2 equivalents or more and 10 equivalents or less.

(909) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include water solvent, ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, nitrile solvents such as acetonitrile, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(910) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1a-h).

(911) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −10° C. or higher and 100° C. or lower or a boiling point of the solvent or lower.

(912) As a post treatment after the reaction, it is possible to remove undissolved metal by filtration. Further, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(913) The reaction mixture obtained above which contains the compound represented by Formula (1a-i) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(914) The reaction mixture obtained above which contains the compound represented by Formula (1a-i) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(915) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a-i) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(916) [Production Method AE]

(917) ##STR03509##

(918) In the formula, FR represents a fluorinating agent, and R1, Het, X and Y are the same as defined hereinabove.

(919) Production Method AE is a method of obtaining a compound represented by Formula (1a-j) having a fluorine atom which belongs to the compounds represented by Formula (1a), and is a production method which comprises reacting a compound represented by Formula (1a-i) and a fluorinating agent (FR) in a solvent.

(920) The fluorinating agent to be used in the present reaction may include (diethylamino)sulfur trifluoride, bis(2-methoxyethyl)aminosulfur trifluoride, N,N-diethyl-1,1,2,3,3,3-hexafluoropropylamine, 2,2-difluoro-1,3-dimethylimidazolidine and the like.

(921) An amount of the fluorinating agent to be used in the present reaction may be 2 equivalents or more relative to the compound represented by Formula (1a-i), which is not particularly limited as long as the target reaction proceeds, and is usually 2 equivalents or more and 10 equivalents or less.

(922) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, nitrile solvents such as acetonitrile, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(923) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (1a-i).

(924) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −80° C. or higher and 100° C. or lower or a boiling point of the solvent or lower.

(925) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(926) The reaction mixture obtained above which contains the compound represented by Formula (1a-j) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(927) The reaction mixture obtained above which contains the compound represented by Formula (1a-j) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(928) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (1a-j) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(929) [Production Method AF]

(930) ##STR03510##

(931) In the formula, Ox represents an oxidizing agent, and R2, Het, X and Y are the same as defined hereinabove.

(932) Production Method AF is a method of obtaining a compound represented by Formula (2-a), and is a production method which comprises reacting a compound represented by Formula (2) and an oxidizing agent (Ox) in a solvent.

(933) By using the compound represented by Formula (2) in place of the compound represented by Formula (1b) in Production Method E, Production Method AF can be carried out in accordance with Production Method E.

(934) [Production Method AG]

(935) ##STR03511##

(936) In the formula, R2b represents a halogen atom, HalR represents a halogenating agent, and Het, X and Y are the same as defined hereinabove.

(937) Production Method AG is a production method of obtaining a compound represented by Formula (2-c), which belongs to the compounds represented by Formula (2-a), wherein R2b represents a halogen atom, and is a production method which comprises reacting a compound represented by Formula (2-b) and a halogenating agent (HalR) in a solvent.

(938) By using the compound represented by Formula (2-b) in place of the compound represented by Formula (1a-a) in Production Method F, Production Method AG can be carried out in accordance with Production Method F.

(939) [Production Method AH]

(940) ##STR03512##

(941) In the formula, RNH.sub.2 represents an aminating agent, and R2, Het, X and Y are the same as defined hereinabove.

(942) Production Method AH is a method of obtaining a compound represented by Formula (2-d), and is a production method which comprises a compound represented by Formula (2-a) and an aminating agent (RNH.sub.2) in the presence of a base in a solvent.

(943) The aminating agent to be used in the present reaction may include diphenyl-phosphineamide, O-(4-nitrobenzoyl)hydroxylamine, O-(2,4-dinitrophenyl)-hydroxylamine, O-(diphenylphosphinyl)hydroxylamine and the like.

(944) An amount of the aminating agent to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (2-a), which is not particularly limited as long as the target reaction proceeds, and is usually 1 equivalent or more and 5 equivalents or less.

(945) The base to be used in the present reaction may be exemplified by inorganic bases such as lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate and tripotassium phosphate, metal alkoxides such as sodium methoxide, sodium ethoxide and potassium t-butoxide, metal hydrides such as sodium hydride, and metal amides such as lithium diisopropylamide, hexamethyldisilazane lithium, hexamethyldisilazane sodium and hexamethyldisilazane potassium, and is not particularly limited as long as the target reaction proceeds.

(946) An amount of the base to be used in the present reaction a base may be 1 equivalent or more relative to the compound represented by Formula (2-a), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(947) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, nitrile solvents such as acetonitrile, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(948) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (2-a).

(949) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually −80° C. or higher and 100° C. or lower or a boiling point of the solvent or lower.

(950) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(951) The reaction mixture obtained above which contains the compound represented by Formula (2-d) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(952) The reaction mixture obtained above which contains the compound represented by Formula (2-d) may be distilled under reduced pressure to remove the solvent as long as, the compound is not decomposed.

(953) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (2-d) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(954) [Production Method AI]

(955) ##STR03513##

(956) In the formula, Raa represents a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group, and R2, Het, Lv, X and Y are the same as defined hereinabove.

(957) Production Method AI is a method of obtaining a compound represented by Formula (2-e), and is a production method which comprises reacting a compound represented by Formula (2-d) and Raa-Lv in the presence of a base in a solvent.

(958) The Raa-Lv to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method.

(959) An amount of the Raa-Lv to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (2-d), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(960) The base to be used in the present reaction may be exemplified by inorganic bases such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate and sodium hydride, and is not particularly limited as long as the target reaction proceeds.

(961) An amount of the base to be used in the present reaction may be 1 equivalent or more relative to the compound represented by Formula (2-d), which is not particularly limited as long as the target reaction proceeds, and preferably 1 equivalent or more and 10 equivalents or less.

(962) The solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and may include ether solvents such as diethyl ether, diisopropyl ether, methyl-t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane, alcohol solvents such as methanol, ethanol and isopropanol, benzene based solvents such as benzene, toluene, xylene, mesitylene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, nitrile solvents such as acetonitrile, amide solvents such as N-methylpyrrolidone, N,N-dimethylformamide and N,N-dimethylacetamide, urea solvents such as 1,3-dimethyl-2-imidazolidinone, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, sulfur solvents such as dimethylsulfoxide and sulforane, ketone solvents such as acetone, methyl ethyl ketone and methyl isobutyl ketone and water solvent, and the like. These solvents may be used singly, or two or more kinds may be used in combination in an optional ratio.

(963) An amount of the solvent to be used in the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 3 times by weight or more and 200 times by weight or less relative to the compound represented by Formula (2-d).

(964) A temperature to carry out the present reaction is not particularly limited as long as the target reaction proceeds, and is usually 0° C. or higher and 150° C. or lower or a boiling point of the solvent or lower.

(965) As a post treatment after the reaction, it is possible to carry out a liquid separating operation by adding water or a suitable aqueous solution to the reaction mixture. When an aqueous solution is to be used, an acidic aqueous solution in which hydrochloric acid, sulfuric acid, ammonium chloride or the like is dissolved, an alkaline aqueous solution in which potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate or the like is dissolved, an aqueous solution in which a salt containing a sulfur atom such as sodium thiosulfate, sodium sulfite or the like is dissolved or a saline solution or the like can be optionally used. At the time of the liquid separating operation, if necessary, it is possible to add a solvent which is immiscible with water including benzene based solvents such as toluene, xylene, benzene, chlorobenzene and dichlorobenzene, ester solvents such as ethyl acetate, isopropyl acetate and butyl acetate, ether solvents such as diethyl ether, diisopropyl ether and methyl-t-butyl ether, halogen based solvents such as dichloromethane, dichloroethane, chloroform and carbon tetrachloride, hydrocarbon solvents such as hexane, heptane, cyclohexane and methylcyclohexane, and the like. In addition, it is possible to use these solvents singly or to mix two or more kinds with an optional ratio. The number of times of the liquid separation is not particularly limited, and may be carried out in accordance with the purity and yield to be desired.

(966) The reaction mixture obtained above which contains the compound represented by Formula (2-e) may be dehydrated with a drying agent such as sodium sulfate and magnesium sulfate, but this is not essential.

(967) The reaction mixture obtained above which contains the compound represented by Formula (2-e) may be distilled under reduced pressure to remove the solvent as long as the compound is not decomposed.

(968) The reaction mixture obtained after distillation of the solvent which contains the compound represented by Formula (2-e) may be purified by washing, reprecipitation, recrystallization, column chromatography and the like, using a suitable solvent. It may be optionally set in accordance with the desired purity.

(969) [Production Method AJ]

(970) ##STR03514##

(971) In the formula, Rba represents a C1-C6 alkyl group optionally substituted with substituent(s) B, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group, and R2, Het, Lv, X and Y are the same as defined hereinabove.

(972) Production Method AJ is a method of obtaining a compound represented by Formula (2-f), and is a production method which comprises reacting a compound represented by Formula (2-e) and Rba-Lv in the presence of a base in a solvent.

(973) The Rba-Lv to be used in the present reaction can be obtained as a commercially available product or produced by a conventionally known method.

(974) By using the compound represented by Formula (2-e) in place of the compound represented by Formula (2-d) in Production Method AI, Production Method AJ can be carried out in accordance with Production Method AI. Also, when Raa and Rba are the same, by using 2 equivalents or more of Raa-Lv relative to Formula (2-d) in Production Method AI, the compound represented by Formula (2-f) can be synthesized.

(975) The compounds represented by Formula (1) can be produced by optionally combining Production Method A to Production Method AJ shown hereinabove. Or else, the compounds represented by Formula (1) can be produced even when the conventionally known method and Production Method A to Production Method AJ are optionally combined.

(976) The compounds of the present invention can protect plants from harmful organisms and thus may be used as agricultural chemicals. Specifically, examples thereof includes fungicides, insecticides, herbicides, plant growth regulators and the like. It is preferably fungicides.

(977) The compounds of the present invention can be used as an agricultural and horticultural fungicide in farms, paddy fields, tea gardens, orchards, meadows, grasses, forests, gardens, roadside trees, etc., for prevention and treatment of plant diseases.

(978) Plant diseases referred to in the present invention mean that systemic, abnormal pathological symptoms such as wilting, damping-off, yellowing, dwarfism, and spindly growth, or partial pathological symptoms such as spotting, leaf blight, mosaic pattern, leaf rolling, die back, root rot, club root, and knotting are induced in plants such as crops, flowering plants, flowering trees and shrubs, and trees. That is, the plants are to get sick. As pathogens that cause plant diseases, there may be mainly mentioned fungi, bacteria, spiroplasmas, phytoplasmas, viruses, viroids, parasitic higher plants, nematodes and the like. The compounds of the present invention are effective against fungi, but it is not limited thereto.

(979) Diseases caused by fungi are mainly fungal diseases. Examples of fungi (pathogens) that cause fungal diseases include Plasmodiophora, Oomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes. For example, Plasmodiophora may include club root fungus, potato powdery scab fungus and beet necrotic yellow vein virus, Oomycetes may include blight fungus, downy mildew fungus, Pythium species fungus and Aphanomyces species fungus, Zygomycetes may include Rhizopus species fungus, Ascomycetes may include peach leaf curl fungus, corn brown spot fungus, rice blast fungus, powdery mildew fungus, anthracnose fungus, Fusarium head blight fungus, bakanae disease fungus and sclerotial disease fungus, Basidiomycetes may include rust disease fungus, smut fungus, violet root rot fungus, blister blight fungus and rice sheath blight fungus, and Deuteromycetes may include gray mold fungus, Alternaria species fungus, Fusarium species fungus, Penicillium species fungus, Rhizoctonia species fungus, southern blight fungus and the like.

(980) The compounds of the present invention are effective against various plant diseases. The following provides specific examples of disease names and pathogens thereof.

(981) Rice: blast (Magnaporthe grisea), sheath blight (Thanatephorus cucumeris), brown sclerotial disease (Ceratobasidium setariae), small sclerotial disease (Waitea circinata), brown sheath blight (Thanatephorus cucumeris), globular sclerotial disease (Sclerotium hydrophilum), red sclerotial disease (Wairea circinata), black leaf blight (Entyloma dactylidis), stem rot (Magnaporthe salvinii), gray sclerotial disease (Ceratobasidium cornigerum), brown spot (Cochliobolus miyabeanus), Cercospora leaf spot (Sphaerulina oryzina), bakanae disease (Gibberella fujikuroi), seedling damping-off (Pythium spp., Fusarium spp., Trichoderma spp., Rhizopus spp., Rhizoctonia solani, Mucor sp., Phoma sp.), seedling rot (Pythium spp., Achlya spp., Dictyuchus spp.), rice false smut (Claviceps virens), kernel smut (Tilletia barclayana), discolored rice grains (Curvularia spp., Alternaria spp.), crazy top (Sclerophthora macrospora), bacterial leaf blight (Xanthomonas oryzae pv. oryzae), bacterial brown stripe (Acidovorax avenae subsp. avenae), bacterial palea browning (Erwinia ananas), bacterial seedling damping-off (Burkholderia plantarii), bacterial grain rot (Burkholderia glumae), sheath brown rot (Pseudomonas fuscovaginae), bacterial halo blight (Pseudomonas syringae pv. oryzae), bacterial foot rot (Erwinia chrysanthemi), yellow dwarf (Phytoplasma oryzae), rice stripe (Rice stripe tenuivirus), rice dwarf (Rice dwarf reovirus);

(982) wheat and barley: powdery mildew (Blumeria graminis fsp. hordei; fsp. tritici), rust (Puccinia striiformis, Puccinia graminis, Puccinia recondita, Puccinia hordei), barley stripe (Pyrenophora graminea), net blotch (Pyrenophora teres), Fusarium head blight (Gibberella zeae, Fusarium culmorum, Fusarium avenaceum, Monographella nivalis), Typhula snow blight (Typhula incarnata, Typhula ishikariensis, Monographella nivalis), loose kernel smut (Ustilago nuda), stinking smut (Tilletia caries, Tilletia controversa), eye spot (Pseudocercosporella herpotrichoides), foot rot (Ceratobasidium gramineum), leaf scald (Rhynchosporium secalis), speckled leaf blotch (Septoria tritici), glume blotch (Phaeosphaeria nodorum), damping-off (Fusarium spp., Pythium spp., Rhizoctonia spp., Septoria spp., Pyrenophora spp.), seedling blight (Gaeumannomyces graminis), anthracnose (Colletotrichum graminicola), ergot (Claviceps purpurea), leaf spot (Cochliobolus sativus), bacterial black node (Pseudoronas syringae pv. syringae);
corn: leaf rust (Gibberella zeae, etc.), damping-off (Fusarium avenaceum, Penicillium spp., Pythium spp., Rhizoctonia spp.), rust (Puccinia sorghi), brown spot (Cochliobolus heterostrophus), loose smut (Ustilago maydis), anthracnose (Colletotrichum graminicola), northern leaf spot (Cochliobolus carbonum), bacterial brown stripe (Acidovorax avenae subsp. avenae), bacterial stripe (Burkholderia andropogonis), bacterial stalk rot (Erwinia chrysanthemi pv. zeae), bacterial wilt (Erwinia stewartii); grapes: downy mildew (Plasmopara viticola), rust (Physopella ampelopsidis), powdery mildew (Uncinula necator), scab (Elsinoe amnpelina), ripe rot (Glomerella cingulata, Colletotrichum acutatum), black rot (Guignardia bidwellii), Phomopsis leaf spot (Phomopsis viticola), fly speck (Zygophiala jamaicensis), gray mold (Botrytis cinerea), twig blight (Diaporthe medusaea), violet root rot (Helicobasidium mompa), white root rot (Rosellinia necatrix), crown gall (Agrobacterium vitis); apples: powdery mildew (Podosphaera leucotricha), black spot disease (Venturia inaequalis), Alternaria leaf spot (Alternaria mali), rust (Gymnosporangium yamadae), blossom blight (Monilinia mali), apple canker (Valsa ceratosperma), ring spot (Botyosphaeria berengeriana), anthracnose (Colletotrichurn acutatum, Glomerella cingulata), fly speck (Zygophiala jamaicensis), sooty spot (Gloeodes pomigena), fruit spot (Mycosphaerella pomi), violet root rot (Helicobasidium mompa), white root rot (Rosellinia necatrix), canker (Phomopsis mali, Diaporthe tanakae), apple blotch (Diplocarpon mali), fire blight (Erwinia amylovora), crown gall (Agrobacterium tumefaciens), hairy root disease (Agrobacterium rhizogenes);
Japanese pears: black spot (Alternaria kikuchiana), pear scab (Venturia nashicola), rust (Gymnosporangium asiaticum), ring spot (Botryosphaeria berengeriana fsp. piricola), pear canker (Phomopsis fukushii), bacterial shoot blight (Erwinia sp.), crown gall (Agrobacterium tumefaciens), rusty canker (Erwinia chrysanthemi pv. chrysanthemi), bacterial petal blight (Pseudomonas syringae pv. syringae); European pears: blight (Phytophthora cactorum, Phytophthora syringae), bacterial shoot blight (Erwinia sp.); peaches: black spot (Cladosporium carpophilum), Phomopsis rot (Phomopsis sp.), blight (Phytophthora sp.), anthracnose (Colletotrichum gloeosporioides), leaf curl (Taphrina deformans), bacterial shot hole (Xhanthomonas campestris pv. pruni), crown gall (Agrobacterium tumefaciens); cherries: anthracnose (Glomerella cingulata), young fruit sclerotial disease (Monilinia kusanoi), gray spot (Monilinia fructicola), crown gall (Agrobacterium tumefaciens), bacterial gummosis. (Pseudomonas syringae pv. syringae); persimmons: anthracnose (Glomerella cingulata), brown stem rot (Cercospora kaki; Mycosphaerella nawae), powdery mildew (Phyllactinia kakikora), crown gall (Agrobacterium tumefaciens); citrus fruits: melanose (Diaporthe citri), green mold disease (Penicillium digitatum), blue mold disease (Penicillium italicum), scab (Elsinoe fawcettii), brown rot (Phytophthora citrophthora), canker (Xhanthomonas campestris pv. citri), bacterial brown spot (Pseudomonas syringae pv. syringae), greening disease (Liberibactor asiaticus), crown gall (Agrobacterium tumefaciens); tomato, cucumbers, beans, strawberries, potatoes, cabbage, eggplants, lettuce and the like: gray mold (Botrytis cinerea); tomatoes, cucumbers, beans, strawberries, potatoes, rapeseed, cabbage, eggplants, lettuce and the like: sclerotial disease (Sclerotinia sclerotiorum); various vegetables such as tomatoes, cucumbers, beans, radishes, watermelons, eggplants, rapeseed, green peppers, spinach, beets and the like: seedling damping-off (Rhizoctonia spp., Pythium spp., Fusarium spp., Phythophthora spp., Sclerotinia sclerotiorum, etc.); solanaceous plants: bacterial wilt (Ralstonia solanacearum); melons: downy mildew (Pseudoperonospora cubensis), powdery mildew (Sphaerotheca fuliginea), anthracnose (Colletotrichum orbiculare), gummy stem blight (Didymella bryoniae), stem rot (Fusarium oxysporum), late blight (Phytophthora parasitica, Phytophthora melonis, Phytophthora nicotianae, Phytophthora drechsleri, Phytophthora capsici, etc.), bacterial brown spot (Xhanthomonas campestris pv. cucurbitae), soft rot (Erwinia carotovora subsp. carotovora), bacterial spot (Pseudomonas syringae pv. lachrymans), marginal blight (Pseudomonas marginalis pv. marginalis), canker (Streptomyces sp.), hairy root disease (Agrobacterium rhizogenes), cucumber mosaic virus (Cucumber mosaic virus);
tomatoes: ring spot (Alternaria solani), leaf mold (Fulvia fulva), late blight (Phytophthora infestans), wilt disease (Fusarium oxysporum), root rot (Pythium myriotylum, Pythium dissotocum), anthracnose (Colletotrichum gloeosporioides), canker (Clavibacter michiganensis), pith necrosis (Pseudomonas corrugata), bacterial black spot (Pseudomonas viridiflava), soft rot (Erwinia carotovora subsp. carotovora), bacterial leaf gall (Crynebacterium sp.), yellowing wilt (Phytoplasma asteris), yellow dwarfism (Tobacco leaf curl subgroup III geminivirus); eggplants: powdery mildew (Sphaerotheca fidiginea, etc.), leaf mold (Mycovellosiella nattrassii), blight (Phytophthora infestans), brown rot (Phytophthora capsici), bacterial brown spot (Pseudomonas cichorii), necrotic leaf spot (Pseudomonas corrugata), bacterial stem rot (Erwinia chrysantherni), soft rot (Erwinia carotovora subsp. carotovora), bacterial spot (Pseudomonas sp.); rapeseed: black spot (Alternaria brassicae), black rot (Xhanthomonas campestris pv. campestris), bacterial black spot (Pseudomonas syringae pv. maculicola), soft rot (Erwinia carotovora); cruciferous vegetables: black spot (Alternaria brassicae, etc.), white spot (Cercosporella brassicae), black leg (Phoma lingam), club root (Plasmodiophora brassicae), downy mildew (Peronospora parasitica), black rot (Xhanthomonas campestris pv. campestris), bacterial black spot (Pseudomonas syringae pv. maculicola), soft rot (Erwinia carotovora subsp. carotovora);
cabbage: club foot (Thanatephorus cucumeris), yellowing wilt (Fusarium oxysporum), alternaria sooty spot (Alternaria brassisicola); Chinese cabbage: bottom rot (Rhizoctonia solani), yellowing (Verticillium dahliae); green onions: rust (Puccinia allii), black spot (Alternaria porri), southern blight (Sclerotium rolfsii), white rot (Phytophthora porri), black rot (Sclerotium cepivorum); onions: canker (Curtobacterium flaccumfaciens), soft rot (Erwinia carotovora subsp. carotovora), bacterial spot (Pseudomonas syringae pv. syringae), rot (Erwinia rhapontici), scale rot (Burkholderia gladioli), yellowing wilt (Phytoplasma asteris); garlic: soft rot (Erwinia carotovora subsp. carotovora), spring rot (Pseudomonas marginalis pv. marginalis); soybeans: purple seed stain (Cercospora kikuchii), scab (Elsinoe glycines), black spot (Diaporthe phaseolorum), Rhizoctonia root rot (Rhizoctonia solani), stem rot (Phytophthora sojae), downy mildew (Peronospora manshurica), rust (Phakopsora pachyrhizi), anthracnose (Colletotrichum truncatum, etc.), leaf scald (Xhanthomonas campestris pv. glycines), bacterial spot (Pseudomonas syringae pv. glycinea); green beans: anthracnose (Colletotrichum lindemuthianum), bacterial wilt (Ralstonia solanacearum), halo blight (Pseudomonas syringae pv. phaseolicola), bacterial brown spot (Pseudomonas viridiflava), leaf scald (Xhanthomonas campestris pv. phaseoli); peanuts: leaf spot (Mycosphaerella berkeleyi), brown spot (Mycosphaerella arachidis), bacterial wilt (Ralstonia solanacearum); peas: powdery mildew (Erysiphe pisi), downy mildew (Peronospora pisi), bacterial stem blight (Pseudomonas syringae pv. pisi), bacterial stem rot (Xhanthomonas campestris pv. pisi); broad beans: downy mildew (Peronospora viciae), blight (Phytophthora nicotianae); potatoes: early blight (Alternaria solani), black scurf (Thanatephorus cucumeris), blight (Phytophthora infestans), silver scurf (Helminthosporium solani), soft rot (Fusarium oxysporum, Fusarium solani), powdery scab (Spongospora subterranea), bacterial wilt (Ralstonia solanacearum), black foot disease (Erwinia carotovora subsp. atroseptica), common scab (Streptomyces scabies, Streptomyces acidiscabies), soft rot (Erwinia carotovora subsp. carotovora), slimy rot (Crostridium spp.), ring rot (Clavibacter michiganensis subsp. sepedonicus); sweet potatoes: damping-off (Streptomyces ipomoeae); beets: brown spot (Cercospora beticola), downy mildew (Peronospora schachtii), black root rot (Aphanomyces cochioides), leaf spot (Phoma betae), crown gall (Agrobacterium tumefaciens), scab (Streptomyces scabies), bacterial spot (Pseudomonas syringae pv. aptata);
carrots: leaf blight (Alternaria dauci), bacterial gall (Rhizobacter dauci), crown gall (Agrobacterium tumefaciens), Streptomyces scab (Streptomyces spp.), soft rot (Erwinia carotovora subsp. carotovora); strawberries: powdery mildew (Sphaerotheca aphanis var. aphanis), blight (Phytophthora nicotianae, etc.), anthracnose (Glomerella cingulata, etc.), fruit rot (Pythium ultimum), bacterial wilt (Ralstonia solanacearum), angular leaf spot (Xhanthomonas campestris), bacterial bud blight (Pseudomonas marginalis pv. marginalis); tea: net blister blight (Exobasidium reticulatum), white scab (Elsinoe leucospila), anthracnose (Colletotrichum theae-sinensis), ring spot (Pestalotiopsis longiseta), red blight (Pseudomonas syringae pv. theae), canker (Xhanthomonas campestris pv. theicola), witch's broom (Pseudomonas sp.); tobacco: red spot (Alternaria alternata), powdery mildew (Erysiphe cichoracearum), anthracnose (Colletotrichum gloeosporioides), blight (Phytophthora nicotianae), wildfire (Pseudomonas syringae pv. tabaci), bacterial leaf spot (Pseudomonas syringae pv. mellea), hollow root (Erwinia carotovora subsp. carotovora), damping-off (Ralstonia solanacearum), tobacco mosaic virus (Tobacco mosaic virus);
coffee: rust disease (Hemileia vastatrix); banana: black sigatoka (Mycosphaerella fijiensis), panama disease (Fusarium oxysporum fsp cubense); cotton: damping-off (Fusarium oxysporum), frosty mildew (Ramularia areola); sunflowers: sclerotial disease (Sclerotinia sclerotiorum), angular leaf spot (Xhanthomonas campestris pv. malvacearum), hollow root (Erwinia carotovora subsp. carotovora), bacterial spot (Pseudomonas syringae pv. helianthi); roses: black spot (Diplocarpon rosae), powdery mildew (Sphaerotheca pannosa, etc.), blight (Phytophthora megasperma), downy mildew (Peronospora sparsa), crown gall (Agrobacterium tumefaciens); chrysanthemums: brown spot (Septoria obesa), white rust (Puccinia horiana), blight (Phytophthora cactorum), bacterial spot (Pseudomonas cichorii), soft rot (Erwinia carotovora subsp. carotovora), crown gall (Agrobacterium tumefaciens), hairy root disease (Agrobacterium rhizogenes), chrysanthemum virescence (Phytoplasma aurantifolia); grasses: brown patch disease (Rhizoctonia solani), dollar spot disease (Sclerotinia homoeocarpa), curvularia leaf blight (Curvularia sp.), rust (Puccinia zoysiae), helminthosporium leaf blight (Cochliobolus sp.), scald (Rhynchosporium secalis), damping-off (Gaeumannomyces graminis), anthracnose (Colletotrichum sp.), Typhula brown snow blight (Typhula incarnata), Typhula black snow blight (Typhula ishikariensis), Sclerotinia (Myriosclerotinia borealis), fairy ring disease (Marasmius oreades, etc.), Pythium blight (Pythium aphanidermatum, etc.), blast (Pyricularia grisea) and the like.

(983) The compounds of the present invention may be used singly, but preferably can be used as a composition such as powder, wettable powder, granular wettable powder, water-soluble powder, granular water-soluble powder, granules, an emulsion, a liquid, a microemulsion, an aqueous suspension preparation, an aqueous emulsion preparation, or a suspoemulsion preparation by mixing with a solid carrier, liquid carrier, gas carrier, surfactant, adhesive agent, dispersant, stabilizer, or the like. The compositions are not limited thereto as long as the effects are demonstrated.

(984) The followings show specific formulating examples, but which are not limitative.

Preparation Example 1: Flowable

(985) The compounds of the present invention (10 parts by mass), a sodium salt of naphthalene sulfonate formaldehyde condensate (5 parts by mass), polyoxyethylene aryl phenyl ether (1 part by mass), propylene glycol (5 parts by mass), a silicone antifoaming agent (0.1 part by mass), xanthan gum (0.2 part by mass), and ion exchanged water (78.7 parts by mass) are mixed to make a slurry, and further the slurry is wet milled with Dyno-Mill KDL using glass beads having a diameter of 1.0 mm to obtain a flowable.

Preparation Example 2: Emulsion

(986) The compounds of the present invention (5 parts by mass) is dissolved in a mixed solution of xylene (40 parts by mass) and cyclohexane (35 parts by mass), and Tween 20 (20 parts by mass) is added to this solution, and the mixture is mixed to obtain an emulsion.

Preparation Example 3: Wettable Powder

(987) The compounds of the present invention (10 parts by mass), white carbon (10 parts by mass), polyvinyl alcohol (2 parts by mass), dioctylsulfosuccinic acid sodium salt (0.5 part by mass), alkylbenzene sulfonic acid sodium salt (5 parts by mass), calcined diatomaceous earth (10 parts by mass) and kaolinite clay (62.5 parts by mass) are mixed thoroughly, and the mixture is pulverized by an air mill to obtain a wettable powder.

(988) In the following, the application of the composition of the present invention (agricultural and horticultural pest control agents, and agricultural and horticultural fungicides) will be described.

(989) As the method for applying the composition containing the compound of the present invention, there may be mentioned a method of bringing the composition into contact with a plant body or seeds, or a method of bringing cultivation soil containing the composition into contact with the roots or underground stem of a plant. Specific examples thereof may include a treatment of spraying the composition onto the stem and leaves of a plant individual, an injection treatment, a treatment of seedling nursery boxes, a cell tray treatment, a treatment of spraying the composition to plant seeds, a treatment of coating the composition to plant seeds, a treatment of immersing the composition to plant seeds, a treatment of dressing the composition to plant seeds, a treatment of spraying the composition onto the surface of soil, soil mixing after a treatment of spraying the composition to the surface of the soil, a treatment of injecting the composition into soil, soil mixing after a treatment of injecting the composition into the soil, a treatment of irrigating the composition into soil, soil mixing after a treatment of irrigating the composition into the soil and the like. The composition demonstrates adequate effects when applied by any method usually used by a person skilled in the art.

(990) A “plant” referred to in the present invention means a matter which thrives by photosynthesis without moving. Specific examples thereof include rice, wheat, barley, corn, coffee, bananas, grapes, apples, pears, peaches, cherries, citrus fruits, soybeans, kidney beans, cotton, strawberries, potatoes, cabbage, lettuce, tomatoes, cucumbers, eggplants, watermelons, sugar beets, spinach, field peas, squash, sugar cane, tobacco, green peppers, sweet potatoes, taro potatoes, konjak, cotton, sunflowers, roses, tulips, chrysanthemums, turf grasses and the like, and F1 hybrids thereof, and the like. In addition, gene recombinant crops that are created by artificially manipulating gene, etc., and are inherently not present in nature are also included and, for example, may include agricultural and horticultural crops such as soybeans, corn, cotton and the like to which resistance to herbicides had been imparted, rice, tobacco and the like which are acclimated to cold climates, corn, cotton and the like to which an ability to produce insecticidal substances had been imparted, and the like. Further, there may be mentioned trees such as pines, ash trees, ginkgos, maples, oaks, poplars, zelkova and the like. Also, a “plant body” referred to in the present invention means that all the sites constituting the above-mentioned plant individual are collectively called and, for example, there may be mentioned stems, leaves, roots, seeds, flowers, fruits and the like.

(991) A “seed” referred to in the present invention means a matter which stores nutrients for germination of young plant and is used for agricultural breeding. Specific examples thereof include seeds of corn, soybeans, cotton, rice, sugar beets, wheat, barley, sunflowers, tomato, cucumbers, eggplants, spinach, field peas, squash, sugar cane, tobacco, green peppers, rape and the like, and F1 hybrids thereof and the like, seed tubers of taro potatoes, potatoes, sweet potatoes, konjak and the like, bulbs of edible lilies, tulips and the like, seed bulbs of scallions, etc., and seeds and tubers of gene recombinant crops and the like.

(992) An application amount and an application concentration of the composition containing the compound of the present invention may vary depending on the target crop, target disease, degree of progression of the disease, dosage form of the compound, application method and various environmental conditions and the like, and in the case of spraying or irrigating, it is suitably 0.1 to 10,000 g per hectare as an amount of active ingredient and preferably 10 to 1,000 g per hectare. In addition, an amount used in the case of seed treatment is 0.0001 to 1,000 g per 1 kg of seeds as an amount of active ingredient and preferably 0.001 to 100 g. When the composition containing the compound of the present invention is used for a treatment of spraying the composition onto the stem and leaves of a plant individual, a treatment of spraying the composition onto the surface of soil, a treatment of injecting the composition into soil or a treatment of irrigating the composition into soil, the treatment may be carried out after having diluted to a suitable concentration in a suitable carrier. When the composition containing the compound of the present invention is bringing into contact with the plant seeds, after diluting to a suitable concentration, the plant seeds may be subjected to immersion, dressing, spraying or coating treatment. An amount of the composition when subjecting to immersion, dressing, spraying or coating treatment as the amount of the active ingredient is usually about 0.05 to 50% based on the dry weight of the plant seeds, and is preferably 0.1 to 30%, but is not limited thereto, and the amount may be appropriately set depending on the form of the composition or the kind of the plant seeds targeted for the treatment.

(993) The composition-containing the compound of the present invention can be used by mixing with other agricultural chemicals as necessary, for example, including agricultural chemicals such as fungicides, insecticides, acaricides, nematicides, herbicides, biological pesticides and plant growth regulators, disease control agents containing nucleic acids as an active ingredient (WO 2014/062775), soil improvers, or fertilizing substances. As a method for using the compounds of the present invention and other agricultural chemicals by mixing, there may be mentioned a method of using the compounds of the present invention and other agricultural chemicals in one dosage form into which they are formulated, a method of using them in such a manner as to formulate each of them into separate dosage form and then mix the dosage forms immediately before use, a method of using them in such a manner as to formulate each of them into separate dosage form and then simultaneously use the dosage forms, or a method of using them in such a manner as to formulate each of them into separate dosage form and then use either one of them and thereafter use the other.

(994) Specific components contained in the fungicides which can be used in combination with the compounds of the present invention are exemplified in the following Group b, including these salts, isomers and N-oxides. The known fungicides are not limited to these.

(995) Group b:

(996) b-1: Phenylamide-Based Fungicides

(997) As phenylamide-based fungicides, there are [b-1.1]: benalaxyl, [b-1.2] benalaxyl-Mor kiralaxyl, [b-1.3] furalaxyl, [b-1.4] metalaxyl, [b-1.5] metalaxyl-Mor mefenoxam, [b-1.6] oxadixyl, [b-1.7] ofurace, and the like.

(998) b-2: Karyokinesis and Cell Division Inhibitors

(999) As karyokinesis and cell division inhibitors, there are [b-2.1] benomyl, [b-2.2]carbendazim, [b-2.3] fuberidazole, [b-2.4] thiabendazole, [b-2.5] thiophanate, [b-2.6]thiophanate-methyl, [b-2.7] diethofencarb, [b-2,8] zoxamide, [b-2.9] ethaboxam, [b-2.10] pencycuron, [b-2.11] fluopicolide, [b-2.12] phenamacril, and the like.

(1000) b-3: Succinate Dehydrogenase Inhibitors (SDHI Agent)

(1001) As succinate dehydrogenase inhibitors (SDHI agent), there are [b-3.1] benodanil, [b-3.2] benzovindiflupyr, [b-3.3] bixafen, [b-3.4] boscalid, [b-3.5] carboxin, [b-3.6] fenfuram, [b-3.7] fluopyram, [b-3.8] flutolanil, [b-3.9] fluxapyroxad, [b-3.10] furametpyr, [b-3.11] isofetamid, [b-3.12] isopyrazam, [b-3.13] mepronil, [b-3.14]oxycarboxin, [b-3.15] penthiopyrad, [b-3.16] penflufen, [b-3.17] pydiflumetofen, [b-3.18] sedaxane, [b-3.19] thifluzamide, [b-3.20] pyraziflumid, and the like.

(1002) b-4: Quinone Outside Inhibitors (QoI Agent)

(1003) As quinone outside inhibitors (QoI agent), there are [b-4.1] azoxystrobin, [b-4.2] coumoxystrobin, [b-4.3] dimoxystrobin, [b-4.4] enoxastrobin, [b-4.5] famoxadone, [b-4.6] fenamidone, [b-4.7] fenaminstrobin, [b-4.8] flufenoxystrobin, [b-4.9] fluoxastrobin, [b-4.10] kresoxim-methyl, [b-4.11] mandestrobin, [b-4.12] metominostrobin, [b-4.13] orysastrobin, [b-4.14] picoxystrobin, [b-4.15] pyraclostrobin, [b-4.16] pyrametostrobin, [b-4.17] pyraoxystrobin, [b-4.18] pyribencarb, [b-4.19]triclopyricarb, [b-4.20] trifloxystrobin, and the like.

(1004) b-5: Quinone Inside Inhibitors (QiI Agent)

(1005) As quinone inside inhibitors (QiI agent), there are [b-5.1] cyazofamid, [b-5.2] amisulbrom, and the like.

(1006) b-6: Oxidative Phosphorylation Decoupling Inhibitors

(1007) As oxidative phosphorylation decoupling inhibitors, there are [b-6.1] binapacryl, [b-6.2] meptyldinocap, [b-6.3] dinocap, [b-6.4] fluazinam, and the like.

(1008) b-7: Quinone Outside Stigmaterin Binding Subsite Inhibitors (QoSI Agent)

(1009) As quinone outside stigmaterin binding subsite inhibitors (QoSIagent), there are [b-7.1] ametoctradin, and the like.

(1010) b-8: Amino Acid Biosynthesis Inhibitors

(1011) As amino acid biosynthesis inhibitors, there are [b-8.1] cyprodinil, [b-8.2] mepanipyrim, [b-8.3] pyrimethanil, and the like.

(1012) b-9: Protein Biosynthesis Inhibitors

(1013) As protein biosynthesis inhibitors, there are [b-9.1] streptomycin, [b-9.2] blasticidin-S, [b-9.3] kasugamycin, [b-9.4] oxytetracycline, and the like.

(1014) b-10: Signal Transduction Inhibitors

(1015) As signal transduction inhibitors, there are [b-10.1] fenpiclonil, [b-10.2] fludioxonil, [b-10.3] quinoxyfen, [b-10.4] proquinazid, [b-10.5] chlozolinate, [b-10.6]dimethachlone, [b-10.7] iprodione, [b-10.8] procymidone, [b-10.9] vinclozolin, and the like.

(1016) b-11: Lipid and Cell Membrane Biosynthesis Inhibitors

(1017) As lipid and cell membrane biosynthesis inhibitors, there are [b-11.1] edifenphos, [b-11.2] iprobenfos, [b-11.3] pyrazophos, [b-11.4] isoprothiolane, [b-11.5]biphenyl, [b-11.6] chloroneb, [b-11.7] dicloran, [b-11.8] quintozene, [b-11.9] tecnazene, [b-11.10] tolclofos-methyl, [b-11.11] echlomezol or etridiazole, [b-11.12] iodocarb, [b-11.13] propamocarb, [b-11.14] prothiocarb, and the like.

(1018) b-12: Demethylation Inhibitors (DMI Agent)

(1019) As demethylation inhibitors (DMI agent), there are [b-12.1] azaconazole, [b-12.2] bitertanol, [b-12.3] bromuconazole, [b-12.4] cyproconazole, [b-12.5] difenoconazole, [b-12.6] diniconazole, [b-12.7] diniconazole-M, [b-12.8] epoxiconazole, [b-12.9] etaconazole, [b-12.10] fenarimol, [b-12.11] fenbuconazole, [b-12.12] fluquinconazole, [b-12.13] quinconazole, [b-12.14] flusilazole, [b-12.15] flutriafol, [b-12.16] hexaconazole, [b-12.17] imazalil, [b-12.18] imibenconazole, [b-12.19] ipconazole, [b-12.20] metconazole, [b-12.21] myclobutanil, [b-12.22] nuarimol, [b-12.23] oxpoconazole, [b-12.24] oxpoconazole fumarate, [b-12.25] pefurazoate, [b-12.26] penconazole, [b-12.27] prochloraz, [b-12.28] propiconazole, [b-12.29] prothioconazole, [b-12.30] pyrifenox, [b-12.31] pyrisoxazole, [b-12.32] simeconazole, [b-12.33] tebuconazole, [b-12.34] tetraconazole, [b-12.35] triadimefon, [b-12.36]triadimenol, [b-12.37] triflumizole, [b-12.38] triforine, [b-12.39] triticonazole, [b-12.40] mefentrifluconazole, [b-12.41] ipfentrifluconazole, and the like.

(1020) b-13: Amine-Based Fungicides

(1021) As amine-based fungicides, there are [b-13.1] aldimorph, [b-13.2] dodemorph, [b-13.3] fenpropimorph, [b-13.4] tridemorph, [b-13.5] fenpropidin, [b-13.6] piperalin, [b-13.7] spiroxamine, and the like.

(1022) b-14: 3-Ketoreductase Inhibitors in C4-Position Demethylation of Sterol Biosynthesis

(1023) As 3-ketoreductase inhibitors in C4-position demethylation of sterol biosynthesis, there are [b-14.1] fenhexamid, [b-14.2] fenpyrazamine, and the like.

(1024) b-15: Squalene Epoxidase Inhibitors of Sterol Biosynthesis

(1025) As squalene epoxidase inhibitors of sterol biosynthesis, there are [b-15.1]pyributicarb, [b-15.2] naftifine, [b-15.3] terbinafine, and the like.

(1026) b-16: Cell Wall Biosynthesis Inhibitors

(1027) As cell wall biosynthesis inhibitors, there are [b-16.1] polyoxins, [b-16.2]dimethomorph, [b-16.3] flumorph, [b-16.4] pyrimorph, [b-16.5] benthiavalicarb, [b-16.6] benthivalicarb-isopropyl, [b-16.7] iprovalicarb, [b-16.8] mandipropamid, [b-17.9] valifenalate, and the like.

(1028) b-17: Melanine Biosynthesis Inhibitors

(1029) As melanine biosynthesis inhibitors, there are [b-17.1] phthalide or fthalide, [b-17.2] pyroquilone, [b-17.3] tricyclazole, [b-17.4] carpropamid, [b-17.5] diclocymet, [b-17.6] fenoxanil, [b-17.7] tolprocarb, and the like.

(1030) b-18: Host Plant Resistance Inducers

(1031) As host plant resistance inducers, there are [b-18.1] acibenzolar-S-methyl, [b-18.2] probenazole, [b-18.3] tiadinil, [b-18.4] isotianil, [b-18.5] laminarin, and the like.

(1032) b-19: Dithiocarbamate-Based Fungicides

(1033) As dithiocarbamate-based fungicides, there are [b-19.1] mancozeb or manzeb, [b-19.2] maneb, [b-19.3] metiram, [b-19.4] propineb, [b-19.5] thiram, [b-19.6] zineb, [b-19.7] ziram, [b-19.8] ferbam, and the like.

(1034) b-20: Phthalimide-Based Fungicides

(1035) As phthalimide-based fungicides, there are [b-20.1] captan, [b-20.2] captafol, [b-20.3] folpet, [b-20.4] fluorofolpet, and the like.

(1036) b-21: Guanidine-Based Fungicides

(1037) As guanidine-based fungicides, there are [b-21.1] guazatine, [b-21.2]iminoctadine, [b-21.3] iminoctadine albesilate, [b-21.4] iminoctadine triacetate, and the like.

(1038) b-22: Multi-Site Contact Activity Type Ungicides

(1039) As multi-site contact activity type fungicides, there are [b-22.1] basic copper chloride (copper oxychloride), [b-22.2] copper(II) hydroxide, [b-22.3] basic copper sulfate (copper hydroxide sulfate), [b-22.4] organocopper compound, [b-22.5]dodecylbenzenesulfonic acid bisethylenediamine copper[II] complex salt (Dodecylbenzenesulphonic acid bisethylcnediamine copper[II] salt, DBEDC), [b-22.6] sulphur, [b-22.7] fluoroimide, [b-22.8] chlorothalonil, [b-22.9] dichlofluanid, [b-22.10] tolylfluanid, [b-22.11] anilazine, [b-22.12] dithianon, [b-22.13] chinomethionat or quinomethionate, [b-22.14] Extract from cotyledon of lupine seedling (BLAD), and the like.

(1040) b-23: Other Fungicides

(1041) As the other fungicides, there are [b-23.1] dichlobentiazox, [b-23.2] fenpicoxamid, [b-23.3] dipymetitrone, [b-23.4] bupirimate, [b-23.5] dimethirimol, [b-23.6] ethirimol, [b-23.7] triphenyl tin acetate (fentin acetate), [b-23.8] triphenyltin chloride (fentin chloride), [b-23.9] triphenyltin hydroxide (fentin hydroxide), [b-23.10]oxolinic acid, [b-23.11] hymexazol, [b-23.12] octhilinone, [b-23.13] fosetyl, [b-23.14]phosphorous acid), [b-23.15] sodium phosphite, [b-23.16] ammonium phosphite, [b-23.17] potassium phosphite, [b-23.18] tecloftalam, [b-23.19] triazoxide, [b-23.20] flusulfamide, [b-23.21] diclomezine, [b-23.22] silthiofam, [b-23.23] diflumetorim, [b-23.24] methasulfocarb, [b-23.25] cyflufenamid, [b-23.26] metrafenone, [b-23.27]pyriofenone, [b-23.28] dodine, [b-23.29] flutianil, [b-23.30] ferimzone, [b-23.31]oxathiapiprolin, [b-23.32] tebufloquin, [b-23.33] picarbutrazox, [b-23.34] validamycins, [b-23.35] cymoxanil, [b-23.36] quinofumelin,

(1042) [b-23.37] a compound represented by Formula (s1)

(1043) ##STR03515##
(see WO98/046607),

(1044) [b-23.38] a compound represented by Formula (s2)

(1045) ##STR03516##
(see WO 08/148570),

(1046) [b-23.39] a compound represented by Formula (s3)

(1047) ##STR03517##
(see WO92/012970),

(1048) [b-23.40] a compound represented by Formula (s4)

(1049) ##STR03518##
(see WO 12/084812),

(1050) [b-23.41] a compound represented by Formula (s5)

(1051) ##STR03519##
(gougerotiri),

(1052) [b-23.42] a compound represented by Formula (s6)

(1053) ##STR03520##
(ningnanmycin),

(1054) [b-23.43] a compound represented by Formula (s7)

(1055) ##STR03521##
(see WO 10/136475),

(1056) [b-23.44] a compound represented by Formula (s8)

(1057) ##STR03522##
(see WO 14/010737),

(1058) [b-23.45] a compound represented by Formula (s9)

(1059) ##STR03523##
(see WO 11/085084),

(1060) [b-23.46] a compound represented by Formula (s10)

(1061) ##STR03524##
(see WO 11/137002),

(1062) [b-23.47] a compound represented by Formula (s11)

(1063) ##STR03525##
(see WO 13/162072),

(1064) [b-23.48] a compound represented by Formula (s12)

(1065) ##STR03526##
(see WO 08/110313),

(1066) [b-23.49] a compound represented by Formula (s13)

(1067) ##STR03527##
(see WO 09/156098),

(1068) [b-23.50] a compound represented by Formula (s14)

(1069) ##STR03528##
(see WO 12/025557),

(1070) [b-23.51] a compound represented by Formula (s15)

(1071) ##STR03529##
(see WO 14/006945),

(1072) [b-23.52] a compound represented by Formula (s16)

(1073) ##STR03530##
[wherein A3 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group or a cyano group, A4 represents a hydrogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group or a C3-C8 cycloalkyl group.] (see WO 14/095675),

(1074) [b-23.53] a compound represented by Formula (s17)

(1075) ##STR03531##
[wherein m1 represents an integer of 0 to 3, A5 and A6 each independently represents a halogen atom or a C1-C6 alkyl group, A7 and A8 each independently represents a halogen atom or a C1-C6 alkoxy group, and when m1 is 2 or more, the 2 or more of A7's each represents independent substituents, which may be the same as or different from each other.] (see WO 09/137538 and WO 09/137651),

(1076) [b-23.54] a compound represented by Formula (s18)

(1077) ##STR03532##
[wherein A9 and A10 each independently represents a hydrogen atom or halogen atom, A11 represents a halogen atom, A12 represents a halogen atom or a C1-C6 alkyl group, A13 represents a halogen atom, a cyano group, a C1-C6 alkyl group or a C1-C6 alkoxy group.] (see WO 12/031061),

(1078) [b-23.55] a compound represented by Formula (s19)

(1079) ##STR03533##
[wherein m2 represents an integer of 0 to 6, A14 and A15 each independently represents a halogen atom, a cyano group or C1-C6 alkyl group, A16 represents a hydrogen atom, a halogen atom or a C1-C6 alkoxy group, A17 represents a halogen atom or a C1-C6 alkoxy group, when m2 is 2 or more, the 2 or more A17's each represents independent substituents, which may be the same as or different from each other.] (see WO 05/121104),

(1080) [b-23.56] a compound represented by Formula (s20)

(1081) ##STR03534##
[wherein A18 and A19 each independently represents a halogen atom, a cyano group or a C1-C6 alkyl group, A20, A21 and A22 each independently represents a hydrogen atom, a halogen atom or a C1-C6 alkoxy group.] (see WO 07/066601),

(1082) [b-23.57] a compound represented by Formula (s21)

(1083) ##STR03535##
[wherein A23 and A24 each independently represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group or a C3-C8 cycloalkyl group, X represents an oxygen atom or a sulfur atom.] (see WO 07/087906, WO 09/016220 and WO 10/130767),

(1084) [b-23.58] a compound represented by Formula (s22)

(1085) ##STR03536##
[wherein m3 represents an integer of 0 to 5, A25 represents a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group or a C3-C8 cycloalkyl group, when m3 is 2 or more, the 2 or more A25's each represent independent substituents, which may be the same as or different from each other.] (see WO 13/092224),

(1086) [b-23.59] a compound represented by Formula (s23)

(1087) ##STR03537##
[wherein A26 represents a hydrogen atom or a halogen atom, V1 and V2 each independently represents an oxygen atom or a sulfur atom.] (see WO 12/025450),

(1088) [b-23.60] a compound represented by Formula (s24) or Formula (s25)

(1089) ##STR03538##
[wherein m4 represents an integer of 0 to 5, A27 represents a C1-C6 alkyl group, A28 represents a halogen atom, a cyano group, a C1-C6 alkyl group or a C1-C6 haloalkyl group, when m4 is 2 or more, the 2 or more A28's each represent independent substituents, which may be the same as or different from each other, and A29 represents a C1-C6 alkyl group, a C2-C6 alkenyl group or a C3-C6 alkynyl group.] (see WO 13/037717),

(1090) [b-23.61] a compound represented by Formula (s26) or Formula (s27)

(1091) ##STR03539##
[wherein m5 represents an integer of 0 to 5, A30 represents a C1-C6 alkyl group, A31 represents a halogen atom, a cyano group, a C1-C6 alkyl group or a C1-C6 haloalkyl group, when m5 is 2 or more, the 2 or more A31 's each represent independent substituents, which may be the same as or different from each other, and A32 represents a C1-C6 alkyl group, a C2-C6 alkenyl group or a C3-C6 alkynyl group.] (see WO 13/037717),

(1092) [b-23.62] a compound represented by Formula (s28)

(1093) ##STR03540##
[wherein A33, A34, A35 and A36 each independently represents a hydrogen atom or a halogen atom, A37 represents a hydrogen-atom, an acetyl group or a benzoyl group.] (see WO 06/031631, WO 10/069882),

(1094) [b-23.63] a compound represented by Formula (s29)

(1095) ##STR03541##
[wherein A38 represents a C1-C6 alkyl group or a C1-C6 haloalkyl group, A39 and A40 each independently represents a hydrogen atom or halogen atom.] (see WO 14/043376),

(1096) [b-23.64] a compound represented by Formula (s30)

(1097) ##STR03542##
[wherein A41 represents a hydrogen atom, a sulfhydryl group (—SH), a thiocyanate group (—SCN) or a C1-C6 alkylthio group, A42, A43, A44 and A45 each independently represents a hydrogen atom or a halogen atom.] (see WO 09/077443),

(1098) [b-23.65] a compound represented by Formula (s31) or Formula (s32)

(1099) ##STR03543##
[wherein A46 represents a hydrogen atom or halogen atom, A47 represents a C1-C6 alkyl group, and A48 represents a halogen atom.] (see WO 11/070771),

(1100) [b-23.66] a compound represented by Formula (s33)

(1101) ##STR03544##
[wherein A49, A50 and A51 each independently represents a hydrogen atom or a halogen atom.] (see WO 11/081174), and the like.

(1102) Specific components contained in insecticides that can be used in combination with the compounds of the present invention are exemplified in the following Group c, including these salts, isomers and N-oxides. The known insecticides are not limited to these.

(1103) Group c:

(1104) c-1: Carbamate-Based Acetylcholine Esterase (AChE) Inhibitors

(1105) As carbamate-based acetylcholine esterase (AChE) inhibitors, there are [c-1.1]phosphocarb, [c-1.2] alanycarb, [c-1.3] butocarboxim, [c-1.4] butoxycarboxim, [c-1.5]thiodicarb, [c-1.6] thiofanox, [c-1.7] aldicarb, [c-1.8] bendiocarb, [c-1.9] benfuracarb, [c-1.10] carbaryl, [c-1.11] carbofuran, [c-1.12] carbosulfan, [c-1.13] ethiofencarb, [c-1.14] fenobucarb, [c-1.15] formetanate, [c-1.16] furathiocarb, [c-1.17] isoprocarb, [c-1.18] methiocarb, [c-1.19] methomyl, [c-1.20] oxamyl, [c-1.21] pirimicarb, [c-1.22]propoxur, [c-1.23] trimethacarb, [c-1.24] XMC (3,5-xylyl methylcarbamate), [c-1.25] allyxycarb, [c-1.26] aldoxycarb, [c-1.27] bufencarb, [c-1.28] butacarb, [c-1.29]carbanolate, [c-1.30] metolcarb, [c-1.31] xylylcarb, [c-1.32] fenothiocarb, [c-1.33] xylylcarb, [c-1.34] bendiocarb, and the like.

(1106) c-2: Organic Phosphorus-Based Acetylcholine Esterase (AChE) Inhibitors

(1107) As organic phosphorus-based acetylcholine esterase (AChE) inhibitors, there are [c-2.1] acephate, [c-2.2] azamethiphos, [c-2.3] azinphos-methyl, [c-2.4]azinphos-ethyl, [c-2.5] ethephon, [c-2.6] cadusafos, [c-2.7] chlorethoxyfos, [c-2.8] chlorfenvinphos, [c-2.9] chlormephos, [c-2.10] chlorpyrifos, [c-2.11] chlorpyrifos-methyl, [c-2.12] coumaphos, [c-2.13] cyanophos, [c-2.14] demeton-S-methyl, [c-2.15] diazinon, [c-2.16] dichlofenthion, [c-2.17] dichlorvos, [c-2.18] dicrotophos, [c-2.19] dimethoate, [c-2.20] dimethylvinphos, [c-2.21] disulfoton, [c-2.22] O-ethyl O-4-nitrophenyl phenylphosphonothioate, [c-2.23] ethion, [c-2.24]ethoprophos, [c-2.25] famphur, [c-2.26] fenamiphos, [c-2.27] fenitrothion, [c-2.28] fenthion, [c-2.29] fosthiazate, [c-2.30] heptenophos, [c-2.31] isofenphos-methyl, [c-2.32] Isocarbophos, [c-2.33] isoxathion, [c-2.34] malathion, [c-2.35] mecarbam, [c-2.36] methamidophos, [c-2.37] methidathion, [c-2.38] mevinphos, [c-2.39] monocrotophos, [c-2.40] naled, [c-2.41] omethoate, [c-2.42] oxydemeton-methyl, [c-2.43] parathions, [c-2.44] parathion-methyl, [c-2.45] phenthoate, [c-2.46] phorate, [c-2.47] phosalone, [c-2.48] phosmet, [c-2.49] phosphamidon, [c-2.50] phoxim, [c-2.51] pirimiphos-methyl, [c-2.52] profenofos, [c-2.53] propetamphos, [c-2.54] prothiofos, [c-2.55] pyraclofos, [c-2.56] pyridaphenthion, [c-2.57] quinalphos, [c-2.58] sulfotep, [c-2.59] tebupirimfos, [c-2.60] temephos, [c-2.61] terbufos, [c-2.62] thiometon, [c-2.63]triazophos, [c-2.64] trichlorfon, [c-2.65] vamidothion, [c-2.66] chlorothion, [c-2.67] bromfenvinfos, [c-2.68] bromophos, [c-2.69] bromophos-ethyl, [c-2.70] butathiofos, [c-2.71] carbophenothion, [c-2.72] chlorphoxim, [c-2.73] sulprofos, [c-2.74] diamidafos, [c-2.75] tetrachlorvinphos, [c-2.76] propaphos, [c-2.77] mesulfenfos, [c-2.78]dioxabenzofos, [c-2.79] etrimfos, [c-2.80] oxydeprofos, [c-2.81] formothion, [c-2.82] fensulfothion, [c-2.83] isazofos, [c-2.84] imicyafos, [c-2.85] isamidofos, [c-2.86]thionazin, [c-2.87] fosthietan, and the like.

(1108) c-3: GABAergic Chlorine Ion Channel Blockers

(1109) As GABAergic chlorine ion channel blockers, there are [c-3.1] chlordane, [c-3.2] endosulfan, [c-3.3] lindane, [c-3.4] dienochlor, [c-3.5] ethiprole, [c-3.6] fipronil, [c-3.7] acetoprole, and the like.

(1110) c-4: Sodium Channel Modulators

(1111) As sodium channel modulators, there are [c-4.1] acrinathrin, [c-4.2] allethrin [(1R)-isomer], [c-4.3] bifenthrin, [c-4.4] bioallethrin, [c-4.5] bioallethrin S-cyclo-pentenyl isomer, [c-4.6] bioresmethrin, [c-4.7] cycloprothrin, [c-4.8] cyfluthrin, [c-4.9] beta-cyfluthrin, [c-4.10] cyhalothrin, [c-4.11] gamma-cyhalothrin, [c-4.12] lambda-cyhalothrin, [c-4.13] cypennmethrin, [c-4.14] alpha-cypermethrin, [c-4.15] beta-cypermethrin, [c-4.16] theta-cypennethrin, [c-4.17] zeta-cypermethrin, [c-4.18] cyphenothrin [(1R)-trans-isomer], [c-4.19] deltamethrin, [c-4.20] empenthrin [(EZ)-(1R)-isomer], [c-4:21] esfenvalerate, [c-4.22] ethofenprox, [c-4.23] fenpropathrin, [c-4.24] fenvalerate, [c-4.25] flucythrinate, [c-4.26] flumethrin, [c-4.27] tau-fluvalinate, [c-4.28] halfenprox, [c-4.29] imiprothrin, [c-4.30] methothrin, [c-4.31] metofluthrin, [c-4.32] epsilon-metofluthrin, [c-4.33] momfluorothrin, [c-4.34] epsilon-momfluorothrin, [c-4.35] pennethrin, [c-4.36] phenothrin [(1R)-trans-isomer], [c-4.37] prallethrin, [c-4.38] resmethrin, [c-4.39] kadethrin, [c-4.40] silafluofen, [c-4.41] tefluthrin, [c-4.42] tetramethrin, [c-4.43] tetramethrin [(1R)-isomer], [c-4.44] tralomethrin, [c-4.45] transfluthrin, [c-4.46] ZXI8901 (3-(4-bromophenoxy)phenyl]-cyanomethyl 4-(difluoromethoxy)-α-(1-methylethyl)benzeneacetate), [c-4.47] biopermethrin, [c-4.48] furamethrin, [c-4.49] profluthrin, [c-4.50] flubrocythrinate, [c-4.51] dimefluthrin, [c-4.52] DDT (dichloro-diphenyl-trichloroethane), [c-4.53] methoxychlor, [c-4.54]phenothrin, [c-4.55] fluvalinate, and the like.

(1112) c-5: Nicotinic Acetylcholine. Receptor (nAChR) Competitive Modulators

(1113) As nicotinic acetylcholine receptor (nAChR) competitive modulators, there are [c-5.1] acetamiprid, [c-5.2] clothianidin, [c-5.3] dinotefuran, [c-5.4] imidacloprid, [c-5.5] nitenpyram, [c-5.6] thiacloprid, [c-5.7] thiamethoxam, [c-5.8] nicotine, [c-5.9]nicotine sulfate, [c-5.10] sulfoxaflor, [c-5.11] flupyradifurone, [c-5.12] triflumezopyrim, and the like.

(1114) c-6: Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulators

(1115) As nicotinic acetylcholine receptor (nAChR) allosteric modulators, there are [c-6.1] spinosad, [c-6.2] spinetoram, and the like.

(1116) c-7: Glutamate-Gated Chloride Channel (GluCl) Allosteric Modulators

(1117) As glutamate-gated chloride channel (GluCl) allosteric modulators, there are [c-7.1] abamectin, [c-7.2] emamectin benzoate, [c-7.3] lepimectin, [c-7.4] milbemectin, and the like.

(1118) c-8: Juvenile Hormone Analogues

(1119) As juvenile hormone analogues, there are [c-8.1] hydroprene, [c-8.2] kinoprene, [c-8.3] methoprene, [c-8.4] fenoxycarb, [c-8.5] pyriproxyfen, and the like.

(1120) c-9: Nonspecific (Multisite) Inhibitors

(1121) As nonspecific (multisite) inhibitors, there are [c-9.1] methyl bromide, [c-9.2] chloropicrin, [c-9.3] cryolite, [c-9.4] sulfuryl fluoride, [c-9.5] borax, [c-9.6] boric acid, [c-9.7] disodium octaborate, [c-9.8] sodium metaborate, [c-9.9] antimony potassium tartrate (tartar emetic), [c-9.10] dazomet, [c-9.11] metam, [c-9.12] carbam sodium salt (metham sodium), and the like.

(1122) c-10: Chordotonal Organ TRPV Channel Modulators

(1123) Chordotonal organ TRPV channel modulators, there are [c-10.1] pymetrozine, [c-10.2] Pyrifluquinazon, and the Like.

(1124) c-11: Acari Growth Inhibitors

(1125) As acari growth inhibitors, there are [c-11.1] clofentezine, [c-11.2] diflovidazin, [c-11.3] hexythiazox, [c-11.4] etoxazole, and the like.

(1126) c-12: Mitochondrial ATP Synthase Inhibitors

(1127) As mitochondrial ATP synthase inhibitors, there are [c-12.1] diafenthiuron, [c-12.2] azocyclotin, [c-12.3] cyhexatin, [c-12.4] fenbutatin oxide, [c-12.5] propargite, [c-12.6] tetradifon, and the like.

(1128) c-13: Unicouplers of Oxidative Phosphorylation Via Disruption of Proton Gradient

(1129) As unicouplers of oxidative phosphorylation via disruption of proton gradient, there are [c-13.1] chlorfenapyl, [c-13.2] DNOC (dinitro-ortho-cresol), [c-13.3] binapacryl, [c-13.4] sulfluramid, and the like.

(1130) c-14: Nicotinic Acetylcholine Receptor (nAChR) Channel Blockers

(1131) As nicotinic acetylcholine receptor (nAChR) channel blockers, there are [c-14.1] bensultap, [c-14.2] cartap hydrochloride, [c-14.3] thiocyclam, [c-14.4] monosultap, and the like.

(1132) c-15: Chitin Biosynthesis Inhibitors Type 0

(1133) As chitin biosynthesis inhibitors type 0, there are [c-15.1] bistrifluron, [c-15.2] chlorfluazuron, [c-15.3] diflubenzuron, [c-15.4] flucycloxuron, [c-15.5] flufenoxuron, [c-15.6] hexaflumuron, [c-15.7] lufenuron, [c-15.8] novaluron, [c-15.9] noviflumuron, [c-15.10] teflubenzuron, [c-15.11] triflumuron, and the like.

(1134) c-16: Chitin Biosynthesis Inhibitor Type 1

(1135) As chitin biosynthesis inhibitor type 1, there are [c-16.1] buprofezin, and the like.

(1136) c-17: Diptera Insect Molting Inhibitors

(1137) As diptera insect molting inhibitors, there are [c-17.1] cyromazine, and the like.

(1138) c-18: Molting Hormone (Ecdysone) Receptor Agonists

(1139) As molting hormone (ecdysone) receptor agonists, there are [c-18.1]chromafenozide, [c-18.2] halofenozide, [c-18.3] methoxyfenozide, [c-18.4] tebufenozide, and the like.

(1140) c-19: Octopamine Receptor Agonists

(1141) As octopamine receptor agonists, there are [c-19.1] amitraz, and the like.

(1142) c-20: Mitochondrial electron transport system complex III inhibitors

(1143) As mitochondrial electron transport system complex III inhibitors, there are [c-20.1] hydramethylnon, [c-20.2] acequinocyl, [c-20.3] fluacrypyrim, [c-20.4] bifenazate, and the like.

(1144) c-21: Mitochondrial Electron Transport System Complex I Inhibitors (METI)

(1145) As mitochondrial electron transport system complex I inhibitors (METI), there are [c-21.1] fenazaquin, [c-21.2] fenpyroximate, [c-21.3] pyridaben, [c-21.4] pylimidifen, [c-21.5] tebufenpyrad, [c-21.6] tolfenpyrad, [c-21.7] rotenone, and the like.

(1146) c-22: Voltage-Gated Sodium Channel Blockers

(1147) As voltage-gated sodium channel blockers, there are [c-22.1] indoxacarb, [c-22.2] metaflumizone, and the like.

(1148) c-23: Acetyl CoA Carboxylase Inhibitors

(1149) As acetyl CoA carboxylase inhibitors, there are [c-23.1] spirodiclofen, [c-23.2] spiromesifen, [c-23.3] spirotetramat, and the like.

(1150) c-24: Mitochondrial Electron Transport System Complex IV Inhibitors

(1151) As mitochondrial electron transport system complex IV inhibitors, there are [c-24.1] aluminum phosphide, [c-24.2] calcium phosphide, [c-24.3] hydrogen phosphide (phosphine), [c-24.4] zinc phosphide, [c-24.5] calcium cyanide, [c-24.6] sodium cyanide, [c-24.7] potassium cyanide, and the like.

(1152) c-25: Mitochondrial Electron Transport System Complex II Inhibitors

(1153) As mitochondrial electron transport system complex II inhibitors, there are [c-25.1] cyenopyrafen, [c-25.2] cyflumetofen, [c-25.3] pyflubumide, and the like.

(1154) c-26: Ryanodine Receptor Modulators

(1155) As ryanodine receptor modulators, there are [c-26.1] chlorantraniliprole, [c-26.2] cyantraniliprole, [c-26.3] flubendiamide, and the like.

(1156) c-27: Target Site-Unspecified Chordotonal Organ Modulators

(1157) As target site-unspecified chordotonal organ modulators, there are [c-27.1] flonicamid, and the like.

(1158) c-28: Other Insecticideinsecticides

(1159) As the other insecticides, there are [c-28.1] azadirachtin, [c-28.2] benzoximate, [c-28.3] phenisobromolate, [c-28.4] chinomethionat, [c-28.5] dicofol, [c-28.6] pyridalyl, [c-28.7] bromopropylate, [c-28.8] triazamate, [c-28.9] dicyclanil, [c-28.10] dinobuton, [c-28.11] dinocap, [c-28.12] hydrogen cyanide, [c-28.13] methyliodide, [c-28.14]karanjin, [c-28.15] mercury chloride, [c-28.16] methyl isothiocyanate, [c-28.17]pentachlorophenol, [c-28.18] phosphine, [c-28.19] piperonyl butoxide (piperonylbutoxide), [c-28.20] polynactin complex (polynactins), [c-28.21] sabadilla, [c-28.22] sulcofuron salt (sulcofuron-sodium), [c-28.23] tribufos, [c-28.24] aldrin, [c-28.25] amidithion, [c-28.26] amidothioate, [c-28.27] aminocarb, [c-28.28] amiton, [c-28.29] aramite, [c-28.30] athidathion, [c-28.31] azothoate, [c-28.32] barium polysulphide, [c-28.33] benclothiaz, [c-28.34]5-(1,3-benzodioxol-5-yl)-3-hexylcyclohexa-2-enone, [c-28.35]1,1-bis(4-chlorophenyl)-2-ethoxyethanol, [c-28.36] butonate, [c-28.37] butopyronoxyl, [c-28.38] 2-(2-butoxyethoxy)ethyl thiocyanate, [c-28.39] camphechlor, [c-28.40] chlorbenside, [c-28.41] chlordecone, [c-28.42] chlordimeform, [c-28.43] chlorfenethol, [c-28.44] chlorfenson, [c-28.45] fluazuron, [c-28.46] metaldehyde, [c-28.47] bialaphos, [c-28.48] hydrochloric acid levamisol (levamisol), [c-28.49] amidoflumet, [c-28.50]pyrafluprole, [c-28.51] pyriprole, [c-28.52] tralopyril, [c-28.53] flupyrazofos, [c-28.54] diofenolan, [c-28.55] chlorobenzilate, [c-28.56] flufenzine, [c-28.57] benzomate, [c-28.58] flufenerim, [c-28.59] albendazole, [c-28.60] oxibendazole, [c-28.61] fenbendazole, [c-28.62] metam-sodium, [c-28.63] 1,3-dichloropropene, [c-28.64] flometoquin, [c-28.65] cyclaniliprole, [c-28.66] tetraniliprole, [c-28.67] broflanilide, [c-28.68] dicloromezotiaz, [c-28.69] ethylene dibromide, [c-28.70] acrylonitrile, [c-28.71] bis(2-chloroethyl)ether, [c-28.72] 1-bromo-2-chloroethane, [c-28.73]3-bromo-1-chloroprop-1-ene, [c-28.74] bromocyclen, [c-28.75] carbon disulfide, [c-28.76] carbon tetrachloride (tetrachloromethane), [c-28.77] nemadectin, [c-28.78] cymiazole, [c-28.79] calcium polysulfide, [c-28.80] cytokinin, [c-28.81]2-(octylthio)ethanol, [c-28.82] potassium oleate, [c-28.83] sodium oleate, [c-28.84] machine oil, [c-28.85] tar oil, [c-28.86] anabasine, [c-28.87] morantel tartrate, [c-28.88] insect flower (pyrethrum), [c-28.89] rape seed oil, [c-28.90] soybean lecithin, [c-28.91] starch, [c-28.92] hydroxypropyl starch (hydroxypropylstarch), [c-28.93] fatty acid glyceride (decanoyloctanoylglycerol), [c-28.94] propylene glycol monofatty acid ester (propylene glycol fatty acid ester), [c-28.95] diatomaceous earth (diatomite), [c-28.96] afoxolaner, [c-28.97] fluazaindolizine, [c-28.98] afidopyropen, [c-28.99] cyhalodiamide, [c-28.100] tioxazafen, [c-28.101] fluhexafon, [c-28.102] fluralaner, [c-28.103] fluxametamide, [c-28.104] tetrachlorantraniliprole, [c-28.105] sarolaner, [c-28.106] lotilaner, [c-28.107] cycloxaprid, [c-28.108] fluensulfone, [c-28.109] TPIC (tripropyl isocyanurate), [c-28.110] D-D (1,3-Dichloropropene), [c-28.111] peroxocarbonate, [c-28.112] MB-599 (verbutin), [c-28.113] bis(2,3,3,3-tetrachloropropyl) ether, [c-28.114] DCIP (bis(2-chloro-1-methylethyl) ether), [c-28.115] ENT-8184 (N-(2-Ethylhexyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboximide), [c-28.116] Bayer 22408 (O,O-diethyl O-naphthalimidophosphorothioate), [c-28.117] Bayer 32394 (tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate),

(1160) [c-28.118] a compound represented by Formula (s34)

(1161) ##STR03545##
(see WO 10/051926),

(1162) [c-28.119] a compound represented by Formula (s35)

(1163) ##STR03546##
(see WO 13/115391),

(1164) [c-28.120] a compound represented by Formula (s36)

(1165) ##STR03547##
(see WO 12/029672),

(1166) [c-28.121] a compound represented by Formula (s37)

(1167) ##STR03548##
(see WO 06/056108),

(1168) [c-28.122] a compound represented by Formula (s38)

(1169) ##STR03549##
(see WO 14/053450, and WO 15/144683),

(1170) [c-28.123] a compound represented by Formula (s39)

(1171) ##STR03550##
(see WO 14/053450, and WO 15/144683),

(1172) [c-28.124] a compound represented by Formula (s40)

(1173) ##STR03551##
(see WO 14/053450, and WO 15/144683),

(1174) [c-28.125] a compound represented by Formula (s41)

(1175) ##STR03552##
[wherein m6 represents an integer of 0 to 2.] (see WO 10/129497),

(1176) [c-28.126] a compound represented by Formula (s42)

(1177) ##STR03553##
[wherein m7 represents an integer of 0 to 2.] (see WO 11/152320),

(1178) [c-28.127] a compound represented by Formula (s43)

(1179) ##STR03554##
[wherein m8 represents an integer of 0 to 2.] (see JP Hei27-160813A),

(1180) [c-28.128] a compound represented by Formula (s44)

(1181) ##STR03555##
[wherein A52 represents a hydrogen atom or a fluorine atom;] (see WO 11/134964, and WO 14/005982),

(1182) [c-28.129] a compound represented by Formula (s45)

(1183) ##STR03556##
[wherein m9 represents an integer of 0 to 2, and A53 represents a fluorine atom or a chlorine atom.] (see WO 15/025826),

(1184) [c-28.130] a compound represented by Formula (s46)

(1185) ##STR03557##
[wherein V3 represents a nitrogen atom, a carbon atom or C—F, and V4 and V5 each independently represents a nitrogen atom or a carbon atom.] (see WO 11/134964, and WO 14/005982),

(1186) [c-28.131] a compound represented by Formula (s47)

(1187) ##STR03558##
[wherein A54 represents a hydrogen atom, a methyl group, a methoxy group or an ethoxy group, A55 represents a chlorine atom or a methyl group, and A56 represents a methyl group or an ethyl group:] (see WO 09/049851),

(1188) [c-28.132] a compound represented by Formula (s48)

(1189) ##STR03559##
[wherein A57 represents a hydrogen atom, a fluorine atom or a chlorine atom, A58 represents one kind of a partial structure selected from the group consisting of

(1190) ##STR03560##
(see WO 11/067272),

(1191) [c-28.133] a compound represented by Formula (s49)

(1192) ##STR03561##
[wherein A59 represents a hydrogen atom, a fluorine atom or a chlorine atom, A60 represents a partial structure selected from the group consisting of

(1193) ##STR03562##
(see WO 10/090344),

(1194) [c-28.134] a compound represented by Formula (s50)

(1195) ##STR03563##
[wherein m10 represents an integer of 0 to 2, A61 represents a trifluoromethyl group, a trifluoromethylthio group, a trifluoromethylsulfinyl group or a trifluoromethylsulfonyl group, A62 represents a hydrogen atom or a trifluoromethyl group, V6 represents a nitrogen atom or a carbon atom, and V7 represents an oxygen atom or an N-methyl group.] (see WO 14/104407),

(1196) [c-28.135] a compound represented by Formula (s51)

(1197) ##STR03564##
[wherein A63 represents a hydrogen atom or a fluorine atom, an amide group is bonded to the 4-position or 5-position, and A64 represents a partial structure selected from the group consisting of

(1198) ##STR03565##
(see WO 15/038503, WO 16/144351, and WO 16/144678),

(1199) [c-28.136] a compound represented by Formula (s52)

(1200) ##STR03566##
[wherein A65 represents a hydrogen atom, a C1-C6 alkyl group or a C1-C6 haloalkyl group, A66 represents a hydrogen atom, a halogen atom or a C1-C6 alkyl group, A67 and A68 each independently represents a hydrogen atom, a C1-C6 alkyl group optionally substituted with a cyano group, an alkyl group optionally substituted with a methoxy group, an alkyl group optionally substituted with an ethoxy group or a C3-C8 cycloalkyl group, and
A69 represents a hydrogen atom, a cyano group, a C1-C6 haloalkyl group optionally substituted with a cyano group, a C1-C6 alkyl group or a C3-C8 cycloalkyl group.] (see WO 12/143317, and WO 16/016369),

(1201) [c-28.137] a compound represented by Formula (s53) or Formula (s54)

(1202) ##STR03567##
[wherein A70 represents a methyl group, an ethyl group, an isopropyl group, a 2,2,2-trifluoroethyl group or a phenyl group, A71 represents a partial structure selected from the group consisting of

(1203) ##STR03568##
A72 represents a partial structure selected from the group consisting of

(1204) ##STR03569##
and V8 represents an oxygen atom, a sulfur atom, —CH.sub.2— or —CH.sub.2CH—.] (see WO 14/167084, and WO 16/055431),

(1205) [c-28.138] a compound represented by Formula (s55)

(1206) ##STR03570##
[wherein m11 represents an integer of 0 to 1, A73 represents a chlorine atom, a bromine atom, a methyl group or a trifluoromethyl group, A74 represents a hydrogen atom, a chlorine atom, a bromine atom, a cyano group or a trifluoromethyl group, A75 represents a hydrogen atom, a chlorine atom or a bromine atom, A76 and A77 each independently represents a C1-C6 alkyl group or a C3-C8 cycloalkyl group, and A78 represents a chlorine atom, a bromine atom, a cyano group, a nitro group, a difluoromethyl group or a trifluoromethyl group.] (see WO 13/024009),

(1207) [c-28.139] a compound represented by Formula (s56)

(1208) ##STR03571##
[wherein A79, A80, A81 and A82 each independently represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkoxy group or a C3-C8 cycloalkoxy group.] (see WO 12/027521),

(1209) [c-28.140] a compound represented by Formula (s57)

(1210) ##STR03572##
[wherein m12 represents an integer of 0 to 2, A83 represents a hydrogen atom or a fluorine atom, A84 represents a partial structure selected from the group consisting of

(1211) ##STR03573##
(see WO 13/162715),

(1212) [c-28.141] acynonapyr,

(1213) [c-28.142] a compound represented by Formula (s59)

(1214) ##STR03574##
[A90 represents a halogen atom, a C1-C6 alkyl group or a C1-C6 haloalkyl group, A91 represents a C1-C6 haloalkyl group, A92 and A93 each independently represents a hydrogen atom, a C1-C6 alkyl group, an acetyl group, a propionoyl group, a methanesulfonylethyl group, a methoxycarbonyl group or an ethoxycarbonyl group, and A94 and A95 each independently represents a hydrogen atom, a C1-C6 alkyl group or a C1-C6 haloalkyl group.] (see WO 12/164698), and the like.

(1215) A mixing ratio of the compound(s) of the present invention and a pest control agent is not particularly limited as long as the effects are developed, and the pest control agent is usually used in a weight ratio of 0.001 to 1,000 relative to that of the compound(s) of the present invention, and preferably a ratio of 0.01 to 100.

EXAMPLES

(1216) In the following, the present invention will be shown in more detail by referring to Synthetic Examples, Reference Examples and Test Examples, but the present invention is not limited by these.

Synthetic Example 1

Step 1: Synthesis of 6-(2,6-difluorophenyl)-5-(thiophen-2-yl)-3,4-dihydropyridine 2(1H)-one

(1217) ##STR03575##

(1218) To 8.64 g of 5-(2,6-difluorophenyl)-5-oxo-4-(thiophen-2-yl)pentanoic acid obtained in Reference Example 3 were added 107.31 g of ammonium acetate and 43 ml of acetic acid, and the mixture was stirred at 100° C. for 4 hours. After cooling to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. Water was added to the obtained organic layer, then, the mixture was neutralized by adding sodium carbonate. After separating the liquids to the organic layer and the aqueous layer, the obtained organic layer was washed with saturated brine, and dried over magnesium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 4.98 g of dark brown solid.

(1219) .sup.1H-NMR (CDCl.sub.3) δ: 7.42 (1H, m), 7.06 (1H, m), 6.97 (2H, m), 6.86 (2H, m), 6.77 (1H, m), 2.99 (2H, m), 2.72 (2H, m).

Step 2: Synthesis of 6-(2,6-difluorophenyl)-1-ethyl-5-(thiophen-2-yl)-3,4-dihydropyridin-2(1H)-one (Compound No.: 2)

(1220) ##STR03576##

(1221) 20 ml of DMF containing 2.00 g of 6-(2,6-difluorophenyl)-5-(thiophen-2-yl)-3,4-dihydropyridine 2(1-H)-one, 1.65 ml of ethyl iodide and 6.71 g of cesium carbonate was stirred at 50° C. for 3 hours. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over magnesium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 1.92 g of brown oily product.

Synthetic Example 2

Synthesis of 6-(2,6-difluorophenyl)-1-ethyl-5-(thiophen-2-yl)pyridin-2(1H)-one (Compound No.: 5)

(1222) ##STR03577##

(1223) To 15 ml of a dichloromethane solution containing 520 mg of 6-(2,6-difluorophenyl)-1-ethyl-5-(thiophen-2-yl)-3,4-dihydropyridin-2(1H)-one was added 7.08 g of manganese dioxide, and the mixture was stirred under reflux by heating for 16 hours. 3.54 g of manganese dioxide was further added and the resulting mixture was stirred under reflux by heating for 6 hours. After cooling the mixture to room temperature, the reaction mixture was filtered through Celite, and the residue was washed with ethyl acetate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 212 mg of a white solid.

Synthetic Example 3

Synthesis of 5-(5-chlorothiophen-2-yl)-6-(2,6-difluorophenyl)-1-ethylpyridin-2(1H)-one (Compound No.: 6)

(1224) ##STR03578##

(1225) 3 ml of a DMF solution containing 85 mg of 6-(2,6-difluorophenyl)-1-ethyl-5-(thiophen-2-yl)pyridin-2(1H)-one and 39 mg of N-chlorosuccinimide was stirred at 80° C. for 2 hours. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography, and then the precipitates were washed with a solution in which diisopropyl ether and hexane had been mixed. The title compound was obtained as 66 mg of a white solid.

Synthetic Example 4

Synthesis of 3-chloro-5-(5-chlorothiophen-2-yl)-6-(2,6-difluorophenyl)-1-ethylpyridin-2(1H)-one (Compound No.: 7)

(1226) ##STR03579##

(1227) 3 ml of a DMF solution containing 97 mg of

(1228) 5-(5-chlorothiophen-2-yl)-6-(2,6-difluorophenyl)-1-ethylpyridin-2(1H)-one and 41 mg of N-chlorosuccinimide was stirred at 80° C. for 2 hours. 21 mg of N-chlorosuccinimide was further added, and the resulting mixture was stirred at 120° C. for 5 hours. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 32 mg of a white solid.

Synthetic Example 5

Step 1: Synthesis of 2-chloro-2-(2,6-difluorophenyl)-4,5-dihydro-[3,3′-bipyridin]-6(1H)-one

(1229) ##STR03580##

(1230) To 280 mg of 4-(2-chloropyridin-3-yl)-5-(2,6-difluorophenyl)-5-oxopentanoic acid obtained in Reference Example 6 were added 2.80 g of ammonium acetate and 5 ml of acetic acid, and the mixture was stirred at 100° C. for 5 hours. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. Water was added to the obtained organic layer, and then, the mixture was neutralized by adding potassium carbonate. After separating the liquids to the organic layer and the aqueous layer, the obtained organic layer was successively washed with water and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 39.5 mg of a brown solid.

(1231) .sup.1H-NMR (CDCl.sub.3) δ: 8.21 (1H, dd, J=4.7, 1.8 Hz), 7.34 (1H, dd, J=7.6, 1.8 Hz), 7.26-7.23 (1H, m), 7.02 (1H, dd, J=7.6, 4.7 Hz), 6.83-6.81 (3H, m), 3.15-2.65 (4H, m).

Step 2: Synthesis of 2-chloro-2-(2,6-difluorophenyl)-1-ethyl-4,5-dihydro-[3,3′-bipyridin]-6(1H)-one

(1232) ##STR03581##

(1233) 3 ml of DMF containing 39.5 mg of 2-chloro-2-(2,6-difluorophenyl)-4,5-dihydro-[3,3′-bipyridin]-6(1H)-one, 29.3 μl of ethyl iodide and 120.2 mg of cesium carbonate was stirred at 60° C. for 3 hours. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with water and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 37.5 mg of a pale yellow solid.

(1234) .sup.1H-NMR (CDCl.sub.3) δ: 8.17 (1H, dd, J=4.9, 1.8 Hz), 7.37-7.35 (1H, m), 7.24-7.21 (1H, m), 6.99 (1H, dd, J=7.6, 4.9 Hz), 6.82-6.77 (2H, m), 3.52-3.46 (1H, m), 3.41-3.33 (1H, m), 2.92-2.83 (2H, m), 2.75-2.69 (1H, m), 2.62-2.56 (1H, m), 0.99 (3H, t, J=7.2 Hz).

Synthetic Example 6

Synthesis of 2-chloro-2-(2,6-difluorophenyl)-1-ethyl-[3,3′-bipyridin]-6(1H)-one (Compound No.: 17)

(1235) ##STR03582##

(1236) To 3 ml of a carbon tetrachloride solution containing 37.5 mg of 2-chloro-2-(2,6-difluorophenyl)-1-ethyl-4,5-dihydro-[3,3′-bipyridin]-6(1H)-one were added 20.1 mg of N-bromosuccinimide and 1.8 mg of azobisisobutyronitrile, and the mixture was stirred at 80° C. for 1 hour. After cooling the mixture to room temperature, an aqueous sodium thiosulfate solution was added. Water and ethyl acetate were added to the resulting reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the title compound was obtained as 32.3 mg of a solid.

Synthetic Example 7

Synthesis of 2,5-dichloro-2-(2,6-difluorophenyl)-1-ethyl-[3,3′-bipyridin]-6(1H)-one (Compound No.: 18)

(1237) ##STR03583##

(1238) 3 ml of a DMF solution containing 12.3 mg of 2-chloro-2-(2,6-difluoro-phenyl)-1-ethyl-[3,3′-bipyridin]-6(1H)-one and 11.4 mg of N-chlorosuccinimide was stirred at 60° C. for 10.5 hours. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with water and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 10.7 mg of a white solid.

Synthetic Example 8

Synthesis of 3-chloro-1-ethyl-5-(1-methyl-1H-pyrazol-5-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 20)

(1239) ##STR03584##

(1240) 5 ml of an ethanol solution containing 400 mg of 3-chloro-5-(3-(dimethyl-amino)acryloyl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one obtained in Reference Example 16 and 165 μl of methylhydrazine was stirred at 60° C. for 2 hours. After cooling the mixture to room temperature, 1N hydrochloric acid and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 250 mg of a yellow solid.

Synthetic Example 9

Synthesis of 5-(4-bromo-1-methyl-1H-pyrazol-5-yl)-3-chloro-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 21)

(1241) ##STR03585##

(1242) 3 ml of a DMF solution containing 100 mg of 3-chloro-1-ethyl-5-(1-methyl-1H-pyrazol-5-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 53 mg of N-bromosuccinimide was stirred at 60° C. for 2 hours. After cooling the mixture to room temperature, water and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 117 mg of a white solid.

Synthetic Example 10

Synthesis of 5-(4-bromo-1-methyl-1H-pyrazol-5-yl)-3-chloro-6-(2,6-difluoro-4-methoxyphenyl)-1-ethylpyridin-2(1H)-one (Compound No.: 23)

(1243) ##STR03586##

(1244) 3 ml of a methanol solution containing 69 mg of 5-(4-bromo-1-methyl-1H-pyrazol-5-yl)-3-chloro-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 149 μl of 28% sodium methoxide methanol solution was stirred under reflux by heating for 5 hours. After cooling the mixture to room temperature, water and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 59 mg of a white solid.

Synthetic Example 11

Step 1: Synthesis of 3-chloro-1-ethyl-5-(1-methyl-1H-pyrazol-3-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one

(1245) ##STR03587##

(1246) 4 ml of acetone containing 546 μl of methylhydrazine was stirred at room temperature for 1 hour. Then, 1 ml of an acetone solution containing 400 mg of 3-chloro-5-(3-(dimethylamino)acryloyl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one obtained in Reference Example 16 was added and the mixture was stirred under reflux by heating for 3 hours. After cooling the mixture to room temperature, the solvent was distilled off under reduced pressure. To the resulting reaction mixture were added 3 ml of ethanol and 0.5 ml of conc. hydrochloric acid and the mixture was stirred at 60° C. for 8 hours. After cooling the mixture to room temperature, water and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 29 mg of a yellow oily product.

(1247) .sup.1H-NMR (CDCl.sub.3) δ: 8.09 (1H, s), 7.14 (1H, d, J=2.4 Hz), 6.81-6.79 (2H, m), 5.47 (1H, d, J=2.4 Hz), 3.95 (2H, q, J=7.1 Hz), 3.80 (3H, s), 1.17 (3H, t, J=7.1 Hz).

Step 2: Synthesis of 5-(4-bromo-1-methyl-1H-pyrazol-3-yl)-3-chloro-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 24)

(1248) ##STR03588##

(1249) 2 ml of a DMF solution containing 29 mg of 3-chloro-1-ethyl-5-(1-methyl-1H-pyrazol-3-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 15 mg of N-bromosuccinimide was stirred at 60° C. for 2 hours. After cooling the mixture to room temperature, water and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 29 mg of a white solid.

Synthetic Example 12

Synthesis of 3-chloro-5-(1,3-dioxan-2-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)-pyridin-2(1H)-one (Compound No.: 8)

(1250) ##STR03589##

(1251) 5 ml of a toluene solution containing 150 mg of 5-chloro-1-ethyl-6-oxo-2-(2,4,6-trifluorophenyl)-1,6-dihydropyridin-3-carboaldehyde obtained in Reference Example 13, 52 μl of 1,3-propandiol and 8 mg of p-toluenesulfonic acid monohydrate was stirred under reflux by heating for 4 hours. After cooling the mixture to room temperature, water and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 153 mg of a white solid.

Synthetic Example 13

Step 1: Synthesis of 5-(1H-1,2,4-triazol-1-yl)-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one

(1252) ##STR03590##

(1253) To 914 mg of 5-oxo-4-(1H-1,2,4-triazol-1-yl)-5-(2,4,6-trifluorophenyl)-pentanoic acid were added 4.50 g of ammonium acetate and 9.14 ml of acetic acid, and the mixture was stirred under reflux by heating for 30 minutes. After cooling the mixture to room temperature, an aqueous saturated sodium hydrogen carbonate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 547 mg of a brown solid.

(1254) .sup.1H-NMR (CDCl.sub.3) δ: 7.92 (1H, s), 7.81 (1H, s), 6.84 (1H, s), 6.72-6.69 (2H, m), 3.06-3.05 (2H, m), 2.89-2.88 (2H, m).

Step 2: Synthesis of 1-ethyl-5-(1H-1,2,4-triazol-1-yl)-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one

(1255) ##STR03591##

(1256) 5 ml of DMF containing 547 mg of 5-(1H-1,2,4-triazol-1-yl)-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one, 446 μl of ethyl iodide and 1.82 g of cesium carbonate was stirred at 50° C. for 1.5 hours. After cooling the mixture to room temperature, an aqueous saturated ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 482 mg of a white solid.

(1257) .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.83 (1H, s), 6.71-6.68 (2H, m), 3.42 (2H, q, J=7.1 Hz), 2.90-2.89 (4H, m), 0.99 (3H, t, J=7.1 Hz).

Step 3: Synthesis of 1-ethyl-5-(1H-1,2,4-triazol-1-yl)-6-(2,4,6-trifluorophenyl)-pyridin-2(1H)-one

(1258) ##STR03592##

(1259) 5 ml of a toluene solution containing 482 mg of 1-ethyl-5-(1H-1,2,4-triazol-1-yl)-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one and 1.02 g of 2,3-dichloro-5,6-dicyano-p-benzoquinone was stirred under reflux by heating for 5 hours. 340 mg of 2,3-dichloro-5,6-dicyano-p-benzoquinone was further added to the reaction mixture, and the mixture was stirred under reflux by heating for 4.5 hours. After cooling the mixture to room temperature, the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography. The title compound was obtained as 97 mg of a brown solid.

(1260) .sup.1H-NMR (CDCl.sub.3) δ: 7.99 (1H, s), 7.86 (1H, s), 7.42 (1H, d, J=9.8 Hz), 6.79 (1H, d, J=9.8 Hz), 6.75-6.73 (2H, m), 3.89 (2H, q, J=7.2 Hz), 1.18 (3H, t, J=7.2 Hz).

Step 4: Synthesis of 3-chloro-1-ethyl-5-(1H-1,2,4-triazol-1-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 34)

(1261) ##STR03593##

(1262) 3 ml of a DMF solution containing 97 mg of 1-ethyl-5-(1H-1,2,4-triazol-1-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 49 mg of N-chlorosuccinimide was stirred at 70° C. for 4 hours. 32 mg of N-chlorosuccinimide was further added to the reaction mixture, and the mixture was stirred at 70° C. for 1 hour. After cooling the mixture to room temperature, water and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 86 mg of a white solid.

Synthetic Example 14

Synthesis of 5-(5-bromo-1H-1,2,4-triazol-1-yl)-3-chloro-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 35)

(1263) ##STR03594##

(1264) To 2 ml of a carbon tetrachloride solution containing 58 mg of 3-chloro-1-ethyl-5-(1H-1,2,4-triazol-1-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one were added 35 mg of N-bromosuccinimide and 5 mg of azobisisobutyronitrile, and the mixture was stirred under reflux by heating for 2 hours. 39 mg of N-bromosuccinimide and 5.4 mg of azobisisobutyronitrile were further added to the reaction mixture, and the mixture was stirred under reflux by heating for 3.5 hours. After cooling the mixture to room temperature, an aqueous sodium thiosulfate solution was added. Water and ethyl acetate were added to the resulting reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound as 34 mg of a white solid.

Synthetic Example 15

Step 1: Synthesis of 5-(1H-pyrazol-1-yl)-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one

(1265) ##STR03595##

(1266) To 3.66 g of 5-oxo-4-(1H-pyrazol-1-yl)-5-(2,4,6-trifluorophenyl)pentanoic acid obtained in Reference Example 24 were added 9.03 g of ammonium acetate and 36.6 m1 of acetic acid, and the mixture was stirred at 120° C. for 1.5 hours. After cooling the mixture to room temperature, an aqueous saturated sodium hydrogen carbonate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 1.10 g of a brown solid.

(1267) .sup.1H-NMR (CDCl.sub.3) δ: 7.53 (1H, dd, J=1.8, 0.6 Hz), 7.10 (1H, d, J=2.4 Hz), 6.72-6.65 (2H, m), 6.71 (1H, br s), 6.16 (1H, dd, J=2.4, 1.8 Hz), 3.10-3.09 (2H, m), 2.86-2.84 (2H, m).

Step 2: Synthesis of 1-ethyl-5-(1H-pyrazol-1-yl)-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one (Compound No.: 25)

(1268) ##STR03596##

(1269) 4.5 ml of DMF containing 448 mg of 5-(1H-pyrazol-1-yl)-6-(2,4,6-trifluoro-phenyl)-3,4-dihydropyridin-2(1H)-one, 244 μl of ethyl iodide and 996 mg of cesium carbonate was stirred at 50° C. for 30 minutes. After cooling the mixture to room temperature, an aqueous saturated ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 430 mg of a brown solid.

Synthetic Example 16

Synthesis of 1-ethyl-5-(1H-pyrazol-1-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 26)

(1270) ##STR03597##

(1271) 8 ml of a toluene solution containing 430 mg of 1-ethyl-5-(1H-pyrazol-1-yl)-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one and 1.22 g of 2,3-dichloro-5,6-dicyano-p-benzoquinone was stirred under reflux by heating for 4 hours. After cooling the mixture to room temperature, the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography. The title compound was obtained as 315 mg of a brown solid.

Synthetic Example 17

Step 1: Synthesis of 5-(4-bromo-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluoro-phenyl)pyridin-2(1H)-one

(1272) ##STR03598##

(1273) 3 ml of a DMF solution containing 136 mg of 1-ethyl-5-(H-pyrazol-1-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 83 mg of N-bromosuccinimide was stirred at 60° C. for 15 minutes. After cooling the mixture to room temperature, an aqueous sodium thiosulfate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 153 mg of a white solid.

(1274) .sup.1H-NMR (CDCl.sub.3) δ: 7.41 (1H, d, J=9.5 Hz), 7.40 (1H, d, J=0.7 Hz), 7.34 (1H, s), 6.76-6.71 (2H, m), 6.75 (1H, d, J=9.5 Hz), 3.88 (2H, q, J=7.1 Hz), 1.17 (3H, t, J=7.1 Hz).

Step 2: Synthesis of 5-(4-bromo-1H-pyrazol-1-yl)-3-chloro-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 70)

(1275) ##STR03599##

(1276) 3 ml of a DMF solution containing 153 mg of 5-(4-bromo-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 56 mg of N-chlorosuccinimide was stirred at 80° C. for 3 hours. 56 mg of N-chlorosuccinimide was further added to the reaction mixture, and the mixture was stirred at 80° C. for 55 minutes. After cooling the mixture to room temperature, an aqueous sodium thiosulfate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 154 mg of a white solid.

Synthetic Example 18

Synthesis of 5-(4-bromo-1H-pyrazol-1-yl)-3-chloro-6-(2,6-difluoro-4-methoxyphenyl)-1-ethylpyridin-2(1H)-one (Compound No.: 72)

(1277) ##STR03600##

(1278) 3 ml of a methanol solution containing 51 mg of 5-(4-bromo-1H-pyrazol-1-yl)-3-chloro-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 118 μl of a 5M sodium methoxide-methanol solution was stirred at 60° C. for 1 hour. After cooling the mixture to room temperature, an aqueous ammonium chloride solution and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 44 mg of a white solid.

Synthetic Example 19

Synthesis of 3-chloro-1-ethyl-5-(oxazol-5-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 36)

(1279) ##STR03601##

(1280) 20 ml of a methanol solution containing 2.00 g of 5-chloro-1-ethyl-6-oxo-2-(2,4,6-trifluorophenyl)-1,6-dihydropyridin-3-carboaldehyde, 1.36 g of p-toluenesulfonylmethyl isocyanide and 1.76 g of potassium carbonate was stirred at room temperature for 2 hours. Then, the reaction mixture was stirred at 50° C. for 30 minutes. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 1.50 g of a white solid.

Synthetic Example 20

Synthesis of 3-chloro-5-(4-chlorooxazol-5-yl)-1-ethyl-6-(2,4,6-trifluoro-phenyl)pyridin-2(1H)-one (Compound No.: 112)

(1281) ##STR03602##

(1282) To 2 ml of a DMF solution containing 100 mg of 3-chloro-1-ethyl-5-(oxazol-5-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one was added dropwise 0.23 ml of a 1.3 mol/L hexamethyldisilazane lithium-THF solution at −60° C. and the mixture was stirred at 1 hour. Then, after adding 38 mg of N-chlorosuccinimide to the reaction mixture, the resulting mixture was stirred at room temperature for 3 hours. An aqueous sodium thiosulfate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with 1N hydrochloric acid and saturated brine, and dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 62 mg of a pale yellow solid.

Synthetic Example 21

Synthesis of 3-chloro-6-(2,6-difluorophenyl)-1-ethyl-5-(4-methyloxazol-5-yl)pyridin-2(1H)-one (Compound No.: 43)

(1283) ##STR03603##

(1284) 3 ml of a methanol solution containing 100 mg of 5-chloro-2-(2,6-difluoro-phenyl)-1-ethyl-6-oxo-1,6-dihydropyridin-3-carboaldehyde, 77 mg of 1-((1-isocyano-ethyl)sufonyl)-4-methylbenzene and 93 mg of potassium carbonate was stirred under reflux by heating for 5.5 hours. After cooling the mixture to room temperature, an aqueous saturated ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 55 mg of an orange solid.

Synthetic Example 22

Synthesis of 4-(5-chloro-1-ethyl-6-oxo-2-(2,6-difluorophenyl)-1,6-dihydro-pyridin-3-yl)-1H-pyrrol-3-carbonitrile (Compound No.: 88)

(1285) ##STR03604##

(1286) A solution comprising 3 ml of diethyl ether and 1 ml of dimethylsulfoxide which contains 150 mg of (E)-3-(5-chloro-1-ethyl-6-oxo-2-(2,6-difluorophenyl)-1,6-dihydropyridin-3-yl)acrylonitrile obtained in Reference Example 31, 109 mg of p-toluenesulfonylmethylisocyanide and 26 mg of 60% sodium hydride was stirred under room temperature for 2.5 hours. Water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 88 mg of a brown solid.

Synthetic Example 23

Step 1: Synthesis of 5-(4,5-dichloro-1H-imidazol-1-yl)-6-(2,4,6-trifluoro-phenyl)-3,4-dihydropyridin-2(1H)-one

(1287) ##STR03605##

(1288) To 2.61 g of ethyl 4-(4,5-dichloro-1H-imidazol-1-yl)-5-oxo-5-(2,4,6-trifluoro-phenyl)pentanoate obtained in Reference Example 33 were added 9.77 g of ammonium acetate and 25.0 ml of acetic acid, and the mixture was stirred at 120° C. for 7 hours. After cooling the mixture to room temperature, an aqueous saturated sodium hydrogen carbonate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 1.05 g of a brown solid.

(1289) .sup.1H-NMR (CDCl.sub.3) δ: 7.17 (1H, s), 6.78 (1H, s), 6.71-6.69 (2H, m), 2.87-2.85 (4H, m).

Step 2: Synthesis of 5-(4,5-dichloro-1H-imidazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one

(1290) ##STR03606##

(1291) 4.2 ml of DMF containing 419 mg of 5-(4,5-dichloro-1H-imidazol-1-yl)-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one, 139 μl of ethyl iodide and 565 mg of cesium carbonate was stirred at 50° C. for 40 minutes. After cooling the mixture to room temperature, an aqueous saturated ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 388 mg of a brown solid.

(1292) .sup.1H-NMR (CDCl.sub.3) δ: 7.17 (1H, s), 6.71-6.69 (2H, m), 3.41 (2H, s), 2.83-2.74 (4H, m), 0.99 (3H, t, J=7.1 Hz).

Step 3: Synthesis of 5-(4,5-dichloro-1H-imidazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 136)

(1293) ##STR03607##

(1294) To 7.8 ml of a carbon tetrachloride solution containing 388 mg of 5-(4,5-dichloro-1H-imidazol-1-yl)-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one were added 194 mg of N-bromosuccinimide and 16 mg of azobisisobutyronitrile, and the mixture was stirred at 90° C. for 30 minutes. An aqueous saturated ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 284 mg of a brown solid.

Synthetic Example 24

Synthesis of 3-chloro-5-(4,5-dichloro-1H-imidazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 138)

(1295) ##STR03608##

(1296) 3 ml of a DMF solution containing 122 mg of 5-(4,5-dichloro-1H-imidazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 55 mg of N-chlorosuccinimide was stirred at 80° C. for 1 hour. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 79 mg of a white solid.

Synthetic Example 25

Synthesis of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)-pyridin-2(1H)-one (Compound No.: 27)

(1297) ##STR03609##

(1298) 3 ml of a DMF solution containing 176 mg of 1-ethyl-5-(1H-pyrazol-1-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 82.3 mg of N-chlorosuccinimide was stirred at 70° C. for 50 minutes. After cooling the mixture to room temperature, an aqueous sodium thiosulfate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 163 mg of a white solid.

Synthetic Example 26

Synthesis of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-3-iodo-6-(2,4,6-trifluoro-phenyl)pyridin-2(1H)-one (Compound No.: 140)

(1299) ##STR03610##

(1300) 14 ml of a methanol solution containing 750 mg of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one, 954 mg of N-iodosuccinimide and 113 μl of sulfuric acid was stirred at 60° C. for 5 hours. Then, 954 mg of N-iodosuccinimide and 113 μl of sulfuric acid were added to the solution, and the resulting mixture was stirred at 60° C. for 2 hours. After cooling the mixture to room temperature, an aqueous sodium thiosulfate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 954 mg of a pale yellow solid.

Synthetic Example 27

Step 1: Synthesis of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluoro-phenyl)-3-((trimethylsilyl)ethynyl)pyridin-2(1H)-one

(1301) ##STR03611##

(1302) To 1 ml of a DMF solution containing 300 mg of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-3-iodo-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one obtained in Synthetic Example 26, 865 μl of trimethylsilylacetylene, 44 mg of dichlorobis(triphenylphosphine)palladium(II) and 12 mg of copper iodide was added 3 ml of triethylamine, and the resulting mixture was stirred at room temperature for 1 hour. 1N Hydrochloric acid and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 258 mg of a yellow solid.

(1303) .sup.1H-NMR (CDCl.sub.3) δ: 7.64 (1H, s), 7.35 (1H, s), 7.32 (1H, s), 6.75-6.71 (2H, m), 3.89 (2H, q, J=7.1 Hz), 1.18 (3H, t, J=7.1 Hz), 0.26 (9H, s).

Step 2: Synthesis of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-3-ethynyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 223)

(1304) ##STR03612##

(1305) 5 ml of a methanol solution containing 255 mg of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)-3-((trimethylsilyl)ethyny 1)pyridin-2(1H)-one and 391 mg of potassium carbonate was stirred at room temperature for 15 minutes. An aqueous saturated ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 161 mg of a yellow solid.

Synthetic Example 28

Synthesis of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-3-methoxy-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 225)

(1306) ##STR03613##

(1307) 3 ml of a toluene solution containing 143 mg of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-3-iodo-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one obtained in Synthetic Example 26, 6.7 mg of palladium(II) acetate, 32 mg of 2-di-t-butylphosphino-2,4,6-triisopropylbiphenyl, 147 mg of cesium carbonate and 1 m1 of methanol was stirred at 60° C. for 4 hours. 1N Hydrochloric acid and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 33 mg of a white solid.

Synthetic Example 29

Synthesis of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-3-bromo-6-(2,4,6-trifluoro-phenyl)pyridin-2(1H)-one (Compound No.: 71)

(1308) ##STR03614##

(1309) 7 ml of a DMF solution containing 730 mg of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 551 mg of N-bromosuccinimide was stirred at 80° C. for 1 hour. After cooling the mixture to room temperature, an aqueous sodium thiosulfate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 836 mg of a white solid.

Synthetic Example 30

Synthesis of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-3-methyl-6-(2,4,6-trifluoro-phenyl)pyridin-2(1H)-one (Compound No.: 206)

(1310) ##STR03615##

(1311) A mixed solution of 6.8 ml of toluene containing 836 mg of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-3-bromo-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one, 463 mg of methylboronic acid, 43 mg of palladium(II) acetate, 1.44 g of tripotassium phosphate and 108 mg of tricyclohexylphosphine, and 1.7 ml of water was stirred under reflux by heating for 20 minutes. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and then, dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 559 mg of a brown solid.

Synthetic Example 31

Step 1: Synthesis of 5-(4-chloro-1H-pyrazol-1-yl)-3-(dibromomethyl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one

(1312) ##STR03616##

(1313) To 11.2 ml of chlorobenzene solution containing 559 mg of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-3-methyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one were added 568 mg of N-bromosuccinimide and 25 mg of azobisisobutyronitrile, and the mixture was stirred at 110° C. for 20 minutes. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. Then, the solvent was distilled off under reduced pressure to obtain 829 mg of the yellow oily product containing the title compound.

(1314) .sup.1H-NMR (CDCl.sub.3) δ: 8.05 (1H, s), 7.39 (1H, s), 7.38 (1H, s), 6.96 (1H, s), 6.77-6.75 (2H, m), 3.93 (2H, q, J=7.1 Hz), 1.19 (3H, t, J=7.1 Hz).

Step 2: Synthesis of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-2-oxo-6-(2,4,6-trifluorophenyl)-1,2-dihydropyridin-3-carboaldehyde (Compound No.: 265)

(1315) ##STR03617##

(1316) To 8 ml of acetonitrile solution containing 829 mg of 5-(4-chloro-1H-pyrazol-1-yl)-3-(dibromomethyl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one obtained in Step 1 of Synthetic Example 30 was added 4 ml of an aqueous solution containing 536 mg of silver nitrate, and the mixture was stirred under room temperature for 10 minutes. The reaction mixture was filtered through Celite, and washed with ethyl acetate. The obtained organic layer was successively washed with water, 1N hydrochloric acid and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 505 mg of a white solid.

Synthetic Example 32

Synthesis of 5-(4-chloro-H-pyrazol-1-yl)-3-(difluoromethyl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one (Compound No.: 266)

(1317) ##STR03618##

(1318) 3 ml of a dichloromethane solution containing 208 mg of 5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-2-oxo-6-(2,4,6-trifluorophenyl)-1,2-dihydropyridin-3-carboaldehyde and 286 μl of (diethylamino)sulfur trifluoride was stirred under room temperature for 30 minutes. Then, 1N hydrochloric acid and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and then, dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 169 mg of a white solid.

Synthetic Example 33

Synthesis of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluoro-phenyl)pyridin-2(1H)-one (Compound No.: 40)

(1319) ##STR03619##

(1320) 12 ml of a DIF solution containing 1.19 g of 1-ethyl-5-(1H-pyrazol-1-yl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 1.49 g of N-chlorosuccinimide was stirred at 80° C. for 40 minutes. After cooling the mixture to room temperature, an aqueous sodium thiosulfate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 1.13 g of a white solid.

Synthetic Example 34

Synthesis of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-6-(2,6-difluoro-4-methoxyphenyl)-1-ethylpyridin-2(1H)-one (Compound No.: 41)

(1321) ##STR03620##

(1322) 6 ml of a methanol solution containing 578 mg of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 402 mg of sodium methoxide was stirred at 0.60° C. for 5 hours. Then, 402 mg of sodium methoxide was added thereto, and the mixture was further stirred at 60° C. for 2 hours. After cooling the mixture to room temperature, an aqueous ammonium chloride solution and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 520 mg of a white solid.

Synthetic Example 35

Synthesis of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-6-(2,6-difluoro-4-hydroxyphenyl)-1-ethylpyridin-2(1H)-one (Compound No.: 184)

(1323) ##STR03621##

(1324) 2 ml of an acetic acid solution containing 27 mg of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-6-(2,6-difluoro-4-methoxyphenyl)-1-ethylpyridin-2(1H)-one and 2 ml of hydrobromic acid and the mixture was stirred at 110° C. for 7 hours. After cooling the mixture to room temperature, the mixture was neutralized by adding an aqueous sodium hydrogen carbonate solution. Ethyl acetate was added to the mixture and the liquids were separated, the obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 22 mg of a white solid.

Synthetic Example 36

Synthesis of 4-(5-chloro-3-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-6-oxo-1,6-dihydropyridin-2-yl)-3,5-difluorophenylacetic acid (Compound No.: 205)

(1325) ##STR03622##

(1326) 2 ml of a dichloroethane solution containing 80 mg of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-6-(2,6-difluoro-4-hydroxyphenyl)-1-ethylpyridin-2(1H)-one, 98 μl of anhydrous acetic acid and 33 μl of pyridine was stirred at room temperature for 3 hours. 1N hydrochloric acid and dichloromethane were added to the reaction mixture; and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 70 mg of an orange white solid.

Synthetic Example 37

Synthesis of 6-(4-(allyloxy)-2,6-difluorophenyl)-3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-1-ethylpyridin-2(1H)-one (Compound No.: 202)

(1327) ##STR03623##

(1328) 2 ml of an acetonitrile solution containing 70 mg of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-6-(2,6-difluoro-4-hydroxyphenyl)-1-ethylpyridin-2(1H)-one, 23 μl of allyl bromide and 89 mg of cesium carbonate was stirred at room temperature for 3 hours. Then, 31 μl of allyl bromide was added, and the mixture was stirred at room temperature for 1 hour. An aqueous ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 49 mg of a yellowish white solid.

Synthetic Example 38

Synthesis of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-6-(2,6-difluoro-4-(propargyloxy)phenyl)-1-ethyl pyridin-2(1H)-one (Compound No.: 201)

(1329) ##STR03624##

(1330) 2 ml of an acetonitrile solution containing 70 mg of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-6-(2,6-difluoro-4-hydroxyphenyl)-1-ethylpyridin-2(1H)-one, 20 μl of propargyl bromide and 85 mg of cesium carbonate was stirred at room temperature for 3 hours. Then, 27 μl of propargyl bromide was added thereto, and the mixture was stirred at room temperature for 1 hour. An aqueous ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 64 mg of a yellowish white solid.

Synthetic Example 39

Synthesis of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-6-(2,6-difluoro-4-(2-methoxyethoxy)phenyl)-1-ethylpyridin-2(1H)-one (Compound No.: 204)

(1331) ##STR03625##

(1332) 4 ml of a THF solution containing 75 mg of 3-chloro-5-(4-chloro-1H-pyrazol-1-yl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one, 23 mg of 60% sodium hydride and 46 μl of 2-methoxyethanol was stirred at room temperature for 2 hours. An aqueous ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 65 mg of a white solid.

Synthetic Example 40

Step 1: Synthesis of 6-(2,4-difluorophenyl)-5-(4-methyl-1H-pyrazol-1-yl)-3,4-dihydropyridin-2(1H)-one

(1333) ##STR03626##

(1334) To 4.79 g of ethyl 5-(2,4-difluorophenyl)-4-(4-methyl-1H-pyrazol-1-yl)-5-oxopentanoate obtained in Reference Example 35 were added 21.8 g of ammonium acetate and 24.0 ml of acetic acid, and the mixture was stirred at 120° C. for 1.5 hours. After cooling the mixture to room temperature, an aqueous potassium carbonate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 2.42 g of a brown solid.

(1335) .sup.1H-NMR (CDCl.sub.3) δ: 7.35 (1H, s), 7.06-7.00 (1H, m), 6.87-6.78 (2H, m), 6.75 (1H, s), 6.71 (1H, s), 3.03-3.01 (2H, m), 2.83-2.79 (2H, m), 1.93 (3H, s).

Step 2: Synthesis of 6-(2,4-difluorophenyl)-1-ethyl-5-(4-methyl-1H-pyrazol-1-yl)-3,4-dihydropyridin-2(1H)

(1336) ##STR03627##

(1337) 5 ml of DMF containing 513 mg of 6-(2,4-difluorophenyl)-5-(4-methyl-1H-pyrazol-1-yl)-3,4-dihydropyridin-2(1H)-one, 211 μl of ethyl iodide and 859 mg of cesium carbonate was stirred at 50° C. for 1.5 hours. Further, 70.3 μl of ethyl iodide and 286 mg of cesium carbonate were added thereto, and the mixture was stirred at 50° C. for 30 minutes. After cooling the mixture to room temperature, an aqueous saturated ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 463 mg of a brown solid.

(1338) .sup.1H-NMR (CDCl.sub.3) δ: 7.28-7.25 (1H, m), 7.13-7.07 (1H, m), 6.87-6.79 (2H, m), 6.74 (1H, s), 3.62-3.55 (1H, m), 3.22-3.18 (1H, m), 3.01-2.94 (1H, m), 2.83-2.72 (3H, m), 1.90 (3H, s), 0.94 (3H, t, J=7.1 Hz).

Step 3: Synthesis of 6-(2,4-difluorophenyl)-1-ethyl-5-(4-methyl-1H-pyrazol-1-yl)pyridin-2(1H)-one (Compound No.: 505)

(1339) ##STR03628##

(1340) To 9.0 ml of a carbon tetrachloride solution containing 463 mg of 6-(2,4-difluorophenyl)-1-ethyl-5-(4-methyl-1H-pyrazol-1-yl)-3,4-dihydropyridin-2(1H)-one were added 312 mg of N-bromosuccinimide and 68 mg of 2,2′-azobis(4-methoxy-2,4-dimethylvaleryonitrile), and the mixture was stirred at 40° C. for 1.5 hours. Water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 249 mg of a white solid.

Synthetic Example 41

Synthesis of 3-bromo-6-(2,4-difluorophenyl)-1-ethyl-5-(4-methyl-1H-pyrazol-1-yl)pyridin-2(1H)-one (Compound No.: 226)

(1341) ##STR03629##

(1342) 4 ml of an acetonitrile solution containing 249 mg of 6-(2,4-difluorophenyl)-1-ethyl-5-(4-methyl-1H-pyrazol-1-yl)pyridin-2(1H)-one and 169 mg of N-bromosuccinimide was stirred at 50° C. for 10 minutes. After cooling the mixture to room temperature, an aqueous sodium thiosulfate solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 230 mg of a white solid.

Synthetic Example 42

Synthesis of 3-bromo-5-(5-chloro-4-methyl-1H-pyrazol-1-yl)-6-(2,4-difluoro-phenyl)-1-ethylpyridin-2(1H)-one (Compound No.: 228)

(1343) ##STR03630##

(1344) 3 ml of an acetonitrile solution containing 184 mg of 3-bromo-6-(2,4-difluorophenyl)-1-ethyl-5-(4-methyl-1H-pyrazol-1-yl)pyridin-2(1H)-one and 81 mg of N-chlorosuccinimide was stirred at 80° C. for 30 minutes. Further, 19 mg of N-chlorosuccinimide was added thereto at 50° C., and the mixture was stirred at 80° C. for 10 minutes. After cooling the mixture to room temperature; water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium, sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 64 mg of a white solid.

Reference Example 1

Synthesis of 1-(2,6-difluorophenyl)-2-(thiophen-2-yl)ethan-1-one

(1345) ##STR03631##

(1346) To 100 ml of a THF solution containing 10.00 g of 2-(thiophen-2-yl)acetic acid was added dropwise 118.5 ml of a 1.9 mol/L THF solution of hexamethyldisilazane sodium at −78° C. and the mixture was stirred for 1 hour. Then, 20 ml of a THF solution containing 12.11 g of methyl 2,6-difluorobenzoate was added dropwise thereto, then, the temperature of the mixture was raised from −78° C. to room temperature and stirred for 2.5 hours. To the mixture was added an aqueous saturated ammonium chloride solution followed by stirring for 1 hour. Thereafter, ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over magnesium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 10.35 g of a red oily product.

(1347) .sup.1H-NMR (CDCl.sub.3) δ: 7.39 (1H, m), 7.22 (1H, m), 6.95 (4H, m), 4.36 (1H, s).

Reference Example 2

Synthesis of ethyl 5-(2,6-difluorophenyl)-5-oxo-4-(thiophen-2-yl)pentanoate

(1348) ##STR03632##

(1349) To 104 ml of a THF solution containing 10.35 g of 1-(2,6-difluorophenyl)-2-(thiophen-2-yl)ethan-1-one obtained in Reference Example 1 were added 730 mg of potassium t-butoxide and 5.20 ml of ethyl acrylate, and the mixture was stirred at −3° C. for 23 hours. To the mixture were added 1N hydrochloric acid and ethyl acetate and after separating the liquids, the obtained organic layer was washed with saturated brine, and dried over magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 12.79 g of a red oily product containing the title compound. The product was used in the next reaction without further purification.

Reference Example 3

Synthesis of 5-(2,6-difluorophenyl)-5-oxo-4-(thiophen-2-yl)pentanoic acid

(1350) ##STR03633##

(1351) To a mixed solution of 102 ml of THF containing 3.37 g of ethyl 5-(2,6-difluorophenyl)-5-oxo-4-(thiophen-2-yl)pentanoate obtained in Reference Example 2 and 26 ml of water was added 7.93 g of lithium hydroxide monohydrate, and the mixture was stirred at 50° C. for 2.5 hours. After cooling the mixture to room temperature, the solvent of the reaction mixture was distilled off until the amount of the liquid became about a half. To the residue were added water and diethyl ether and the liquids were separated, conc. hydrochloric acid and ethyl acetate were added to the obtained aqueous layer and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over magnesium sulfate. Then, the solvent was distilled off under reduced pressure to obtain 8.64 g of a pale yellowish oily product containing the title compound. The product was used in the next reaction without further purification.

Reference Example 4

Synthesis of 2-(2-chloropyridin-3-yl)-1-(2,6-difluorophenyl)ethan-1-one

(1352) ##STR03634##

(1353) To 30 ml of a THF solution containing 700 mg of 2-(2-chloropyridin-3-yl)acetic acid was added dropwise 7.75 ml of a 1.9 mol/L THF solution of hexamethyldisilazane sodium at −78° C. and the mixture was stirred for 10 minutes. Then, 616 μl of methyl 2,6-difluorobenzoate was added dropwise thereto, and then, the temperature of the mixture was raised from −78° C. to room temperature and stirred for 1 hour. To the mixture was added an aqueous saturated ammonium chloride solution followed by stirring the mixture for 1 hour. Thereafter, ethyl acetate was added thereto and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 450 mg of a transparent oily product.

(1354) .sup.1H-NMR (CDCl.sub.3) δ: 8.35 (1H, dd, J=4.7, 1.8 Hz), 7.66 (1H, dd, J=7.6, 1.8 Hz), 7.44-7.43 (1H, m), 7.25 (2H, dd, J=7.6, 4.7 Hz), 7.00-6.96 (2H, m).

Reference Example 5

Synthesis of ethyl 4-(2-chloropyridin-3-yl)-5-(2,6-difluorophenyl)-5-oxopentanoate

(1355) ##STR03635##

(1356) To 10 ml of a THF solution containing 450 mg of 2-(2-chloropyridin-3-yl)-1-(2,6-difluorophenyl)ethan-1-one were added 84 mg of potassium t-butoxide and 192 μl of ethyl acrylate, and the mixture was stirred at room temperature for 2.5 hours. Further, 28 mg of potassium t-butoxide and 154 μl of ethyl acrylate were added thereto, and the mixture was stirred at 60° C. for 7 hours. After cooling the mixture to room temperature, 1N hydrochloric acid and ethyl acetate were added thereto followed by separating the liquids. Thereafter, the obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure to obtain 589 mg of a yellow oily product containing the title compound. The product was used in the next reaction without further purification.

Reference Example 6

Synthesis of 4-(2-chloropyridin-3-yl)-5-(2,6-difluorophenyl)-5-oxopentanoic acid

(1357) ##STR03636##

(1358) To a mixed solution of 15 ml of THF containing 589 mg of ethyl 4-(2-chloropyridin-3-yl)-5-(2,6-difluorophenyl)-5-oxopentanoate obtained in Reference Example 5 and 15 ml of water was added 335 mg of lithium hydroxide monohydrate, and the mixture was stirred at 60° C. for 3.5 hours. After cooling the mixture to room temperature, an aqueous saturated sodium hydrogen carbonate solution and diethyl ether were added thereto to separate the liquids, then, conc. hydrochloric acid and ethyl acetate were added to the obtained aqueous layer and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over magnesium sulfate. Then, the solvent was distilled off under reduced pressure to in 250 mg of a yellow oily product containing the title compound. The product was used in the next reaction without further purification.

(1359) .sup.1H-NMR (CDCl.sub.3) δ: 8.30 (1H, dd, J=4.6, 1.8 Hz), 7.67 (1H, dd, J=7.6, 1.8 Hz), 7.36-7.34 (1H, m), 7.28-7.24 (1H, m), 6.90-6.85 (2H, m), 4.92 (1H, t, J=7.2 Hz), 2.63-2.26 (5H, m).

Reference Example 7

Synthesis of N-phenyl-1-(2,4,6-trifluorophenyl)propan-1-imine

(1360) ##STR03637##

(1361) To 30 ml of a dichloromethane solution containing 3.64 ml of aniline and 7.41 ml of triethylamine was added dropwise 15 ml of a dichloromethane solution containing 4.37 ml of titanium tetrachloride at 00° C., and the mixture was stirred for 15 minutes. Then, 10 ml of a dichloromethane solution containing 5.00 g of 1-(2,4,6-trifluoro-phenyl)propan-1-one was added thereto at 000° C., and the mixture was stirred under room temperature for 3.5 hours. 1N hydrochloric acid and dichloromethane were added to the obtained reaction mixture and the liquids were separated. The obtained organic layer was washed with water, and dried over sodium sulfate. The solvent was distilled off under reduced pressure to obtain 7.08 g of a yellow oily product containing the title compound.

(1362) .sup.1H-NMR (CDCl.sub.3) δ: 7.16-7.11 (2H, m), 6.96-6.92 (1H, m), 6.69-6.67 (2H, m), 6.52-6.49 (2H, m), 2.73 (2H, q, J=7.4 Hz), 1.25 (3H, t, J=7.4 Hz).

Reference Example 8

Synthesis of 5-methyl-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one

(1363) ##STR03638##

(1364) To 70 ml of 1,4-dioxane containing 7.08 g of N-phenyl-1-(2,4,6-trifluoro-phenyl)propan-1-imine obtained in Reference Example 7 were added 3.90 g of aluminum chloride and 2.08 g of acrylamide, and the mixture was stirred at 90° C. for 5 hours. After cooling the mixture to room temperature, 1N hydrochloric acid and ethyl acetate were added thereto and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 3.86 g of a white solid.

(1365) .sup.1H-NMR (CDCl.sub.3) δ: 6.76-6.72 (2H, m), 6.58 (1H, s), 2.60-2.57 (2H, ni), 2.47-2.45 (2H, m), 1.61 (3H, s).

Reference Example 9

Synthesis of 1-ethyl-5-methyl-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one

(1366) ##STR03639##

(1367) 40 ml of DMF containing 3.86 g of 5-methyl-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one, 5.12 ml of ethyl iodide and 20.85 g of cesium carbonate was stirred at 60° C. for 10 hours. After cooling the mixture to room temperature, water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained solid was washed with diisopropyl ether. The title compound was obtained as 4.01 g of a white solid.

(1368) .sup.1H-NMR (CDCl.sub.3) δ: 6.77-6.72 (2H, m), 3.32 (2H, q, J=7.1 Hz), 2.59-2.56 (2H, m), 2.37-2.35 (2H, m), 0.92 (3H, t, J=7.1 Hz).

Reference Example 10

Synthesis of 1-ethyl-5-methyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one

(1369) ##STR03640##

(1370) 60 ml of a toluene solution containing 4.00 g of 1-ethyl-5-methyl-6-(2,4,6-trifluorophenyl)-3,4-dihydropyridin-2(1H)-one obtained in Reference Example 9 and 6.75 g of 2,3-dichloro-5,6-dicyano-p-benzoquinone was stirred at 120° C. for 5 hours. Further, 1.69 g of 2,3-dichloro-5,6-dicyano-p-benzoquinone was added to the reaction mixture, and the mixture was stirred at 120° C. for 2 hours. After cooling the mixture to room temperature, the obtained reaction mixture was filtered. After the solvent of the organic layer was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography, and then, the solid was washed with diisopropyl ether. The title compound was obtained as 3.50 g of a white solid.

(1371) .sup.1H-NMR (CDCl.sub.3) δ: 7.26 (1H, d, J=9.5 Hz), 6.88-6.84 (2H, m), 6.64 (1H, d, J=9.5 Hz), 3.82 (2H, q, J=7.1 Hz), 1.81 (3H, s), 1.10 (3H, t, J=7.1 Hz).

Reference Example 11

Synthesis of 3-chloro-1-ethyl-5-methyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one

(1372) ##STR03641##

(1373) 3 ml of DMF solution containing 97 mg of 1-ethyl-5-methyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one and 49 mg of N-chlorosuccinimide was stirred at 70° C. for 4 hours. Further, 32 mg of N-chlorosuccinimide was added to the reaction mixture, and the mixture was stirred at 70° C. for 1 hour. After cooling the mixture to room temperature, water and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 86 mg of a white solid.

(1374) .sup.1H-NMR (CDCl.sub.3) δ: 7.50 (1H, s), 6.89-6.85 (2H, m), 3.87 (2H, q, J=7.1 Hz), 1.82 (3H, s), 1.13 (3H, t, J=7.1 Hz).

Reference Example 12

Synthesis of 3-chloro-5-(dibromomethyl)-1-ethyl-6-(2,4,6-trifluorophenyl)-pyridin-2-one

(1375) ##STR03642##

(1376) To 70 ml of chlorobenzene solution containing 3.86 g of 3-chloro-1-ethyl-5-methyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one were added 4.78 g of N-bromosuccinimide and 113.9 mg of azobisisobutyronitrile, and the mixture was stirred at 110° C. for 1 hour. After cooling the mixture to room temperature, water and dichloromethane were added thereto and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 5.40 g of brown oily product.

(1377) .sup.1H-NMR (CDCl.sub.3) δ: 8.13 (1H, s), 6.97-6.93 (2H, m), 5.96 (1H, s), 3.81 (2H, q, J=7.1 Hz), 1.14 (3H, t, J=7.1 Hz).

Reference Example 13

Synthesis of 5-chloro-1-ethyl-6-oxo-2-(2,4,6-trifluorophenyl)-1,6-dihydro-pyridin-3-carboaldehyde

(1378) ##STR03643##

(1379) To 95 ml of acetonitrile solution containing 5.40 g of 3-chloro-5-(dibromomethyl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2-one was added 47 ml of an aqueous solution containing 5.99 g of silver nitrate, and the mixture was stirred under room temperature for 1 hour. The reaction mixture was filtered through Celite, and washed with ethyl acetate. The obtained organic layer was successively washed with water, 1N hydrochloric acid and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained solid was washed with diisopropyl ether. The title compound was obtained as 3.56 g of a white solid.

(1380) .sup.1H-NMR (CDCl.sub.3) δ: 9.23 (1H, s), 8.12 (1H, s), 6.97-6.94 (2H, m), 3.94 (2H, q, J=7.1 Hz), 1.20 (3H, t, J=7.1 Hz).

Reference Example 14

Synthesis of 3-chloro-1-ethyl-5-(1-hydroxyethyl)-6-(2,4,6-trifluorophenyl)-pyridin-2(1H)-one

(1381) ##STR03644##

(1382) To 12 ml of a THF solution containing 1.13 g of 5-chloro-1-ethyl-6-oxo-2-(2,4,6-trifluorophenyl)-1,6-dihydropyridin-3-carboaldehyde was added dropwise 1.32 ml of a 3 mol/l THF solution of methylmagnesium chloride at −78° C. and stirred for 20 minutes. An aqueous saturated ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 920 mg of a white solid.

(1383) .sup.1H-NMR (CDCl.sub.3) δ: 7.85 (1H, s), 6.92-6.86 (2H, m), 4.24 (1H, dq, J=2.8, 6.4 Hz), 3.85-3.81 (2H, m), 1.64 (1H, d, J=2.8 Hz), 1.30 (3H, d, J=6.4 Hz), 1.13 (3H, t, J=7.0 Hz).

Reference Example 15

Synthesis of 5-acetyl-3-chloro-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one

(1384) ##STR03645##

(1385) To 18 ml of a dichloromethane solution containing 910 mg of 3-chloro-1-ethyl-5-(1-hydroxyethyl)-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one was added 1.28 g of Dess-Martin periodinane (1,1,1-triacetoxy-1,1-dihydro-1,2-benziodoxol-3-(1H)-one), and the mixture was stirred at room temperature for 1 hour. Ethyl acetate was added to the reaction mixture and the mixture was filtered through Celite. After the solvent of the organic layer was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 870 mg of a white solid.

(1386) .sup.1H-NMR (CDCl.sub.3) δ: 8.02 (1H, s), 6.83-6.81 (2H, m), 3.91 (2H, q, J=7.1 Hz), 2.31 (3H, s), 1.14 (3H, t, J=7.1 Hz).

Reference Example 16

Synthesis of 3-chloro-5-(3-(dimethylamino)acryloyl)-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one

(1387) ##STR03646##

(1388) To 870 mg of 5-acetyl-3-chloro-1-ethyl-6-(2,4,6-trifluorophenyl)pyridin-2(1H)-one was added 8 ml of N,N-dimethylformamide dimethylacetal, and the mixture was stirred at 100° C. for 5 hours. After cooling the mixture to room temperature, ethyl acetate and water were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 859 mg of a yellow solid.

(1389) .sup.1H-NMR (CDCl.sub.3) δ: 7.88 (1H, s), 7.48 (1H, d, J=12.2 Hz), 6.79-6.77 (2H, m), 5.08 (1H, d, J=12.2 Hz), 3.92 (2H, q, J=7.1 Hz), 3.08 (3H, s), 2.81 (3H, s), 1.16 (3H, t, J=7.1 Hz).

Reference Example 17

Synthesis of 2-bromo-1-(2,4,6-trifluorophenyl)ethan-1-one

(1390) ##STR03647##

(1391) To 100 ml of a dichloromethane solution containing 5.50 g of 1,3,5-trifluorobenzene and 11.1 g of aluminum chloride was added dropwise 4.33 ml of bromoacetyl bromide at 0° C., and the reaction mixture was stirred under reflux by heating for 15 hours. After cooling the mixture to room temperature, an aqueous saturated sodium hydrogen carbonate solution and dichloromethane were added thereto and the mixture was filtered through Celite. After separating the liquids to the organic layer and the aqueous layer, the obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 4.26 g of an oily product.

(1392) .sup.1H-NMR (CDCl.sub.3) δ: 6.79-6.76 (2H, m), 4.33-4.33 (2H, m).

Reference Example 18

Synthesis of 2-(1H-1,2,4-triazol-1-yl)-1-(2,4,6-trifluorophenyl)ethan-1-one

(1393) ##STR03648##

(1394) An ethyl acetate solution containing 4.26 g of 2-bromo-1-(2,4,6-trifluorophenyl)ethan-1-one, 2.56 g of 1H-1,2,4-triazole and 2.37 m1 of triethylamine was stirred under reflux by heating for 1.5 hours. After cooling the mixture to room temperature, the reaction mixture was filtered through Celite, and washed with ethyl acetate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 1.22 g of a brown solid.

(1395) .sup.1H-NMR (CDCl.sub.3) δ: 8.22 (1H, s), 7.99 (1H, s), 6.81-6.79 (2H, m), 5.46-5.45 (2H, m).

Reference Example 19

Synthesis of ethyl 5-oxo-4-(1H-1,2,4-triazol-1-yl)-5-(2,4,6-trifluorophenyl)-pentanoate

(1396) ##STR03649##

(1397) To 14 ml of a THF solution containing 1.43 g of 2-(1H-1,2,4-triazol-1-yl)-1-(2,4,6-trifluorophenyl)ethan-1-one were added 133 mg of potassium t-butoxide and 712 μl of ethyl acrylate, and the mixture was stirred under room temperature for 40 minutes. An aqueous saturated ammonium chloride solution and ethyl acetate were added to the mixture followed by separating the liquids. Thereafter, the obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 828 mg of a brown oily product.

(1398) .sup.1H-NMR (CDCl.sub.3) δ: 8.22 (1H, s), 7.90 (1H, s), 6.71-6.65 (2H, m), 5.79-5.76 (1H, m), 4.13 (2H, q, J=7.2 Hz), 2.67-2.63 (1H, m), 2.43-2.35 (2H, m), 2.12-2.07 (1H, m), 1.25 (3H, t, J=7.2 Hz).

Reference Example 20

Synthesis of 5-oxo-4-(1H-1,2,4-triazol-1-yl)-5-(2,4,6-trifluorophenyl)pentanoic acid

(1399) ##STR03650##

(1400) 305 mg of lithium hydroxide monohydrate was added to a mixed solution comprising 8 ml of THF containing 828 mg of ethyl 5-oxo-4-(1H-1,2,4-triazol-1-yl)-5-(2,4,6-trifluorophenyl)pentanoate and 4 ml of water, and the mixture was stirred under room temperature for 1.5 hours. Diethyl ether was added to the reaction mixture followed by separation of the liquids, conc. hydrochloric acid and ethyl acetate were added to the obtained aqueous layer and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. Then, the solvent was distilled off under reduced pressure to obtain 709 mg of a brown solid containing the title compound. The product was used in the next reaction without further purification.

(1401) .sup.1H-NMR (CDCl.sub.3) δ: 8.26 (1H, s), 7.91 (1H, s), 6.70-6.67 (2H, m), 5.77-5.75 (1H, m), 3.52 (1H, br s), 2.68-2.65 (1H, m), 2.51-2.44 (2H, m), 2.25-2.18 (1H, m).

Reference Example 21

Synthesis of 2-chloro-1-(2,4,6-trifluorophenyl)ethan-1-one

(1402) ##STR03651##

(1403) 28.0 ml of dichloroethane solution containing 12.0 ml of 1,3,5-trifluorobenzene, 30.9 g of aluminum chloride and 11.1 ml of chloroacetyl chloride was stirred at 70° C. for 1 hour. After cooling the mixture to room temperature, iced water and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous saturated sodium hydrogen carbonate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, 24.8 g of a pale yellowish solid containing the title compound was obtained. The product was used in the next reaction without further purification.

(1404) .sup.1H-NMR (CDCl.sub.3) δ: 6.80-6.76 (2H, m), 4.51 (2H, t, J=1.1 Hz).

Reference Example 22

Synthesis of 2-(1H-pyrazol-1-yl)-1-(2,4,6-trifluorophenyl)ethan-1-one

(1405) ##STR03652##

(1406) 70.0 ml of a methyl isobutyl ketone solution containing 7.28 g of 2-chloro-1-(2,4,6-trifluorophenyl)ethan-1-one obtained in Reference Example 21 and 11.9 g of 1H-pyrazole was stirred at 120° C. for 5.5 hours. After cooling the mixture to room temperature, ethyl acetate and 1N hydrochloric acid were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous saturated sodium hydrogen carbonate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 3.74 g of a brown solid.

(1407) .sup.1H-NMR (CDCl.sub.3) δ: 7.55 (1H, d, J=1.7 Hz), 7.49 (1H, d, J=2.2 Hz), 6.77-6.72 (2H, m), 6.34 (1H-1, dd, J=2.2, 1.7 Hz), 5.37 (2H, t, J=1.2 Hz).

Reference Example 23

Synthesis of ethyl 5-oxo-4-(1H-pyrazol-1-yl)-5-(2,4,6-trifluorophenyl)-pentanoate

(1408) ##STR03653##

(1409) To 37.0 ml of a THF solution containing 3.74 g of 2-(1H-pyrazol-1-yl)-1-(2,4,6-trifluorophenyl)ethan-1-one were added 349 mg of potassium t-butoxide and 1.86 ml of ethyl acrylate, and the mixture was stirred at 40° C. for 55 minutes. After cooling the mixture to room temperature, an aqueous saturated ammonium chloride solution and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure to obtain 5.33 g of a reddish brown oily product containing the title compound. The product was used in the next reaction without further purification.

(1410) .sup.1H-NMR (CDCl.sub.3) δ: 7.47 (1H, d, J=2.4 Hz), 7.45 (1H, d, J=1.8 Hz), 6.64-6.59 (2H, m), 6.22 (1H, dd, J=2.4, 1.8 Hz), 5.57 (1H, dd, J=10.4, 4.9 Hz), 4.13 (2H, q, J=7.1 Hz), 2.66-2.59 (1H, m), 2.43-2.41 (1H, m), 2.33-2.31 (1H, m), 2.15-2.11 (1H, m), 1.25 (3H, t, J=7.1 Hz).

Reference Example 24

Synthesis of 5-oxo-4-(1H-pyrazol-1-yl)-5-(2,4,6-trifluorophenyl)pentanoic acid

(1411) ##STR03654##

(1412) To 20 ml of THF containing 5.33 g of ethyl 5-oxo-4-(1H-pyrazol-1-yl)-5-(2,4,6-trifluorophenyl)pentanoate obtained in Reference Example 23 was added 10 ml of an aqueous solution containing 1.96 g of lithium hydroxide monohydrate, and the mixture was stirred at room temperature for 25 minutes. Diethyl ether was added to the reaction mixture followed by separation of the liquids, conc. hydrochloric acid and ethyl acetate were added to the obtained aqueous layer and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. Then, the solvent was distilled off under reduced pressure to obtain 3.66 g of a brown solid containing the title compound. The product was used in the next reaction without further purification.

(1413) .sup.1H-NMR (CDCl.sub.3) δ: 7.49 (1H, d, J=2.4 Hz), 7.48 (1H, d, J=1.8 Hz), 6.65-6.62 (2H, m), 6.25 (1H, dd, J=2.4, 1.8 Hz), 5.63 (1H, dd, J=10.2, 4.7 Hz), 2.69-2.61 (1H, m), 2.44-2.37 (2H, m), 2.21-2.15 (1H, m).

Reference Example 25

(1414) ##STR03655##

Step 1: Synthesis of 1-(2,6-difluorophenyl)-N-phenylpropan-1-imine

(1415) To 100 ml of a methylene chloride solution containing 11.74 g of aniline and 17.01 g of triethylamine was added dropwise 50 ml of a methylene chloride solution containing 23.91 g of titanium tetrachloride under ice-cooling. After 30 ml of a methylene chloride solution containing 14.30 g of 1-(2,6-difluorophenyl)propan-1-one was added dropwise to the reaction mixture, a temperature of the mixture was raised from ice-cooling to room temperature and the mixture was stirred overnight. To the obtained reaction mixture was added 1N hydrochloric acid followed by separation of the liquids, and the organic layer was dried over sodium sulfate. The solvent was distilled off under reduced pressure to obtain 21.10 g of a dark green oily product containing the title compound. The product was used in the next reaction without further purification.

Step 2: Synthesis of 6-(2,6-difluorophenyl)-5-methyl-3,4-dihydropyridin-2(1H)-one

(1416) To 200 ml of a dioxane solution containing 21.10 g of 1-(2,6-difluorophenyl)-N-phenylpropan-1-imine obtained in Step 1 and 12.33 g of aluminum chloride was added 6.57 g of an acrylamide monomer, and the mixture was stirred at 90° C. for 3 hours. After the solvent of the reaction mixture was distilled off under reduced pressure until the amount of the liquid became about a half, 1N hydrochloric acid and ethyl acetate were added thereto and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The obtained solid was washed with isopropyl ether, and the title compound was obtained as 11.65 g of a white solid.

(1417) .sup.1H-NMR (CDCl.sub.3) δ: 7.36-7.34 (1H, m), 6.97-6.94 (2H, m), 6.52 (1H, br s), 2.61-2.59 (2H, m), 2.48-2.47 (2H, m), 1.63 (3H, s).

Reference Example 26

Synthesis of 6-(2,6-difluorophenyl)-1-ethyl-5-methyl-3,4-dihydropyridin-2(1H)-one

(1418) ##STR03656##

(1419) 120 ml of a DMF solution containing 12.40 g of 6-(2,6-difluorophenyl)-5-methyl-3,4-dihydropyridin-2(1H)-one, 54.30 g of cesium carbonate and 25.99 g of ethyl iodide was stirred at 50° C. for 3.5 hours. Then, 27.15 g of cesium carbonate and 13.01 g of ethyl iodide were additionally added thereto, and then, the mixture was stirred at 50° C. for 2 hours, and further stirred at 60° C. for 1.5 hours. After cooling to room temperature, the reaction mixture was filtered to remove the insoluble materials. After the solvent of the filtrate was distilled off under reduced pressure, ethyl acetate and water were added to the residue and the liquids were separated. The obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained solid was washed with isopropyl ether. The title compound was obtained as 11.98 g of a white solid.

(1420) .sup.1H-NMR (CDCl.sub.3) δ: 7.38-7.35 (1H, m), 6.97-6.96 (2H, m), 3.33 (2H, q, J=7.1 Hz), 2.60-2.58 (2H, m), 2.38-2.36 (2H, m), 1.59 (3H, s), 0.91 (3H, t, J=7.1 Hz).

Reference Example 27

Synthesis of 6-(2,6-difluorophenyl)-1-ethyl-5-methylpyridin-2(1H)-one

(1421) ##STR03657##

(1422) 170 ml of a toluene solution containing 11.98 g of 6-(2,6-difluorophenyl)-1-ethyl-5-methyl-3,4-dihydropyridin-2(1H)-one and 21.65 g of 2,3-dichloro-5,6-dicyano-p-benzoquinone was stirred at 120° C. for 1.5 hours. After cooling the mixture to room temperature, the reaction mixture was filtered to remove the insoluble materials. After the solvent of the filtrate was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The obtained solid was washed with isopropyl ether, and the title compound was obtained as 9.34 g of a pale yellow solid.

(1423) .sup.1H-NMR (CDCl.sub.3) δ: 7.50-7.49 (1H, m), 7.27 (2H, d, J=9.5 Hz), 7.09-7.06 (2H, m), 6.63 (1H, d, J=9.5 Hz), 3.83 (2H, q, J=7.1 Hz), 1.80 (3H, s), 1.10 (3H, t, J=7.1 Hz).

Reference Example 28

Synthesis of 3-chloro-6-(2,6-difluorophenyl)-1-ethyl-5-methylpyridin-2(1H)-one

(1424) ##STR03658##

(1425) 110 ml of a DMF solution containing 11.36 g of 6-(2,6-difluorophenyl)-1-ethyl-5-methylpyridin-2(1H)-one and 6.69 g of N-chlorosuccinimide was stirred at 70° C. for 50 minutes. After cooling the mixture to room temperature, the solvent of the reaction mixture was distilled off under reduced pressure. Ethyl acetate and water were added thereto followed by separation of the liquids. Thereafter, the obtained organic layer was successively washed with an aqueous sodium thiosulfate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained solid was washed with isopropyl ether. The title compound was obtained as 11.41 g of a white solid.

(1426) .sup.1H-NMR (CDCl.sub.3) δ: 7.53-7.49 (1H, m), 7.50 (1H, s), 7.09-7.07 (2H, m), 3.88 (2H, q, J=7.1 Hz), 1.81 (3H, s), 1.12 (3H, t, J=7.1 Hz).

Reference Example 29

Synthesis of 3-chloro-5-(dibromomethyl)-6-(2,6-difluorophenyl)-1-ethyl-pyridin-2(1H)-one

(1427) ##STR03659##

(1428) To 230 ml of a chlorobenzene solution containing 12.65 g of 3-chloro-6-(2,6-difluorophenyl)-1-ethyl-5-methylpyridin-2(1H)-one were added 16.67 g of N-bromosuccinimide and 366 mg of azobisisobutyronitrile, and the mixture was stirred at 110° C. for 50 minutes. After cooling the mixture to room temperature, water and dichloromethane were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with an aqueous sodium thiosulfate solution, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained solid was washed with isopropyl ether. The title compound was obtained as 16.88 g of a pale brown solid.

(1429) .sup.1H-NMR (CDCl.sub.3) δ: 8.13 (1H, s), 7.65-7.63 (1H, m), 7.18 (2H, dd, J=8.5, 6.8 Hz), 5.96 (1H, s), 3.82 (2H, q, J=7.1 Hz), 1.13 (3H, t, J=7.1 Hz).

Reference Example 30

Synthesis of 5-chloro-2-(2,6-difluorophenyl)-1-ethyl-6-oxo-1,6-dihydro-pyridin-3-carboaldehyde

(1430) ##STR03660##

(1431) To 380 ml of acetonitrile containing 18.95 g of 3-chloro-5-(dibromomethyl)-6-(2,6-difluorophenyl)-1-ethylpyridin-2(1H)-one was added 190 ml of an aqueous solution containing 21.87 g of silver nitrate, and the mixture was stirred at room temperature for 15 minutes. The obtained reaction mixture was filtered to remove insoluble materials. After the solvent of the filtrate was distilled off under reduced pressure, water and ethyl acetate were added and the liquids were separated. The obtained organic layer was washed with 1N hydrochloric acid and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained solid was washed with isopropyl ether. The title compound was obtained as 11.37 g of a pale yellow solid.

(1432) .sup.1H-NMR (CDCl.sub.3) δ: 9.19 (1H, t, J=1.0 Hz), 8.13 (1H, s), 7.67-7.63 (1H, m), 7.18-7.16 (2H, m), 3.94 (2H, q, J=7.1 Hz), 1.19 (3H, t, J=7.1 Hz).

Reference Example 31

Synthesis of (E)-3-(5-chloro-1-ethyl-6-oxo-2-(2,6-difluorophenyl)-1,6-dihydropyridin-3-yl)acrylonitrile

(1433) ##STR03661##

(1434) To 10 ml of a THF solution containing 202 mg of 60% sodium hydride was added 792 μl of diethyl cyanomethylphosphonate and the mixture was stirred at 0° C. for 30 minutes. Then, 500 mg of 5-chloro-2-(2,6-difluorophenyl)-1-ethyl-6-oxo-1,6-dihydropyridin-3-carboaldehyde was added thereto, and the mixture was stirred at 0° C. for 4 hours. An aqueous saturated ammonium chloride solution and ethyl acetate were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over magnesium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 343 mg of a white solid.

(1435) .sup.1H-NMR (CDCl.sub.3) δ: 7.78 (1H, s), 7.67-7.63 (1H, m), 7.18-7.16 (2H, m), 6.58 (1H, d, J=16.4 Hz), 5.59 (1H, d, J=16.4 Hz), 3.89 (2H, q, J=7.1 Hz), 1.15 (3H, t, J=7.1 Hz).

Reference Example 32

Synthesis of 2-(4,5-dichloro-1H-imidazol-1-yl)-1-(2,4,6-trifluorophenyl)ethan-1-one

(1436) ##STR03662##

(1437) 20.0 ml of a ethyl acetate solution containing 2.12 g of 2-chloro-1-(2,4,6-trifluorophenyl)ethan-1-one obtained in Reference Example 21, 1.70 g of 4,5-dichloroimidazole and 1.45 ml of triethylamine was stirred at 90° C. for 3 hours. Then, 1.70 g of 4,5-dichloroimidazole was added to the solution, and the mixture was stirred at 90° C. for 2 hours. After cooling the mixture to room temperature, ethyl acetate and 1N hydrochloric acid were added to the reaction mixture and the liquids were separated. The obtained organic layer was successively washed with an aqueous saturated sodium hydrogen carbonate solution and saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography. The title compound was obtained as 1.96 g of a white solid.

(1438) .sup.1H-NMR (CDCl.sub.3) δ: 7.44 (1H, s), 6.84-6.82 (2H, m), 5.14 (2H, s).

Reference Example 33

Synthesis of ethyl 4-(4,5-dichloro-1H-imidazol-1-yl)-5-oxo-5-(2,4,6-trifluoro-phenyl)pentanoate

(1439) ##STR03663##

(1440) To 20.0 ml of a THF solution containing 1.96 g of 2-(4,5-dichloro-1H-imidazol-1-yl)-1-(2,4,6-trifluorophenyl)ethan-1-one obtained in Reference Example 32 were added 142 mg of potassium t-butoxide and 0.73 ml of ethyl acrylate, and the mixture was stirred at room temperature for 5.5 hours. Then, 71 mg of potassium t-butoxide and 173 μl of ethyl acrylate were added to the solution, and the mixture was stirred at room temperature for 1 hour. An aqueous saturated ammonium chloride solution and ethyl acetate were added to the obtained solution and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, 2.61 g of reddish black oily product containing the title compound was obtained. The product was used in the next reaction without further purification.

(1441) .sup.1H-NMR (CDCl.sub.3) δ: 7.48 (1H, s), 6.76-6.74 (2H, m), 5.59 (1H, dd, J=10:3, 4.6 Hz), 4.19-4.10 (2H, m), 2.63-2.58 (1H, m), 2.41-2.36 (1H, m), 2.28-2.16 (2H, m), 1.28-1.23 (3H, m).

Reference Example 34

Synthesis of 1-(2,4-difluorophenyl)-2-(4-methyl-1H-pyrazol-1-yl)ethan-1-one

(1442) ##STR03664##

(1443) 30.0 ml of a methyl isobutyl ketone solution containing 10.1 g of 2-bromo-1-(2,4-difluorophenyl)ethan-1-one and 4.23 g of 4-methyl-1H-pyrazole was stirred at 120° C. for 1 hour. After cooling the mixture to room temperature, ethyl acetate and an aqueous saturated sodium hydrogen carbonate solution were added to the reaction mixture and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, the obtained residue was washed with isopropyl ether. The title compound was obtained as 4.78 g of a brown solid.

(1444) .sup.1H-NMR (CDCl.sub.3) δ: 8.02 (1H, td, J=8.5, 6.4 Hz), 7.40 (1H, s), 7.25-7.25 (1H, m), 7.04-7.00 (1H, m), 6.97-6.92 (1H, m), 5.45 (2H, d, J=3.7 Hz), 2.13 (3H, s).

Reference Example 35

Synthesis of ethyl 5-(2,4-difluorophenyl)-4-(4-methyl-1H-pyrazol-1-yl)-5-oxopentanoate

(1445) ##STR03665##

(1446) To 40.0 ml of a THF solution containing 4.69 g of 1-(2,4-difluorophenyl)-2-(4-methyl-1H-pyrazol-1-yl)ethan-1-one obtained in Reference Example 34 were added 2.94 ml of 1,8-diazabicyclo[5.4.0]-7-undecene and 2.25 ml of ethyl acrylate, and the mixture was stirred at room temperature for 1.5 hours. An aqueous saturated ammonium chloride solution and ethyl acetate were added to the obtained solution and the liquids were separated. The obtained organic layer was washed with saturated brine, and dried over sodium sulfate. After the solvent was distilled off under reduced pressure, 4.79 g of a blackish red oily product containing the title compound was obtained. The product was used in the next reaction without further purification.

(1447) .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, td, J=8.6, 6.4 Hz), 7.32 (1H, s), 7.28 (1H, s), 6.97-6.93 (1H, m), 6.85-6.81 (1H, m), 5.74 (1H, dd, J=10.4, 4.3 Hz), 4.13 (2H, q, J=7.2 Hz), 2.50-2.47 (1H, m), 2.32-2.25 (3H, m), 2.06 (31-, s), 1.25 (3H, t, J=7.2 Hz).

(1448) Compounds synthesized according to the above-mentioned Examples are shown in Table 5, but the present invention is not limited to these.

(1449) In Table 5, Ph represents a phenyl group, 2-Thio represents a thiophen-2-yl group, 3-Thio represents a thiophen-3-yl group, 3-Py represents a pyridin-3-yl group, 3-Pyra represents a 1H-pyrazol-3-yl group, 5-Pyra represents a 1H-pyrazol-5-yl group, 1-Pyra represents a 1H-pyrazol-1-yl group, 5-Oxa represents an oxazol-5-yl group, 2-Oxa represents an oxazol-2-yl group, 1H-1,2,4-triazol-1-yl represents a 1H-1,2,4-triazol-1-yl group, 1-Pyrrolyl represents a 1H-pyrrol-1-yl group, 4-Pyrrolyl represents a 1H-pyrrol-4-yl group, 1-Imida represents a 1H-imidazol-1-yl group, and 1H-tetrazol-1-yl represents a 1H-tetrazol-1-yl group.

(1450) For example, the description “2,4,6-tri-F-Ph” in Table 5 means that it is a phenyl group in which fluorine atoms are bound to the 2-position, 4-position and 6-position, and the description “2-Cl-3-Py” means that it is a pyridin-3-yl group in which a chlorine atom is bound to the 2-position, and the other descriptions are also the same.

(1451) In Table 5, Structure A indicates the following.

(1452) ##STR03666##

(1453) In Table 5, Structure B indicates the following.

(1454) ##STR03667##

(1455) In Table 5, Structure C indicates the following.

(1456) ##STR03668##

(1457) In Table 5, Structure D indicates the following.

(1458) ##STR03669##

(1459) TABLE-US-00005 TABLE 5 Compound Structure R1 R2 Het Y 1 B Me H 2-Thio 2,6-di-F—Ph 2 B Et H 2-Thio 2,6-di-F—Ph 3 B Me H 3-Thio 2,6-di-F—Ph 4 B Et H 3-Thio 2,6-di-F—Ph 5 A Et H 2-Thio 2,6-di-F—Ph 6 A Et H 5-Cl-2-Thio 2,6-di-F—Ph 7 A Et Cl 5-Cl-2-Thio 2,6-di-F—Ph 8 A Et Cl 1,3-dioxan-2-yl 2,4,6-tri-F—Ph 9 A Et Cl 1,3-dioxolan-2-yl 2,4,6-tri-F—Ph 10 A Et Cl 1,3-dioxan-2-yl 2,6-di-F-4-MeO—Ph 11 A Et Cl 1,3-dioxan-2-yl 2,6-di-F—Ph 12 A Et Cl 1,3-dioxolan-2-yl 2,6-di-F-4-MeO—Ph 13 A Et Cl 1,3-dioxolan-2-yl 2,6-di-F—Ph 14 A Me H 2-Thio 2,6-di-F—Ph 15 A Me H 3-Thio 2,6-di-F—Ph 16 A Et H 3-Thio 2,6-di-F—Ph 17 A Et H 2-Cl-3-Py 2,6-di-F—Ph 18 A Et Cl 2-Cl-3-Py 2,6-di-F—Ph 19 A Et Cl 1,4-di-Me-3-Pyra 2,4,6-tri-F—Ph 20 A Et Cl 1-Me-5-Pyra 2,4,6-tri-F—Ph 21 A Et Cl 4-Br-1-Me-5-Pyra 2,4,6-tri-F—Ph 22 A Et Cl 4-Cl-1-Me-5-Pyra 2,4,6-tri-F—Ph 23 A Et Cl 4-Br-1-Me-5-Pyra 2,6-di-F-4-MeO—Ph 24 A Et Cl 4-Br-1-Me-3-Pyra 2,4,6-tri-F—Ph 25 B Et H 1-Pyra 2,4,6-tri-F—Ph 26 A Et H 1-Pyra 2,4,6-tri-F—Ph 27 A Et H 4-Cl-1-Pyra 2,4,6-tri-F—Ph 28 A Et Cl 1-Me-5-Pyra 2,6-di-F-4-MeO—Ph 29 A Et Cl 4-Cl-1-Me-5-Pyra 2,6-di-F-4-MeO—Ph 30 B Et H 1-Pyra 2,6-di-F—Ph 31 A Et H 1-Pyra 2,6-di-F—Ph 32 A Et Cl 5-Oxa 2-Cl-4-F—Ph 33 A Et Cl 5-Oxa 2-Cl-4-MeO—Ph 34 A Et Cl 1H-1,2,4-triazol-1-yl 2,4,6-tri-F—Ph 35 A Et Cl 5-Br-1H-1,2,4-triazol-1-yl 2,4,6-tri-F—Ph 36 A Et Cl 5-Oxa 2,4,6-tri-F—Ph 37 A Et Cl 5-Oxa 2,6-di-F-4-MeO—Ph 38 A Et Cl 4-Me-5-Oxa 2-Cl-4-F—Ph 39 A Et Cl 4-Me-5-Oxa 2-Cl-4-MeO—Ph 40 A Et Cl 4-Cl-1-Pyra 2,4,6-tri-F—Ph 41 A Et Cl 4-Cl-1-Pyra 2,6-di-F-4-MeO—Ph 42 A Et Cl 5-Oxa 2,6-di-F—Ph 43 A Et Cl 4-Me-5-Oxa 2,6-di-F—Ph 44 A Et H 2-Br-3-Thio 2,6-di-F—Ph 45 A Et Cl 2-Br-3-Thio 2,6-di-F—Ph 46 A Et Br 5-Br-1H-1,2,4-triazol-1-yl 2,4,6-tri-F—Ph 47 A Et Br 1H-1,2,4-triazol-1-yl 2,4,6-tri-F—Ph 48 A Et Cl 5-I-1H-1,2,4-triazol-1-yl 2,4,6-tri-F—Ph 49 A Et Cl 4-Br-5-Oxa 2,6-di-F—Ph 50 A Et Cl 4-Cl-5-Oxa 2,6-di-F—Ph 51 A Et Cl 4-F-5-Oxa 2,6-di-F—Ph 52 A Et H 4-Cl-1-Pyra 2,6-di-F—Ph 53 A Et Cl 4-Cl-1-Pyra 2,6-di-F—Ph 54 A Et Br 2-Br-3-Thio 2,6-di-F—Ph 55 A Et Br 2-Cl-3-Py 2,6-di-F—Ph 56 A F2CHCH2— H 2-Cl-3-Py 2,6-di-F—Ph 57 A F2CHCH2— Cl 2-Cl-3-Py 2,6-di-F—Ph 58 A F3CCH2— H 2-Cl-3-Py 2,6-di-F—Ph 59 A F2CHCH2— Br 2-Cl-3-Py 2,6-di-F—Ph 60 A F3CCH2— Cl 2-Cl-3-Py 2,6-di-F—Ph 61 A Et H 2-Cl-3-Py 2,4,6-tri-F—Ph 62 A Et Cl 2-Cl-3-Py 2,4,6-tri-F—Ph 63 A Et Br 2-Cl-3-Py 2,4,6-tri-F—Ph 64 A F3CCH2— Br 2-Cl-3-Py 2,6-di-F—Ph 65 A Et I 2-Cl-3-Py 2,6-di-F—Ph 66 A Et Me 2-Cl-3-Py 2,6-di-F—Ph 67 A F2CHCH2— H 2-Cl-3-Py 2,4,6-tri-F—Ph 68 A F2CHCH2— Cl 2-Cl-3-Py 2,4,6-tri-F—Ph 69 A F2CHCH2— Br 2-Cl-3-Py 2,4,6-tri-F—Ph 70 A Et Cl 4-Br-1-Pyra 2,4,6-tri-F—Ph 71 A Et Br 4-Cl-1-Pyra 2,4,6-tri-F—Ph 72 A Et Cl 4-Br-1-Pyra 2,6-di-F-4-MeO—Ph 73 A Et Br 4-Cl-1-Pyra 2,6-di-F-4-MeO—Ph 74 A Et Cl 4-I-5-Oxa 2,6-di-F—Ph 75 A Et Cl 2,4-di-I-5-Oxa 2,6-di-F—Ph 76 A Et H 4-Br-3,5-di-Me-1-Pyra 2,4,6-tri-F—Ph 77 A Et Br 4-Br-1-Pyra 2,4,6-tri-F—Ph 78 A Et Br 4-Br-1-Pyra 2,6-di-F-4-MeO—Ph 79 A Et H 2-Cl-3-Py 2,6-di-F-4-MeO—Ph 80 A Et Cl 2-Cl-3-Py 2,6-di-F-4-MeO—Ph 81 A Et Br 2-Cl-3-Py 2,6-di-F-4-MeO—Ph 82 A Et H 5-Cl-4-Me-1-Pyra 2,4,6-tri-F—Ph 83 A Et Cl 5-Cl-4-Me-1-Pyra 2,4,6-tri-F—Ph 84 A Et Cl 1-Pyra 2,4,6-trl-F—Ph 85 A Et Cl 4-Me-1-Pyra 2,4,6-tri-F—Ph 86 A Et Me 4-Me-1-Pyra 2,4,6-tri-F—Ph 87 A Et Cl 2-Cl-5-Oxa 2,6-di-F—Ph 88 A Et Cl 3-N≡C-4-Pyrrolyl 2,6-di-F—Ph 89 A Et Br 5-Oxa 2,4,6-tri-F—Ph 90 A Et Br 5-Oxa 2,6-di-F-4-MeO—Ph 91 A Et Cl 4-MeO-5-Oxa 2,6-di-F—Ph 92 A Et Cl 2-I-5-Oxa 2,6-di-F—Ph 93 A Et H 3,5-di-Me-1-Pyra 2,4,6-tri-F—Ph 94 A Et H 3,5-di-Me-1-Pyra 2,6-di-F-4-MeO—Ph 95 A Et H 4-Cl-3,5-di-Me-1-Pyra 2,4,6-tri-F—Ph 96 A Et Br 2,4-di-Br-5-Oxa 2,4,6-tri-F—Ph 97 A Et Br 4-Br-5-Oxa 2,4,6-tri-F—Ph 98 A Me H 2-Cl-3-Py 2,4,6-tri-F—Ph 99 A Me H 2-Cl-3-Py 2,6-di-F—Ph 100 A Me Cl 2-Cl-3-Py 2,4,6-tri-F—Ph 101 A Et Br 4-Me-1-Pyra 2,4,6-tri-F—Ph 102 A Et Br 2,4-di-Br-5-Oxa 2,6-di-F-4-MeO—Ph 103 A Et Br 4-Br-5-Oxa 2,6-di-F-4-MeO—Ph 104 A Me Br 2-Cl-3-Py 2,4,6-tri-F—Ph 105 A Me Cl 2-Cl-3-Py 2,6-di-F—Ph 106 A Me Br 2-Cl-3-Py 2,6-di-F—Ph 107 A Et Br 4-Cl-5-Oxa 2,4,6-tri-F—Ph 108 A Et H 4-Br-3-Me-1-Pyra 2,4,6-tri-F—Ph 109 A Et H 3,4-di-Me-1-Pyra 2,4,6-tri-F—Ph 110 A F2CHCH2— Cl 4-Cl-1-Pyra 2,4,6-tri-F—Ph 111 A F2CHCH2— Cl 4-Cl-1-Pyra 2,6-di-F-4-MeO—Ph 112 A Et Cl 4-Cl-5-Oxa 2,4,6-tri-F—Ph 113 A Et Cl 4-Br-5-Oxa 2,4,6-tri-F—Ph 114 A Et Cl 2,4-di-Cl-5-Oxa 2,6-di-F-4-MeO—Ph 115 A Et Cl 4-Cl-5-Oxa 2,6-di-F-4-MeO—Ph 116 A Et Cl 2,4-di-Br-5-Oxa 2,6-di-F-4-MeO—Ph 117 A Et Br 4-Br-3,5-di-Me-1-Pyra 2,4,6-tri-F—Ph 118 A Et Cl 4-Br-5-Oxa 2,6-di-F-4-MeO—Ph 119 A Et Cl 5-Oxa 2,6-di-F-4-MeHN—Ph 120 A Et Cl 4-F-5-Oxa 2,4,6-tri-F—Ph 121 A F3CCH2— Cl 4-Cl-1-Pyra 2,4,6-tri-F—Ph 122 A F3CCH2— Cl 4-Cl-1-Pyra 2,6-di-F-4-MeO—Ph 123 A Et Cl 4-HC(═O)-1-Pyra 2,4,6-tri-F—Ph 124 A Et Cl 4-F2HC-1-Pyra 2,4,6-tri-F—Ph 125 A Et Cl 2,5-di-Me-1-Pyrrolyl 2,4,6-tri-F—Ph 126 A Et Cl 2,5-di-Me-1-Pyrrolyl 2,6-di-F-4-MeO—Ph 127 A Et Cl 4-F-5-Oxa 2,6-di-F-4-MeO—Ph 128 A Et Cl 4-MeO-1-Pyra 2,4,6-tri-F—Ph 129 A Et Cl 5-EtOC(═O)-1-Imida 2,4,6-tri-F—Ph 130 A Et Cl 2-MeO-5-Oxa 2,6-di-F—Ph 131 A Et Cl 2-Me2N-5-Oxa 2,6-di-F—Ph 132 A Et Cl 1-Pyrrolyl 2,4,6-tri-F—Ph 133 A Et Cl 2,5-di-Cl-1-Pyrrolyl 2,4,6-tri-F—Ph 134 A Et Cl 2-MeNH-5-Oxa 2,6-di-F—Ph 135 A Et Cl 2-H2N-5-Oxa 2,6-di-F—Ph 136 A Et H 4,5-di-Cl-1-Imida 2,4,6-tri-F—Ph 137 A Et Cl 2,4,5-tri-Cl-1-Imida 2,4,6-tri-F—Ph 138 A Et Cl 4,5-di-Cl-1-Imida 2,4,6-tri-F—Ph 139 A Et Br 4,5-di-Cl-1-Imida 2,4,6-tri-F—Ph 140 A Et I 4-Cl-1-Pyra 2,4,6-tri-F—Ph 141 A Et H 4-Cl-3-Me-1-Pyra 2,4,6-tri-F—Ph 142 A Et Cl 4-Cl-3-Me-1-Pyra 2,4,6-tri-F—Ph 143 A Et Cl 4-Cl-3-Me-1-Pyra 2,6-di-F-4-MeO—Ph 144 A Et Br 4-Cl-3-Me-1-Pyra 2,4,6-tri-F—Ph 145 A Et H 4-Cl-1-Pyra 2,4-di-F—Ph 146 A Et Br 4-Cl-3-Me-1-Pyra 2,6-di-F-4-MeO—Ph 147 A Et Br 4-Br-3-Me-1-Pyra 2,4,6-tri-F—Ph 148 A Et Cl 4-Cl-1-Pyra 2,4-di-F—Ph 149 A Et Cl 4-Cl-1-Pyra 2-F-4-MeO—Ph 150 A Et Br 4-Cl-1-Pyra 2,4-di-F—Ph 151 A Et Br 4-Br-3-Me-1-Pyra 2,6-di-F-4-MeO—Ph 152 A Et Br 4-Cl-1-Pyra 2-F-4-MeO—Ph 153 A Et H 5-Cl-4-Me-1-Pyra 2,6-di-F—Ph 154 A Et F3C— 4-F3C-1-Pyra 2,4,6-tri-F—Ph 155 A Et Cl 4-F3C-1-Pyra 2,4,6-tri-F—Ph 156 A Et H 4-Cl-1-Pyra 2-Cl-4-F—Ph 157 A Et Cl 4-Cl-1-Pyra 2-Cl-4-F—Ph 158 A Et Br 4-Cl-1-Pyra 2-Cl-4-F—Ph 159 A Et Cl 4-Cl-1-Pyra 2-Cl-4-MeO—Ph 160 A Et Cl 4-I-1-Pyra 2,4,6-tri-F—Ph 161 A Et Cl 4-NO2-1-Pyra 2,4,6-tri-F—Ph 162 A Et Cl 5-MeO-2-Oxa 2,6-di-F—Ph 163 A Et Cl 4-MeC(═O)NH-1-Pyra 2,4,6-tri-F—Ph 164 A Et H 4-Cl-1-Pyra 2-Br-4-F—Ph 165 A Et Cl 4-Cl-1-Pyra 2-Br-4-F—Ph 166 A Et Br 4-Cl-1-Pyra 2-Br-4-F—Ph 167 A Et Cl 4-Cl-1-Pyra 2-Br-4-MeO—Ph 168 A Et H 4-Cl-1-Pyra 4-F-2-Me—Ph 169 A Et H 4-Cl-1-Pyra 2-Cl—Ph 170 A Et Cl 4-Cl-1-Pyra 4-F-2-Me—Ph 171 A Et Br 4-Cl-1-Pyra 4-F-2-Me—Ph 172 A Et Cl 4-Cl-1-Pyra 2-Cl—Ph 173 A Et Br 4-Cl-1-Pyra 2-Cl—Ph 174 A Me H 4-Cl-1-Pyra 2,4,6-tri-F—Ph 175 A Me Cl 4-Cl-1-Pyra 2,4,6-tri-F—Ph 176 A Me Br 4-Cl-1-Pyra 2,4,6-tri-F—Ph 177 A Me Cl 4-Cl-1-Pyra 2,6-di-F-4-MeO—Ph 178 A Me Br 4-Cl-1-Pyra 2,6-di-F-4-MeO—Ph 179 A Et Cl 5-Cl-4-Me-1-Pyra 2-Cl—Ph 180 A Et Br 4-Me-1-Pyra 2-Cl—Ph 181 A Et Br 5-Cl-4-Me-1-Pyra 2-Cl—Ph 182 A Et Cl 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 183 A Et H 4-Cl-1-Pyra 2-Br—Ph 184 A Et Cl 4-Cl-1-Pyra 2,6-di-F-4-OH—Ph 185 C Et H 4-Cl-1-Pyra 2,4,6-tri-F—Ph 186 A F2CHCH2— H 4-Me-1-Pyra 2,6-di-F—Ph 187 A Me Cl 5-Cl-4-Me-1-Pyra 2,6-di-F—Ph 188 A Me Br 4-Me-1-Pyra 2,6-di-F—Ph 189 A Me Br 5-Cl-4-Me-1-Pyra 2,6-di-F—Ph 190 A F2CHCH2— Cl 5-Cl-4-Me-1-Pyra 2,6-di-F—Ph 191 A Et H 4-F-1-Pyra 2,4,6-tri-F—Ph 192 A Et Cl 4-F-1-Pyra 2,4,6-tri-F—Ph 193 A F2CHCH2— Br 5-Cl-4-Me-1-Pyra 2,6-di-F—Ph 194 A Et Br 4-F-1-Pyra 2,4,6-tri-F—Ph 195 A Et Cl 4-Cl-1-Pyra 2-Br—Ph 196 A Et Br 4-Cl-1-Pyra 2-Br—Ph 197 A Et H 4-Cl-1-Pyra 2-Cl-6-F—Ph 198 A Et Cl 4-Cl-1-Pyra 2-Cl-6-F—Ph 199 A Et Br 4-Cl-1-Pyra 2-Cl-6-F—Ph 200 A Et Cl 4-Cl-1-Pyra 2,6-di-F-4-EtO—Ph 201 A Et Cl 4-Cl-1-Pyra 2,6-di-F-4-HC≡C— CH2O—Ph 202 A Et Cl 4-Cl-1-Pyra 2,6-di-F-4-H2C═CH— CH2O—Ph 203 A Et Cl 4-Cl-1-Pyra 6-di-F-4-MeOCH2O— Ph 204 A Et Cl 4-Cl-1-Pyra 2,6-di-F-4-MeOCH2— CH2O—Ph 205 A Et Cl 4-Cl-1-Pyra 2,6-di-F-4-MeC(═O)O— Ph 206 A Et Me 4-Cl-1-Pyra 2,4,6-tri-F—Ph 207 A F2CHCH2— Br 4-Cl-1-Pyra 2,4,6-tri-F—Ph 208 A Et H 4,5-di-Cl-1-Imida 2-Cl—Ph 209 A Et Cl 4,5-di-Cl-1-Imida 2-Cl—Ph 210 A Et Br 4,5-di-Cl-1-Imida 2-Cl—Ph 211 A F2CHCH2— H 4-Cl-1-Pyra 2,4-di-F—Ph 212 A F2CHCH2— Cl 4-Cl-1-Pyra 2,4-di-F—Ph 213 A F2CHCH2— Cl 4-Cl-1-Pyra 2-F-4-MeO—Ph 214 A F2CHCH2— Br 4-Cl-1-Pyra 2,4-di-F—Ph 215 A F2CHCH2— Br 4-Cl-1-Pyra 2-F-4-MeO—Ph 216 A Et H 4-Cl-1-Pyra 2-Br-6-F—Ph 217 A Et H 4-Cl-1-Pyra 2-F—Ph 218 A Et Cl 4-Cl-1-Pyra 2-Br-6-F—Ph 219 A Et Br 4-Cl-1-Pyra 2-Br-6-F—Ph 220 A Et Cl 4-Cl-1-Pyra 2-F—Ph 221 A Et Br 4-Cl-1-Pyra 2-F—Ph 222 A F2CHCH2— Br 4-Cl-1-Pyra 2,6-di-F-4-MeO—Ph 223 A Et HCC- 4-Cl-1-Pyra 2,4,6-tri-F—Ph 224 A Et HCEC- 4-Cl-1-Pyra 2,6-di-F-4-MeO—Ph 225 A Et MeO- 4-Cl-1-Pyra 2,4,6-tri-F—Ph 226 A Et Br 4-Me-1-Pyra 2,4-di-F—Ph 227 A F2CHCH2— H 4-Me-1-Pyra 2-Cl—Ph 228 A Et Br 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 229 A F2CHCH2— Cl 5-Cl-4-Me-1-Pyra 2-Cl—Ph 230 A F2CHCH2— Br 5-Cl-4-Me-1-Pyra 2-Cl—Ph 231 A F2CHCH2— H 4,5-di-Cl-1-Imida 2-Cl—Ph 232 A F2CHCH2— Cl 4,5-di-Cl-1-Imida 2-Cl—Ph 233 A F2CHCH2— H 4-Cl-1-Pyra 2-Cl-4-F—Ph 234 A F2CHCH2— Cl 4-Cl-1-Pyra 2-Cl-4-F—Ph 235 A F2CHCH2— Br 4-Cl-1-Pyra 2-Cl-4-F—Ph 236 A F2CHCH2— Br 4,5-di-Cl-1-Imida 2-Cl—Ph 237 A Et Br 4-Me-1-Pyra 2-Me—Ph 238 A Et H 4-Cl-1-Pyra 2,6-di-F-4-MeO—Ph 239 A F2CHCH2— Cl 4-Cl-1-Pyra 2-Cl-4-MeO—Ph 240 A F2CHCH2— Br 4-Cl-1-Pyra 2-Cl-4-MeO—Ph 241 A Et Br 4-Cl-1-Pyra 2-MeO—Ph 242 A Et H 4-Cl-1-Pyra 2-MeO—Ph 243 A Et Cl 4-Cl-1-Pyra 2-MeO—Ph 244 A Et Cl 5-Cl-4-Me-1-Pyra 2-Me—Ph 245 A Et Br 5-Cl-4-Me-1-Pyra 2-Me—Ph 246 A Et H 4-Me-1-Pyra 2-MeO—Ph 247 A Et Br 4-Me-1-Pyra 2-MeO—Ph 248 A Et Cl 5-Cl-4-Me-1-Pyra 2-MeO—Ph 249 A Et Br 5-Cl-4-Me-1-Pyra 2-MeO—Ph 250 A Et H 4-F-1-Pyra 2,4-di-F—Ph 251 A Et Cl 4-F-1-Pyra 2,4-di-F—Ph 252 A Et Br 4-F-1-Pyra 2,4-di-F—Ph 253 A Et I 4-Cl-1-Pyra 2,6-di-F-3-I-4-MeO—Ph 254 A F2CHCH2— H 4-Me-1-Pyra 2,4-di-F—Ph 255 A F2CHCH2— Cl 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 256 A F2CHCH2— Br 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 257 A Et Br 4-Cl-1-Pyra 2-NO2—Ph 258 A Et Cl 4-Cl-1-Pyra 2-NO2—Ph 259 A Et H 4-Me-1-Pyra 2-F—Ph 260 A Et Br 4-Me-1-Pyra 2-F—Ph 261 A Et Cl 3-Cl-1H-1,2,4-triazol-1-yl 2,4,6-tri-F—Ph 262 A Et Br 3-Cl-1H-1,2,4-triazol-1-yl 2,4,6-tri-F—Ph 263 A Et Cl 5-Cl-4-Me-1-Pyra 2-F—Ph 264 A Et Br 5-Cl-4-Me-1-Pyra 2-F—Ph 265 A Et HC(═O)— 4-Cl-1-Pyra 2,4,6-tri-F—Ph 266 A Et F2CH— 4-Cl-1-Pyra 2,4,6-tri-F—Ph 267 A Et Cl 3-Cl-1H-1,2,4-triazol-1-yl 2,6-di-F-4-MeO—Ph 268 A Et H 4-Me-1-Pyra 2-Br—Ph 269 A Et Br 4-Me-1-Pyra 2-Br—Ph 270 A Et Br 5-Br-4-Me-1-Pyra 2,4-di-F—Ph 271 A Et Br 5-Cl-4-Me-1-Pyra 2-Br—Ph 272 A Et Cl 5-Cl-4-Me-1-Pyra 2-Br—Ph 273 A F2CHCH2— H 4-Cl-1-Pyra 2-Br-4-F—Ph 274 A F2CHCH2— Cl 4-Cl-1-Pyra 2-Br-4-F—Ph 275 A F2CHCH2— Br 4-Cl-1-Pyra 2-Br-4-F—Ph 276 A F2CHCH2— H 4-Cl-1-Pyra 2-F—Ph 277 A F2CHCH2— Cl 4-Cl-1-Pyra 2-F—Ph 278 A F2CHCH2— Br 4-Cl-1-Pyra 2-F—Ph 279 A Et Cl 4-Cl-1-Pyra 4-N≡C-2-F—Ph 280 A Et Br 4-Cl-1-Pyra 4-N≡C-2-F—Ph 281 A Et H 1H-tetrazol-1-yl 2,4,6-tri-F—Ph 282 A F2CHCH2— H 4-F-1-Pyra 2,4,6-tri-F—Ph 283 A F2CHCH2— Br 4-F-1-Pyra 2,4,6-tri-F—Ph 284 A F2CHCH2— H 4-F-1-Pyra 2,4-di-F—Ph 285 A F2CHCH2— Cl 4-F-1-Pyra 2,4-di-F—Ph 286 A F2CHCH2— Br 4-F-1-Pyra 2,4-di-F—Ph 287 A F2CHCH2— Cl 4-Cl-1-Pyra 2-Br-4-MeO—Ph 288 A F2CHCH2— Br 4-Cl-1-Pyra 2-Br-4-MeO—Ph 289 A F2CHCH2— H 4-Cl-1-Pyra 2-Br—Ph 290 A F2CHCH2— Cl 4-Cl-1-Pyra 2-Br—Ph 291 A F2CHCH2— Br 4-Cl-1-Pyra 2-Br—Ph 292 A F2CHCH2— H 4-Cl-1-Pyra 2-Cl—Ph 293 A F2CHCH2— Cl 4-Cl-1-Pyra 2-Cl—Ph 294 A F2CHCH2— Br 4-Cl-1-Pyra 2-Cl—Ph 295 B Et H 2-Cl-3-Thio 2,6-di-F—Ph 296 A Et H 2-Cl-3-Thio 2,6-di-F—Ph 297 A Et Cl 2,5-di-Cl-3-Thio 2,6-di-F—Ph 298 A Et Cl 2-Cl-3-Thio 2,6-di-F—Ph 299 A Et Br 2-Cl-3-Thio 2,6-di-F—Ph 300 A Et H 4-F-1-Pyra 2-F-4-MeO—Ph 301 A Et Cl 4-F-1-Pyra 2-F-4-MeO—Ph 302 A Et Br 4-F-1-Pyra 2-F-4-MeO—Ph 303 A F2CHCH2— H 4-Me-1-Pyra 2-Me—Ph 304 A F2CHCH2— Br 4-Me-1-Pyra 2-Me—Ph 305 A F2CHCH2— H 4-Me-1-Pyra 2-F—Ph 306 A F2CHCH2— Cl 5-Cl-4-Me-1-Pyra 2-Me—Ph 307 A F2CHCH2— Br 5-Cl-4-Me-1-Pyra 2-Me—Ph 308 A Et H 4-F-1-Pyra 2,6-di-F-4-MeO-Ph 309 A F2CHCH2— Br 4-Me-1-Pyra 2-F—Ph 310 A F2CHCH2— Cl 5-Cl-4-Me-1-Pyra 2-F—Ph 311 A Et H 4-F-1-Pyra 2,6-di-F-4-EtO—Ph 312 A F2CHCH2— Br 5-Cl-4-Me-1-Pyra 2-F—Ph 313 A Et Br 4-F-1-Pyra 2-Cl—Ph 314 A Et Cl 4-F-1-Pyra 2,6-di-F-4-MeO—Ph 315 A Et Br 4-F-1-Pyra 2,6-di-F-4-MeO—Ph 316 A Et Cl 4-F-1-Pyra 2,6-di-F-4-EtO—Ph 317 A Et Br 4-F-1-Pyra 2,6-di-F-4-EtO—Ph 318 A Et H 4-F-1-Pyra 2,6-di-F—Ph 319 A Et Cl 4-F-1-Pyra 2,6-di-F—Ph 320 A Et Br 4-F-1-Pyra 2,6-di-F—Ph 321 A Et Br 4-Me-1-Pyra 2-Et—Ph 322 A Et Br 5-Cl-4-Me-1-Pyra 2-Et—Ph 323 A F2CHCH2— H 2-Br-3-Thio 2,6-di-F—Ph 324 A F2CHCH2— H 2,5-di-Br-3-Thio 2,6-di-F—Ph 325 A F2CHCH2— Br 2,5-di-Br-3-Thio 2,6-di-F—Ph 326 A Et H 4-F-1-Pyra 2-Br-4-F—Ph 327 A Et H 4-F-1-Pyra 2-Cl-4-F—Ph 328 A Et Cl 4-F-1-Pyra 2-Cl-4-F—Ph 329 A Et Br 4-F-1-Pyra 2-Cl-4-F—Ph 330 A Et H 4-Me-1-Pyra 2-Br-4-F—Ph 331 A Et Cl 5-Cl-4-Me-1-Pyra 2-Br-4-F—Ph 332 A Et Br 4-Me-1-Pyra 2-Br-4-F—Ph 333 A Et Br 5-Cl-4-Me-1-Pyra 2-Br-4-F—Ph 334 A Et H 4-Me-1-Pyra 2-Cl-4-F—Ph 335 A Et Br 4-Me-1-Pyra 2-Cl-4-F—Ph 336 A Et Cl 5-Cl-4-Me-1-Pyra 2-Cl-4-F—Ph 337 A Et Br 5-Cl-4-Me-1-Pyra 2-Cl-4-F—Ph 338 A F2CHCH2— H 4-Me-1-Pyra 2-Br-4-F—Ph 339 A F2CHCH2— Br 4-Me-1-Pyra 2-Br-4-F—Ph 340 A F2CHCH2— Cl 5-Cl-4-Me-1-Pyra 2-Br-4-F—Ph 341 A F2CHCH2— Br 5-Cl-4-Me-1-Pyra 2-Br-4-F—Ph 342 A F2CHCH2— H 4-Me-1-Pyra 2-Cl-4-F—Ph 343 A F2CHCH2— Cl 5-Cl-4-Me-1-Pyra 2-Cl-4-F—Ph 344 A F2CHCH2— Br 4-Me-1-Pyra 2-Cl-4-F—Ph 345 A F2CHCH2— Br 5-Cl-4-Me-1-Pyra 2-Cl-4-F—Ph 346 A F2CHCH2— Br 2-Br-3-Thio 2,6-di-F—Ph 347 A F2CHCH2— Cl 2-Br-3-Thio 2,6-di-F—Ph 348 A F2CHCH2— H 2-Br-5-Cl-3-Thio 2,6-di-F—Ph 349 A F2CHCH2— Cl 2-Br-5-Cl-3-Thio 2,6-di-F—Ph 350 A Et H 4-F-1-Pyra 2-Cl—Ph 351 A Et Cl 4-F-1-Pyra 2-Cl—Ph 352 A Et Cl 4-F-1-Pyra 2-Br-4-F—Ph 353 A Et Br 4-F-1-Pyra 2-Br-4-F—Ph 354 A Et H 4-F-1-Pyra 2-Br-4-MeO—Ph 355 A Et Cl 4-F-1-Pyra 2-Br-4-MeO—Ph 356 A Et H 4-F-1-Pyra 2-Br—Ph 357 A Et Cl 4-F-1-Pyra 2-Br—Ph 358 A Et Br 4-F-1-Pyra 2-Br—Ph 359 A Et H 3-Me-2-Thio 2,6-di-F—Ph 360 A Et H 4-F-1-Pyra 2-Br-6-F—Ph 361 A Et Cl 4-F-1-Pyra 2-Cl-4-MeO—Ph 362 A Et H 4-F-1-Pyra 2-Cl-4-MeO—Ph 363 A Et Br 4-F-1-Pyra 2-Cl-4-MeO—Ph 364 A Et H 3-Br-2-Thio 2,6-di-F—Ph 365 A Et Cl 3-Br-2-Thio 2,6-di-F—Ph 366 A F2CHCH2— H 2-Cl-3-Thio 2,6-di-F—Ph 367 A Et H 4-Me-1-Pyra 4-F-2-Me—Ph 368 A Et Br 5-Cl-4-Me-1-Pyra 2-F-4-MeNH—Ph 369 A Et Cl 5-Cl-4-Me-1-Pyra 4-F-2-Me—Ph 370 A Et Br 4-Me-1-Pyra 4-F-2-Me—Ph 371 A Et Br 5-Cl-4-Me-1-Pyra 4-F-2-Me—Ph 372 A Et H 4-Me-1-Pyra 2-F3C—Ph 373 A Et Br 5-Cl-4-Me-1-Pyra 2-F-4-MeS—Ph 374 A Et Br 4-Me-1-Pyra 2-F3C—Ph 375 A Et Cl 5-Cl-4-Me-1-Pyra 2-F3C—Ph 376 A NH2 Br 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 377 A Et H 2-Me-3-Thio 2,6-di-F—Ph 378 A Et H 4-F-1-Pyra 2-Cl-6-F—Ph 379 A Et Cl 4-F-1-Pyra 2-Cl-6-F—Ph 380 A Et Br 4-F-1-Pyra 2-Cl-6-F—Ph 381 A Et Cl 3-Me-2-Thio 2,6-di-F—Ph 382 A Et H 4-F-1-Pyra 2-F—Ph 383 A Et Cl 4-F-1-Pyra 2-F—Ph 384 A Et Br 4-F-1-Pyra 2-F—Ph 385 A F2CHCH2— H 3-Me-2-Thio 2,6-di-F—Ph 386 A Et H 5-Br-3-Me-2-Thio 2,6-di-F—Ph 387 A Et Cl 5-Br-3-Me-2-Thio 2,6-di-F—Ph 388 A Et Br 5-Br-3-Me-2-Thio 2,6-di-F—Ph 389 A Et Br 3-Me-2-Thio 2,6-di-F—Ph 390 A Et Cl 2-Me-3-Thio 2,6-di-F—Ph 391 A Et Cl 4-F-1-Pyra 2-Br-6-F—Ph 392 A Et Br 4-F-1-Pyra 2-Br-6-F—Ph 393 A Et H 3-Cl-2-Thio 2,6-di-F—Ph 394 A F2CHCH2— H 3-Cl-2-Thio 2,6-di-F—Ph 395 A Et Cl 3-Cl-2-Thio 2,6-di-F—Ph 396 A Et Cl 3,5-di-Cl-2-Thio 2,6-di-F—Ph 397 A Et Br 3-Cl-2-Thio 2,6-di-F—Ph 398 A Et Br 5-Br-3-Cl-2-Thio 2,6-di-F—Ph 399 A NH2 Br 2-Cl-3-Thio 2,6-di-F—Ph 400 A F2CHCH2— Br 5-Br-2-Cl-3-Thio 2,6-di-F—Ph 401 A F2CHCH2— H 5-Br-2-Cl-3-Thio 2,6-di-F—Ph 402 A F2CHCH2— Br 2-Cl-3-Thio 2,6-di-F—Ph 403 A F2CHCH2— Cl 5-Br-2-Cl-3-Thio 2,6-di-F—Ph 404 A F2CHCH2— Cl 2-Cl-3-Thio 2,6-di-F—Ph 405 A F2CHCH2— H 4-Me-1-Pyra 2-Br—Ph 406 A Me H 4-Me-1-Pyra 2,4-di-F—Ph 407 A F2CHCH2— Cl 5-Cl-4-Me-1-Pyra 2-Br—Ph 408 A F2CHCH2— Br 4-Me-1-Pyra 2-Br—Ph 409 A F2CHCH2— Br 5-Cl-4-Me-1-Pyra 2-Br—Ph 410 A Me Cl 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 411 A Me Br 4-Me-1-Pyra 2,4-di-F—Ph 412 A Me Br 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 413 A Me H 4-F-1-Pyra 2,6-di-F—Ph 414 A MeNH Br 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 415 A Et Br 3,5-di-Br-2-Thio 2,6-di-F—Ph 416 A Et Br 3-Br-2-Thio 2,6-di-F—Ph 417 A Et H 3,5-di-Br-2-Thio 2,6-di-F—Ph 418 A F2CHCH2— H 3-Br-2-Thio 2,6-di-F—Ph 419 A F2CHCH2— Cl 3-Br-5-Cl-2-Thio 2,6-di-F—Ph 420 A F2CHCH2— Cl 3-Br-2-Thio 2,6-di-F—Ph 421 A F2CHCH2— H 3-Br-5-Cl-2-Thio 2,6-di-F—Ph 422 A F2CHCH2— Br 3,5-di-Br-2-Thio 2,6-di-F—Ph 423 A F2CHCH2— Br 3-Br-2-Thio 2,6-di-F—Ph 424 A F2CHCH2— H 2-Me-3-Thio 2,6-di-F—Ph 425 A F2CHCH2— H 4-F-1-Pyra 2-Cl-4-F—Ph 426 A F2CHCH2— Cl 4-F-1-Pyra 2-Cl-4-F—Ph 427 A Et Br 4-Cl-1-Pyra 2-Cl-4-MeO—Ph 428 A Et H 4-Cl-1-Pyra 2-Cl-4-MeO—Ph 429 A Me Cl 2-Br-3-Thio 2,6-di-F—Ph 430 A Me Br 2-Br-3-Thio 2,6-di-F—Ph 431 A Me H 2-Me-3-Thio 2,6-di-F—Ph 432 A F2CHCH2— Br 5-Br-3-Cl-2-Thio 2,6-di-F—Ph 433 A F2CHCH2— Br 3-Cl-2-Thio 2,6-di-F—Ph 434 A F2CHCH2— H 5-Br-3-Cl-2-Thio 2,6-di-F—Ph 435 A Me H 3-Cl-2-Thio 2,6-di-F—Ph 436 A F2CHCH2— Cl 3,5-di-Cl-2-Thio 2,6-di-F—Ph 437 A F2CHCH2— Cl 3-Cl-2-Thio 2,6-di-F—Ph 438 A F2CHCH2— H 3,5-di-Cl-2-Thio 2,6-di-F—Ph 439 A Me Cl 3-Cl-2-Thio 2,6-di-F—Ph 440 A Me Cl 3,5-di-Cl-2-Thio 2,6-di-F—Ph 441 A Me Br 3-Cl-2-Thio 2,6-di-F—Ph 442 A Me Br 5-Br-3-Cl-2-Thio 2,6-di-F—Ph 443 A F2CHCH2— H 5-Br-3-Me-2-Thio 2,6-di-F—Ph 444 A Et Br 2-Me-3-Thio 2,6-di-F—Ph 445 A F2CHCH2— Cl 3-Me-2-Thio 2,6-di-F—Ph 446 A F2CHCH2— Br 3-Me-2-Thio 2,6-di-F—Ph 447 A F2CHCH2— H 4-F-1-Pyra 2-Br-4-F—Ph 448 A F2CHCH2— Cl 4-F-1-Pyra 2-Br-4-F—Ph 449 A F2CHCH2— Br 4-F-1-Pyra 2-Br4-F—Ph 450 A F2CHCH2— Br 4-F-1-Pyra 2-Br-4-MeO—Ph 451 A Me H 4-Cl-1-Pyra 2-Cl-4-F—Ph 452 A Me Cl 4-Cl-1-Pyra 2-Cl-4-F—Ph 453 A Me Br 4-Cl-1-Pyra 2-Cl-4-F—Ph 454 B Me H 2-Br-3-Thio 2,6-di-F—Ph 455 A Me2N Br 2-Cl-3-Thio 2,6-di-F—Ph 456 A Me H 2-Br-3-Thio 2,6-di-F—Ph 457 B Me H 3-Me-2-Thio 2,6-di-F—Ph 458 A Et H 2-Cl-3-Thio 2-Cl-4-F—Ph 459 A Et Br 2-Cl-3-Thio 2-Cl-4-F—Ph 460 A Et Cl 2-Cl-3-Thio 2-Cl-4-F—Ph 461 A Me Cl 4-F-1-Pyra 2,6-di-F—Ph 462 A Me Br 4-F-1-Pyra 2,6-di-F—Ph 463 A Me H 4-F-1-Pyra 2,4-di-F—Ph 464 A Me Cl 4-F-1-Pyra 2,4-di-F—Ph 465 A Me Br 4-F-1-Pyra 2,4-di-F—Ph 466 A Et Br 5-Cl-4-Me-1-Pyra 2-F-4-(pyrrolidin-1-yl)-Ph 467 A NH2 Br 4-F-1-Pyra 2,6-di-F—Ph 468 A MeNH Br 4-F-1-Pyra 2,6-di-F—Ph 469 A Et Br 5-Cl-4-Me-1-Pyra 2-F-4-(piperidin-1-yl)-Ph 470 A Me2N Br 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 471 A Et Br 4-Me-1-Pyra 2-N≡C—Ph 472 A Et Br 5-Cl-4-Me-1-Pyra 2-N≡C—Ph 473 A NH2 Br 5-Cl-4-Me-1-Pyra 2,6-di-F—Ph 474 A Me H 4-Me-1-Pyra 2-Cl-4-F—Ph 475 A MeNH Br 5-Cl-4-Me-1-Pyra 2,6-di-F—Ph 476 A Me Cl 5-Cl-4-Me-1-Pyra 2-Cl-4-F—Ph 477 A NH2 Br 5-Cl-4-Me-1-Pyra 2-Cl-4-F—Ph 478 A MeNH Br 5-Cl-4-Me-1-Pyra 2-Cl-4-F—Ph 479 A Me2N Br 5-Cl-4-Me-1-Pyra 2-Cl-4-F—Ph 480 A F2CHCH2— Cl 2-Me-3-Thio 2,6-di-F—Ph 481 A Me H 4-F-1-Pyra 2-Cl-4-F—Ph 482 A Me Cl 4-F-1-Pyra 2-Cl-4-F—Ph 483 A Me Br 4-F-1-Pyra 2-Cl-4-F—Ph 484 A Me Cl 2-Me-3-Thio 2,6-di-F—Ph 485 A Et H 4-Me-1-Pyra 4-Br-2-F—Ph 486 A Et Br 5-Cl-4-Me-1-Pyra 2-N≡C-4-F—Ph 487 A Me H 4-Me-1-Pyra 2-F—Ph 488 A Me Cl 5-Cl-4-Me-1-Pyra 2-F—Ph 489 A Me Br 4-Me-1-Pyra 2-F—Ph 490 A Me Br 5-Cl-4-Me-1-Pyra 2-F—Ph 491 A Me H 5-Br-2-Me-3-Thio 2,6-di-F—Ph 492 A Me Br 2-Me-3-Thio 2,6-di-F—Ph 493 A F2CHCH2— H 3-Thio 2,6-di-F—Ph 494 A F2CHCH2— Br 5-Br-2-Me-3-Thio 2,6-di-F—Ph 495 A F2CHCH2— Br 5-Br-2-BrCH2-3-Thio 2,6-di-F—Ph 496 A Me H 3-Me-2-Thio 2,6-di-F—Ph 497 A Et H 2-Cl-3-Thio 2-Cl-4-MeO—Ph 498 A Me Cl 3-Me-2-Thio 2,6-di-F—Ph 499 A Et Br 2-Br-3-Thio 2,4-di-F—Ph 500 A Et H 2-Br-3-Thio 2,4-di-F—Ph 501 A Et Cl 2-Br-3-Thio 2,4-di-F—Ph 502 A Et Cl 2-Cl-3-Thio 2-Cl-4-MeO—Ph 503 A Et H 2-Me-3-Thio 2,4-di-F—Ph 504 A Et Br 2-Cl-3-Thio 2-Cl-4-MeO—Ph 505 A Et H 4-Me-1-Pyra 2,4-di-F—Ph 506 A Et H 5-Cl-4-Me-1-Pyra 2,4-di-F—Ph 507 A Et Cl 5-Cl-4-Me-1-Pyra 4-N≡C-2-F—Ph 508 A Et Cl 4-F-1-Pyra 4-N≡C-2-F—Ph 509 A Me Cl 4-F-1-Pyra 2-Cl-6-F—Ph 510 A Me Br 4-F-1-Pyra 2-Cl-6-F—Ph 511 A Me H 4-Me-1-Pyra 4-F-2-Me—Ph 512 A Me Cl 5-Cl-4-Me-1-Pyra 4-F-2-Me—Ph 513 A Me Br 4-Me-1-Pyra 4-F-2-Me—Ph 514 A Me Br 5-Cl-4-Me-1-Pyra 4-F-2-Me—Ph 515 A Me Br 5-Cl-4-Me-1-Pyra 2-Cl-4-F—Ph

(1460) Next, with regard to the compounds shown in Table 5, H-NMR data thereof are shown in Table 6.

(1461) TABLE-US-00006 TABLE 6 Compound .sup.1H-NMR 1 .sup.1H-NMR CDCl.sub.3) δ: 7.45-7.43 (1H, m), 7.04 (1H, dd, J = 5.3, 1.1 Hz), 6.98 (2H, dd, J = 8.2, 6.9 Hz), 6.84 (1H, dd, J = 5.0, 3.7 Hz), 6.76 (1H, dd, J = 3.7, 0.9 Hz), 2.92 (2H, dd, J = 8.9, 6.2 Hz), 2.88 (3H, s), 2.75 (2H, dd, J = 8.9, 6.2 Hz). 2 .sup.1H-NMR (CDCl.sub.3) δ: 7.45-7.43 (1H, m), 7.03 (1H, dd, J = 5.0, 1.4 Hz), 6.97 (2H, dd, J = 8.5, 7.1 Hz), 6.83 (1H, dd, J = 5.0, 3.7 Hz), 6.73 (1H, dd, J = 3.7, 0.9 Hz), 3.42 (2H, q, J = 7.2 Hz), 2.90 (2H, dd, J = 9.4, 6.2 Hz), 2.73 (2H, dd, J = 8.7, 6.0 Hz), 0.97 (3H, t, J = 7.1 Hz). 3 .sup.1H-NMR (CDCl.sub.3) δ: 7.35-7.33 (1H, m), 7.09 (1H, dd, J = 5.0, 3.2 Hz), 6.90 (2H, dd, J = 8.5, 7.1 Hz), 6.74 (1H, dd, J = 3.2, 1.4 Hz), 6.63 (1H, dd, J = 5.0, 1.4 Hz), 2.87 (3H, s), 2.83-2.69 (4H, m). 4 .sup.1H-NMR (CDCl.sub.3) δ: 7.35-7.33 (1H, m), 7.08 (1H, dd, J = 5.0, 2.7 Hz), 6.89 (2H, dd, J = 8.2, 6.9 Hz), 6.71 (1H, dd, J = 3.2, 1.4 Hz), 6.63 (1H, dd, J = 5.0, 1.4 Hz), 3.41 (2H, q, J = 7.0 Hz), 2.81-2.69 (4H, m), 0.95 (3H, q, J = 7.9 Hz). 5 .sup.1H-NMR (CDCl.sub.3) δ: 7.53 (1H, d, J = 9.5 Hz), 7.43 (1H, tt, J = 8.6, 6.3 Hz), 7.12 (1H, dd, J = 5.1, 1.2 Hz), 6.99-6.94 (2H, m), 6.83 (1H, dd, J = 5.1, 3.7 Hz), 6.73 (1H, dd, J = 3.7, 1.2 Hz), 6.72 (1H, d, J = 9.5 Hz), 3.90 (2H, q, J = 7.1 Hz), 1.15 (3H, t, J = 7.1 Hz). 6 .sup.1H-NMR (CDCl.sub.3) δ: 7.48-7.45 (2H, m), 7.00 (2H, dd, J = 8.5, 7.1 Hz), 6.71 (1H, d, J = 9.5 Hz), 6.65 (1H, d, J = 3.9 Hz), 6.52 (1H, d, J = 3.9 Hz), 3.87 (2H, q, J = 7.1 Hz), 1.14 (3H, t, J = 7.1 Hz). 7 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.49 (1H, tt, J = 8.5, 6.4 Hz), 7.00 (2H, dd, J = 8.5, 7.1 Hz), 6.66 (1H, d, J = 3.9 Hz), 6.56 (1H, d, J = 3.9 Hz) 3.92 (2H, q, J = 7.1 Hz), 1.16 (3H, 1, J = 7.1 Hz). 8 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 6.88-6.84 (2H, m), 4.75 (1H, s), 4.09-4.07 (2H, m), 3.85 (2H, q, J = 7.1 Hz), 3.60-3.57 (2H, m), 2.07-2.02 (1H, m), 1.30-1.27 (1H, m), 1.14 (3H, t, J = 7.1 Hz). 9 .sup.1H-NMR (CDCl.sub.3) δ: 7.77 (1H, s), 6.87 (2H, td, J = 8.6, 1.8 Hz), 5.09 (1H, s), 4.06-4.02 (2H, m), 3.87-3.84 (4H, m), 1.15 (3H, t, J = 7.1 Hz). 10 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 6.63-6.59 (2H, m), 4.77 (1H, s), 4.11-4.08 (2H, m), 3.89 (3H, s), 3.87 (2H, q, J = 7.1 Hz), 3.62-3.59 (2H, m), 2.10- 2.06 (1H, m), 1.30-1.26 (1H, m), 1.13 (3H, t, J = 7.1 Hz). 11 .sup.1H-NMR (CDCl.sub.3) δ: 7.93 (1H, s), 7.55 (1H, tt, J = 8.4, 6.4 Hz), 7.10-7.07 (2H, m), 4.74 (1H, s), 4.08-4.06 (2H, m), 3.86 (2H, q, J = 7.1 Hz), 3.56- 3.53 (2H, m), 2.08-2.03 (1H, m), 1.28-1.24 (1H, m), 1.14 (3H, t, J = 7.1 Hz). 12 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 6.62-6.60 (2H, m), 5.11 (1H, s), 4.07-4.05 (2H, m), 3.88-3.86 (7H, m), 1.14 (3H, t, J = 7.1 Hz). 13 .sup.1H-NMR (CDCl.sub.3) δ: 7.77 (1H, s), 7.54 (1H, tt, J = 8.5, 6.4 Hz), 7.09 (2H, dd, J = 8.5, 7.0 Hz), 5.08 (1H, s), 4.05-4.03 (2H, m), 3.87-3.83 (4H, m), 1.14 (3H, t, J = 7.1 Hz). 14 .sup.1H-NMR (CDCl.sub.3) δ: 7.56 (1H, d, J = 9.5 Hz), 7.45-7.43 (1H, m), 7.12 (1H, dd, J = 5.2, 1.2 Hz), 6.99-6.95 (2H, m), 6.84 (1H, dd, J = 5.0, 3.5 Hz), 6.74-6.73 (2H, m), 3.37 (3H, s). 15 .sup.1H-NMR (CDCl.sub.3) δ: 7.47 (1H, d, J = 9.5 Hz), 7.40-7.38 (1H, m), 7.13 (1H, dd, J = 5.0, 3.1 Hz), 6.96-6.90 (2H, m), 6.89 (1H, dd, J = 2.9, 1.2 Hz), 6.75-6.72 (2H, m), 3.38 (3H, s). 16 .sup.1H-NMR (CDCl.sub.3) δ: 7.44 (1H, d, J = 9.5 Hz), 7.39-7.37 (1H, m), 7.11 (1H, dd, J = 5.0, 2.9 Hz), 6.93-6.91 (2H, m), 6.89 (1H, dd, J = 2.9, 1.4 Hz), 6.75 (1H, dd, J = 4.9, 1.2 Hz), 6.72 (1H, d, J = 9.5 Hz), 3.90 (2H, q, J = 7.0 Hz), 1.14 (3H, t, J = 7.0 Hz). 17 .sup.1H-NMR (CDCl.sub.3) δ: 8.23 (1H, dd, J = 4.9, 2.0 Hz), 7.42 (1H, dt, J = 7.6, 2.0 Hz), 7.36-7.29 (2H, m), 7.04 (1H, dd, J = 7.6, 4.9 Hz), 6.91-6.83 (2H, m), 6.76 (1H, d, J = 9.3 Hz), 3.96-3.87 (2H, m), 1.16 (3H, t, J = 7.1 Hz). 18 .sup.1H-NMR (CDCl.sub.3) δ: 8.25 (1H, dd, J = 4.8, 1.9 Hz), 7.57 (1H, s), 7.43 (1H, dt, J = 7.6, 1.9 Hz), 7.38-7.30 (1H, m), 7.06 (1H, dd, J = 7.6, 4.8 Hz) 6.91-6.85 (2H, m), 4.01-3.92 (2H, m), 1.19 (3H, t, J = 7.1 Hz). 19 .sup.1H-NMR (CDCl.sub.3) δ: 7.60 (1H, s), 6.99 (1H, s), 6.67-6.65 (2H, m), 3.97 (2H, q, J = 7.2 Hz), 3.64 (3H, s), 1.87 (3H, d, J = 0.5 Hz), 1.18 (3H, t, J = 7.2 Hz). 20 .sup.1H-NMR (CDCl.sub.3) δ: 7.53 (1H, s), 7.28 (1H, d, J = 2.0 Hz), 6.71-6.69 (2H, m), 5.93 (1H, d, J = 2.0 Hz), 3.94 (2H, q, J = 7.1 Hz), 3.69 (3H, s), 1.19 (3H, t, J = 7.1 Hz). 21 .sup.1H-NMR (CDCl.sub.3) δ: 7.47 (1H, s), 7.32 (1H, s), 6.77-6.76 (1H, m), 6.69-6.64 (1H, m), 4.19-4.13 (1H, m), 3.87-3.81 (1H, m), 3.69 (3H, d, J = 1.5 Hz), 1.18 (3H, t, J = 7.1 Hz). 22 .sup.1H-NMR (CDCl.sub.3) δ: 7.48 (1H, s), 7.28 (1H, s), 6.78-6.76 (1H, m), 6.67-6.64 (1H, m), 4.19 (1H, dq, J = 13.5, 7.0 Hz), 3.81 (1H, dq, J = 13.5, 7.0 Hz), 3.68 (3H, d, J = 1.2 Hz), 1.19 (3H, t, J = 7.0 Hz). 23 .sup.1H-NMR (CDCl.sub.3) δ: 7.45 (1H, s), 7.32 (1H, s), 6.48 (1H, dt, J = 11.2, 1.8 Hz), 6.41 (1H, dt, J = 11.2, 1.8 Hz), 4.12 (1H, dq, J = 13.5, 7.0 Hz), 3.91 (1H, dq, J = 13.5, 7.0 Hz), 3.80 (3H, s), 3.66 (3H, d, J = 1.2 Hz), 1.18 (3H, t, J = 7.0 Hz). 24 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.26 (1H, s), 6.69-6.67 (2H, m), 3.97 (2H, q, J = 7.1 Hz), 3.69 (3H, s), 1.18 (3H, t, J = 7.1 Hz). 25 .sup.1H-NMR (CDCl.sub.3) δ: 7.47 (1H, d, J = 2.0 Hz), 7.14 (1H, d, J = 2.2 Hz), 6.69-6.63 (2H, m), 6.11 (1H, dd, J = 2.2, 2.0 Hz), 3.42 (2H, q, J = 7.2 Hz), 2.95-2.90 (2H, m), 2.88-2.83 (2H, m), 0.98 (3H, t, J = 7.2 Hz). 26 .sup.1H-NMR (CDCl.sub.3) δ: 7.46-7.45 (2H, m), 7.29 (1H, d, J = 2.4 Hz), 6.75 (1H, d, J = 9.8 Hz), 6.72-6.68 (2H, m), 6.19-6.18 (1H, m), 3.89 (2H, q, J = 7.2 Hz), 1.17 (3H, t, J = 7.2 Hz). 27 .sup.1H-NMR (CDCl.sub.3) δ: 7.40 (1H, d, J = 9.8 Hz), 7.37 (1H, s), 7.31 (1H, s), 6.75-6.72 (3H, m), 3.88 (2H, q, J = 7.0 Hz), 1.17 (3H, t, J = 7.0 Hz). 28 .sup.1H-NMR (CDCl.sub.3) δ: 7.51 (1H, s), 7.28 (1H, d, J = 1.8 Hz), 6.44-6.42 (2H, m), 5.96 (1H, d, J = 1.8 Hz), 3.97 (2H, q, J = 7.1 Hz), 3.79 (3H, s), 3.68 (3H, s), 1.18 (3H, t, J = 7.1 Hz). 29 .sup.1H-NMR (CDCl.sub.3) δ: 7.46 (1H, s), 7.28 (1H, s), 6.49 (1H, ddd, J = 10.7, 2.2, 1.5 Hz), 6.40 (1H, ddd, J = 11.0, 2.2, 1.5 Hz), 4.17-4.10 (1H, m), 3.90- 3.87 (1H, m), 3.80 (3H, s), 3.66 (3H, d, J = 1.2 Hz), 1.18 (3H, t, J = 7.1 Hz). 30 .sup.1H-NMR (CDCl.sub.3) δ: 7.47 (1H, d, J = 1.8 Hz), 7.34-7.32 (1H, m), 7.11 (1H, d, J = 2.4 Hz), 6.90-6.88 (2H, m), 6.06-6.06 (1H, m), 3.42 (2H, q, J = 7.0 Hz). 2.95-2.93 (2H, m), 2.88-2.85 (2H, m), 0.98 (3H, t, J = 7.0 Hz). 31 .sup.1H-NMR (CDCl.sub.3) δ: 7.48 (1H, d, J = 9.5 Hz), 7.44 (1H, dd, J = 1.8, 0.9 Hz), 7.40-7.38 (1H, m), 7.27-7.27 (1H, m), 6.95-6.91 (2H, m), 6.75 (1H, d, J = 9.5 Hz), 6.14 (1H, dd, J = 2.4, 1.8 Hz), 3.89 (2H, q, J = 7.2 Hz), 1.17 (3H, t, J = 7.2 Hz). 32 .sup.1H-NMR (CDCl.sub.3) δ: 8.00 (1H, s), 7.76 (1H, s), 7.37 (1H, dd, J = 8.3, 2.6 Hz), 7.31 (1H, dd, J = 8.6, 5.8 Hz), 7.21 (1H, ddd, J = 8.6, 7.6, 2.6 Hz), 5.77 (1H, s), 4.23-4.16 (1H, m), 3.62-3.56 (1H, m), 1.18 (3H, t, J = 7.0 Hz). 33 .sup.1H-NMR (CDCl.sub.3) δ: 8.03 (1H, s), 7.76 (1H, s), 7.18 (1H, d, J = 8.6 Hz), 7.12 (1H, d, J = 2.8 Hz), 6.99 (1H, dd, J = 8.6, 2.8 Hz), 5.66 (1H, s), 4.23-4.16 (1H, m), 3.90 (3H, s), 3.68-3.61 (1H, m), 1.18 (3H, t, J = 7.0 Hz). 34 .sup.1H-NMR (CDCl.sub.3) δ: 7.99 (1H, s), 7.87 (1H, s), 7.68 (1H, s), 6.76-6.74 (2H, m), 3.95 (2H, q, J = 7.2 Hz), 1.21 (3H, t, J = 7.2 Hz). 35 .sup.1H-NMR (CDCl.sub.3) δ: 7.76 (1H, s), 7.60 (1H, s), 6.75-6.73 (2H, m), 3.97 (2H, q, J = 7.2 Hz), 1.22 (3H, t, J = 7.2 Hz). 36 .sup.1H-NMR (CDCl.sub.3) δ: 7.94 (1H, s), 7.77 (1H, s), 6.93-6.86 (2H, m), 6.19 (1H, s), 3.95 (2H, q, J = 7.1 Hz), 1.19 (3H, t, J = 7.1 Hz). 37 .sup.1H-NMR (CDCl.sub.3) δ: 7.98 (1H, s), 7.78 (1H, s), 6.66-6.61 (2H, m), 6.04 (1H, s), 3.98 (2H, q, J = 7.1 Hz), 3.89 (3H, s), 1.19 (3H, t, J = 7.1 Hz). 38 .sup.1H-NMR (CDCl.sub.3) δ: 7.57 (1H, s), 7.53 (1H, s), 7.24 (1H, dd, J = 8.6, 5.8 Hz), 7.19 (1H, dd, J = 8.3, 2.4 Hz), 7.04 (1H, ddd, J = 8.6, 8.0, 2.4 Hz), 4.29-4.22 (1H, m), 3.60-3.53 (1H, m), 2.05 (3H, s), 1.15 (3H, t, J = 7.0 Hz). 39 .sup.1H-NMR (CDCl.sub.3) δ: 7.55 (1H, s), 7.55 (1H, s), 7.11 (1H, d, J = 8.5 Hz), 6.93 (1H, d, J = 2.4 Hz), 6.80 (1H, dd, J = 8.5, 2.4 Hz), 4.30-4.22 (1H, m), 3.82 (3H, s), 3.65-3.57 (1H, m), 2.02 (3H, s), 1.14 (3H, t, J = 7.1 Hz). 40 .sup.1H-NMR (CDCl.sub.3) δ: 7.66 (1H, s), 7.38 (1H, s), 7.32 (1H, s), 6.76-6.74 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 41 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.40 (1H, s), 7.28 (1H, s), 6.51-6.48 (2H, m), 3.95 (2H, q, J = 7.2 Hz), 3.83 (3H, s), 1.18 (3H, t, J = 7.2 Hz). 42 .sup.1H-NMR (CDCl.sub.3) δ: 7.98 (1H, s), 7.75 (1H, s), 7.63-7.56 (1H, m), 7.15-7.10 (2H, m), 6.01 (1H, s), 3.96 (2H, q, J = 7.1 Hz), 1.19 (3H, t, J = 7.1 Hz). 43 .sup.1H-NMR (CDCl.sub.3) δ: 7.59 (1H, s), 7.56 (1H, s), 7.43 (1H, tt, J = 8.6, 6.4 Hz), 6.99-6.94 (2H, m), 3.97 (2H, q, J = 7.1 Hz), 1.99 (3H, s), 1.17 (3H, t, J = 7.1 Hz). 44 .sup.1H-NMR (CDCl.sub.3) δ: 7.38-7.32 (2H, m), 7.00 (1H, d, J = 5.8 Hz), 6.91-6.89 (2H, m), 6.76 (1H, d, J = 9.5 Hz), 6.54 (1H, d, J = 5.8 Hz), 3.91 (2H, q, J = 7.0 Hz), 1.16 (3H, t, J = 7.0 Hz). 45 .sup.1H-NMR (CDCl.sub.3) δ: 7.59 (1H, s), 7.37 (1H, tt, J = 8.6, 6.4 Hz), 7.01 (1H, d, J = 5.8 Hz), 6.92-6.90 (2H, m), 6.55 (1H, d, J = 5.8 Hz), 3.96 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 46 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.76 (1H, s), 6.76-6.72 (2H, m), 3.97 (2H, q, J = 7.0 Hz), 1.22 (3H, t, J = 7.0 Hz). 47 .sup.1H-NMR (CDCl.sub.3) δ: 7.99 (1H, s), 7.88 (1H, s), 7.87 (1H, s), 6.77-6.73 (2H, m), 3.95 (2H, q, J = 7.2 Hz), 1.21 (3H, t, J = 7.2 Hz). 48 .sup.1H-NMR (CDCl.sub.3) δ: 7.79 (1H, s), 7.60 (1H, s), 6.74-6.72 (2H, m), 3.97 (2H, q, J = 72 Hz), 1.23 (3H, t, J = 7.2 Hz). 49 .sup.1H-NMR (CDCl.sub.3) δ: 7.74 (1H, s), 7.57 (1H, s), 7.49-7.43 (1H, m), 7.01-6.97 (2H, m), 3.97 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 50 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.56 (1H, s), 7.47 (1H, tt, J = 8.5, 6.3 Hz), 7.03-6.97 (2H, m), 3.97 (2H, q, J = 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 51 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.51 (1H, tt, J = 8.5, 6.3 Hz), 7.43 (1H, d, J = 2.0 Hz), 7.06-7.00 (2H, m), 3.95 (2H, q, J = 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 52 .sup.1H-NMR (CDCl.sub.3) δ: 7.44-7.42 (2H, m), 7.35 (1H, s), 7.28 (1H, s), 6.98-6.96 (2H, m), 6.74 (1H, d, J = 9.8 Hz), 3.88 (2H, q, J = 7.2 Hz), 1.16 (3H, t, J = 7.2 Hz). 53 .sup.1H-NMR (CDCl.sub.3) δ: 7.68 (1H, s), 7.46-7.43 (1H, m), 7.36 (1H, s), 7.28 (1H, s), 6.99-6.97 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 54 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.37 (1H, tt, J = 8.4, 6.4 Hz), 7.01 (1H, d, J = 5.8 Hz), 6.91 (2H, dd, J = 8.4, 7.2 Hz), 6.54 (1H, d, J = 5.8 Hz), 3.96 (2H, q, J = 7.2 Hz), 1.17 (3H, t, J = 7.2 Hz). 55 .sup.1H-NMR (CDCl.sub.3) δ: 8.25 (1H, dd, J = 4.8, 2.0 Hz), 7.78 (1H, s), 7.43 (1H, dt, J = 7.6, 1.7 Hz), 7.38-7.30 (1H, m), 7.07 (1H, dd, J = 7.6, 4.8 Hz), 6.91-6.85 (2H, m), 4.01-3.92 (2H, m), 1.18 (3H, t, J = 7.2 Hz). 56 .sup.1H-NMR (CDCl.sub.3) δ: 8.25 (1H, dd, J = 4.9, 2.0 Hz), 7.44 (1H, dt, J = 7.6, 2.0 Hz), 7.42-7.33 (2H, m), 7.08 (1H, dd, J = 7.6, 4.9 Hz), 6.90-6.85 (2H, m), 6.79 (1H, d, J = 9.5 Hz), 6.16 (1H, tt, J = 56.4, 4.6 Hz), 4.28-4.08 (2H, m). 57 .sup.1H-NMR (CDCl.sub.3) δ: 8.28 (1H, dd, J = 4.8, 2.0 Hz), 7.63 (1H, s), 7.47 (1H, dt, J = 7.5, 2.0 Hz), 7.41-7.35 (1H, m), 7.10 (1H, dd, J = 7.5, 4.8 Hz), 6.91-6.87 (2H, m), 6.19 (1H, tt, J = 56.4, 4.5 Hz), 4.34-4.25 (1H, m), 4.20-4.10 (1H, m). 58 .sup.1H-NMR (CDCl.sub.3) δ: 8.24 (1H, dd, J = 4.9, 2.0 Hz), 7.45-7.41 (1H, m), 7.38- 7.30 (2H, m), 7.07 (1H, dd, J = 7.6, 4.9 Hz), 6.88-6.79 (3H, m), 4.70 (1H, br s), 4.53 (1H, br s). 59 .sup.1H-NMR (CDCl.sub.3) δ: 8.27 (1H, dd, J = 4.7, 1.9 Hz), 7.83 (1H, s), 7.46 (1H, dt, J = 7.6, 1.9 Hz), 7.41-7.34 (1H, m), 7.10 (1H, dd, J = 7.6, 4.7 Hz), 6.91-6.86 (2H, m), 6.19 (1H, tt, J = 56.3, 4.5 Hz), 4.35-4.24 (1H, m), 4.21- 4.10 (1H, m). 60 .sup.1H-NMR (CDCl.sub.3) δ: 8.28 (1H, dd, J = 4.7, 2.0 Hz), 7.60 (1H, s), 7.50-7.46 (1H, m), 7.42-7.34 (1H, m), 7.12 (1H, dd, J = 7.6, 4.7 Hz), 6.92-6.85 (2H, m), 4.88-4.75 (1H, br m), 4.60-4.49 (1H, br m). 61 .sup.1H-NMR (CDCl.sub.3) δ: 8.28 (1H, dd, J = 4.8, 1.7 Hz), 7.42 (1H, dt, J = 7.5, 1.7 Hz), 7.33 (1H, d, J = 9.3 Hz), 7.10 (1H, dd, J = 7.5, 4.8 Hz), 6.77 (1H, d, J = 9.3 Hz), 6.69-6.62 (2H, m), 3.96-3.86 (2H, m), 1.16 (3H, t, J = 7.0 Hz). 62 .sup.1H-NMR (CDCl.sub.3) δ: 8.30 (1H, dd, J = 4.8, 1.9 Hz), 7.56 (1H, s), 7.43 (1H, dt, J = 7.6, 1.9 Hz), 7.12 (1H, dd, J = 7.6, 4.8 Hz), 6.69-6.64 (2H, m), 4.03-3.89 (2H, m), 1.19 (3H, t, J = 7.2 Hz). 63 .sup.1H-NMR (CDCl.sub.3) δ: 8.29 (1H, dd, J = 4.8, 1.9 Hz), 7.76 (1H, s), 7.43 (1H, dt, J = 7.6, 1.9 Hz), 7.12 (1H, dd, J = 7.6, 4.8 Hz), 6.69-6.64 (2H, m) 4.03-3.89 (2H, m), 1.19 (3H, t, J = 7.0 Hz). 64 .sup.1H-NMR (CDCl.sub.3) δ: 8.28 (1H, dd, J = 4.9, 1.8 Hz), 7.81 (1H, s), 7.49-7.46 (1H, m), 7.41-7.35 (1H, m), 7.12 (1H, dd, J = 7.6, 4.9 Hz), 6.92-6.85 (2H, m), 4.88-4.77 (1H, br m), 4.60-4.49 (1H, br m). 65 .sup.1H-NMR (CDCl.sub.3) δ: 8.24 (1H, dd, J = 4.9, 1.9 Hz), 8.00 (1H, s), 7.43 (1H, dt, J = 7.6, 1.9 Hz), 7.38-7.30 (1H, m), 7.06 (1H, dd, J = 7.6, 4.9 Hz), 6.91-6.85 (2H, m), 4.01-3.91 (2H, m), 1.17 (3H, t, J = 7.1 Hz). 66 .sup.1H-NMR (CDCl.sub.3) δ: 8.22 (1H, dd, J = 4.9, 2.0 Hz), 7.42 (1H, dt, J = 7.6, 2.0 Hz), 7.33-7.28 (1H, m), 7.23-7.22 (1H, m), 7.04 (1H, dd, J = 7.6, 4.9 Hz), 6.89-6.83 (2H, m), 3.92 (2H, q, J = 7.2 Hz), 2.27 (3H, d, J = 1.2 Hz), 1.16 (3H, t, J = 7.2 Hz). 67 .sup.1H-NMR (CDCl.sub.3) δ: 8.30 (1H, dd, J = 4.9, 2.0 Hz), 7.44 (1H, dt, J = 7.5, 2.0 Hz), 7.39 (1H, d, J = 9.5 Hz), 7.13 (1H, dd, J = 7.6, 4.6 Hz), 6.80 (1H, d, J = 9.5 Hz), 6.68-6.63 (2H, m), 6.16 (1H, tt, J = 56.6, 4.4 Hz), 4.28-4.19 (1H, m), 4.14-4.05 (1H, m). 68 .sup.1H-NMR (CDCl.sub.3) δ: 8.32 (1H, dd, J = 4.7, 2.0 Hz), 7.62 (1H, s), 7.46 (1H, dt, J = 7.6, 2.0 Hz), 7.15 (1H, dd, J = 7.6, 4.7 Hz), 6.70-6.63 (2H, m), 6.18 (1H, tt, J = 56.4, 4.4 Hz), 4.37-4.25 (1H, m), 4.16-4.06 (1H, m). 69 .sup.1H-NMR (CDCl.sub.3) δ: 8.31 (1H, dd, J = 4.9, 2.0 Hz), 7.82 (1H, s), 7.46 (1H, dt, J = 7.6, 2.0 Hz), 7.15 (1H, dd, J = 7.6, 4.9 Hz), 6.70-6.62 (2H, m), 6.18 (1H, tt, J = 56.4, 4.5 Hz), 4.37-4.26 (1H, m), 4.16-4.05 (1H, m). 70 .sup.1H-NMR (CDCl.sub.3) δ: 7.66 (1H, s), 7.41 (1H, s), 7.34 (1H, s), 6.76-6.74 (2H, m), 3.94 (2H, q, J = 7.1 Hz), 1.20 (3H, t, J = 7.1 Hz). 71 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.38 (1H, s), 7.31 (1H, s), 6.78-6.72 (2H, m), 3.94 (2H, q, J = 7.1 Hz), 1.19 (3H, t, J = 7.1 Hz). 72 .sup.1H-NMR (CDCl.sub.3) δ: 7.66 (1H, s), 7.43 (1H, s), 7.31 (1H, s), 6.50-6.49 (2H, m), 3.95 (2H, q, J = 7.0 Hz), 3.83 (3H, s), 1.19 (3H, t, J = 7.0 Hz). 73 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.40 (1H, s), 7.28 (1H, s), 6.51-6.48 (2H, m), 3.95 (2H, q, J = 7.2 Hz), 3.83 (3H, s), 1.18 (3H, t, J = 7.2 Hz). 74 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.58 (1H, s), 7.48-7.42 (1H, m), 7.00-6.96 (2H, m), 3.97 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 75 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.52-7.46 (1H, m), 7.04-6.99 (2H, m), 3.98 (2H, q, J = 7.1 Hz), 1.19 (3H, t, J = 7.1 Hz). 76 .sup.1H-NMR (CDCl.sub.3) δ: 7.26 (1H, d, J = 9.5 Hz), 6.73-6,68 (3H, m), 3.88 (2H, q, J = 7.0 Hz), 2.08 (3H, s), 2.04 (3H, s), 1.17 (3H, t, J = 7,0 Hz). 77 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.41 (1H, s), 7.34 (1H, s), 6.77-6.73 (2H, m), 3.94 (2H, q, J = 7.1 Hz), 1.19 (3H, t, J = 7.1 Hz). 78 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.43 (1H, s), 7.31 (1H, s), 6.50-6.48 (2H, m), 3.95 (2H, q, J = 7.2 Hz), 3.83 (3H, s), 1.19 (3H, t, J = 7.2 Hz), 79 .sup.1H-NMR (CDCl.sub.3) δ: 8.25 (1H, dd, J = 4.8, 1.8 Hz), 7.42 (1H, dt, J = 7.6, 1.8 Hz), 7.32 (1H, d, J = 9.5 Hz), 7.08 (1H, dd, J = 7.6, 4.8 Hz), 6.74 (1H, d, J = 9.5 Hz), 6.43-6.36 (2H, m), 3.93 (2H, q, J = 7.1 Hz), 3.76 (3H, s), 1.16 (3H, t, J = 7.1 Hz). 80 .sup.1H-NMR (CDCl.sub.3) δ: 8.25 (1H, dd, J = 4.9, 1.8 Hz), 7.53 (1H, s), 7.41 (1H, dt, J = 7.6, 1.8 Hz), 7.08 (1H, dd, J = 7.6, 4.9 Hz), 6.40-6.34 (2H, m), 4.02-3.88 (2H, m), 3.74 (3H, s), 1.16 (3H, t, J = 7.1 Hz). 81 .sup.1H-NMR (CDCl.sub.3) δ: 8.27 (1H, dd, J = 4.8, 1.9 Hz), 7.75 (1H, s), 7.43 (1H, dt, J = 7.6, 1.9 Hz), 7.10 (1H, dd, J = 7.6, 4.8 Hz), 6.42-6.37 (2H, m), 4.04-3.91 (2H, m), 3.76 (3H, s), 1.18 (3H, t, J = 7.0 Hz). 82 .sup.1H-NMR (CDCl.sub.3) δ: 7.32 (1H, d, J = 9.5 Hz), 7.24 (1H, s), 6.73-6.68 (3H, m), 3.90 (2H, q, J = 7.2 Hz), 1.93 (3H, s), 1.18 (3H, t, J = 7.2 Hz). 83 .sup.1H-NMR (CDCl.sub.3) δ: 7.57 (1H, s), 7.25 (1H, s), 6.73-6.67 (2H, m), 3.96 (2H, q, J = 7.1 Hz), 1.93 (3H, s). 1.20 (3H, t, J = 7.1 Hz). 84 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.46 (1H, d, J = 2.0 Hz), 7.29 (1H, d, J = 2.4 Hz), 6.72-6.70 (2H, m), 6.20 (1H, dd, J = 2.4, 2.0 Hz), 3.95 (2H, g, J = 7.1 Hz), 1.20 (3H, t, J = 7.1 Hz). 85 .sup.1H-NMR (CDCl.sub.3) δ: 7.68 (1H, s), 7.25 (1H, s), 7.04 (1H, s), 6.74-6.69 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.97 (3H, s). 1.19 (3H, t, J = 7.2 Hz). 86 .sup.1H-NMR (CDCl.sub.3) δ: 7.33 (1H, d, J = 1.2 Hz), 7.24 (1H, s), 7.03 (1H, s), 6.70-6.69 (2H, m), 3.88 (2H, q, J = 7.0 Hz), 2.24 (3H, d, J = 1.2 Hz), 1.97 (3H, s). 1.16 (3H, t, J = 7.0 Hz). 87 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.64-7.57 (1H, m), 7.16-7.10 (2H, m), 5.96 (1H, s), 3.95 (2H, q, J = 7.1 Hz), 1.19 (3H, t, J = 7.1 Hz). 88 .sup.1H-NMR (CDCl.sub.3) δ: 8.90 (1H, br s), 7.69 (1H, s), 7.44-7.36 (1H, m), 7.17 (1H, dd, J = 3.2, 2.0 Hz), 6.97-6.91 (2H, m), 6.42-6.41 (1H, m), 3.95 (2H, q, J = 7.1 Hz), 1.16 (4H, t, J = 7.1 Hz). 89 .sup.1H-NMR (CDCl.sub.3) δ: 8.15 (1H, s), 7.77 (1H, s), 6.92-6.87 (2H, m), 6.19 (1H, s), 3.95 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 90 .sup.1H-NMR (CDCl.sub.3) δ: 8.18 (1H, s), 7.78 (1H, s), 6.65-6.61 (2H, m), 6.05 (1H, s), 3.98 (2H, q, J = 7.1 Hz), 3.89 (3H, s), 1.19 (3H, t, J = 7.1 Hz). 91 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.51-7.44 (1H, m), 7.34 (1H, s), 7.03-6.97 (2H, m), 3.94 (2H, q, J = 7.1 Hz), 3.78 (3H, s), 1.15 (3H, t, J = 7.1 Hz). 92 .sup.1H-NMR (CDCl.sub.3) δ: 7.92 (1H, s), 7.63-7.57 (1H, m), 7.15-7.10 (2H, m), 5.96 (1H, s), 3.95 (2H, q, J = 7.0 Hz), 1.19 (3H, t, J = 7.0 Hz). 93 .sup.1H-NMR (CDCl.sub.3) δ: 7.31 (1H, d, J = 9.8 Hz), 6.72 (1H, d, J = 9.8 Hz), 6.69- 6.66 (2H, m), 5.71 (1H, s), 3.89 (2H, q, J = 7.2 Hz), 2.07 (3H, s), 2.02 (3H, s), 1.17 (3H, t, J = 7.2 Hz). 94 .sup.1H-NMR (CDCl.sub.3) δ: 7.30 (1H, d, J = 9.5 Hz), 6.69 (1H, d, J = 9.5 Hz), 6.44- 6.42 (2H, m), 5.70 (1H, s), 3.91 (2H, q, J = 7.0 Hz), 3.80 (3H, s), 2.052 (3H, s), 2.048 (3H, s), 1.16 (3H, t, J = 7.0 Hz). 95 .sup.1H-NMR (CDCl.sub.3) δ: 7.26 (1H, d, J = 9.5 Hz), 6.74-6.68 (3H, m), 3.89 (2H, q, J = 7.2 Hz), 2.07 (3H, s), 2.03 (3H, s), 1.17 (3H, t, J = 7.2 Hz). 96 .sup.1H-NMR (CDCl.sub.3) δ: 7.93 (1H, s), 6.84-6.79 (2H, m), 3.97 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 97 .sup.1H-NMR (CDCl.sub.3) δ: 7.94 (1H, s), 7.62 (1H, s), 6.80-6.75 (2H, m), 3.96 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 98 .sup.1H-NMR (CDCl.sub.3) δ: 8.28 (1H, dd, J = 4.6, 1.9 Hz), 7.41 (1H, dt, J = 7.6, 1.9 Hz), 7.34 (1H, d, J = 9.5 Hz), 7.11 (1H, dd, J = 7.6, 4.6 Hz), 6.79 (1H, d, J = 9.5 Hz), 6.69-6.63 (2H, m), 3.39 (3H, s). 99 .sup.1H-NMR (CDCl.sub.3) δ: 8.24 (1H, dd, J = 4.6, 1.9 Hz), 7.40 (1H, dt, J = 7.6, 1.9 Hz), 7.37-7.29 (2H, m), 7.06 (1H, dd, J = 7.6, 4.9 Hz), 6.91-6.82 (2H, m), 6.78 (1H, d, J = 9.3 Hz), 3.39 (3H, s). 100 .sup.1H-NMR (CDCl.sub.3) δ: 8.31 (1H, dd, J = 4.8, 1.9 Hz), 7.58 (1H, s), 7.43 (1H, dt, J = 7.6, 1.9 Hz), 7.14 (1H, dd, J = 7.6, 4.8 Hz), 6.70-6.64 (2H, m), 3.46 (3H, s). 101 .sup.1H-NMR (CDCl.sub.3) δ: 7.88 (1H, s), 7.25 (1H, s), 7.04 (1H, s), 6.73-6.70 (2H, m), 3.94 (2H, q, J = 7.1 Hz), 1.97 (3H, s). 1.19 (3H, t, J = 7.1 Hz). 102 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 6.55-6.51 (2H, m), 3.99 (2H, q, J = 7.1 Hz), 3.85 (3H, s), 1.18 (3H, t, J = 7.1 Hz). 103 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 7.62 (1H, s), 6.52-6.48 (2H, m), 3.99 (2H, q, J = 7.0 Hz). 3.83 (3H, s), 1.17 (3H, t, J = 7.0 Hz). 104 .sup.1H-NMR (CDCl.sub.3) δ: 8.30 (1H, dd, J = 4.7, 1.9 Hz), 7.78 (1H, s), 7.43 (1H, dt, J = 7.7, 1.9 Hz), 7.13 (1H, dd, J = 7.7, 4.7 Hz), 6.70-6.63 (2H, m), 3.46 (3H, s). 105 .sup.1H-NMR (CDCl.sub.3) δ: 8.26 (1H, dd, J = 4.9, 2.0 Hz), 7.59 (1H, s), 7.44-7.41 (1H, m), 7.39-7.32 (1H, m), 7.08 (1H, dd, J = 7.6, 4.9 Hz), 6.91-6.86 (2H, m), 3.46 (3H, s). 106 .sup.1H-NMR (CDCl.sub.3) δ: 8.26 (1H, dd, J = 4.9, 1.9 Hz), 7.79 (1H, s), 7.42 (1H, dt, J = 7.5, 1.9 Hz), 7.39-7.31 (1H, m), 7.08 (1H, dd, J = 7.5, 4.9 Hz), 6.90-6.86 (2H, m), 3.46 (3H, s). 107 .sup.1H-NMR (CDCl.sub.3) δ: 7.95 (1H, s), 7.61 (1H, s), 6.80-6.75 (2H, m), 3.96 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 108 .sup.1H-NMR (CDCl.sub.3) δ: 7.40 (1H, d, J = 9.8 Hz), 7.23 (1H, s), 6.78-6.72 (3H, m), 3.87 (2H, q, J = 7.2 Hz), 2.12 (3H, s), 1.16 (3H, t, J = 7.2 Hz). 109 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.5 Hz), 6.92 (1H, s), 6.73-6.70 (3H, m), 3.86 (2H, q, J = 7.1 Hz), 2.06 (3H, s), 1.87 (3H, s), 1.15 (3H, t, J = 7.1 Hz). 110 .sup.1H-NMR (CDCl.sub.3) δ: 7.74 (1H, s), 7.40 (1H, s), 7.32 (1H, s), 6.77-6.75 (2H, m), 6.17 (1H, tt, J = 56.3, 4.6 Hz), 4.19 (2H, td, J = 12.6, 4.6 Hz). 111 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.42 (1H, s), 7.27 (1H, s), 6.52-6.49 (2H, m), 6.17 (1H, tt, J = 56.5, 4.4 Hz), 4.21 (2H, td, J = 12.6, 4.4 Hz), 3.84 (3H, s). 112 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.62 (1H, s), 6.81-6.75 (2H, m), 3.96 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 113 .sup.1H-NMR (CDCl.sub.3) δ: 7.74 (1H, s), 7.62 (1H, s), 6.80-6.74 (2H, m), 3.96 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 114 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 6.56-6.52 (2H, m), 3.99 (2H, q, J = 7.1 Hz), 3.85 (3H, s), 1.17 (3H, t, J = 7.1 Hz). 115 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.61 (1H, s), 6.53-6.48 (2H, m), 3.99 (2H, q, J = 7.1 Hz), 3.84 (3H, s), 1.17 (3H, t, J = 7.1 Hz). 116 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 6.56-6.51 (2H, m), 3.99 (2H, q, J = 7.1 Hz), 3.85 (3H, s), 1.18 (3H, t, 3 = 7.1 Hz). 117 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 6.74-6.68 (2H, m), 3.94 (2H, q, J = 7.1 Hz), 2.09 (3H, s), 2.04 (3H, s), 1.20 (3H, t, J = 7.1 Hz). 118 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.62 (1H, s), 6.62-6.48 (2H, m), 3.98 (2H, q, J = 7.1 Hz), 3.83 (3H, s), 1.17 (3H, t, J = 7.1 Hz). 119 .sup.1H-NMR (CDCl.sub.3) δ: 8.00 (1H, s), 7.79 (1H, s), 6.24 (2H, d, J = 10.0 Hz), 6.05 (1H, s), 4.42-4.38 (1H, m), 4.02 (2H, q, J = 7.1 Hz), 2.90 (3H, d, J = 5.1 Hz), 1.20 (3H, t, J = 7.1 Hz). 120 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.47 (1H, d, J = 2.0 Hz), 6.85-6.78 (2H, m), 3.94 (2H, q, J = 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 121 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.39 (1H, s), 7.33 (1H, s), 6.77-6.75 (2H, m), 4.63-4.61 (2H, br m). 122 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.42 (1H, s), 7.27 (1H, s), 6.51-6.49 (2H, m), 4.66-4.64 (2H, br m), 3.84 (3H, s). 123 .sup.1H-NMR (CDCl.sub.3) δ: 9.81 (1H, s), 7.90 (1H, s), 7.85 (1H, s), 7.70 (1H, s), 6.75-6.74 (2H, m), 3.95 (2H, q, J = 7.2 Hz), 1.21 (3H, t, J = 7.2 Hz). 124 .sup.1H-NMR (CDCl.sub.3) δ: 7.69 (1H, s), 7.58 (1H, s), 7.50 (1H, s), 6.76-6.47 (3H, m), 3.95 (2H, q, J = 7.2 Hz), 1.20 (3H, t, J = 7.2 Hz). 125 .sup.1H-NMR (CDCl.sub.3) δ: 7.45 (1H, s), 6.73-6.71 (2H, m), 5.68 (2H, s), 3.96 (2H, q, J = 7.2 Hz), 1.96 (6H, s), 1.19 (3H, t, J = 7.2 Hz). 126 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, s), 6.47-6.45 (2H, m), 5.68 (2H, s), 3.98 (2H, q, J = 7.2 Hz), 3.79 (3H, s), 1.96 (6H, s), 1.18 (3H, t, J = 7.2 Hz). 127 .sup.1H-NMR (CDCl.sub.3) δ: 7.73 (1H, s), 7.47 (1H, d, J = 1.8 Hz), 6.56-6.52 (2H, m), 3.97 (2H, q, J = 7.0 Hz), 3.86 (3H, s), 1.17 (3H, t, J = 7.0 Hz). 128 .sup.1H-NMR (CDCl.sub.3) δ: 7.83 (1H, s), 7.81 (1H, s), 7.68 (1H, s), 6.75-6.73 (2H, m), 3.95 (2H, q, J = 7.1 Hz), 3.81 (3H, s), 1.20 (3H, t, J = 7.1 Hz). 129 .sup.1H-NMR (CDCl.sub.3) δ: 7.63 (1H, s), 7.61 (1H, s), 7.41 (1H, s), 6.76-6.74 (1H, m), 6.69-6.67 (1H, m), 4.29-4.19 (2H, m), 3.91 (2H, q, J = 7.2 Hz), 1.26 (3H, t, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 130 .sup.1H-NMR (CDCl.sub.3) δ: 7.88 (1H, s), 7.60-7.54 (1H, m), 7.13-7.09 (2H, m), 5.67 (1H, s), 3.99 (3H, s), 3.93 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 131 .sup.1H-NMR (CDCl.sub.3) δ: 7.83 (1H, s), 7.57-7.50 (1H, m), 7.12-7.06 (2H, m), 5.81 (1H, s), 3.92 (2H, q, J = 7.1 Hz), 2.95 (6H, s), 1.17 (3H, t, J = 7.1 Hz). 132 .sup.1H-NMR (CDCl.sub.3) δ: 7.63 (1H, s), 6.71-6.69 (2H, m), 6.49 (2H, t, J = 2.1 Hz), 6.05 (2H, t, J = 2.1 Hz), 3.92 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 133 .sup.1H-NMR (CDCl.sub.3) δ: 7.48 (1H, s), 6.73-6.72 (2H, m), 5.95 (2H, s), 4.00 (2H, q, J = 7.0 Hz), 1.19 (3H, t, J = 7.0 Hz). 134 .sup.1H-NMR (CDCl.sub.3) δ: 7.85 (1H, s), 7.59-7.52 (1H, m), 7.13-7.07 (2H, m), 5.67 (1H, s), 4.51-4.47 (1H, m), 3.93 (2H, q, J = 7.1 Hz), 2.90 (3H, d, J = 5.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 135 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.61-7.52 (1H, m), 7.13-7.08 (2H, m), 5.59 (1H, s), 4.61 (2H, br s), 3.93 (2H, q, J = 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 136 .sup.1H-NMR (CDCl.sub.3) δ: 7.28-7.26 (2H, m), 7.24 (1H, s), 6.79-6.78 (3H, m), 3.96- 3.94 (1H, m), 3.82-3.80 (1H, m), 1.17 (3H, t, J = 7.2 Hz). 137 .sup.1H-NMR (CDCl.sub.3) δ: 7.47 (1H, s), 6.81-6.80 (2H, m), 4.01-3.94 (2H, m), 1.20 (3H, t, J = 7.0 Hz). 138 .sup.1H-NMR (CDCl.sub.3) δ: 7.54 (1H, s), 7.25 (1H, s), 6.80-6.78 (2H, m), 4.03-4.01 (1H, m), 3.88-3.86 (1H, m), 1.20 (3H, t, J = 7.0 Hz). 139 .sup.1H-NMR (CDCl.sub.3) δ: 7.74 (1H, s), 7.25 (1H, s), 6.80-6.78 (2H, m), 4.03-4.01 (1H, m), 3.88-3.85 (1H, m), 1.20 (3H, t, J = 7.1 Hz). 140 .sup.1H-NMR (CDCl.sub.3) δ: 8.08 (1H, s), 7.37 (1H, s), 7.31 (1H, s), 6.75-6.73 (2H, m), 3.93 (2H, q, J = 7.2 Hz), 1.18 (3H, t, J = 7.2 Hz). 141 .sup.1H-NMR (CDCl.sub.3) δ: 7.40 (1H, d, J = 9.8 Hz), 7.20 (1H, s), 6.76-6.73 (3H, m), 3.86 (2H, q, J = 7.2 Hz), 2.12 (3H, s), 1.16 (3H, t, J = 7.2 Hz). 142 .sup.1H-NMR (CDCl.sub.3) δ: 7.66 (1H, s), 7.20 (1H, s), 6.77-6.76 (2H, m), 3.93 (2H, q, J = 7.2 Hz), 2.12 (3H, s), 1.19 (3H, t, J = 7.2 Hz). 143 .sup.1H-NMR (CDCl.sub.3) δ: 7.68 (1H, s), 7.15 (1H, s), 6.52-6.50 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 3.84 (3H, s), 2.15 (3H, s), 1.17 (3H, t, J = 7.2 Hz). 144 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.20 (1H, s), 6.77-6.75 (2H, m), 3.92 (2H, q, J = 7.0 Hz), 2.12 (3H, s), 1.18 (3H, t, J = 7.0 Hz). 145 .sup.1H-NMR (CDCl.sub.3) δ: 7.40 (1H, d, J = 9.8 Hz), 7.36 (1H, s), 7.20 (1H, s), 7.17-7.14 (1H, m), 6.92-6.89 (2H, m), 6.71 (1H, d, J = 9.8 Hz), 4.03-3.98 (1H, m), 3.73-3.69 (1H, m), 1.14 (3H, t, J = 7.1 Hz). 146 .sup.1H-NMR (CDCl.sub.3) δ: 7.88 (1H, s), 7.15 (1H, s), 6.52-6.50 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 3.84 (3H, s), 2.15 (3H, s), 1.17 (3H, t, J = 7.2 Hz). 147 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.22 (1H, s), 6.78-6.74 (2H, m), 3.92 (2H, q, J = 7.1 Hz), 2.12 (3H, s), 1.18 (3H, t, J = 7.1 Hz). 148 .sup.1H-NMR (CDCl.sub.3) δ: 7.66 (1H, s), 7.38 (1H, s), 7.19 (1H, s), 7.16-7.14 (1H, m), 6.95-6.88 (2H, m), 4.11-4.02 (1H, m), 3.79-3.76 (1H, m), 1.16 (3H, t, J = 7.1 Hz). 149 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.39 (1H, s), 7.16 (1H, s), 7.05-7.01 (1H, m), 6.70-6.67 (2H, m), 4.09-4.06 (1H, m), 3.83-3.78 (4H, m), 1.15 (3H, t, J = 7.2 Hz). 150 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.38 (1H, s), 7.20 (1H, s), 7.19-7.14 (1H, m), 6.95-6.89 (2H, m), 4.07-4.04 (1H, m), 3.79-3.76 (1H, m), 1.16 (3H, t, J = 7.0 Hz). 151 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.18 (1H, s), 6.52-6.49 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 3.84 (3H, s), 2.15 (3H, s), 1.17 (3H, t, J = 7.2 Hz). 152 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.39 (1H, s), 7.16 (1H, s), 7.03-7.01 (1H, m), 6.69-6.67 (2H, m), 4.11-4.05 (1H, m), 3.82-3.79 (4H, m), 1.15 (3H, t, J = 7.1 Hz). 153 .sup.1H-NMR (CDCl.sub.3) δ: 7.41-7.38 (1H, m), 7.33 (1H, d, J = 9.8 Hz), 7.20 (1H, s), 6.92-6.90 (2H, m), 6.73 (1H, d, J = 9.8 Hz), 3.91 (2H, q, J = 7.2 Hz), 1.91 (3H, s), 1.17 (3H, t, J = 7.2 Hz). 154 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.66 (1H, s), 7.64 (1H, s), 6.78-6.77 (2H, m), 3.95 (2H, q, J = 7.0 Hz), 1.22 (3H, t, J = 7.0 Hz). 155 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.64 (1H, s), 7.61 (1H, s), 6.76-6.74 (2H, m), 3.95 (2H, q, J = 7.1 Hz), 1.22 (3H, t, J = 7.1 Hz). 156 .sup.1H-NMR (CDCl.sub.3) δ: 7.42 (1H, d, J = 9.8 Hz), 7.37 (1H, s), 7.27-7.24 (1H, m), 7.23-7.21 (2H, m), 7.03-6.99 (1H, m), 6.71 (1H, d, J = 9.8 Hz), 4.27- 4.20 (1H, m), 3.46-3.38 (1H, m), 1.12 (3H, t, J = 7.0 Hz). 157 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.38 (1H, s), 7.26-7.22 (2H, m), 7.21 (1H, s), 7.05-7.00 (1H, m), 4.30-4.25 (1H, m), 3.53-3.46 (1H, m), 1.14 (3H, t, J = 7.0 Hz). 158 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.38 (1H, d, J = 0.6 Hz), 7.26-7.22 (2H, m), 7.21 (1H, d, J = 0.6 Hz), 7.04-7.00 (1H, m), 4.30-4.23 (1H, m), 3.53- 3.46 (1H, m), 1.14 (3H, t, J = 7.0 Hz). 159 .sup.1H-NMR (CDCl.sub.3) δ: 7.69 (1H, s), 7.40 (1H, s), 7.18 (1H, s), 7.11 (1H, d, J = 8.6 Hz), 6.99 (1H, d, J = 2.7 Hz), 6.80 (1H, dd, J = 8.6, 2.7 Hz), 4.31- 4.24 (1H, m), 3.84 (3H, s), 3.57-3.50 (1H, m), 1.13 (3H, t, J = 7.0 Hz). 160 .sup.1H-NMR (CDCl.sub.3) δ: 7.65 (1H, s), 7.45 (1H, s), 7.36 (1H, s), 6.75-6.73 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 161 .sup.1H-NMR (CDCl.sub.3) δ: 8.07 (1H, s), 8.00 (1H, s), 7.69 (1H, s), 6.79-6.77 (2H, m), 3.95 (2H, q, J = 7.0 Hz), 1.21 (3H, t, J = 7.0 Hz). 162 .sup.1H-NMR (CDCl.sub.3) δ: 8.25 (1H, s), 7.57-7.51 (1H, m), 7.10-7.05 (2H, m), 5.99 (1H, s), 3.94 (2H, q, J = 7.1 Hz), 3.72 (3H, s), 1.17 (3H, t, J = 7.1 Hz). 163 .sup.1H-NMR (CDCl.sub.3) δ: 7.65 (1H, s), 7.45 (1H, s), 7.36 (1H, s), 6.75-6.73 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 164 .sup.1H-NMR (CDCl.sub.3) δ: 7.43-7.37 (3H, m), 7.28-7.27 (1H, m), 7.25 (1H, d, J = 0.7 Hz), 7.08-7.04 (1H, m), 6.71 (1H, d, J = 9.5 Hz), 4.32-4.24 (1H, m), 3.41-3.33 (1H, m), 1.12 (3H, t, J = 7.1 Hz). 165 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.42-7.37 (2H, m), 7.28-7.24 (4H, m), 7.10- 7.05 (1H, m), 4.37-4.28 (1H, m), 3.49-3.40 (1H, m), 1.14 (3H, t, J = 7.1 Hz). 166 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.41-7.37 (2H, m), 7.28-7.24 (2H, m), 7.10- 7.04 (1H, m), 4.36-4.28 (1H, m), 3.49-3.41 (1H, m), 1.14 (3H, t, J = 7.0 Hz). 167 .sup.1H-NMR (CDCl.sub.3) δ: 7.69 (1H, s), 7.40 (1H, d, J = 0.6 Hz), 7.22 (1H, d, J = 0.6 Hz), 7.16 (1H, d, J = 2.4 Hz), 7.13 (1H, d, J = 8.6 Hz), 6.85 (1H, dd, J = 8.6, 2.4 Hz), 4.36-4.29 (1H, m), 3.84 (3H, s), 3.53-3.46 (1H, m), 1.13 (3H, t, J = 7.0 Hz). 168 .sup.1H-NMR (CDCl.sub.3) δ: 7.45 (1H, d, J = 9.8 Hz), 7.36 (1H, d, J = 0.6 Hz), 7.17-7.13 (1H, m), 7.01 (1H, d, J = 0.6 Hz), 6.97-6.91 (2H, m), 6.68 (1H, d, J = 9.8 Hz), 4.21-4.11 (1H, m), 3.48-3.39 (1H, m), 2.13 (3H, s), 1.10 (3H, t, J = 7.1 Hz). 169 .sup.1H-NMR (CDCl.sub.3) δ: 7.47-7.43 (2H, m), 7.39 (1H, td, J = 7.7, 1.8 Hz), 7.36 (1H, s), 7.29 (1H, dd, J = 7.7, 1.3 Hz), 7.23 (1H, dd, J = 7.7, 1.8 Hz), 7.18 (1H, s), 6.71 (1H, d, J = 9.8 Hz), 4.28-4.19 (1H, m), 3.48-3.40 (1H, m), 1.11 (3H, t, J = 7.0 Hz). 170 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.37 (1H, d, J = 0.7 Hz), 7.17-7.12 (1H, m), 7.00 (1H, d, J = 0.7 Hz), 6.97-6.93 (2H, m), 4.27-4.17 (1H, m), 3.55- 3.47 (1H, m), 2.12 (3H, s), 1.13 (3H, t, J = 7.1 Hz). 171 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 7.37 (1H, d, J = 0.6 Hz), 7.17-7.12 (1H, m), 7.00 (1H, d, J = 0.6 Hz), 6.97-6.93 (2H, m), 4.26-4.17 (1H, m), 3.55- 3.46 (1H, m), 2.13 (3H, s), 1.12 (3H, t, J = 7.1 Hz). 172 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.48 (1H, dd, J = 8.0, 1.0 Hz), 7.42 (1H, td, J = 7.5, 1.8 Hz), 7.37 (1H, d, J = 0.7 Hz), 7.30 (1H, td, J = 7.5, 1.0 Hz), 7.22 (1H, dd, J = 7.5, 1.8 Hz), 7.17 (1H, d, J = 0.7 Hz), 4.32-4.25 (1H, m), 3.54-3.48 (1H, m), 1.14 (3H, t, J = 7.0 Hz). 173 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.48 (1H, dd, J = 8.0, 1.5 Hz), 7.42 (1H, td, J = 7.6, 1.5 Hz), 7.37 (1H, d, J = 0.6 Hz), 7.29 (1H, td, J = 7.6, 1.2 Hz), 7.23 (1H, dd, J = 7.6, 1.2 Hz), 7.17 (1H, d, J = 0.6 Hz), 4.31-4.24 (1H, m), 3.55-3.48 (1H, m), 1.14 (3H, t, J = 7.0 Hz). 174 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.8 Hz), 7.38 (1H, s), 7.31 (1H, s), 6.76-6.74 (3H, m), 3.38 (3H, s). 175 .sup.1H-NMR (CDCl.sub.3) δ: 7.69 (1H, s), 7.39 (1H, s), 7.31 (1H, s), 6.79-6.74 (2H, m), 3.45 (3H, s). 176 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.25-7.24 (3H, m), 7.04-7.02 (2H, m), 3.95- 3.93 (2H, br m), 1.86 (3H, s), 1.17 (3H, t, J = 7.0 Hz). 177 .sup.1H-NMR (DMSO-D6) δ: 8.15 (1H, s), 8.09 (1H, s), 7.58 (1H, s), 6.89-6.86 (2H, m), 3.80 (3H, s), 3.34 (3H, s). 178 .sup.1H-NMR (DMSO-D6) δ: 8.29 (1H, s), 8.09 (1H, s), 7.58 (1H, s), 6.89-6.87 (2H, m), 3.80 (3H, s), 3.34 (3H, s). 179 .sup.1H-NMR (CDCl.sub.3) δ: 7.54 (1H, s), 7.40 (1H, dd, J = 8.2, 1.3 Hz), 7.36-7.30 (2H, m), 7.24-7.22 (1H, m), 7.20 (1H, s), 4.36-4.32 (1H, m), 3.55-3.50 (1H, m), 1.87 (3H, s), 1.15 (3H, t, J = 7.1 Hz). 180 .sup.1H-NMR (CDCl.sub.3) δ: 7.92 (1H, s), 7.46-7.44 (1H, m), 7.39-7.37 (1H, m), 7.26- 7.24 (3H, m), 6.91 (1H, s), 4.31-4.28 (1H, m), 3.52-3.49 (1H, m), 1.88 (3H, s), 1.13 (3H, t, J = 7.0 Hz). 181 .sup.1H-NMR (CDCl.sub.3) δ: 7.74 (1H1 s), 7.40-7.39 (1H, m), 7.35-7.30 (2H, m), 7.24- 7.23 (1H, m), 7.21 (1H, s), 4.35-4.32 (1H, m), 3.54-3.52 (1H, m), 1.87 (3H, s), 1.14 (3H, t, J = 7.2 Hz). 182 .sup.1H-NMR (CDCl.sub.3) δ: 7.55 (1H, s), 7.26 (1H, s), 7.19-7.18 (1H, m), 6.87-6.84 (2H, m), 4.16-4.14 (1H, m), 3.76-3.73 (1H, m), 1.89 (3H, s), 1.16 (3H, t, J = 7.2 Hz). 183 .sup.1H-NMR (CDCl.sub.3) δ: 7.64 (1H, dd, J = 7.0, 2.1 Hz), 7.44 (1H, d, J = 9.6 Hz), 7.36 (1H, d, J = 0.6 Hz), 7.35-7.29 (2H, m), 7.26-7.24 (1H, m), 7.22 (1H, d, J = 0.6 Hz), 6.71 (1H, d, J = 9.6 Hz), 4.32-4.25 (1H, m), 3.43-3.36 (1H, m), 1.12 (3H, t, J = 7.0 Hz). 184 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.42 (1H, s), 7.28 (1H, br s), 7.13 (1H, br s), 6.50-6.48 (2H, m), 3.98 (2H, q, J = 7.1 Hz), 1.20 (3H, t, J = 7.1 Hz). 185 .sup.1H-NMR (CDCl.sub.3) δ: 7.84 (1H, d, J = 9.3 Hz), 7.39 (1H, s), 7.33 (1H, s), 7.20 (1H, d, J = 9.3 Hz), 6.78-6.76 (2H, m), 4.52 (2H, q, J = 7.1 Hz), 1.27 (3H, t, J = 7.1 Hz). 186 .sup.1H-NMR (CDCl.sub.3) δ: 7.54 (1H, d, J = 9.8 Hz), 7.47-7.40 (1H, m), 7.24 (1H, s), 7.01 (1H, s), 6.96-6.94 (2H, m), 6.76 (1H, d, J = 9.8 Hz), 6.15 (1H, tt, J = 56.6, 4.6 Hz), 4.14 (2H, td, J = 12.8, 4.6 Hz), 1.94 (3H, s). 187 .sup.1H-NMR (CDCl.sub.3) δ: 7.60 (1H, s), 7.41-7.39 (1H, m), 7.24 (1H, s), 6.94-6.92 (2H, m), 3.47 (3H, s), 1.91 (3H, s). 188 .sup.1H-NMR (CDCl.sub.3) δ: 7.94 (1H, s), 7.44-7.42 (1H, m), 7.26 (1H, s), 6.99 (1H, s), 6.97-6.95 (2H, m), 3.45 (3H, s), 1.94 (3H, s). 189 .sup.1H-NMR (CDCl.sub.3) δ: 7.79 (1H, s), 7.41-7.39 (1H, m), 7.24 (1H, s), 6.94-6.92 (2H, m), 3.47 (3H, s), 1.91 (3H, s). 190 .sup.1H-NMR (CDCl.sub.3) δ: 7.65 (1H, s), 7.44-7.40 (1H, m), 7.24 (1H, s), 6.94-6.92 (2H, m), 6.17 (1H, tt, J = 56.3, 4.5 Hz), 4.23 (2H, td, J = 12.6, 4.5 Hz), 1.92 (3H, s). 191 .sup.1H-NMR (CDCl.sub.3) δ: 7.42 (1H, d, J = 9.8 Hz), 7.31-7.30 (1H, m), 7.21-7.20 (1H, m), 6.75-6.73 (3H, m), 3.87 (2H, q, J = 7.0 Hz), 1.17 (3H, t, J = 7.0 Hz). 192 .sup.1H-NMR (CDCl.sub.3) δ: 7.68 (1H, s), 7.33-7.32 (1H, m), 7.22-7.21 (1H, m), 6.76- 6.74 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 193 .sup.1H-NMR (CDCl.sub.3) δ: 7.85 (1H, s), 7.47-7.40 (1H, m), 7.24 (1H, s), 6.94-6.92 (2H, m), 6.17 (1H, tt, J = 56.3, 4.5 Hz), 4.23 (2H, td, J = 12.6, 4.5 Hz), 1.91 (3H, s). 194 .sup.1H-NMR (CDCl.sub.3) δ: 7.88 (1H, s), 7.324-7.315 (1H, m), 7.22-7.21 (1H, m), 6.77-6.73 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 195 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.66-7.64 (1H, m), 7.37 (1H, d, J = 0.6 Hz), 7.36-7.33 (2H, m), 7.25-7.23 (1H, m), 7.21 (1H, d, J = 0.6 Hz), 4.37- 4.30 (1H, m), 3.50-3.43 (1H, m), 1.14 (3H, t, J = 7.2 Hz). 196 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.67-7.63 (1H, m), 7.37 (1H, d, J = 0.6 Hz), 7.36-7.32 (2H, m), 7.25-7.23 (1H, m), 7.21 (1H, d, J = 0.6 Hz), 4.36- 4.29 (1H, m), 3.51-3.44 (1H, m), 1.14 (3H, t, J = 7.0 Hz). 197 .sup.1H-NMR (CDCl.sub.3) δ: 7.44 (1H, d, J = 9.8 Hz), 7.42-7.38 (1H, m), 7.36 (1H, d, J = 0.6 Hz), 7.29 (1H, s), 7.27-7.25 (1H, m), 7.09 (1H, td, J = 8.4, 0.9 Hz), 6.75 (1H, d, J = 9.8 Hz), 4.13-4.05 (1H, m), 3.64-3.57 (1H, m), 1.17 (3H, t, J = 7.0 Hz). 198 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.44-7.40 (1H, m), 7.37 (1H, d, J = 0.6 Hz), 7.28-7.27 (2H, m), 7.10 (1H, td, J = 8.4, 0.9 Hz), 4.18-4.11 (1H, m), 3.71-3.64 (1H, m), 1.19 (3H, t, J = 7.2 Hz). 199 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.44-7.40 (1H, m), 7.37 (1H, d, J = 0.6 Hz), 7.28-7.26 (2H, m), 7.10 (1H, td, J = 8.4, 0.9 Hz), 4.17-4.10 (1H, m), 3.71-3.64 (1H, m), 1.19 (3H, t, J = 7.2 Hz). 200 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.40 (1H, s), 7.27 (1H, s), 6.48-6.46 (2H, m), 4.02 (2H, q, J = 7.0 Hz), 3.95 (2H, q, J = 7.0 Hz), 1.44 (3H, t, J = 7.0 Hz), 1.18 (3H, t, J = 7.0 Hz). 201 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.40 (1H, s), 7.28 (1H, s), 6.60-6.59 (2H, m), 4.71 (2H, d, J = 2.1 Hz), 3.96 (2H, q, J = 7.1 Hz), 2.62 (1H, t, J = 2.1 Hz) 1.19 (3H, t, J = 7.1 Hz). 202 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.40 (1H, s), 7.27 (1H, s), 6.52-6.50 (2H, m), 6.00 (1H, ddt, J = 17.4, 10.5, 5.3 Hz), 5.42 (1H, dq, J = 17.4, 1.5 Hz), 5.36 (1H, dq, J = 10.5, 1.0 Hz), 4.53 (2H, dt, J = 5.3, 1.5 Hz), 3.95 (2H, q, J = 7.0 Hz), 1.19 (3H, t, J = 7.0 Hz). 203 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.41 (1H, s), 7.27 (1H, s), 6.66-6.64 (2H, m), 5.17 (2H, s), 3.96 (2H, q, J = 7.1 Hz), 3.49 (3H, s), 1.20 (3H, t, J = 7.1 Hz). 204 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.40 (1H, s), 7.28 (1H, s), 6.54-6.52 (2H, m), 4.11-4.10 (2H, m), 3.94 (2H, q, J = 7.1 Hz), 3.76-3.75 (2H, m), 3.45 (3H, s), 1.18 (3H, t, J = 7.1 Hz). 205 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.39 (1H, s), 7.30 (1H, s), 6.87-6.81 (2H, m), 3.96 (2H, q, J = 7.1 Hz), 2.32 (3H, s), 1.20 (3H, t, J = 7.1 Hz). 206 .sup.1H-NMR (CDCl.sub.3) δ: 7.37 (1H, s), 7.31 (1H, q, J = 0.9 Hz), 7.30 (1H, s), 6.75-6.71 (2H, m), 3.88 (2H, q, J = 7.1 Hz), 2.25 (3H, d, J = 0.9 Hz), 1.16 (3H, t, J = 7.1 Hz). 207 .sup.1H-NMR (CDCl.sub.3) δ: 7.94 (1H, s), 7.39 (1H, s), 7.32 (1H, s), 6.77-6.75 (2H, m), 6.17 (1H, tt, J = 56.4, 4.5 Hz), 4.18 (2H, td, J = 12.6, 4.5 Hz). 208 .sup.1H-NMR (CDCl.sub.3) δ: 7.47-7.45 (1H, m), 7.41 (1H, td, J = 7.7, 1.5 Hz), 7.31- 7.28 (3H, m), 7.20-7.18 (1H, br m), 6.73 (1H, d, J = 9.5 Hz), 4.19-4.17 (1H, br m), 3.47-3.45 (1H, br m), 1.15 (3H, t, J = 7.0 Hz). 209 .sup.1H-NMR (CDCl.sub.3) δ: 7.53 (1H, s), 7.48-7.47 (1H, m), 7.43 (1H, td, J = 7.7, 1.6 Hz), 7.35-7.20 (3H, m), 4.24-4.23 (1H, br m), 3.55-3.53 (1H, br m), 1.18 (3H, t, J = 7.0 Hz). 210 .sup.1H-NMR (CDCl.sub.3) δ: 7.73 (1H, s), 7.46-7.43 (2H, m), 7.35-7.20 (3H, m), 4.24- 4.21 (1H, br m), 3.56-3.53 (1H, br m), 1.17 (3H, t, J = 7.1 Hz). 211 .sup.1H-NMR (CDCl.sub.3) δ: 7.50 (1H, d, J = 9.8 Hz), 7.39 (1H, s), 7.18-7.15 (2H, m), 6.94-6.90 (2H, m), 6.75 (1H, d, J = 9.8 Hz), 6.19 (1H, tdd, J = 56.7, 5.9, 3.3 Hz), 4.43-4.34 (1H, m), 3.86-3.81 (1H, m). 212 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.40 (1H, s), 7.18-7.16 (2H, m), 6.94-6.93 (2H, m), 6.21 (1H, tdd, J = 56.6, 5.9, 3.3 Hz), 4.48-4.39 (1H, m), 3.91- 3.86 (1H, m). 213 .sup.1H-NMR (CDCl.sub.3) δ: 7.76 (1H, s), 7.42 (1H, s), 7.14 (1H, s), 7.04-7.02 (1H, m), 6.71-6.68 (2H, m), 6.21 (1H, tdd, J = 56.8, 5.9, 3.4 Hz), 4.46-4.40 (1H, m), 3.98-3.92 (1H, m), 3.84 (3H, s). 214 .sup.1H-NMR (CDCl.sub.3) δ: 7.95 (1H, s), 7.40 (1H, s), 7.19-7.15 (2H, m), 6.94-6.92 (2H, m), 6.21 (1H, tdd, J = 56.6, 5.9, 3.3 Hz), 4.46-4.40 (1H, m), 3.91- 3.87 (1H, m). 215 .sup.1H-NMR (CDCl.sub.3) δ: 7.96 (1H, s), 7.41 (1H, s), 7.14 (1H, s), 7.05-7.03 (1H, m), 6.71-6.67 (2H, m), 6.21 (1H, tdd, J = 56.7, 5.8, 3.4 Hz), 4.45-4.39 (1H, m), 4.02-3.91 (1H, m), 3.84 (3H, s). 216 .sup.1H-NMR (CDCl.sub.3) δ: 7.45-7.41 (2H, m), 7.36 (1H, d, J = 0.6 Hz), 7.35-7.32 (1H, m), 7.31 (1H, s), 7.14 (1H, td, J = 8.5, 1.0 Hz), 6.75 (1H, d, J = 9.5 Hz), 4.17-4.10 (1H, m), 3.59-3.52 (1H, m), 1.18 (3H, t, J = 7.0 Hz). 217 .sup.1H-NMR (CDCl.sub.3) δ: 7.47-7.41 (2H, m), 7.36-7.35 (1H, br m), 7.18-7.13 (4H, m), 6.70 (1H, d, J = 9.8 Hz), 4.06-3.97 (1H, m), 3.77-3.68 (1H, m), 1.13 (3H, t, J = 7.1 Hz). 218 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.45-7.42 (1H, m), 7.38-7.32 (2H, m), 7.30 (1H, s), 7.15 (1H, td, J = 8.4, 1.1 Hz), 4.23-4.10 (1H, m), 3.67-3.58 (1H, m), 1.20 (3H, t, J = 7.1 Hz). 219 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.44-7.42 (1H, m), 7.37 (1H, d, J = 0.6 Hz), 7.36-7.33 (1H, m), 7.30 (1H, s), 7.14 (1H, td, J = 8.3, 0.9 Hz), 4.21- 4.15 (1H m), 3.66-3.59 (1H, m), 1.20 (3H, t, J = 7.0 Hz). 220 .sup.1H-NMR (CDCl.sub.3) δ: 7.69 (1H, s), 7.49-7.44 (1H, m), 7.37 (1H, d, J = 0.6 Hz), 7.19-7.14 (4H, m), 4.09-4.01 (1H, m), 3.83-3.76 (1H, m), 1.16 (3H, t, J = 7.0 Hz). 221 .sup.1H-NMR (CDCl.sub.3) δ: 7.89 (1H, s), 7.49-7.44 (1H, m), 7.37 (1H, s), 7.19-7.13 (4H, m), 4.10-4.03 (1k, m), 3.83-3.76 (1H, m), 1.16 (3H, t, J = 7.2 Hz). 222 .sup.1H-NMR (CDCl.sub.3) δ: 7.95 (1H, s), 7.42 (1H, s), 7.28 (1H, s), 6.51-6.49 (2H, m), 6.17 (1H, tt, J = 56.5, 4.5 Hz), 4.21 (2H, td, J = 12.6, 4.5 Hz), 3.84 (3H, s). 223 .sup.1H-NMR (CDCl.sub.3) δ: 7.66 (1H, s), 7.37 (1H, s), 7.32 (1H, s), 6.75-6.74 (2H, m), 3.91 (2H, q, J = 7.0 Hz), 3.45 (1H, s), 1.19 (3H, t, J = 7.0 Hz). 224 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.39 (1H, s), 7.29 (1H, s), 6.50-6.48 (2H, m), 3.92 (2H, q, J = 7.1 Hz), 3.82 (2H, s), 3.43 (1H, s), 1.18 (3H, t, J = 7.1 Hz). 225 .sup.1H-NMR (CDCl.sub.3) δ: 7.40 (1H, s), 7.32 (1H, s), 6.75-6.71 (3H, m), 3.91 (2H, q, J = 7.0 Hz), 3.89 (3H, s), 1.16 (3H, t, J = 7.0 Hz). 226 .sup.1H-NMR (CDCl.sub.3) δ: 7.88 (1H, s), 7.25 (1H, s), 7.17-7.15 (1H, m), 6.92-6.85 (3H, m), 4.09-4.06 (1H, m), 3.78-3.75 (1H, m), 1.93 (3H, s), 1.15 (3H, t, J = 7.2 Hz). 227 .sup.1H-NMR (CDCl.sub.3) δ: 7.57 (1H, d, J = 9.8 Hz), 7.46 (1H, dd, J = 8.2, 0.9 Hz), 7.38 (1H, ddd, J = 8.6, 6.8, 1.3 Hz), 7.26-7.21 (3H, m), 6.86 (1H, s), 6.73 (1H, d, J = 9.8 Hz), 6.35-6.04 (1H, m), 4.62-4.50 (1H, m), 3.62-3.57 (1H, m). 228 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.26 (1H, s), 7.19-7.18 (1H, br m), 6.87- 6.84 (2H, m), 4.16-4.14 (1H, br m), 3.76-3.74 (1H, br m), 1.89 (3H, s), 1.16 (3H, t, J = 7.0 Hz). 229 .sup.1H-NMR (CDCl.sub.3) δ: 7.62 (1H, s), 7.42-7.41 (1H, m), 7.37-7.35 (1H, m), 7.26- 7.22 (3H, m), 6.29-6.13 (1H, m), 4.71-4.61 (1H, m), 3.73-3.65 (1H, m), 1.88 (3H, s). 230 .sup.1H-NMR (CDCl.sub.3) δ: 7.82 (1H, s), 7.42-7.41 (1H, m), 7.38-7.33 (1H, m), 7.26- 7.23 (3H, m), 6.28-6.14 (1H, m), 4.67-4.62 (1H, m), 3.72-3.67 (1H, m), 1.88 (3H, s). 231 .sup.1H-NMR (CDCl.sub.3) δ: 7.46-7.43 (2H, m), 7.36-7.32 (2H, m), 7.21-7.19 (2H, m), 6.77 (1H, d, J = 9.8 Hz), 6.37-6.06 (1H, m), 4.60-4.49 (1H, m), 3.59- 3.57 (1H, br m). 232 .sup.1H-NMR (CDCl.sub.3) δ: 7.61 (1H, s), 7.47-7.45 (2H, m), 7.36-7.34 (1H, m), 7.22- 7.20 (2H, m), 6.31-6.16 (1H, m), 4.63-4.56 (1H, m), 3.66-3.64 (1H, br m). 233 .sup.1H-NMR (CDCl.sub.3) δ: 7.52 (1H, d, J = 9.8 Hz), 7.39 (1H, d, J = 0.6 Hz), 7.25-7.20 (2H, m), 7.17 (1H, d, J = 0.6 Hz), 7.05-7.00 (1H, m), 6.75 (1H, d, J = 9.8 Hz), 6.32-6.06 (1H, m), 4.61-4.51 (1H, m), 3.60-3.51 (1H, m). 234 .sup.1H-NMR (CDCl.sub.3) δ: 7.77 (1H, s), 7.40 (1H, d, J = 0.7 Hz), 7.26-7.20 (2H, m), 7.16 (1H, d, J = 0.7 Hz), 7.06-7.01 (1H, m), 6.37-6.05 (1H, m), 4.67- 4.54 (1H, m), 3.67-3.57 (1H, m). 235 .sup.1H-NMR (CDCl.sub.3) δ: 7.96 (1H, s), 7.40 (1H, d, J = 0.7 Hz), 7.25-7.20 (2H, m), 7.16 (1H, d, J = 0.7 Hz), 7.06-7.01 (1H, m), 6.37-6.05 (1H, m), 4.65- 4.53 (1H, m), 3.68-3.57 (1H, m). 236 .sup.1H-NMR (CDCl.sub.3) δ: 7.81 (1H, s), 7.48-7.44 (2H, m), 7.35-7.33 (1H, m), 7.22-7.20 (2H, m), 6.39-6.08 (1H, m), 4.64-4.53 (1H, m), 3.66-3.64 (1H, br m). 237 .sup.1H-NMR (CDCl.sub.3) δ: 7.98 (1H, s), 7.33 (1H, td, J = 7.5, 1.6 Hz), 7.23-7.18 (4H, m), 6.67 (1H, s), 4.24-4.19 (1H, m), 3.57-3.52 (1H, m), 2.10 (3H, s) 1.86 (3H, s), 1.12 (3H, t, J = 7.0 Hz). 238 .sup.1H-NMR (CDCl.sub.3) δ: 7.41 (1H, d, J = 9.5 Hz), 7.39 (1H, s), 7.28 (1H, s), 6.72 (1H, d, J = 9.5 Hz), 6.50-6.48 (2H, m), 3.89 (2H, q, J = 7.1 Hz), 3.82 (3H, s), 1.16 (3H, t, J = 7.1 Hz). 239 .sup.1H-NMR (CDCl.sub.3) δ: 7.78 (1H, s), 7.42 (1H, d, J = 0.6 Hz), 7.12 (1H, d, J = 0.6 Hz), 7.09 (1H, dd, J = 8.6, 2.0 Hz), 7.00 (1H, d, J = 2.5 Hz), 6.81 (1H, dd, J = 8.6, 2.5 Hz), 6.37-6.06 (1H, m), 4.63-4.52 (1H, m), 3.85 (3H, s), 3.73-3.67 (1H, m). 240 .sup.1H-NMR (CDCl.sub.3) δ: 7.98 (1H, s), 7.42 (1H, d, J = 0.7 Hz), 7.13 (1H, d, J = 0.7 Hz), 7.09 (1H, dd, J = 8.7, 2.1 Hz), 7.00 (1H, d, J = 2.4 Hz), 6.81 (1H, dd, J = 8.7, 2.4 Hz), 6.37-6.06 (1H, m), 4.62-4.51 (1H, m), 3.84 (3H, s), 3.76-3.65 (1H, m). 241 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.44-7.40 (1H, m), 7.36 (1H, s), 7.04-7.01 (2H, m), 6.96-6.91 (2H, m), 4.16-4.09 (1H, m), 3.84 (3H, s), 3.69-3.60 (1H, m), 1.11 (3H, t, J = 7.3 Hz). 242 .sup.1H-NMR (CDCl.sub.3) δ: 7.45 (1H, d, J = 9.8 Hz), 7.42-7.38 (1H, m), 7.35 (1H, d, J = 0.6 Hz), 7.04-7.02 (2H, m), 6.95-6.90 (2H, m), 6.66 (1H, d, J = 9.8 Hz), 4.12-4.04 (1H, m), 3.84 (3H, s), 3.61-3.53 (1H, m), 1.09 (3H, t, J = 7.0 Hz). 243 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.44-7.40 (1H, m), 7.37 (1H, d, J = 0.6 Hz), 7.04-7.01 (2H, m), 6.96-6.92 (2H, m), 4.17-4.09 (1H, m), 3.84 (3H, s), 3.68-3.60 (1H, m), 1.11 (3H, t, J = 7.0 Hz). 244 .sup.1H-NMR (CDCl.sub.3) δ: 7.53 (1H, s), 7.29-7.25 (1H, m), 7.19-7.12 (4H, m), 4.29- 4.26 (1H, m), 3.48-3.43 (1H, m), 2.21 (3H, s), 1.86 (3H, s), 1.13 (3H, t, J = 7.1 Hz). 245 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.29-7.25 (1H, m), 7.17-7.14 (4H, m), 4.27- 4.25 (1H, m), 3.48-3.43 (1H, m), 2.21 (3H, s), 1.86 (3H, s), 1.12 (3H, t, J = 7.0 Hz). 246 .sup.1H-NMR (CDCl.sub.3) δ: 7.47 (1H, d, J = 9.8 Hz), 7.38-7.36 (1H, m), 7.23 (1H, s), 7.03 (1H, dd, J = 7.5, 1.7 Hz), 6.91-6.88 (21-1, m), 6.77 (1H, s), 6.65 (1H, d, J = 9.8 Hz), 4.13-4.10 (1H, m), 3.83 (3H, s), 3.57-3.54 (1H, m), 1.86 (3H, s), 1.08 (3H, t, J = 7.2 Hz). 247 .sup.1H-NMR (CDCl.sub.3) δ: 7.93 (1H, s), 7.39-7.38 (1H, m), 7.24 (1H, s), 7.03 (1H, dd, J = 7.5, 1.7 Hz), 6.93-6.88 (2H, m), 6.75 (1H, s), 4.17-4.14 (1H, m), 3.83 (3H, s), 3.64-3.61 (1H, m), 1.86 (3H, s), 1.10 (3H, t, J = 7.0 Hz). 248 .sup.1H-NMR (CDCl.sub.3) δ: 7.53 (1H, s), 7.34-7.32 (1H, m), 7.20 (1H, s), 7.11-7.09 (1H, br m), 6.87-6.84 (2H, m), 4.23-4.22 (1H, br m), 3.78 (3H, s), 3.66- 3.61 (1H, m), 1.85 (3H, s), 1.12 (3H, t, J = 7.0 Hz). 249 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.35-7.32 (1H, m), 7.20 (1H, s), 7.12-7.10 (1H, br m), 6.87-6.84 (2H, m), 4.23-4.21 (1H, br m), 3.78 (3H, s), 3.66- 3.63 (1H, m), 1.85 (3H, s), 1.12 (3H, t, J = 7.0 Hz). 250 .sup.1H-NMR (CDCl.sub.3) δ: 7.42 (1H, d, J = 9.5 Hz), 7.31-7.30 (1H, m), 7.19-7.14 (1H, m), 7.10-7.09 (1H, m), 6.94-6.88 (2H, m), 6.71 (1H, d, J = 9.5 Hz), 4.02-4.00 (1H, m), 3.72-3.69 (1H, m), 1.13 (3H, t, J = 7.2 Hz). 251 .sup.1H-NMR (CDCl.sub.3) δ: 7.68 (1H, s), 7.32 (1H, d, J = 4.9 Hz), 7.18-7.14 (1H, m), 7.09 (1H, d, J = 4.9 Hz), 6.95-6.88 (2H, m), 4.08-4.05 (1H, m), 3.79- 3.76 (1H, m), 1.16 (3H, t, J = 7.1 Hz). 252 .sup.1H-NMR (CDCl.sub.3) δ: 7.88 (1H, s), 7.31 (1H, d, J = 4.9 Hz), 7.19-7.14 (1H, m), 7.09 (1H, d, J = 4.9 Hz), 6.95-6.89 (2H, m), 4.07-4.05 (1H, m), 3.79- 3.76 (1H, m), 1.16 (3H, t, J = 7.0 Hz). 253 .sup.1H-NMR (CDCl.sub.3) δ: 8.08 (1H, s), 7.37 (1H, s), 7.29 (1H, s), 6.48 (1H, dd, J = 10.5, 1.7 Hz), 3.95-3.85 (5H, m), 1.17 (3H, t, J = 7.0 Hz). 254 .sup.1H-NMR (CDCl.sub.3) δ: 7.52 (1H, d, J = 9.8 Hz), 7.26 (1H, s), 7.18-7.14 (1H, m), 6.91-6.86 (3H, m), 6.77 (1H, s), 6.73 (1H, d, J = 9.8 Hz), 6.34-6.03 (1H, m), 4.42-4.36 (1H, m), 3.83-3.81 (1H, br m), 1.93 (3H, s). 255 .sup.1H-NMR (CDCl.sub.3) δ: 7.63 (1H, s), 7.28 (1H, s), 7.19-7.17 (1H, m), 6.88-6.85 (2H, m), 6.32-6.07 (1H, m), 4.57-4.54 (1H, m), 3.89-3.81 (1H, m), 1.89 (3H, s). 256 .sup.1H-NMR (CDCl.sub.3) δ: 7.82 (1H, s), 7.28 (1H, s), 7.20-7.16 (1H, m), 6.88-6.85 (2H, m), 6.35-6.04 (1H, m), 4.61-4.51 (1H, m), 3.87-3.84 (1H, m), 1.89 (3H, s). 257 .sup.1H-NMR (CDCl.sub.3) δ: 8.22-8.20 (1H, m), 7.81 (1H, s), 7.71-7.64 (2H, m), 7.37- 7.35 (1H, m), 7.25 (1H, d, J = 0.6 Hz), 7.17 (1H, d, J = 0.6 Hz), 4.22- 4.14 (1H, m), 3.53-3.45 (1H, m), 1.16 (3H, t, J = 7.2 Hz), 258 .sup.1H-NMR (CDCl.sub.3) δ: 8.22-8.20 (1H, m), 7.71-7.64 (2H, m), 7.61 (1H, s), 7.37- 7.35 (1H, m), 7.25 (1H, d, J = 0.6 Hz), 7.17 (1H, d, J = 0.6 Hz), 4.22- 4.15 (1H, m), 3.52-3.45 (1H, m), 1.17 (3H, t, J = 7.0 Hz). 259 .sup.1H-NMR (CDCl.sub.3) δ: 7.45 (1H, d, J = 9.8 Hz), 7.43-7.38 (1H, m) 7.23 (1H, s), 7.17-7.10 (3H, m), 6.90 (1H, s), 6.69 (1H, d, J = 9.8 Hz), 4.05-4.02 (1H, m), 3.72-3.70 (1H, m), 1.89 (3H, s), 1.13 (3H, t, J = 7.0 Hz). 260 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 7.45-7.40 (1H, m), 7.24 (1H, s), 7.15-7.13 (3H, m), 6.89 (1H, s), 4.12-4.06 (1H, m), 3.79-3.77 (1H, m), 1.89 (3H, s), 1.15 (3H, t, J = 7.0 Hz). 261 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.67 (1H, s), 6.82-6.79 (2H, m), 3.94 (2H, q, J = 7.0 Hz), 1.20 (3H, t, J = 7.0 Hz). 262 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.86 (1H, s), 6.81-6.79 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.20 (3H, t, J = 7.2 Hz). 263 .sup.1H-NMR (CDCl.sub.3) δ: 7.56 (1H, s), 7.41-7.38 (1H, m), 7.23 (1H, s), 7.19-7.17 (1H, m), 7.13-7.07 (2H, m), 4.18-4.15 (1H, m), 3.78-3.75 (1H, m), 1.86 (3H, s), 1.16 (3H, t, J = 7.1 Hz). 264 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.42-7.36 (1H, m), 7.23 (1H, s), 7.19-7.17 (1H, m), 7.13-7.07 (2H, m), 4.18-4.11 (1H, m), 3.79-3.75 (1H, m), 1.86 (3H, s), 1.16 (3H, t, J = 7.1 Hz). 265 .sup.1H-NMR (CDCl.sub.3) δ: 10.40 (1H, s), 8.06 (1H, s), 7.372 (1H, s), 7.367 (1H, s), 6.78-6.76 (2H, m), 3.98 (2H, q, J = 7.0 Hz), 1.23 (3H, t, J = 7.0 Hz) 266 .sup.1H-NMR (CDCl.sub.3) δ: 7.76 (1H, t, J = 1.2 Hz), 7.38 (1H, s), 7.35 (1H, s), 7.01- 6.74 (3H, m), 3.92 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 267 .sup.1H-NMR (CDCl.sub.3) δ: 7.81 (1H, s), 7.69 (1H, s), 6.54-6.51 (2H, m), 3.96 (2H, q, J = 7.1 Hz), 3.84 (3H, s), 1.19 (3H, t, J = 7.1 Hz). 268 .sup.1H-NMR (CDCl.sub.3) δ: 7.62-7.61 (1H, m), 7.46 (1H, d, J = 9.6 Hz), 7.32-7.24 (4H, m), 6.96 (1H, s), 6.70 (1H, d, J = 9.6 Hz), 4.32-4.29 (1H, m), 3.40- 3.37 (1H, m), 1.88 (3H, s), 1.10 (3H, t, J = 7.1 Hz). 269 .sup.1H-NMR (CDCl.sub.3) δ: 7.92 (1H, s), 7.63-7.61 (1H, m), 7.33-7.29 (2H, m), 7.26- 7.25 (2H, m), 6.94 (1H, s), 4.36-4.33 (1H, m), 3.48-3.45 (1H, m), 1.88 (3H, s), 1.13 (3H, t, J = 7.0 Hz). 270 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s, minor), 7.74 (1H, s, major), 7.22-7.15 (1H, m, mixture), 6.91-6.84 (2H, m, mixture), 4.16-4.13 (1H, br m, major), 4.10-4.03 (1H, m, minor), 3.76-3.73 (1H, m, mixture), 1.89 (3H, s, major), 1.87 (3H, s, minor), 1.16-1.15 (3H, m, mixture). 271 .sup.1H-NMR (CDCl.sub.3) δ: 7.74 (1H, s), 7.58-7.57 (1H, m), 7.32-7.23 (3H, m), 7.21 (1H, s), 4.38-4.36 (1H, m), 3.51-3.47 (1H, m), 1.88 (3H, s), 1.15 (3H, t, J = 7.0 Hz). 272 .sup.1H-NMR (CDCl.sub.3) δ: 7.58-7.57 (1H, m), 7.54 (1H, s), 7.34-7.23 (3H, m), 7.20 (1H, s), 4.39-4.36 (1H, m), 3.50-3.47 (1H, m), 1.88 (3H, s), 1.15 (3H, t, J = 7.1 Hz). 273 .sup.1H-NMR (CDCl.sub.3) δ: 7.52 (1H, d, J = 9.8 Hz), 7.41-7.39 (2H, m), 7.25-7.22 (1H, m), 7.20 (1H, d, J = 0.6 Hz), 7.07 (1H, ddd, J = 9.5, 7.0, 1.5 Hz), 6.75 (1H, d, J = 9.8 Hz), 6.32-6.07 (1H, m), 4.60-4.56 (1H, m), 3.55-3.52 (1H, m). 274 .sup.1H-NMR (CDCl.sub.3) δ: 7.77 (1H, s), 7.43-7.41 (2H, m), 7.25-7.22 (1H, m), 7.19 (1H, d, J = 0.6 Hz), 7.09-7.08 (1H, m), 6.34-6.10 (1H, m), 4.65-4.59 (1H, m), 3.61-3.58 (1H, m). 275 .sup.1H-NMR (CDCl.sub.3) δ: 7.97 (1H, s), 7.42-7.41 (2H, m), 7.25-7.22 (1H, m), 7.19 (1H, d, J = 0.6 Hz), 7.09-7.08 (1H, m), 6.34-6.10 (1H, m), 4.66-4.57 (1H, m), 3.63-3.58 (1H, m). 276 .sup.1H-NMR (CDCl.sub.3) δ: 7.52 (1H, d, J = 9.8 Hz), 7.49-7.46 (1H, m), 7.38 (1H, d, J = 0.5 Hz), 7.20-7.14 (4H, m), 6.74 (1H, d, J = 9.8 Hz), 6.19 (1H, t dd, J = 56.8, 5.9, 3.4 Hz), 4.41-4.36 (1H, m), 3.92-3.82 (1H, m). 277 .sup.1H-NMR (CDCl.sub.3) δ: 7.78 (1H, s), 7.53-7.47 (1H, m), 7.39 (1H, d, J = 0.5 Hz), 7.19-7.15 (4H, m), 6.21 (1H, tdd, J = 56.6, 5.9, 3.4 Hz), 4.50-4.38 (1H, m), 3.94-3.90 (1H, m). 278 .sup.1H-NMR (CDCl.sub.3) δ: 7.97 (1H, s), 7.52-7.47 (1H, m), 7.39 (1H, d, J = 0.7 Hz), 7.21-7.13 (4H, m), 6.21 (1H, tdd, J = 56.7, 5.8, 3.3 Hz), 4.49-4.37 (1H, m), 3.94-3.91 (1H, m). 279 .sup.1H-NMR (CDCl.sub.3) δ: 7.65 (1H, s), 7.49-7.46 (2H, m), 7.36-7.32 (2H, m), 7.25 (1H, br s), 4.07-4.00 (1H, m), 3.78-3.70 (1H, m), 1.17 (3H, t, J = 7.0 Hz). 280 .sup.1H-NMR (CDCl.sub.3) δ: 7.85 (1H, s), 7.49-7.46 (2H, m), 7.36-7.32 (2H, m), 7.25 (1H, s), 4.07-4.00 (1H, m), 3.78-3.71 (1H, m), 1.17 (3H, t, J = 7.0 Hz). 281 .sup.1H-NMR (CDCl.sub.3) δ: 8.52 (1H, s), 7.40 (1H, d, J = 9.8 Hz), 6.84 (1H, d, J = 9.8 Hz), 6.79-6.72 (2H, m), 3.91 (2H, q, J = 7.1 Hz), 1.19 (3H, t, J = 7.1 Hz). 282 .sup.1H-NMR (CDCl.sub.3) δ: 7.50 (1H, d, J = 9.8 Hz), 7.32 (1H, d, J = 4.9 Hz), 7.22 (1H, d, J = 4.9 Hz), 6.78-6.74 (3H, m), 6.22-6.07 (1H, m), 4.14-4.12 (2H, m). 283 .sup.1H-NMR (CDCl.sub.3) δ: 7.96 (1H, s), 7.34 (1H, d, J = 4.9 Hz), 7.22 (1H, d, J = 4.9 Hz), 6.77-6.75 (2H, m), 6.29-6.05 (1H, m), 4.20-4.17 (2H, m). 284 .sup.1H-NMR (CDCl.sub.3) δ: 7.52 (1H, d, J = 9.8 Hz), 7.32 (1H, d, J = 4.9 Hz), 7.19- 7.15 (1H, m), 7.08 (1H, d, J = 4.9 Hz), 6.95-6.89 (2H, m), 6.75 (1H, d, J = 9.8 Hz), 6.18 (1H, tdd, J = 56.8, 5.9, 3.2 Hz), 4.42-4.36 (1H, m), 3.85-3.81 (1H, m). 285 .sup.1H-NMR (CDCl.sub.3) δ: 7.77 (1H, s), 7.34 (1H, d, J = 4.9 Hz), 7.19-7.16 (1H, m), 7.07 (1H, d, J = 4.9 Hz), 6.96-6.91 (2H, m), 6.21 (1H, tdd, J = 56.6, 6.0, 3.2 Hz), 4.46-4.42 (1H, m), 3.90-3.87 (1H, m). 286 .sup.1H-NMR (CDCl.sub.3) δ: 7.96 (1H, s), 7.34 (1H, d, J = 4.9 Hz), 7.19-7.16 (1H, m), 7.07 (1H, d, J = 4.9 Hz), 6.96-6.91 (2H, m), 6.21 (1H, tdd, J = 56.7, 5.9, 3.3 Hz), 4.48-4.39 (1H, m), 3.91-3.88 (1H, m). 287 .sup.1H-NMR (CDCl.sub.3) δ: 7.78 (1H, s), 7.42 (1H, d, J = 0.6 Hz), 7.18-7.17 (1H, m), 7.16 (1H, d, J = 0.6 Hz), 7.11 (1H, dd, J = 8.6, 2.1 Hz), 6.86 (1H, dd, J = 8.6, 2.4 Hz), 6.27-6.16 (1H, m), 4.62-4.57 (1H, m), 3.84 (3H, s), 3.70-3.66 (1H, m). 288 .sup.1H-NMR (CDCl.sub.3) δ: 7.98 (1H, s), 7.42 (1H, d, J = 0.6 Hz), 7.17-7.17 (1H, m), 7.16 (1H, d, J = 0.6 Hz), 7.11 (1H, dd, J = 8.6, 2.1 Hz), 6.86 (1H, dd, J = 8.7, 2.6 Hz), 6.34-6.10 (1H, m), 4.62-4.54 (1H, m), 3.84 (3H, s), 3.71-3.67 (1H, m). 289 .sup.1H-NMR (CDCl.sub.3) δ: 7.66-7.65 (1H, m), 7.55 (1H, d, J = 9.8 Hz), 7.39 (1H, d, J = 0.6 Hz), 7.35-7.34 (2H, m), 7.23-7.21 (1H, m), 7.16 (1H, d, J = 0.6 Hz), 6.75 (1H, d, J = 9.8 Hz), 6.32-6.08 (1H, m), 4.61-4.53 (1H, m), 3.61-3.53 (1H, m). 290 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.68-7.67 (1H, m), 7.40 (1H, d, J = 0.6 Hz), 7.37-7.34 (2H, m), 7.23-7.20 (1H, m), 7.14 (1H, d, J = 0.6 Hz), 6.30- 6.13 (1H, m), 4.63-4.60 (1H, m), 3.65-3.63 (1H, m). 291 .sup.1H-NMR (CDCl.sub.3) δ: 8.00 (1H, s), 7.68-7.65 (1H, m), 7.40 (1H, d, J = 0.6 Hz), 7.38-7.34 (2H, m), 7.23-7.21 (1H, m), 7.15 (1H, d, J = 0.6 Hz), 6.29- 6.15 (1H, m), 4,65-4.56 (1H, m), 3.67-3.62 (1H, m). 292 .sup.1H-NMR (CDCl.sub.3) δ: 7.55 (1H, d, J = 9.5 Hz), 7.48 (1H, dd, J = 8.1, 1.2 Hz), 7.44-7.41 (1H, m), 7.38 (1H, d, J = 0.6 Hz), 7.29 (1H, td, J = 7.5, 1.2 Hz), 7.21-7.20 (1H, m), 7.13 (1H, d, J = 0.6 Hz), 6.75 (1H, d, J = 9.5 Hz), 6.32-6.07 (1H, m), 4.60-4.51 (1H, m), 3.63-3.55 (1H, m). 293 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.50 (1H, dd, J = 7.8, 1.1 Hz), 7.46-7.44 (1H, m), 7.40 (1H, d, J = 0.6 Hz), 7.31 (1H, td, J = 7.5, 1.1 Hz), 7.21- 7.20 (1H, m), 7.11 (1H, d, J = 0.6 Hz), 6.29-6.14 (1H, m), 4.63-4.57 (1H, m), 3.68-3.62 (1H, m). 294 .sup.1H-NMR (CDCl.sub.3) δ: 7.99 (1H, s), 7.48-7.45 (2H, m), 7.39 (1H, s), 7.32-7.30 (1H, m), 7.21-7.19 (1H, m), 7.11 (1H, s), 6.36-6.07 (1H, m), 4.64-4.53 (1H, m), 3.69-3.63 (1H, m). 295 .sup.1H-NMR (CDCl.sub.3) δ: 7.28-7.25 (1H, m), 6.85-6.80 (3H, m), 6.48 (1H, d, J = 5.6 Hz), 3.43 (2H, q, J = 7.1 Hz), 2.76-2.67 (4H, m), 0.97 (3H, t, J = 5.6 Hz). 296 .sup.1H-NMR (CDCl.sub.3) δ: 7.39-7.32 (1H, m), 7.36 (1H, d, J = 9.5 Hz), 6.90 (2H, dd, J = 8.4, 7.2 Hz), 6.85 (1H, d, J = 5.6 Hz), 6.73 (1H, d, J = 9.5 Hz), 6.53 (1H, d, J = 5.6 Hz), 3.91 (2H, q, J = 7.1 Hz), 1.15 (3H, t, J = 7.1 Hz). 297 .sup.1H-NMR (CDCl.sub.3) δ: 7.55 (1H, s), 7.43 (1H, tt, J = 8.6, 6.4 Hz), 6.98-6.96 (2H, m), 6.41 (1H, s), 3.95 (2H, q, J = 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 298 .sup.1H-NMR (CDCl.sub.3) δ: 7.60 (1H, s), 7.38 (1H, tt, J = 8.4, 6.4 Hz), 6.92-6.90 (2H, m), 6.87 (1H, d, J = 5.8 Hz), 6.54 (1H, d, J = 5.8 Hz), 3.96 (2H, g, J = 7.0 Hz), 1.17 (3H, t, J = 7.0 Hz). 299 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.37 (1H, tt, J = 8.4, 6.4 Hz), 6.92-6.90 (2H, m), 6.87 (1H, d, J = 5.8 Hz), 6.54 (1H, d, J = 5.8 Hz), 3.96 (2H, g, J = 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 300 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.5 Hz), 7.32 (1H, dd, J = 3.9, 0.7 Hz), 7.06-7.01 (2H, m), 6.69-6.67 (3H, m), 4.04-4.01 (1H, m), 3.83 (3H, s), 3.37-3.71 (1H, m), 1.13 (3H, t, J = 7.0 Hz). 301 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.33 (1H, dd, J = 4.0, 0.6 Hz), 7.06-7.01 (2H, m), 6.70-6.67 (2H, m), 4.12-4.01 (1H, m), 3.82-3.77 (4H, m), 1.15 (3H, t, J = 7.1 Hz). 302 .sup.1H-NMR (CDCl.sub.3) δ: 7.89 (1H, s), 7.34-7.33 (1H, m), 7.05-7.02 (2H, m), 6.69- 6.67 (2H, m), 4.09-4.06 (1H, m), 3.81-3.79 (4H, m), 1.15 (3H, t, J = 7.0 Hz). 303 .sup.1H-NMR (CDCl.sub.3) δ: 7.64 (1H, d, J = 9.8 Hz), 7.34-7.33 (1H, m), 7.26-7.18 (4H, m), 6.71-6.69 (1H, m), 6.67-6.66 (1H, m), 6.25 (1H, tdd, J = 57.1, 5.7, 3.6 Hz), 4.35-4.26 (1H, m), 3.85-3.82 (1H, m), 2.05 (3H, s), 1.86 (3H, s). 304 .sup.1H-NMR (CDCl.sub.3) δ: 8.10 (1H, s), 7.37-7.35 (1H, m), 7.27-7.26 (2H, m), 7.23- 7.22 (1H, m), 7.19-7.18 (1H, m), 6.64 (1H, s), 6.28 (1H, tdd, J = 57.0, 5.6, 3.6 Hz), 4.37-4.32 (1H, m), 3.91-3.88 (1H, m), 2.04 (3H, s), 1.86 (3H, s). 305 .sup.1H-NMR (CDCl.sub.3) δ: 7.55 (1H, d, J = 9.8 Hz), 7.45-7.43 (1H, m), 7.25 (1H, s), 7.15-7.13 (3H, m), 6.87 (1H, s), 6.73 (1H, d, J = 9.8 Hz), 6.19 (1H, tdd, J = 56.7, 5.8, 3.3 Hz), 4.45-4.35 (1H, m), 3.90-3.83 (1H, m), 1.89 (3H, s). 306 .sup.1H-NMR (CDCl.sub.3) δ: 7.60 (1H, s), 7.31-7.28 (1H, m), 7.21-7.15 (4H, m), 6.31- 6.20 (1H, m), 4.42-4.39 (1H, br m), 3.83-3.75 (1H, m), 2.18 (3H, s), 1.86 (3H, s). 307 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.31-7.26 (1H, m), 7.20-7.14 (4H, m), 6.33- 6.19 (1H, m), 4.44-4.39 (1H, m), 3.84-3.74 (1H, m), 2.18 (3H, s), 1.86 (3H, s). 308 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.5 Hz), 7.33 (1H, d, J = 4.2 Hz), 7.17 (1H, d, J = 4.2 Hz), 6.72 (2H, d, J = 9.5 Hz), 6.50-6.47 (2H, m), 3.89 (2H, q, J = 7.2 Hz), 3.82 (3H, s), 1.16 (3H, t, J = 7.2 Hz). 309 .sup.1H-NMR (CDCl.sub.3) δ: 8.00 (1H, s), 7.47-7.45 (1H, m), 7.26 (1H, s), 7.16-7.13 (3H, m), 6.86 (1H, s), 6.21 (1H, tdd, J = 56.6, 6.0, 3.2 Hz), 4.49-4.40 (1H, m), 3.93-3.90 (1H, m), 1.89 (3H, s). 310 .sup.1H-NMR (CDCl.sub.3) δ: 7.63 (1H, s), 7.44-7.41 (1H, m), 7.26 (1H, s), 7.18-7.16 (1H, m), 7.12-7.10 (2H, m), 6.35-6.04 (1H, m), 4.59-4.54 (1H, m), 3.91- 3.86 (1H, m), 1.86 (3H, s). 311 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.8 Hz), 7.33 (1H, d, J = 4.6 Hz), 7.17 (1H, d, J = 4.6 Hz), 6.71 (2H, d, J = 9.8 Hz), 6.48-645 (2H, m), 4.01 (2H, q, J = 7.0 Hz), 3.89 (2H, q, J = 7.0 Hz), 1.43 (3H, t, J = 7.0 Hz) 1.16 (3H, t, J = 7.0 Hz). 312 .sup.1H-NMR (CDCl.sub.3) δ: 7.83 (1H, s), 7.45-7.39 (1H, m), 7.26 (1H, s), 7.18-7.17 (1H, m), 7.13-7.09 (2H, m), 6.35-6.04 (1H, m), 4.61-4.51 (1H, m), 3.91- 3.88 (1H, m), 1.86 (3H, s). 313 .sup.1H-NMR (CDCl.sub.3) δ: 7.92 (1H, s), 7.49-7.47 (1H, m), 7.42-7.41 (1H, m), 7.31- 7.28 (2H, m), 7.23-7.22 (1H, m), 7.08-7.07 (1H, m), 4.30-4.25 (1H, m), 3.54-3.49 (1H, m), 1.13 (3H, t, J = 7.0 Hz). 314 .sup.1H-NMR (CDCl.sub.3) δ: 7.69 (1H, s), 7.34 (1H, d, J = 4.9 Hz), 7.17 (1H, d, J = 4.9 Hz), 6.51-6.48 (2H, m), 3.95 (2H, q, J = 7.1 Hz), 3.83 (3H, s), 1.18 (3H, t, J = 7.1 Hz). 315 .sup.1H-NMR (CDCl.sub.3) δ: 7.89 (1H, s), 7.34 (1H, d, J = 4.9 Hz), 7.17 (1H, d, J = 4.9 Hz), 6.51-6.49 (2H, m), 3.95 (2H, q, J = 7.0 Hz), 3.83 (3H, s), 1.18 (3H, t, J = 7.0 Hz). 316 .sup.1H-NMR (CDCl.sub.3) δ: 7.69 (1H, s), 7.34 (1H, d, J = 4.9 Hz), 7.16 (1H, d, J = 4.9 Hz), 6.49-6.46 (2H, m), 4.02 (2H, q, J = 7.0 Hz), 3.95 (2H, q, J = 7.2 Hz), 1.44 (3H, t, J = 7.0 Hz), 1.18 (3H, t, J = 7.2 Hz). 317 .sup.1H-NMR (CDCl.sub.3) δ: 7.89 (1H, s), 7.34 (1H, d, J = 4.9 Hz), 7.16 (1H, d, J = 4.9 Hz), 6.48-6.46 (2H, m), 4.02 (2H, q, J = 7.0 Hz), 3.95 (2H, q, J = 7.2 Hz), 1.44 (3H, t, J = 7.0 Hz), 1.18 (3H, t, J = 7.2 Hz). 318 .sup.1H-NMR (CDCl.sub.3) δ: 7.45-7.43 (2H, m), 7.29 (1H, d, J = 4.9 Hz), 7.18 (1H, d, J = 4.9 Hz), 6.97-6.96 (2H, m), 6.73 (1H, d, J = 9.8 Hz), 3.88 (2H, q, J = 7.0 Hz), 1.16 (3H, t, J = 7.0 Hz). 319 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.47-7.45 (1H, m), 7.30 (1H, d, J = 4.9 Hz), 7.18 (1H, d, J = 4.9 Hz), 7.00-6.96 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.19 (3H, t, J = 7.2 Hz). 320 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.46-7.44 (1H, m), 7.30 (1H, d, J = 4.9 Hz), 7.18 (1H, d, J = 4.9 Hz), 7.00-6.95 (2H, m), 3.94 (2H, q, J = 7.2 Hz), 1.18 (3H, t, J = 7.2 Hz). 321 .sup.1H-NMR (CDCl.sub.3) δ: 8.00 (1H, s), 7.42-7.38 (1H, m), 7.30-7.20 (4H, m), 6.66 (1H, s), 4.22-4.15 (1H, m), 3.54-3.49 (1H, m), 2.38-2.34 (2H, m), 1.86 (3H, s) 1.14 (3H, t, J = 7.1 Hz), 1.07 (3H, t, J = 7.6 Hz). 322 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.36-7.32 (1H, m), 7.25 (1H, s), 7.19-7.14 (3H, m), 4.28-4.23 (1H, m), 3.47-3.38 (1H, m), 2.59-2.57 (1H, m), 2.44- 2.40 (1H, m), 1.86 (3H, s) 1.19 (3H, t, J = 7.6 Hz), 1.14 (3H, t, J = 7.1 Hz). 323 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.5 Hz), 7.39-7.37 (1H, m), 7.02 (1H, d, J = 5.8 Hz), 6.91-6.90 (2H, m), 6.76 (1H, d, J = 9.5 Hz), 6.55 (1H, d, J = 5.8 Hz), 6.16 (1H, tt, J = 56.7, 4.5 Hz), 4.17 (2H, td, J = 13.0, 4.5 Hz). 324 .sup.1H-NMR (CDCl.sub.3) δ: 7.44 (1H, tt, J = 8.4, 3.5 Hz), 7.38 (1H, d, J = 9.5 Hz), 6.96-6.94 (2H, m), 6.75 (1H, d, J = 9.5 Hz), 6.55 (1H, s), 6.15 (1H, tt, J = 56.6, 4.5 Hz) 4.16 (2H, td, J = 12.9, 4.5 Hz). 325 .sup.1H-NMR (CDCl.sub.3) δ: 7.81 (1H, s), 7.47-7.43 (1H, m), 6.97-6.95 (2H, m), 6.56 (1H, s), 6.17 (1H, tt, J = 56.4, 4.4 Hz), 4.21 (2H, td, J = 12.7, 4.4 Hz). 326 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.8 Hz), 7.39 (1H, dd, J = 7.8, 2.4 Hz), 7.30 (1H, dd, J = 3.9, 0.7 Hz), 7.26 (1H, dd, J = 8.2, 6.0 Hz), 7.15 (1H, dd, J = 4.9, 0.7 Hz), 7.07-7.05 (1H, m), 6.71 (1H, d, J = 9.8 Hz), 4.31-4.27 (1H, m), 3.39-3.34 (1H, m), 1.11 (3H, t, J = 7.1 Hz). 327 .sup.1H-NMR (CDCl.sub.3) δ: 7.44 (1H, d, J = 9.6 Hz), 7.30 (1H, dd, J = 3.9, 0.7 Hz), 7.25-7.20 (2H, m), 7.11 (1H, dd, J = 4.9, 0.7 Hz), 7.04-6.98 (1H, m), 6.71 (1H, d, J = 9.6 Hz), 4.28-4.19 (1H, m), 3.46-3.36 (1H, m), 1.11 (3H, t, J = 7.1 Hz). 328 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.30-7.29 (1H, m), 7.23-7.20 (2H, m), 7.09- 7.07 (1H, m), 7.00 (1H, td, J = 8.3, 2.5 Hz), 4.30-4.22 (1H, m), 3.50-3.42 (1H, m), 1.12 (3H, t, J = 7.0 Hz). 329 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.30-7.28 (1H, m), 7.23-7.20 (2H, m), 7.09- 7.07 (1H, m), 7.02-6.98 (1H, m), 4.30-4.21 (1H, m), 3.51-3.42 (1H, m), 1.11 (3H, t, J = 7.0 Hz). 330 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.8 Hz), 7.37-7.35 (1H, m), 7.28-7.26 (1H, m), 7.24 (1H, s), 7.04-7.02 (1H, m), 6.98 (1H, s), 6.70 (1H, d, J = 9.8 Hz), 4.32-4.29 (1H, m), 3.37-3.35 (1H, m), 1.92 (3H, s), 1.11 (3H, t, J = 7.0 Hz). 331 .sup.1H-NMR (CDCl.sub.3) δ: 7.53 (1H, s), 7.35-7.32 (2H, m), 7.23 (1H, s), 7.03-7.01 (1H, m), 4.39-4.36 (1H, m), 3.48-3.45 (1H, m), 1.91 (3H, s), 1.15 (3H, t J = 7.0 Hz). 332 .sup.1H-NMR (CDCl.sub.3) δ: 7.89 (1H, s), 7.38-7.36 (1H, m), 7.28-7.25 (2H, m), 7.05- 7.03 (1H, m), 6.97 (1H, s), 4.36-4.31 (1H, m), 3.46-3.42 (1H, m), 1.92 (3H, s), 1.13 (3H, t, J = 7.1 Hz). 333 .sup.1H-NMR (CDCl.sub.3) δ: 7.73 (1H, s), 7.34-7.32 (2H, m), 7.23 (1H, s), 7.03-7.01 (1H, m), 4.39-4.34 (1H, m), 3.49-3.45 (1H, m), 1.90 (3H, s), 1.15 (3H, t, J = 7.1 Hz). 334 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.8 Hz), 7.25-7.23 (2H, m), 7.20-7.18 (1H, m), 6.98-6.97 (1H, m), 6.95 (1H, s), 6.70 (1H, d, J = 9.8 Hz), 4.28- 4.23 (1H, m), 3.42-3.39 (1H, m), 1.92 (3H, s), 1.11 (3H, 1, J = 7.2 Hz). 335 .sup.1H-NMR (CDCl.sub.3) δ: 7.89 (1H, s), 7.25-7.20 (3H, m), 7.01-6.96 (1H, m), 6.93 (1H, s), 4.32-4.27 (1H, m), 3.50-3.46 (1H, m), 1.92 (3H, s), 1.13 (3H, t, J = 7.0 Hz). 336 .sup.1H-NMR (CDCl.sub.3) δ: 7.54 (1H, s), 7.31-7.30 (1H, br m), 7.23 (1H, s), 7.16- 7.15 (1H, m), 6.98-6.96 (1H, m), 4.36-4.33 (1H, m), 3.51-3.49 (1H, m), 1.90 (3H, s), 1.15 (3H, t, J = 7.0 Hz). 337 .sup.1H-NMR (CDCl.sub.3) δ: 7.74 (1H, s), 7.31-7.29 (1H, br m), 7.23 (1H, s), 7.16- 7.15 (1H, m), 6.99-6.95 (1H, m), 4.35-4.32 (1H, m), 3.53-3.49 (1H, m), 1.90 (3H, s), 1.15 (3H, t, J = 7.2 Hz). 338 .sup.1H-NMR (CDCl.sub.3) δ: 7.54 (1H, d, J = 9.8 Hz), 7.38 (1H, dd, J = 8.0, 2.4 Hz), 7.25-7.23 (2H, m), 7.04-7.03 (1H, m), 6.93 (1H, s), 6.73 (1H, d, J = 9.8 Hz), 6.32-6.07 (1H, m), 4.63-4.54 (1H, m), 3.55-3.53 (1H, m), 1.92 (3H, s). 339 .sup.1H-NMR (CDCl.sub.3) δ: 7.99 (1H, s), 7.39 (1H, dd, J = 7.8, 2.4 Hz), 7.27-7.22 (2H, m), 7.06-7.04 (1H, m), 6.91 (1H, s), 6.37-6.06 (1H, m), 4.67-4.56 (1H, m), 3.66-3.56 (1H, m), 1.92 (3H, s). 340 .sup.1H-NMR (CDCl.sub.3) δ: 7.61 (1H, s), 7.35-7.33 (1H, m), 7.32-7.29 (1H, br m), 7.24 (1H, s), 7.03-7.01 (1H, m), 6.29-6.14 (1H, m), 4.69-4.65 (1H, m), 3.66-3.61 (1H, m), 1.91 (3H, s). 341 .sup.1H-NMR (CDCl.sub.3) δ: 7.81 (1H, s), 7.35-7.31 (2H, m), 7.24 (1H, s), 7.04-7.00 (1H, m), 6.34-6.09 (1H, m), 4.71-4.62 (1H, m), 3.67-3.63 (1H, m), 1.91 (3H, s). 342 .sup.1H-NMR (CDCl.sub.3) δ: 7.54 (1H, d, J = 9.8 Hz), 7.26 (1H, s), 7.23-7.20 (2H, m), 7.00-6.97 (1H, m), 6.90 (1H, s), 6.73 (1H, d, J = 9.8 Hz), 6.34-6.04 (1H, m), 4.63-4.51 (1H, m), 3.58-3.53 (1H, m), 1.92 (3H, s). 343 .sup.1H-NMR (CDCl.sub.3) δ: 7.61 (1H, s), 7.26-7.24 (2H, m), 7.18-7.16 (1H, m), 7.00- 6.95 (1H, m), 6.35-6.06 (1H, m), 4.72-4.61 (1H, m), 3.67-3.62 (1H, m), 1.90 (3H, s). 344 .sup.1H-NMR (CDCl.sub.3) δ: 7.99 (1H, s), 7.27 (1H, s), 7.23-7.21 (2H, m), 7.01-6.99 (1H, m), 6.88 (1H, s), 6.33-6.09 (1H, m), 4.64-4.55 (1H, m), 3.63-3.60 (1H, m), 1.92 (3H, s). 345 .sup.1H-NMR (CDCl.sub.3) δ: 7.81 (1H, s), 7.30-7.26 (2H, m), 7.18-7.16 (1H, m), 6.98- 6.96 (1H, m), 6.36-6.05 (1H, m), 4.71-4.59 (1H, m), 3.70-3.61 (1H, m), 1.90 (3H, s). 346 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.42-7.37 (1H, m), 7.04 (1H, d, J = 5.8 Hz), 6.93-6.89 (2H, m), 6.56 (1H, d, J = 5.8 Hz), 6.18 (1H, tt, J = 56.4, 4.6 Hz), 4.22 (2H, td, J = 12.7, 4.6 Hz). 347 .sup.1H-NMR (CDCl.sub.3) δ: 7.66 (1H, s), 7.44-7.36 (1H, m), 7.04 (1H, d, J = 5.9 Hz), 6.95-6.88 (2H, m), 6.56 (1H, d, J = 5.9 Hz), 6.18 (1H, tt, J = 56.5, 4.5 Hz), 4.22 (2H, td, J = 12.8, 4.5 Hz). 348 .sup.1H-NMR (CDCl.sub.3) δ: 7.48-7.39 (1H, m), 7.38 (1H, d, J = 9.5 Hz), 6.99-6.93 (2H, m), 6.75 (1H, d, J = 9.5 Hz), 6.42 (1H, s), 6.15 (1H, tt, J = 56.6, 4.4 Hz), 4.16 (2H, td, J = 12.9, 4.4 Hz). 349 .sup.1H-NMR (CDCl.sub.3) δ: 7.61 (1H, s), 7.50-7.42 (1H, m), 7.00-6.94 (2H, m), 6.43 (1H, s), 6.17 (1H, tt, J = 56.4, 4.5 Hz), 4.21 (2H, td, J = 12.8, 4.5 Hz). 350 .sup.1H-NMR (CDCl.sub.3) δ: 7.47-7.45 (2H, m), 7.40 (1H, td, J = 7.8, 1.8 Hz), 7.30- 7.28 (2H, m), 7.23 (1H, dd, J = 7.6, 1.8 Hz), 7.09 (1H, dd, J = 4.7, 0.8 Hz), 6.70 (1H, d, J = 9.5 Hz), 4.25-4.23 (1H, m), 3.47-3.42 (1H, m), 1.11 (3H, t, J = 7.0 Hz). 351 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.48 (1H, dd, J = 8.1, 1.0 Hz), 7.43-7.40 (1H, m), 7.31 (1H, dd, J = 3.9, 0.7 Hz), 7.29 (1H, dd, J = 7.4, 1.3 Hz), 7.22 (1H, dd, J = 7.9, 1.6 Hz), 7.08 (1H, dd, J = 4.9, 0.7 Hz), 4.33-4.24 (1H, m), 3.55-3.46 (1H, m), 1.14 (3H, t, J = 7.1 Hz). 352 .sup.1H-NMR (CDCl.sub.3) δ: 7.69 (1H, s), 7.40 (1H, dd, J = 7.8, 2.4 Hz), 7.32 (1H, dd, J = 4.2, 0.7 Hz), 7.26 (1H, dd, J = 8.5, 5.6 Hz), 7.14 (1H, dd, J = 4.9, 0.7 Hz), 7.10-7.05 (1H, m), 4.38-4.29 (1H, m), 3.48-3.40 (1H, m), 1.14 (3H, t, J = 7.1 Hz). 353 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.40 (1H, dd, J = 7.8, 2.6 Hz), 7.32 (1H, dd, J = 4.0, 0.6 Hz), 7.27 (1H, dd, J = 8.4, 5.4 Hz), 7.15 (1H, dd, J = 4.9, 0.6 Hz), 7.10-7.05 (1H, m), 4.36-4.29 (1H, m), 3.48-3.42 (1H, m), 1.14 (3H, t, J = 7.0 Hz). 354 .sup.1H-NMR (CDCl.sub.3) δ: 7.45 (1H, d, J = 9.5 Hz), 7.32 (1H, dd, J = 4.2, 0.7 Hz), 7.17-7.11 (3H, m), 6.83 (1H, dd, J = 8.7, 2.6 Hz), 6.69 (1H, d, J = 9.8 Hz), 4.33-4.23 (1H, m), 3.83 (3H, s), 3.46-3.37 (1H, m), 1.11 (3H, t, J = 7.0 Hz). 355 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.33 (1H, dd, J = 4.2, 0.7 Hz), 7.16 (1H, d, J = 2.7 Hz), 7.14-7.11 (2H, m), 6.85 (1H, dd, J = 8.5, 2.4 Hz), 4.37- 4.28 (1H, m), 3.84 (3H, s), 3.54-3.44 (1H, m), 1.13 (3H, t, J = 7.1 Hz). 356 .sup.1H-NMR (CDCl.sub.3) δ: 7.65-7.63 (1H, m), 7.46 (1H, d, J = 9.5 Hz), 7.35-7.29 (3H, m), 7.26-7.24 (1H, m), 7.13 (1H, dd, J = 4.9, 0.9 Hz), 6.71 (1H, d, J = 9.5 Hz), 4.29 (1H, td, J = 13.6, 7.0 Hz), 3.39 (1H, td, J = 13.6, 7.0 Hz), 1.11 (3H, t, J = 7.0 Hz). 357 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.66-7.64 (1H, m), 7.35-7.31 (3H, m), 7.25- 7.23 (1H, m), 7.11 (1H, dd, J = 4.9, 0.7 Hz), 4.34 (1H, dt, J = 20.3, 7.1 Hz), 3.46 (1H, dt, J = 20.3, 7.1 Hz), 1.14 (3H, t, J = 7.1 Hz). 358 .sup.1H-NMR (CDCl.sub.3) δ: 7.92 (1H, s), 7.66-7.64 (1H, m), 7.35-7.30 (3H, m), 7.25- 7.23 (1H, m), 7.12 (1H, dd, J = 4.9, 0.7 Hz), 4.33 (1H, dt, J = 20.3, 7.1 Hz), 3.47 (1H, dt, J = 20.3, 7.1 Hz), 1.13 (3H, t, J = 7.1 Hz). 359 .sup.1H-NMR (CDCl.sub.3) δ: 7.36-7.31 (1H, m), 7.34 (1H, d, J = 9.5 Hz), 7.00 (1H, d, J = 5.1 Hz), 6.88 (2H, dd, J = 8.3, 7.3 Hz), 6.70 (1H, d, J = 9.5 Hz), 6.69 (1H, d, J = 5.1 Hz), 3.90 (2H, q, J = 7.1 Hz), 2.04 (3H, s), 1.15 (3H, t, J = 7.1 Hz). 360 .sup.1H-NMR (CDCl.sub.3) δ: 7.46 (1H, d, J = 9.8 Hz), 7.44-7.42 (1H, m), 7.33 (1H, td, J = 8.3, 5.8 Hz), 7.30 (1H, dd, J = 4.0, 0.6 Hz), 7.21 (1H, dd, J = 4.9, 0.6 Hz), 7.14 (1H, td, J = 8.3, 1.0 Hz), 6.75 (1H, d, J = 9.8 Hz), 4.17- 4.10 (1H, m), 3.58-3.51 (1H, m), 1.17 (3H, t, J = 7.2 Hz). 361 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.33 (1H, dd, J = 4.0, 0.6 Hz), 7.11 (1H, d, J = 8.6 Hz), 7.07 (1H, dd, J = 4.6, 0.6 Hz), 6.99 (1H, d, J = 2.4 Hz), 6.80 (1H, dd, J = 8.6, 2.4 Hz), 4.31-4.25 (1H, m), 3.84 (3H, s), 3.56- 3.49 (1H, m), 1.13 (3H, t, J = 7.0 Hz). 362 .sup.1H-NMR (CDCl.sub.3) δ: 7.45 (1H, d, J = 9.8 Hz), 7.31 (1H, dd, J = 3.9, 0.7 Hz), 7.12 (1H, d, J = 8.7 Hz), 7.09 (1H, dd, J = 4.6, 0.7 Hz), 6.98 (1H, d, J = 2.4 Hz), 6.79 (1H, dd, J = 8.7, 2.4 Hz), 6.69 (1H, d, J = 9.8 Hz), 4.28-4.18 (1H, m), 3.83 (3H, s), 3.49-3.43 (1H, m), 1.10 (3H, t, J = 7.0 Hz). 363 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 7.33 (1H, dd, J = 3.9, 0.7 Hz), 7.11 (1H, d, J = 8.5 Hz), 7.08 (1H, dd, J = 4.9, 0.7 Hz), 6.99 (1H, d, J = 2.4 Hz), 6.80 (1H, dd, J = 8.5, 2.4 Hz), 4.32-4.23 (1H, m), 3.84 (3H, s), 3.58- 3.48 (1H, m), 1.13 (3H, t, J = 7.1 Hz). 364 .sup.1H-NMR (CDCl.sub.3) δ: 7.42-7.34 (2H, m), 7.10 (1H, d, J = 5.3 Hz), 6.94-6.90 (2H, m), 6.85 (1H, d, J = 5.3 Hz), 6.73 (1H, d, J = 9.5 Hz), 3.91 (2H, q, J = 7.0 Hz), 1.16 (3H, t, J = 7.0 Hz). 365 .sup.1H-NMR (CDCl.sub.3) δ: 7.64 (1H, s), 7.42-7.36 (1H, m), 7.12 (1H, d, J = 5.5 Hz), 6.95-6.90 (2H, m), 6.86 (1H, d, J = 5.5 Hz), 3.96 (2H, q, J = 7.0 Hz), 1.18 (3H, t, J = 7.0 Hz). 366 .sup.1H-NMR (CDCl.sub.3) δ: 7.44 (1H, d, J = 9.3 Hz), 7.39 (1H, tt, J = 8.4, 6.4 Hz), 6.93-6.87 (3H, m), 6.76 (1H, d, J = 9.3 Hz), 6.55 (1H, d, J = 5.9 Hz), 6.15 (1H, tt, J = 56.6, 4.4 Hz), 4.18 (2H, td, J = 12.9, 4.4 Hz). 367 .sup.1H-NMR (CDCl.sub.3) δ: 7.48 (1H, d, J = 9.8 Hz), 7.24 (1H, s), 7.18-7.16 (1H, m), 6.92-6.90 (2H, m), 6.74 (1H, s), 6.67 (1H, d, J = 9.8 Hz), 4.20-4.12 (1H, m), 3.46-3.43 (1H, m), 2.12 (3H, s), 1.90 (3H, s), 1.10 (3H, t, J = 6.9 Hz). 368 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.29 (1H, s), 6.89-6.87 (1H, m), 6.26-6.22 (2H, m), 4.22-4.20 (1H, br m), 4.06 (1H, br s), 3.83-3.80 (1H, br m), 2.82 (3H, d, J = 5.1 Hz), 1.89 (3H, s), 1.15 (3H, t, J = 7.1 Hz). 369 .sup.1H-NMR (CDCl.sub.3) δ: 7.52 (1H, s), 7.21-7.18 (2H, m), 6.88-6.85 (2H, m), 4.29- 4.27 (1H, br m), 3.45-3.42 (1H, m), 2.21 (3H, s), 1.88 (3H, s), 1.13 (3H, t, J = 7.1 Hz). 370 .sup.1H-NMR (CDCl.sub.3) δ: 7.94 (1H, s), 7.24 (1H, s), 7.18-7.14 (1H, m), 6.94-6.91 (2H, m), 6.73 (1H, s), 4.23-4.20 (1H, m), 3.54-3.49 (1H, m), 2.12 (3H, s), 1.90 (3H, s), 1.12 (3H, t, J = 7.1 Hz). 371 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.21-7.18 (2H, m), 6.88-6.85 (2H, m), 4.27- 4.25 (1H, br m), 3.45-3.42 (1H, m), 2.21 (3H, s), 1.88 (3H, s), 1.13 (3H, t, J = 7.0 Hz). 372 .sup.1H-NMR (CDCl.sub.3) δ: 7.70-7.69 (1H, m), 7.58-7.55 (2H, m), 7.48-7.47 (1H, m), 7.40 (1H, d, J = 9.5 Hz), 7.18 (1H, s), 6.89 (1H, s), 6.68 (1H, d, J = 9.5 Hz), 4.29-4.25 (1H, m), 3.24-3.20 (1H, m), 1.88 (3H, s), 1.11 (3H, t, J = 7.0 Hz). 373 .sup.1H-NMR (CDCl.sub.3) δ: 7.73 (1H, s), 7.27 (1H, s), 7.07-7.05 (1H, m), 6.92-6.90 (2H, m), 4.17-4.15 (1H, br m), 3.78-3.76 (1H, m), 2.48 (3H, s), 1.89 (3H, s), 1.16 (3H, t, J = 7.0 Hz). 374 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.71-7.70 (1H, m), 7.60-7.57 (2H, m), 7.47- 7.46 (1H, m), 7.18 (1H, s), 6.88 (1H, s), 4.32-4.30 (1H, m), 3.31-3.28 (1H, m), 1.88 (3H, s), 1.13 (3H, t, J = 7.0 Hz). 375 .sup.1H-NMR (CDCl.sub.3) δ: 7.67-7.65 (1H, m), 7.58-7.56 (2H, m), 7.53 (1H, s), 7.47- 7.45 (1H, m), 7.15 (1H, s), 4.31-4.28 (1H, m), 3.38-3.35 (1H, m), 1.87 (3H, s), 1.15 (3H, t, J = 7.0 Hz). 376 .sup.1H-NMR (CDCl.sub.3) δ: 7.83 (1H, s), 7.36 (1H, s), 7.04-7.02 (1H, m), 6.91-6.88 (1H, m), 5.23 (2H, s), 1.90 (3H, s). 377 .sup.1H-NMR (CDCl.sub.3) δ: 7.36-7.26 (2H, m), 6.87 (2H, dd, J = 8.3, 7.3 Hz), 6.80 (1H, d, J = 5.2 Hz), 6.71 (1H, d, J = 9.3 Hz), 6.54 (1H, d, J = 5.2 Hz), 3.90 (2H, q, J = 7.1 Hz), 2.25 (3H, s), 1.15 (3H, t, J = 7.1 Hz). 378 .sup.1H-NMR (CDCl.sub.3) δ: 7.45 (1H, d, J = 9.8 Hz), 7.40 (1H, td, J = 8.3, 5.9 Hz), 7.30 (1H, dd, J = 4.0, 0.6 Hz), 7.27-7.25 (1H, m), 7.19 (1H, dd, J = 4.9, 0.6 Hz), 7.09 (1H, td, J = 8.3, 0.9 Hz), 6.74 (1H, d, J = 9.8 Hz), 4.13-4.04 (1H, m), 3.64-3.55 (1H, m), 1.16 (3H, t, J = 7.2 Hz). 379 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.42 (1H, td, J = 8.4, 5.9 Hz), 7.31 (1H, dd, J = 4.0, 0.9 Hz), 7.29-7.26 (1H, m), 7.18 (1H, dd, J = 4.9, 0.9 Hz), 7.10 (1H, td, J = 8.4, 0.9 Hz), 4.18-4.10 (1H, m), 3.70-3.63 (1H, m), 1.19 (3H, t, J = 7.0 Hz). 380 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 7.42 (1H, td, J = 8.4, 6.1 Hz), 7.31 (1H, dd, J = 3.9, 0.6 Hz), 7.29-7.26 (1H, m), 7.18 (1H, dd, J = 4.9, 0.6 Hz), 7.10 (1H, td, J = 8.4, 0.9 Hz), 4.18-4.11 (1H, m), 3.71-3.62 (1H, m), 1.19 (3H, t, J = 7.1 Hz). 381 .sup.1H-NMR (CDCl.sub.3) δ: 7.57 (1H, s), 7.38-7.32 (1H, m), 7.02 (1H, d, J = 5.0 Hz), 6.89 (2H, dd, J = 8.6, 7.0 Hz), 6.69 (1H, d, J = 5.0 Hz), 3.95 (2H, q, J = 7.1 Hz), 2.05 (3H, s), 1.18 (3H, t, J = 7.1 Hz). 382 .sup.1H-NMR (CDCl.sub.3) δ: 7.47-7.41 (1H, m), 7.45 (1H, d, J = 9.5 Hz), 7.29 (1H, dd, J = 4.0, 0.9 Hz), 7.18-7.13 (3H, m), 7.06 (1H, d, J = 4.9 Hz), 6.70 (1H, d, J = 9.5 Hz), 4.02 (1H, dt, J = 20.3, 7.1 Hz), 3.72 (1H, td, J = 13.7, 6.9 Hz), 1.13 (3H, t, J = 7.0 Hz). 383 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.49-7.44 (1H, m), 7.31 (1H, dd, J = 4.2, 0.7 Hz), 7.19-7.15 (3H, m), 7.05 (1H, d, J = 4.9 Hz), 4.07 (1H, td, J = 13.7, 7.1 Hz), 3.79 (1H, td, J = 13.7, 7.1 Hz), 1.16 (3H, t, J = 7.1 Hz). 384 .sup.1H-NMR (CDCl.sub.3) δ: 7.90 (1H, s), 7.49-7.44 (1H, m), 7.30 (1H, dd, J = 3.9, 0.7 Hz), 7.19-7.13 (3H, m), 7.05 (1H, d, J = 4.6 Hz), 4.07 (1H, td, J = 13.6, 7.1 Hz), 3.83-3.75 (1H, m), 1.16 (3H, t, J = 7.1 Hz). 385 .sup.1H-NMR (CDCl.sub.3) δ: 7.42 (1H, d, J = 9.5 Hz), 7.40-7.34 (1H, m), 7.03 (1H, d, J = 4.9 Hz), 6.91-6.88(2H, m), 6.73 (1H, d, J = 9.5 Hz), 6.70 (1H, d, J = 4.9 Hz), 6.17 (1H, tt, J = 56.7, 4.5 Hz), 4.17 (2H, td, J = 12.8, 4.5 Hz), 2.04 (3H, s). 386 .sup.1H-NMR (CDCl.sub.3) δ: 7.43-7.35 (1H, m), 7.29 (1H, d, J = 9.5 Hz), 6.93 (2H, dd, J = 8.4, 7.2 Hz), 6.69 (1H, d, J = 9.5 Hz), 6.66 (1H, s), 3.88 (2H, q, J = 7.1 Hz), 1.98 (3H, s), 1.14 (3H, t, J = 7.1 Hz). 387 .sup.1H-NMR (CDCl.sub.3) δ: 7.53 (1H, s), 7.45-7.37 (1H, m), 6.94 (2H, dd, J = 8.4, 7.2 Hz), 6.66 (1H, s), 3.93 (2H, q, J = 7.1 Hz), 1.99 (3H, s), 1.17 (3H, t, J = 7.1 Hz). 388 .sup.1H-NMR (CDCl.sub.3) δ: 7.74 (1H, s), 7.44-7.37 (1H, m), 6.94 (2H, dd, J = 8.5, 7.3 Hz), 6.66 (1H, s), 3.93 (2H, q, J = 7.1 Hz), 1.99 (3H, s), 1.16 (3H, t, J = 7.1 Hz). 389 .sup.1H-NMR (CDCl.sub.3) δ: 7.78 (1H, s), 7.39-7.31 (1H, m), 7.02 (1H, d, J = 5.1 Hz), 6.89 (2H, dd, J = 8.5, 7.1 Hz), 6,69 (1H, d, J = 5.1 Hz), 3.95 (2H, g, J = 7.1 Hz), 2.05 (3H, s), 1.17 (3H, t, J = 7.1 Hz). 390 .sup.1H-NMR (CDCl.sub.3) δ: 7.52 (1H, s), 7.36-7.30 (1H, m), 6.89-6.86 (2H, m), 6.81 (1H, d, J = 5.2 Hz), 6.54 (1H, d, J = 5.2 Hz), 3.95 (2H, q, J = 7.0 Hz), 2.26 (3H, s), 1.17 (3H, t, J = 7.0 Hz). 391 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.44 (1H, d, J = 8.3 Hz), 7.35 (1H, td, J = 8.3, 5.8 Hz), 7.32-7.31 (1H, m), 7.20 (1H, d, J = 4.9 Hz), 7.16-7.13 (1H, m), 4.22-4.15 (1H, m), 3.65-3.58 (1H, m), 1.20 (3H, t, J = 7.0 Hz). 392 .sup.1H-NMR (CDCl.sub.3) δ: 7.92 (1H, s), 7.44 (1H, d, J = 8.0 Hz), 7.35 (1H, td, J = 8.0, 5.8 Hz), 7.32 (1H, d, J = 4.0 Hz), 7.20 (1H, d, J = 4.9 Hz), 7.16- 7.13 (1H, m), 4.22-4.15 (1H, m), 3.65-3.58 (1H, m), 1.20 (3H, t, J = 7.2 Hz). 393 .sup.1H-NMR (CDCl.sub.3) δ: 7.41-7.34 (1H, m), 7.41 (1H, d, J = 9.5 Hz), 7.09 (1H, d, J = 5.6 Hz), 6.95-6.89 (2H, m), 6.79 (1H, d, J = 5.6 Hz), 6.73 (1H, d, J = 9.5 Hz), 3.91 (2H, q, J = 7.1 Hz), 1.15 (3H, t, J = 7.1 Hz). 394 .sup.1H-NMR (CDCl.sub.3) δ: 7.49 (1H, d, J = 9.5 Hz), 7.45-7.37 (1H, m), 7.13 (1H, d, J = 5.4 Hz), 6.95-6.90 (2H, m), 6.80 (1H, d, J = 5.4 Hz), 6.76 (1H, d, J = 9.5 Hz), 6.15 (1H, tt, J = 56.6, 4.4 Hz), 4.18 (2H, td, J = 12.9, 4.4 Hz). 395 .sup.1H-NMR (CDCl.sub.3) δ: 7.65 (1H, s), 7.42-7.36 (1H, m), 7.12 (1H, d, J = 5.5 Hz), 6.95-6.91 (2H, m), 6.79 (1H, d, J = 5.5 Hz), 3.96 (2H, q, J = 7.1 Hz), 1.18 (3H, t, J = 7.1 Hz). 396 .sup.1H-NMR (CDCl.sub.3) δ: 7.60 (1H, s), 7.49-7.41 (1H, m), 7.00-6.95 (2H, m), 6.66 (1H, s), 3.95 (2H, q, J = 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 397 .sup.1H-NMR (CDCl.sub.3) δ: 7.85 (1H, s), 7.43-7.36 (1H, m), 7.12 (1H, d, J = 5.4 Hz), 6.95-6.90 (2H, m), 6.79 (1H, d, J = 5.4 Hz), 3.96 (2H, q, J = 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 398 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.49-7.41 (1H, m), 7.00-6.94 (2H, m), 6.78 (1H, s), 3.95 (2H, q, J = 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 399 .sup.1H-NMR (CDCl.sub.3) δ: 7.85 (1H, s), 7.37 (1H, tt, J = 8.4, 6.4 Hz), 6.93 (1H, d, J = 5.8 Hz), 6.90-6.88 (2H, m), 6.57 (1H, d, J = 5.8 Hz), 5.18 (2H, s). 400 .sup.1H-NMR (CDCl.sub.3) δ: 7.81 (1H, s), 7.52-7.42 (1H, m), 7.00-6.95 (2H, m), 6.57 (1H, s), 6.16 (1H, tt, J = 56.5, 4.5 Hz), 4.22 (2H, td, J = 12.7, 4.5 Hz). 401 .sup.1H-NMR (CDCl.sub.3) δ: 7.44 (1H, tt, J = 8.5, 6.4 Hz), 7.38 (1H, d, J = 9.5 Hz), 6.97-6.95 (2H, m), 6.75 (1H, d, J = 9.5 Hz), 6.55 (1H, s), 6.14 (1H, tt, J = 56.6, 4.5 Hz), 4.19-4.13 (2H, m). 402 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.43-7.37 (1H, m), 6.93-6.90 (3H, m), 6.56 (1H, d, J = 5.9 Hz), 6.18 (1H, tt, J = 55.4, 4.3 Hz), 4.22 (2H, td, J = 12.8, 4.3 Hz). 403 .sup.1H-NMR (CDCl.sub.3) δ: 7.61 (1H, s), 7.49-7.43 (1H, m), 6.98-6.96 (2H, m), 6.57 (1H, s), 6.16 (1H, tt, J = 56.6, 4.6 Hz), 4.22 (2H, td, J = 12.7, 4.6 Hz). 404 .sup.1H-NMR (CDCl.sub.3) δ: 7.66 (1H, s), 7.41 (1H, tt, J = 8.4, 6.4 Hz), 6.92-6.91 (3H, m), 6.56 (1H, d, J = 5.9 Hz), 6.18 (1H, tt, J = 56.5, 4.5 Hz), 4.22 (2H, td, J = 12.8, 4.5 Hz). 405 .sup.1H-NMR (CDCl.sub.3) δ: 7.64-7.63 (1H, m), 7.57 (1H, d, J = 9.8 Hz), 7.31-7.29 (2H, m), 7.27 (1H, s), 7.23-7.22 (1H, m), 6.89 (1H, s), 6.73 (1H, d, J = 9.8 Hz), 6.35-6.05 (1H, m), 4.64-4.52 (1H, m), 3.63-3.53 (1H, m), 1.88 (3H, s). 406 .sup.1H-NMR (CDCl.sub.3) δ: 7.46 (1H, d, J = 9.8 Hz), 7.27 (1H, s), 7.10-7.08 (1H, m), 6.91-6.85 (3H, m), 6.71 (1H, d, J = 9.8 Hz), 3.34 (3H, s), 1.93 (3H, s). 407 .sup.1H-NMR (CDCl.sub.3) δ: 7.61 (1H, s), 7.60-7.58 (1H, m), 7.28-7.27 (3H, m), 7.22 (1H, s), 6.34-6.10 (1H, m), 4.72-4.62 (1H, m), 3.68-3.66 (1H, m), 1.88 (3H, s). 408 .sup.1H-NMR (CDCl.sub.3) δ: 8.02 (1H, s), 7.66-7.63 (1H, m), 7.34-7.29 (2H, m), 7.27 (1H, s), 7.24-7.21 (1H, m), 6.87 (1H, s), 6.35-6.10 (1H, m), 4.66-4.56 (1H, m), 3.67-3.63 (1H, m), 1.88 (3H, s). 409 .sup.1H-NMR (CDCl.sub.3) δ: 7.81 (1H, s), 7.60-7.57 (1H, m), 7.29-7.26 (3H, m), 7.22 (1H, s), 6.37-6.07 (1H, m), 4.72-4.60 (1H, m), 3.69-3.67 (1H, m), 1.88 (3H, s). 410 .sup.1H-NMR (CDCl.sub.3) δ: 7.58 (1H, s), 7.30 (1H, s), 7.11-7.10 (1H, m), 6.91-6.89 (1H, m), 6.83-6.81 (1H, m), 3.45 (3H, s), 1.89 (3H, s). 411 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 7.28 (1H, s), 7.10-7.08 (1H, m), 6.93-6.91 (1H, m), 6.87-6.85 (2H, m), 3.41 (3H, s), 1.93 (3H, s). 412 .sup.1H-NMR (CDCl.sub.3) δ: 7.78 (1H, s), 7.30 (1H, s), 7.12-7.09 (1H, m), 6.91-6.88 (1H, m), 6.83-6.81 (1H, m), 3.45 (3H, s), 1.89 (3H, s). 413 .sup.1H-NMR (CDCl.sub.3) δ: 7.46-7.43 (2H, m), 7.31 (1H, d, J = 4.9 Hz), 7.17 (1H, d, J = 4.9 Hz), 7.00-6.96 (2H, m), 6.76 (1H, d, J = 9.5 Hz), 3.38 (3H, s). 414 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.34 (1H, s), 7.12-7.08 (1H, m), 6.85-6.83 (1H, m), 6.78-6.76 (1H, m), 5.97 (1H, q, J = 5.9 Hz), 2.46 (3H, d, J = 5.9 Hz), 1.89 (3H, s). 415 .sup.1H-NMR (CDCl.sub.3) δ: 7.79 (1H, s), 7.47-7.42 (1H, m), 6.99-6.95 (2H, m), 6.83 (1H, s), 3.94 (2H, q, J = 7.0 Hz), 1.17 (3H, t, J = 7.0 Hz). 416 .sup.1H-NMR (CDCl.sub.3) δ: 7.84 (1H, s), 7.42-7.36 (1H, m), 7.12 (1H, d, J = 5.4 Hz), 6.95-6.90 (2H, m), 6.85 (1H, d, J = 5.4 Hz), 3.96 (2H, q, J = 7.0 Hz), 1.18 (3H, t, J = 7.0 Hz). 417 .sup.1H-NMR (CDCl.sub.3) δ: 7.46-7.39 (1H, m), 7.35 (1H, d, J = 9.3 Hz), 7.00-6.94 (2H, m), 6.83 (1H, s), 6.72 (1H, d, J = 9.3 Hz), 3.89 (2H, q, J = 7.1 Hz), 1.15 (3H, t, J = 7.0 Hz). 418 .sup.1H-NMR (CDCl.sub.3) δ: 7.48 (1H, d, J = 9.5 Hz), 7.43-7.37 (1H, m), 7.13 (1H, d, J = 5.2 Hz), 6.95-6.90 (2H, m), 6.86 (1H, d, J = 5.2 Hz), 6.76 (1H, d, J = 9.5 Hz), 6.16 (1H, tt, J = 56.6, 4.5 Hz), 4.18 (2H, td, J = 12.8, 4.5 Hz). 419 .sup.1H-NMR (CDCl.sub.3) δ: 7.66 (1H, s), 7.53-7.44 (1H, m), 7.01-6.95 (2H, m), 6.72 (1H, s), 6.16 (1H, tt, J = 56.4, 4.5 Hz), 4.20 (2H, td, J = 12.6, 4.5 Hz). 420 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.47-7.37 (1H, m), 7.15 (1H, d, J = 5.5 Hz), 6.95-6.90 (2H, m), 6.87 (1H, d, J = 5.5 Hz), 6.18 (1H, tt, J = 56.4, 4.5 Hz), 4.22 (2H, td, J = 13.1, 4.5 Hz). 421 .sup.1H-NMR (CDCl.sub.3) δ: 7.52-7.40 (2H, m), 7.00-6.95 (2H, m), 6.75 (1H, d, J = 9.5 Hz), 6.71 (1H, s), 6.14 (1H, tt, J = 56.6, 4.4 Hz), 4.16 (2H, td, J = 12.8, 4.4 Hz). 422 .sup.1H-NMR (CDCl.sub.3) δ: 7.86 (1H, s), 7.52-7.44 (1H, m), 7.01-6.94 (2H, m), 6.84 (1H, s), 6.16 (1H, tt, J = 56.4, 4.5 Hz), 4.20 (2H, td, J = 12.7, 4.5 Hz). 423 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 7.46-7.39 (1H, m), 7.15 (1H, d, J = 5.5 Hz), 6.95-6.90 (2H, m), 6.86 (1H, d, J = 5.5 Hz), 6.18 (1H, tt, J = 56.6, 4.5 Hz), 4.22 (2H, td, J = 12.7, 4.5 Hz). 424 .sup.1H-NMR (CDCl.sub.3) δ: 7.39-7.31 (2H, m), 6.91-6.85 (2H, m), 6.82 (1H, d, J = 5.1 Hz), 6.74 (1H, d, J = 9.3 Hz), 6.53 (1H, d, J = 5.1 Hz), 6.17 (1H, tt, J = 56.8, 4.5 Hz), 4.17 (2H, td, J = 12.9, 4.5 Hz), 2.24 (3H, s). 425 .sup.1H-NMR (CDCl.sub.3) δ: 7.54 (1H, d, J = 9.8 Hz), 7.33 (1H, dd, J = 3.9, 0.7 Hz), 7.25-7.20 (2H, m), 7.07 (1H, dd, J = 4.6, 0.7 Hz), 7.05-6.99 (1H, m), 6.75 (1H, d, J = 9.8 Hz), 6.34-6.04 (1H, m), 4.62-4.50 (1H, m), 3.61-3.50 (1H, m). 426 .sup.1H-NMR (CDCl.sub.3) δ: 7.79 (1H, s), 7.35 (1H, dd, J = 4.0, 0.6 Hz), 7.26-7.19 (2H, m), 7.05-7.03 (2H, m), 6.36-6.06 (1H, m), 4.66-4.54 (1H, m), 3.67- 3.57 (1H, m). 427 .sup.1H-NMR (CDCl.sub.3) δ: 7.89 (1H, s), 7.39 (1H, d, J = 0.5 Hz), 7.18 (1H, d, J = 0.5 Hz), 7.11 (1H, d, J = 8.5 Hz), 6.99 (1H, d, J = 2.4 Hz), 6.80 (1H, dd, J = 8.5, 2.4 Hz), 4.31-4.23 (1H, m), 3.84 (3H, s), 3.57-3.50 (1H, m), 1.13 (3H, t, J = 7.1 Hz). 428 .sup.1H-NMR (CDCl.sub.3) δ: 7.43 (1H, d, J = 9.5 Hz), 7.38 (1H, d, J = 0.5 Hz), 7.19 (1H, d, J = 0.5 Hz), 7.12 (1H, d, J = 8.5 Hz), 6.98 (1H, d, J = 2.4 Hz), 6.79 (1H, dd, J = 8.5, 2.4 Hz), 6.69 (1H, d, J = 9.8 Hz), 4.27-4.18 (1H, m), 3.83 (3H, s), 3.51-3.41 (1H, m), 1.11 (3H, t, J = 7.1 Hz). 429 .sup.1H-NMR (CDCl.sub.3) δ: 7.61 (1H, s), 7.42-7.33 (1H, m), 7.03 (1H, d, J = 5.6 Hz), 6.91 (2H, t, J = 7.9 Hz), 6.53 (1H, d, J = 5.6 Hz), 3.45 (3H, s). 430 .sup.1H-NMR (CDCl.sub.3) δ: 7.81 (1H, s), 7.41-7.33 (1H, m), 7.03 (1H, d, J = 5.6 Hz), 6.91 (2H, dd, J = 8.4, 7.4 Hz), 6.53 (1H, d, J = 5.6 Hz), 3.45 (3H, s). 431 .sup.1H-NMR (CDCl.sub.3) δ: 7.35-7.29 (2H, m), 6.88 (2H, dd, J = 8.3, 7.3 Hz), 6.82 (1H, d, J = 5.2 Hz), 6.73 (1H, d, J = 9.5 Hz), 6.53 (1H, d, J = 5.2 Hz 3.38 (3H, s), 2.23 (3H, s). 432 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.48 (1H, tt, J = 8.5, 6.3 Hz), 7.00-6.95 (2H, m), 6.79 (1H, s), 6.16 (1H, tt, J = 56.5, 4.5 Hz), 4.21 (2H, td, J = 12.7, 4.5 Hz). 433 .sup.1H-NMR (CDCl.sub.3) δ: 7.92 (1H, s), 7.43 (1H, tt, J = 8.5, 6.3 Hz), 7.15 (1H, d, J = 5.4 Hz), 6.96-6.90 (2H, m), 6.80 (1H, d, J = 5.4 Hz), 6.17 (1H, tt, J = 56.5, 4.5 Hz), 4.23 (2H, td, J = 12.7, 4.5 Hz). 434 .sup.1H-NMR (CDCl.sub.3) δ: 7.52-7.42 (1H, m), 7.44 (1H, d, J = 9.5 Hz), 6.99-6.95 (2H, m), 6.78 (1H, s), 6.75 (1H, d, J = 9.5 Hz), 6.14 (1H, tt, J = 56.6, 4.5 Hz), 4.16 (2H, td, J = 12.9, 4.5 Hz). 435 .sup.1H-NMR (CDCl.sub.3) δ: 7.44 (1H, d, J = 9.5 Hz), 7.38 (1H, tt, J = 8.6, 6.4 Hz), 7.11 (1H, d, J = 5.5 Hz), 6.94-6.90 (2H, m), 6.79 (1H, d, J = 5.5 Hz), 6.75 (1H, d, J = 9.5 Hz), 3.39 (3H, s). 436 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.48 (1H, tt, J = 8.6, 6.4 Hz), 7.00-6.97 (2H, m), 6.67 (1H, s), 6.16 (1H, tt, J = 56.4, 4.5 Hz), 4.21 (2H, td, J = 12.6, 4.5 Hz). 437 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.43 (1H, tt, J = 8.5, 6.3 Hz), 7.15 (1H, d, J = 5.4 Hz), 6.95-6.91 (2H, m), 6.80 (1H, d, J = 5.4 Hz), 6.17 (1H, tt, J = 56.5, 4.5 Hz), 4.23 (2H, td, J = 12.7, 4.5 Hz). 438 .sup.1H-NMR (CDCl.sub.3) δ: 7.52-7.43 (1H, m), 7.44 (1H, d, J = 9.5 Hz), 7.00-6.95 (2H, m), 6.75 (1H, d, J = 9.5 Hz), 6.66 (1H, s), 6.14 (1H, tt, J = 56.5, 4.5 Hz), 4.16 (2H, td, J = 12.8, 4.5 Hz). 439 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.40 (1H, tt, J = 8.5, 6.3 Hz), 7.14 (1H, d, J = 5.4 Hz), 6.96-6.90 (2H, m), 6.80 (1H, d, J = 5.4 Hz), 3.46 (3H, s). 440 .sup.1H-NMR (CDCl.sub.3) δ: 7.62 (1H, s), 7.46 (1H, tt, J = 8.5, 6.3 Hz), 7.01-6.95 (2H, m), 6.66 (1H, s), 3.44 (3H, s). 441 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.40 (1H, tt, J = 8.6, 6.4 Hz), 7.14 (1H, d, J = 5.2 Hz), 6.95-6.90 (2H, m), 6.80 (1H, d, J = 5.2 Hz), 3.46 (3H, s). 442 .sup.1H-NMR (CDCl.sub.3) δ: 7.82 (1H, s), 7.45 (1H, tt, J = 8.6, 6.4 Hz), 6.99-6.95 (2H, m), 6.78 (1H, s), 3.44 (3H, s). 443 .sup.1H-NMR (CDCl.sub.3) δ: 7.46-7.39 (1H, m), 7.37 (1H, d, J = 9.4 Hz), 6.96-6.92 (2H, m), 6.72 (1H, d, J = 9.4 Hz), 6.67 (1H, s), 6.15 (1H, tt, J = 56.5, 4.5 Hz), 4.15 (2H, td, J = 12.9, 4.5 Hz), 1.98 (3H, s). 444 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.36-7.29 (1H, m), 6.87 (2H, dd, J = 8.5, 7.3 Hz), 6.80 (1H, d, J = 5.1 Hz), 6.53 (1H, d, J = 5.1 Hz), 3.94 (2H, q, J = 7.1 Hz), 2.25 (3H, s), 1.16 (3H, t, J = 7.1 Hz). 445 .sup.1H-NMR (CDCl.sub.3) δ: 7.65 (1H, s), 7.42-7.35 (1H, m), 7.05 (1H, d, J = 5.1 Hz), 6.90 (2H, dd, J = 8.5, 7.3 Hz), 6.70 (1H, d, J = 5.1 Hz), 6.19 (1H, tt, J = 56.5, 4.5 Hz), 4.21 (2H, td, J = 12.8, 4.5 Hz), 2.05 (3H, s). 446 .sup.1H-NMR (CDCl.sub.3) δ: 7.85 (1H, s), 7.42-7.35 (1H, m), 7.05 (1H, d, J = 5.1 Hz), 6.92-6.88 (2H, m), 6.70 (1H, d, J = 5.1 Hz), 6.19 (1H, tt, J = 56.5, 4.5 Hz), 4.21 (2H, td, J = 12.6, 4.5 Hz), 2.05 (3H, s). 447 .sup.1H-NMR (CDCl.sub.3) δ: 7.54 (1H, d, J = 9.8 Hz), 7.40 (1H, dd, J = 7.6, 2.4 Hz), 7.33 (1H, d, J = 4.0 Hz), 7.25-7.22 (1H, m), 7.10-7.05 (2H, m), 6.75 (1H, d, J = 9.8 Hz), 6.32-6.08 (1H, m), 4.64-4.53 (1H, m), 3.58-3.49 (1H, m). 448 .sup.1H-NMR (CDCl.sub.3) δ: 7.79 (1H, s), 7.42 (1H, dd, J = 7.8, 2.6 Hz), 7.35 (1H, dd, J = 4.0, 0.6 Hz), 7.25-7.22 (1H, m), 7.11-7.06 (2H, m), 6.34-6.09 (1H, m), 4.68-4.57 (1H, m), 3.64-3.56 (1H, m). 449 .sup.1H-NMR (CDCl.sub.3) δ: 7.99 (1H, s), 7.41 (1H, dd, J = 8.0, 2.4 Hz), 7.35 (1H, dd, J = 4.0, 0.6 Hz), 7.25-7.22 (1H, m), 7.11-7.06 (2H, m), 6.33-6.10 (1H, m), 4.66-4.57 (1H, m), 3.65-3.56 (1H, m). 450 .sup.1H-NMR (CDCl.sub.3) δ: 8.01 (1H, s), 7.36 (1H, dd, J = 4.0, 0.6 Hz), 7.17 (1H, d, J = 2.4 Hz), 7.10 (1H, dd, J = 8.6, 2.1 Hz), 7.05 (1H, dd, J = 4.9, 0.6 Hz), 6.86 (1H, dd, J = 8.6, 2.1 Hz), 6.34-6.09 (1H, m), 4.63-4.54 (1H, m), 3.84 (3H, s), 3.74-3.65 (1H, m). 451 .sup.1H-NMR (CDCl.sub.3) δ: 7.46 (1H, d, J = 9.8 Hz), 7.39 (1H, d, J = 0.5 Hz), 7.25 (1H, dd, J = 8.5, 2.6 Hz), 7.19 (1H, d, J = 0.5 Hz), 7.16 (1H, dd, J = 8.5, 5.6 Hz), 7.04-6.98 (1H, m), 6.73 (1H, d, J = 9.5 Hz), 3.29 (3H, s). 452 .sup.1H-NMR (CDCl.sub.3) δ: 7.72 (1H, s), 7.40 (1H, d, J = 0.6 Hz), 7.26 (1H, dd, J = 8.3, 2.4 Hz), 7.19-7.16 (2H, m), 7.05-7.00 (1H, m), 3.37 (3H, s). 453 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 7.40 (1H, d, J = 0.7 Hz), 7.25-7.24 (1H, m), 7.18-7.16 (2H, m), 7.05-6.99 (1H, m), 3.37 (3H, s). 454 .sup.1H-NMR (CDCl.sub.3) δ: 7.26 (1H, tt, J = 8.4, 6.4 Hz), 6.98 (1H, d, J = 5.6 Hz), 6.83-6.81 (2H, m), 6.49 (1H, d, J = 5.6 Hz), 2.89 (3H, s), 2.76-2.74 (4H, m). 455 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.27 (1H, tt, J = 8.4, 6.4 Hz), 6.87 (1H, d, J = 5.6 Hz), 6.85-6.83 (2H, m), 6.55 (1H, d, J = 5.6 Hz), 2.92 (6H, s). 456 .sup.1H-NMR (CDCl.sub.3) δ: 7.37-7.35 (2H, m), 7.01 (1H, d, J = 5.6 Hz), 6.91-6.89 (2H, m), 6.75 (1H, d, J = 9.5 Hz), 6.52 (1H, d, J = 5.6 Hz), 3.39 (3H, s). 457 .sup.1H-NMR (CDCl.sub.3) δ: 7.25 (1H, tt, J = 8.4, 6.4 Hz), 6.96 (1H, d, J = 4.9 Hz), 6.83-6.81 (2H, m), 6.65 (1H, d, J = 4.9 Hz), 2.89 (3H, s), 2.77-2.69 (4H, m), 2.04 (3H, s). 458 .sup.1H-NMR (CDCl.sub.3) δ: 7.35 (1H, d, J = 9.5 Hz), 7.22 (1H, dd, J = 8.6, 5.8 Hz), 7.15 (1H, dd, J = 8.3, 2.4 Hz), 6.98 (1H, ddd, J = 8.6, 8.0, 2.4 Hz), 6.84 (1H, d, J = 5.8 Hz), 6.71 (1H, d, J = 9.5 Hz), 6.47 (1H, d, J = 5.8 Hz), 4.23-4.18 (1H, m), 3.51-3.49 (1H, m), 1.13 (3H, t, J = 7.0 Hz). 459 .sup.1H-NMR (CDCl.sub.3) δ: 7.78 (1H, s), 7.21 (1H, dd, J = 8.6, 5.8 Hz), 7.15 (1H, dd, J = 8.3, 2.8 Hz), 6.99 (1H, ddd, J = 8.6, 8.0, 2.8 Hz), 6.86 (1H, d, J = 5.5 Hz), 6.48 (1H, d, J = 5.5 Hz), 4.24 (1H, dq, J = 13.8, 7.0 Hz) 3.56 (1H, dq, J = 13.8, 7.0 Hz), 1.15 (3H, t, J = 7.0 Hz). 460 .sup.1H-NMR (CDCl.sub.3) δ: 7.58 (1H, s), 7.21 (1H, dd, J = 8.5, 5.6 Hz), 7.16 (1H, dd, J = 8.3, 2.4 Hz), 6.99 (1H, ddd, J = 8.5, 8.3, 2.4 Hz), 6.86 (1H, d, J = 5.9 Hz), 6.48 (1H, d, J = 5.9 Hz), 4.25 (1H, dq, J = 13.7, 7.0 Hz), 3.56 (1H, dq, J = 13.7, 7.0 Hz), 1.15 (3H, t, J = 7.1 Hz). 461 .sup.1H-NMR (CDCl.sub.3) δ: 7.73 (1H, s), 7.52-7.43 (1H, m), 7.32 (1H, d, J = 4.9 Hz), 7.16 (1H, d, J = 4.9 Hz), 7.02-6.97 (2H, m), 3.45 (3H, s). 462 .sup.1H-NMR (CDCl.sub.3) δ: 7.93 (1H, s), 7.47-7.45 (1H, m), 7.32 (1H, d, J = 4.9 Hz), 7.16 (1H, d, J = 4.9 Hz), 7.00-6.98 (2H, m), 3.45 (3H, s). 463 .sup.1H-NMR (CDCl.sub.3) δ: 7.46 (1H, d, J = 9.8 Hz), 7.33 (1H, d, J = 4.9 Hz), 7.11-7.09 (1H, m), 7.05 (1H, d, J = 4.9 Hz), 6.95-6.93 (1H, m), 6.91-6.87 (1H, m), 6.73 (1H, d, J = 9.8 Hz), 3.34 (3H, s). 464 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.35 (1H, d, J = 4.9 Hz), 7.11-7.09 (1H, m), 7.04 (1H, d, J = 4.9 Hz), 6.98-6.88 (2H, m), 3.41 (3H, s). 465 .sup.1H-NMR (CDCl.sub.3) δ: 7.91 (1H, s), 7.34 (1H, d, J = 4.9 Hz), 7.11-7.09 (1H, m), 7.04 (1H, d, J = 4.9 Hz), 6.96-6.94 (1H, m), 6.91-6.89 (1H, m), 3.41 (3H, s). 466 .sup.1H-NMR (CDCl.sub.3) δ: 7.70 (1H, s), 7.30 (1H, s), 6.91-6.89 (1H, br m), 6.19- 6.18 (1H, br m), 6.17-6.15 (1H, br m), 4.23-4.21 (1H, br m), 3.81-3.79 (1H, br m), 3.26-3.25 (4H, m), 2.03-2.00 (4H, m), 1.90 (3H, s), 1.15 (3H, t, J = 7.0 Hz). 467 .sup.1H-NMR (CDCl.sub.3) δ: 8.00 (1H, s), 7.48-7.42 (1H, m), 7.37 (1H, d, J = 4.9 Hz), 7.13 (1H, d, J = 4.9 Hz), 6.99-6.95 (2H, m), 5.15 (2H, br s). 468 .sup.1H-NMR (CDCl.sub.3) δ: 7.98 (1H, s), 7.47-7.40 (1H, m), 7.37 (1H, d, J = 4.6 Hz), 7.13 (1H, d, J = 4.6 Hz), 6.96-6.95 (2H, m), 5.88 (1H, q, J = 5.9 Hz), 2.55 (3H, d, J = 5.9 Hz). 469 .sup.1H-NMR (CDCl.sub.3) δ: 7.71 (1H, s), 7.28 (1H, s), 6.94-6.92 (1H, m), 6.55-6.52 (1H, br m), 6.51-6.50 (1H, m), 4.20-4.17 (1H, br m), 3.81-3.79 (1H, br m), 3.22-3.20 (4H, m), 1.89 (3H, s), 1.66-1.63 (6H, m), 1.15 (3H, t, J = 7.0 Hz). 470 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.30 (1H, s), 7.02-6.97 (1H, m), 6.83-6.81 (1H, m), 6.74-6.72 (1H, m), 3.08 (3H, s), 2.71 (3H, s), 1.88 (3H, s). 471 .sup.1H-NMR (CDCl.sub.3) δ: 7.87 (1H, s), 7.70-7.68 (1H, m), 7.65-7.63 (1H, m), 7.55- 7.51 (1H, m), 7.48-7.47 (1H, m), 7.16 (1H, s), 7.12 (1H, s), 4.05-3.98 (1H, m), 3.74-3.71 (1H, m), 1.92 (3H, s), 1.19 (3H, t, J = 7.1 Hz). 472 .sup.1H-NMR (CDCl.sub.3) δ: 7.77 (1H, s), 7.71-7.69 (1H, m), 7.61-7.59 (1H, m), 7.53- 7.51 (1H, m), 7.46-7.44 (1H, m), 7.20 (1H, s), 4.17-4.12 (1H, m), 3.70- 3.67 (1H, m), 1.86 (3H, s), 1.19 (3H, t, J = 7.0 Hz). 473 .sup.1H-NMR (CDCl.sub.3) δ: 7.84 (1H, s), 7.40-7.38 (1H, m), 7.30 (1H, s), 6.92-6.90 (2H, m), 5.19 (2H, br s), 1.93 (3H, s). 474 .sup.1H-NMR (CDCl.sub.3) δ: 7.48 (1H, d, J = 9.8 Hz), 7.26 (1H, s), 7.23-7.21 (1H, m), 7.17-7.15 (1H, m), 6.98-6.96 (1H, m), 6.92 (1H, s), 6.71 (1H, d, J = 9.8 Hz), 3.29 (3H, s), 1.92 (3H, s). 475 .sup.1H-NMR (CDCl.sub.3) δ: 7.81 (1H, s), 7.37-7.35 (1H, m), 7.29 (1H, s), 6.90-6.88 (2H, m), 5.92 (1H, q, J = 5.9 Hz), 2.55 (3H, d, J = 5.9 Hz), 1.92 (3H, s). 476 .sup.1H-NMR (CDCl.sub.3) δ: 7.56 (1H, s), 7.25-7.17 (3H, m), 6.98-6.95 (1H, m), 3.40 (3H, s), 1.90 (3H, s). 477 .sup.1H-NMR (CDCl.sub.3) δ: 7.80 (1H, s), 7.29 (1H, s), 7.20-7.15 (2H, m), 6.93-6.91 (1H, m), 5.27 (2H, br s), 1.91 (3H, s). 478 .sup.1H-NMR (CDCl.sub.3) δ: 7.78 (1H, s), 7.30 (1H, s), 7.24-7.23 (1H, m), 7.15-7.13 (1H, m), 6.92-6.90 (1H, m), 5.97 (1H, q, J = 5.8 Hz), 2.47 (3H, d, J = 5.9 Hz), 1.91 (3H, s). 479 .sup.1H-NMR (CDCl.sub.3) δ: 7.73 (1H, s), 7.24 (1H, s), 7.19-7.17 (1H, m), 7.11-7.08 (1H, m), 6.92-6.90 (1H, m), 3.08 (3H, s), 2.75 (3H, s), 1.90 (3H, s). 480 .sup.1H-NMR (CDCl.sub.3) δ: 7.60 (1H, s), 7.41-7.32 (1H, m), 6.89 (2H, dd, J = 8.4, 7.4 Hz), 6.84 (1H, d, J = 5.1 Hz), 6.54 (1H, d, J = 5.1 Hz), 6.19 (1H, tt, J = 56.5, 4.5 Hz), 4.21 (2H, td, J = 12.8, 4.5 Hz), 2.25 (3H, s). 481 .sup.1H-NMR (CDCl.sub.3) δ: 7.48 (1H, d, J = 9.8 Hz), 7.32 (1H, dd, J = 3.9, 0.7 Hz), 7.25 (1H, dd, J = 8.3, 2.4 Hz), 7.17 (1H, dd, J = 8.7, 5.7 Hz), 7.09 (1H, dd, J = 4.9, 0.7 Hz), 7.04-6.98 (1H, m), 6.73 (1H, d, J = 9.8 Hz), 3.30 (3H, s). 482 .sup.1H-NMR (CDCl.sub.3) δ: 7.73 (1H, s), 7.34 (1H, dd, J = 3.9, 0.6 Hz), 7.26 (1H, dd, J = 7.8, 2.7 Hz), 7.16 (1H, dd, J = 8.7, 5.7 Hz), 7.08 (1H, dd, J = 4.8, 0.6 Hz), 7.04-7.00 (1H, m), 3.37 (3H, s). 483 .sup.1H-NMR (CDCl.sub.3) δ: 7.93 (1H, s), 7.34 (1H, dd, J = 4.0, 0.7 Hz), 726 (1H, dd, J = 8.4, 2.4 Hz), 7.17 (1H, dd, J = 8.7, 5.7 Hz), 7.08 (1H, dd, J = 4.7, 0.7 Hz), 7.05-6.99 (1H, m), 3.37 (3H, s). 484 .sup.1H-NMR (CDCl.sub.3) δ: 7.54 (1H, s), 7.38-7.30 (1H, m), 6.88 (2H, dd, J = 8.6, 7.3 Hz), 6.83 (1H, d, J = 5.2 Hz), 6.53 (1H, d, J = 5.2 Hz), 3.45 (3H, s), 2.24 (3H, s). 485 .sup.1H-NMR (CDCl.sub.3) δ: 7.41 (1H, d, J = 9.8 Hz), 7.33-7.32 (1H, m), 7.28-7.26 (1H, m), 7.24 (1H, s), 7.06-7.05 (1H, m), 6.94 (1H, s), 6.69 (1H, d, J = 9.8 Hz), 4.03-4.00 (1H, m), 3.69-3.67 (1H, m), 1.94 (3H, s), 1.13 (3H, t, J = 7.0 Hz). 486 .sup.1H-NMR (CDCl.sub.3) δ: 7.77 (1H, s), 7.47-7.44 (1H, m), 7.41-7.39 (1H, m), 7.32- 7.30 (1H, m), 7.23 (1H, s), 4.16-4.13 (1H, m), 3.70-3.67 (1H, m), 1.89 (3H, s), 1.19 (314, t, .J = 7.1 Hz). 487 .sup.1H-NMR (CDCl.sub.3) δ: 7.49 (1H, d, J = 9.8 Hz), 7.44-7.38 (1H, m), 7.26 (1H, s), 7.17-7.05 (3H, m), 6.85 (1H, s), 6.71 (1H, d, J = 9.8 Hz), 3.35 (3H, s), 1.89 (3H, s). 488 .sup.1H-NMR (CDCl.sub.3) δ: 7.59 (1H, s), 7.42-7.39 (1H, m), 7.28 (1H, s), 7.17-7.05 (3H, m), 3.45 (3H, d, J = 1.0 Hz), 1.86 (3H, s). 489 .sup.1H-NMR (CDCl.sub.3) δ: 7.95 (1H, s), 7.46-7.40 (1H, m), 7.27 (1H, s), 7.18-7.05 (3H, m), 6.84 (1H, s), 3.42 (3H, d, J = 1.0 Hz), 1.89 (3H, s). 490 .sup.1H-NMR (CDCl.sub.3) δ: 7.79 (1H, s), 7.41-7.39 (1H, m), 7.28 (1H, s), 7.13-7.07 (3H, m), 3.45 (3H, d, J = 1.2 Hz), 1.86 (3H, s). 491 .sup.1H-NMR (CDCl.sub.3) δ: 7.42-7.33 (1H, m), 7.27-7.24 (1H, m), 6.93 (2H, dd, J = 8.3, 7.3 Hz), 6.72 (1H, d, J = 9.3 Hz), 6.50 (1H, s), 3.37 (3H, s), 2.15 (3H, s). 492 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.37-7.31 (2H, m), 6.88 (2H, dd, J = 8.6, 7.3 Hz), 6.83 (1H, d, J = 5.2 Hz), 6.53 (1H, d, J = 5.2 Hz), 3.45 (3H, s). 493 .sup.1H-NMR (CDCl.sub.3) δ: 7.51 (1H, d, J = 9.5 Hz), 7.41 (1H, tt, J = 8.4, 3.5 Hz), 7.15-7.12 (1H, m), 6.95-6.90 (3H, m), 6.74 (2H, dt, J = 10.3, 3.5 Hz), 6.16 (1H, tt, J = 56.6, 4.6 Hz), 4.16 (2H, td, J = 12.9, 4.6 Hz). 494 .sup.1H-NMR (CDCl.sub.3) δ: 7.76 (1H, s), 7.45-7.39 (1H, m), 6.96-6.92 (2H, m), 6.51 (1H, s), 6.18 (1H, tt, J = 56.6, 4.5 Hz), 4.20 (2H, td, J = 12.7, 4.5 Hz), 2.17 (3H, s). 495 .sup.1H-NMR (CDCl.sub.3) δ: 7.95 (1H, s), 7.48-7.40 (1H, m), 6.95 (2H, t, J = 8.3 Hz), 6.52 (1H, s), 6.18 (1H, tt, J = 56.5, 4.5 Hz), 4.43 (2H, s), 4.19 (2H, td, J = 12.3, 4.5 Hz). 496 .sup.1H-NMR (CDCl.sub.3) δ: 7.37-7.33 (2H, m), 7.02 (1H, d, J = 4.9 Hz), 6.90-6.88 (2H, m), 6.72 (1H, d, J = 9.5 Hz), 6.70 (1H, d, J = 4.9 Hz), 3.38 (3H, s), 2.02 (3H, s). 497 .sup.1H-NMR (CDCl.sub.3) δ: 7.35 (1H, d, J = 9.3 Hz), 7.10 (1H, d, J = 8.7 Hz), 6.91 (1H, d, J = 2.7 Hz), 6.82 (1H, d, J = 5.9 Hz), 6.76 (1H, dd, J = 8.7, 2.7 Hz), 6.68 (1H, d, J = 9.3 Hz), 6.47 (1H, d, J = 5.9 Hz), 4.21 (1H, d q, J = 13.2, 7.1 Hz), 3.81 (3H, s), 3.54 (1H, dq, J = 13.2, 7.1 Hz), 1.12 (3H, t, J = 7.1 Hz). 498 .sup.1H-NMR (CDCl.sub.3) δ: 7.59 (1H, s), 7.41-7.32 (1H, m), 7.04 (1H, d, J = 5.1 Hz), 6.92-6.89 (2H, m), 6.70 (1H, d, J = 5.1 Hz), 3.45 (3H, s), 2.03 (3H, s). 499 .sup.1H-NMR (CDCl.sub.3) δ: 7.76 (1H, s), 7.16-7.10 (1H, m), 7.04 (1H, d, J = 5.6 Hz), 6.88-6.81 (2H, m), 6.49 (1H, dd, J = 5.6, 0.7 Hz), 4.08-4.01 (1H, m) 3.84-3.81 (1H, m), 1.17 (3H, t, J = 7.1 Hz). 500 .sup.1H-NMR (CDCl.sub.3) δ: 7.32 (1H, d, J = 9.5 Hz), 7.15-7.12 (1H, m), 7.02 (1H, d, J = 5.6 Hz), 6.86-6.82 (2H, m), 6.70 (1H, d, J = 9.5 Hz), 6.48 (1H, d, J = 5.6 Hz), 4.04-3.97 (1H, m), 3.78-3.75 (1H, m), 1.14 (3H, t, J = 7.1 Hz). 501 .sup.1H-NMR (CDCl.sub.3) δ: 7.55 (1H, s), 7.15-7.11 (1H, m), 7.04 (1H, d, J = 5.6 Hz), 6.88-6.81 (2H, m), 6.49 (1H, d, J = 5.6 Hz), 4.00-3.88 (2H, m), 1.17 (3H, t, J = 7.1 Hz). 502 .sup.1H-NMR (CDCl.sub.3) δ: 7.58 (1H, s), 7.09 (1H, d, J = 8.6 Hz), 6.91 (1H, d, J = 2.4 Hz), 6.83 (1H, d, J = 5.5 Hz), 6.76 (1H, dd, J = 8.6, 2.4 Hz), 6.48 (1H, d, J = 5.5 Hz), 4.25 (1H, dq, J = 13.1, 7.0 Hz), 3.81 (3H, s), 3.60 (1H, dq, J = 13.1, 7.0 Hz), 1.14 (3H, t, J = 7.0 Hz). 503 .sup.1H-NMR (CDCl.sub.3) δ: 7.28-7.26 (1H, m), 7.10-7.04 (1H, m), 6.86-6.78 (3H, m), 6.68 (1H, d, J = 9.5 Hz), 6.47 (1H, d, J = 5.4 Hz), 4.04-4.00 (1H, m), 3.79-3.75 (1H, m), 2.22 (3H, s), 1.14 (3H, t, J = 7.1 Hz). 504 .sup.1H-NMR (CDCl.sub.3) δ: 7.78 (1H, s), 7.09 (1H, d, J = 8.6 Hz), 6.91 (1H, d, J = 2.8 Hz), 6.83 (1H, d, J = 5.8 Hz), 6.76 (1H, dd, J = 8.6, 2.4 Hz), 6.48 (1H, d, J = 5.8 Hz), 4.26-4.23 (1H, m), 3.81 (3H, s), 3.62-3.59 (1H, m), 1.14 (3H, t, J = 7.0 Hz). 505 .sup.1H-NMR (CDCl.sub.3) δ: 7.42 (1H, d, J = 9.5 Hz), 7.24 (1H, s), 7.17-7.15 (1H, m), 6.93 (1H, s), 6.89-6.86 (2H, m), 6.69 (1H, d, J = 9.5 Hz), 4.04-4.02 (1H, m), 3.71-3.68 (1H, m), 1.93 (3H, s), 1.13 (3H, t, J = 7.0 Hz). 506 .sup.1H-NMR (CDCl.sub.3) δ: 7.30 (1H, d, J = 9.8 Hz), 7.24 (1H, s), 7.19-7.18 (1H, m), 6.86-6.83 (2H, m), 6.70 (1H, d, J = 9.8 Hz), 4.12-4.11 (1H, m), 3.70- 3.67 (1H, m), 1.89 (3H, s), 1.14 (3H, t, J = 7.0 Hz). 507 .sup.1H-NMR (CDCl.sub.3) δ: 7.57 (1H, s), 7.43 (1H, s), 7.42-7.41 (1H, m), 7.35-7.34 (1H, m), 7.24 (1H, s), 4.15-4.12 (1H, m), 3.72-3.69 (1H, m), 1.87 (3H, s), 1.17 (3H, t, J = 7.0 Hz). 508 .sup.1H-NMR (CDCl.sub.3) δ: 7.67 (1H, s), 7.51-7.46 (2H, m), 7.35 (1H, dd, J = 7.9, 6.7 Hz) 7.29 (1H, d, J = 4.2 Hz), 7.15 (1H, d, J = 4.9 Hz), 4.04 (1H, dq, J = 13.8, 7.1 Hz), 3.74 (1H, dq, J = 13.8, 7.1 Hz), 1.17 (3H, t, J = 7.1 Hz). 509 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.43 (1H, td, J = 8.3, 5.9 Hz), 7.34-7.32 (1H, m), 7.31-7.28 (1H, m), 7.17 (1H, d, J = 4.9 Hz), 7.11 (1H, td, J = 8.4, 0.9 Hz), 3.41 (3H, s). 510 .sup.1H-NMR (CDCl.sub.3) δ: 7.94 (1H, s), 7.43 (1H, td, J = 8.3, 6.1 Hz), 7.34-7.31 (1H, m), 7.30-7.27 (1H, m), 7.17 (1H, d, J = 4.9 Hz), 7.11 (1H, td, J = 8.3, 1.0 Hz), 3.41 (3H, s). 511 .sup.1H-NMR (CDCl.sub.3) δ: 7.52 (1H, d, J = 9.8 Hz), 7.25 (1H, s), 7.10-7.08 (1H, m), 6.96-6.89 (2H, m), 6.75 (1H, s), 6.69 (1H, d, J = 9.8 Hz), 3.24 (3H, s), 2.13 (3H, s), 1.91 (3H, s). 512 .sup.1H-NMR (CDCl.sub.3) δ: 7.56 (1H, s), 7.22 (1H, s), 7.11-7.09 (1H, br m), 6.93- 6.91 (1H, m), 6.86-6.84 (1H, m), 3.31 (3H, s), 2.21 (3H, s), 1.89 (3H, s). 513 .sup.1H-NMR (CDCl.sub.3) δ: 7.98 (1H, s), 7.26 (1H, s), 7.10-7.07 (1H, m), 6.95-6.92 (2H, m), 6.73 (1H, s), 3.31 (3H, s), 2.12 (3H, s), 1.90 (3H, s). 514 .sup.1H-NMR (CDCl.sub.3) δ: 7.75 (1H, s), 7.22 (1H, s), 7.11-7.09 (1H, m), 6.93-6.90 (1H, m), 6.86-6.84 (1H, m), 3.31 (3H, s), 2.21 (3H, s), 1.89 (3H, s). 515 .sup.1H-NMR (CDCl.sub.3) δ: 7.76 (1H, s), 7.25 (1H, s), 7.23-7.21 (1H, br m), 7.19- 7.17 (1H, m), 6.98-6.94 (1H, m), 3.40 (3H, s), 1.90 (3H, s).

(1462) Next, it specifically shows that the compounds of the present invention are effective against plant diseases, but the invention is not limited to these examples.

[Test Example A] Blast on Rice

(1463) Seeds of a test plant (rice variety: Sachikaze) were planted and cultivated until the second leaves appeared. In the test, the compounds of the present invention were dissolved into a dimethyl sulfoxide-methanol mixture solution (volume ratio: 9/1), and the resultant solutions were diluted with well water to a concentration of 250 ppm. The dilutions thus obtained were sprayed to the test plant (2.5 ml/pot). After the dilutions dried, a conidial suspension (1-2×10.sup.5 conidia/ml) of Magnaporthe grisea was inoculated to the plant by spraying. After the inoculation, the plant was kept in a mist chamber at room temperature of 20 to 23° C. for about 24 hours to promote the onset of disease. The disease development was investigated 6 to 10 days after the inoculation, and the effectiveness of the dilutions was evaluated.

[Test Example B] Gray Mold on Tomato

(1464) Seeds of a test plant (tomato variety: Oogata Fukuju) were planted and cultivated until three to five first leaves (true leaves) appeared. In the test, the compounds of the present invention were dissolved into a dimethyl sulfoxide-methanol mixture solution (volume ratio: 9/1), and the resultant solutions were diluted with well water to a concentration of 250 ppm. The thus-obtained dilutions were sprayed to the test plant (2.5 ml/pot). After the dilutions dried, a conidial suspension (4-8×10.sup.5 conidia/ml) of Botrytis cinerea was inoculated to the plant by spraying. After the inoculation, the plant was kept in a mist chamber at room temperature of 20 to 23° C. for about 48 hours to promote the onset of disease. The disease development was investigated 2 to 3 days after the inoculation, and the effectiveness of the dilutions was evaluated.

[Test Example C] Alternaria Sooty Spot on Cabbage

(1465) Seeds of a test plant (cabbage variety: Shikidori) were planted and cultivated until the cotyledons extended. In the test, the compounds of the present invention were dissolved into a dimethyl sulfoxide-methanol mixture solution (volume ratio: 9/1), and the resultant solutions were diluted with well water to a concentration of 250 ppm. The thus-obtained dilutions were sprayed to the test plant (2.5 ml/pot). After the dilutions dried, a conidial suspension (4-8×10.sup.5 conidia/ml) of Alternaia brassicicola was inoculated to the plant by spraying. After the inoculation, the plant was kept in a mist chamber at room temperature of 20 to 23° C. for about 48 hours to promote the onset of disease. The disease development was investigated 2 to 3 days after the inoculation, and the effectiveness of the dilutions was evaluated.

[Test Example D] Powdery Mildew on Barley

(1466) Seeds of a test plant (barley variety: Akashinriki) were planted and cultivated until the first leaves appeared. In the test, the compounds of the present invention were dissolved into a dimethyl sulfoxide-methanol mixture solution (volume ratio: 9/1), and the resultant solutions were diluted with well water to a concentration of 250 ppm. The thus-obtained dilutions were sprayed to the test plant (2.5 ml/pot). After the dilutions dried, conidia of Blumeria graminis f. sp. hordei were inoculated to the plant by shaking off. The disease development was investigated 6 to 10 days after the inoculation, and the effectiveness of the dilutions was evaluated.

[Test Example E] Brown Rust on Wheat

(1467) Seeds of a test plant (wheat variety: Norin 61) were planted and cultivated until the first leaves appeared. In the test, the compounds of the present invention were dissolved into a dimethyl sulfoxide-methanol mixture solution (volume ratio: 9/1), and the resultant solutions were diluted with well water to a concentration of 250 ppm. The thus-obtained dilutions were sprayed to the test plant (2.5 ml/pot). After the dilutions dried, a urediniospore suspension (1-2×10.sup.5 urediniospores/ml) of Puccinia recondita was inoculated to the plant by spraying. After the inoculation, the plant was kept in a mist chamber at room temperature of 20 to 23° C. for about 24 hours to promote the onset of disease. The disease development was investigated 7 to 10 days after the inoculation, and the effectiveness of the dilutions was evaluated.

[Test Example F] Late Blight on Tomato

(1468) Seeds of a test plant (tomato variety: Oogata Fukuju) were planted and cultivated until three to five first leaves appeared. In the test, the compounds of the present invention were dissolved into a dimethyl sulfoxide-methanol mixture solution (volume ratio: 9/1), and the resultant solutions were diluted with well water to a concentration of 250 ppm. The thus-obtained dilutions were sprayed to the test plant (2.5 ml/pot). After the dilutions dried, a zoosporangia suspension (4-8×10.sup.3 zoosporangia/ml) of Phytophthora infestans was inoculated to the plant by spraying. After the inoculation, the plant was kept in a mist chamber at room temperature of 20° C. for about 24 hours to promote the onset of disease. The disease development was investigated 5 to 10 days after the inoculation, and the effectiveness of the dilutions was evaluated.

[Test Example G] Downy Mildew on Vine

(1469) Seeds of a test plant (grape variety: Neomuscat) were planted and cultivated until three to four first leaves appeared. In the test, the compounds of the present invention were dissolved into a dimethyl sulfoxide-methanol mixture solution (volume ratio: 9/1), and the resultant solutions were diluted with well water to a concentration of 250 ppm. The thus-obtained dilutions were sprayed to the test plant (2.5 ml/pot). After the dilutions dried, a zoosporangia suspension (1-2×10.sup.4 zoosporangia/ml) of Plasmopara viticola was inoculated to the plant by spraying. After the inoculation, the plant was kept in a mist chamber at room temperature of 20° C. for about 24 hours to promote the onset of disease. The disease development was investigated 7 to 10 days after the inoculation, and the effectiveness of the dilutions was evaluated.

[Test Example H] Anthracnose on Cucumber

(1470) Seeds of a test plant (cucumber variety: Sagami Hanjiro) were planted and cultivated until the first leaf appeared. In the test, the compounds of the present invention were dissolved into a dimethyl sulfoxide-methanol mixture solution (volume ratio: 9/1), and the resultant solutions were diluted with well water to a concentration of 250 ppm. The thus-obtained dilutions were sprayed to the test plant (2.5 ml/pot). After the dilutions dried, a conidial suspension (2-4×10.sup.5 conidia/ml) of Colletotrichum orbiculare was inoculated to the plant by spraying. After the inoculation, the plant was kept in a mist chamber at room temperature of 20 to 23° C. for about 24 hours to promote the onset of disease. The disease development was investigated 6 to 10 days after the inoculation, and the effectiveness of the dilutions was evaluated.

(1471) Disease development in Test Example described above was evaluated in increments of 0.05 by setting 0 as no incidence of disease and 3 as disease development in a plant of untreated group. In addition, control values were calculated using the following equation based on disease development.

(1472) <Control Value>

(1473) Control value=100 {1−(n/3)}

(1474) n=Disease development of each treated groups

(1475) A summary of test results described above is shown in Table 7. In the table, H shows the control value more than 50%, and L shows the control value of 50% or less. Also, nt shows that no test was performed.

(1476) TABLE-US-00007 TABLE 7 Com- Test Test Test Test Test Test Test Test pound A B C D E F G H 1 H L L L L L L H 2 H L L H H L H H 3 H L L L H L H L 4 H L L H H L H H 5 H H H H H H H H 6 H H H L H L L L 7 H H H L H L L L 8 H H H L L L H L 9 H H H H L L L H 10 H H H L L L L H 11 H L H H H L L L 12 H H H L H L L H 13 H H H L H L L H 14 L H L H H L H L 15 L H L H H L L H 16 L H H H H L L H 17 nt H nt H H nt nt nt 18 H H H H H L L H 19 H H H H H L L H 20 H H H H H L L H 21 H H H H H L H H 22 H H H H H L H H 23 H H H H H L L H 24 H H H H H L H H 25 L L H H L L L H 26 H H H H H L L H 27 L H H H H L L H 28 H H H H H L L H 29 H H H H H L L H 30 L L L H L L L L 31 L H H H L L L H 32 L H H L H L L L 33 H L H L L L L L 34 H H H H H L L H 35 H H H H H L L H 36 H L H L H L L H 37 H H H L H L L H 38 H L L L L L L L 39 H H H L H L L H 40 H H H H H L L H 41 H H H H H L L H 42 L H H L H L L H 43 H H H H H L L H 44 H H H H H L H H 45 H H H H H L L L 46 H H H H H L H H 47 L H H H H L L H 48 H H H H H L H H 49 H H H H H L H H 50 H H H H H L H H 51 H H H H H L H H 52 H H H H H L L H 53 H H H L H L L H 54 H H H H H L L L 55 H H H H H L L H 56 H H H H H L H H 57 H H H H H L L H 58 H H L H H L L H 59 H H H H H L L H 60 L H L H L L L L 61 H H H H H L H H 62 H H H H H L H H 63 H H H H H L H H 64 H H L H H L L L 65 H H H H H L H H 66 H nt H nt nt L H H 67 H H H H H L H H 68 H H H H H L L H 69 H H H H H L L H 70 H H H H H L L L 71 H H H H H L L H 72 H H H H H L L H 73 H H H H H L L H 74 H H H H H L H H 75 H H H L L L L L 76 H H H H L L L L 77 H H H H H L L H 78 H H H H H L L H 79 H H H H H L L H 80 H H H H H L L H 81 H H H H H L L H 82 H H H H H L H H 83 H H H H H L L H 84 H H H H H L L H 85 H H H H H L L H 86 H H H H H L L H 87 L L H L L L L L 88 L L H L L L L L 89 H H H L H L L H 90 L H H L H L L H 91 L L H L L L L L 92 L H L L L L L L 93 L H H H L L L H 94 H H H H H L L H 95 H H H H L L L H 96 H L L L L L L L 97 H H H H H L H H 98 H H H H H L L H 99 H H H H H L H H 100 H H H H H L L H 101 H H H H H L L H 102 H H H L L L H H 103 H H H H H L L H 104 H H H H H L L H 105 L H H L H nt L H 106 H H H L H H H H 107 H H H H H L H H 108 H H H H H L L H 109 H H H H H L L H 110 H H H H H L L L 111 H H H H H L L H 112 H H H H H L H H 113 H H H H H L L H 114 H H H L H L L H 115 H H H L H L H H 116 H H H L H H H H 117 L L H L L L L L 118 H H H H H L H H 119 L L H L L L L L 120 H H H L H L L H 121 H L L L L L L L 122 H H H H H L L L 123 L H H L L L L L 124 H H H L L L L H 125 H H H L H L L H 126 H H H L H L L H 127 H H H H H L L H 128 L L H H H L H L 129 H L H L L L H L 130 L L H L L L L L 131 L L H L L L L L 132 H H H H H L H H 133 H H H H H L H H 134 L H L L L L L L 135 L L L L L L H L 136 H H H H H L H H 137 H H H H H L H H 138 H H H H H L L H 139 H H H H H L H H 140 L H H H H L L H 141 H H H H H L L H 142 H L H L L L L H 143 L H H L H L L H 144 H L H L L L L L 145 H H H H H L L H 146 H H H L H L H H 147 H L H L L L L L 148 H H H H H L L H 149 H H H H H L L H 150 H H H H H L L H 151 H H H L H L L L 152 H H H L H L L H 153 H H H H H L H H 154 H L L L L L L L 155 L L H L L L L H 156 H H H H H L L H 157 H H H H H L L H 158 H H H H H L L H 159 H H H H H L L H 160 L H H L L L L L 161 H H H L H L L L 162 L L L L L L H L 163 L L L L L L H L 164 H H H H H L L H 165 H H H H H L L H 166 H H H L H L H H 167 H H H L H L H H 168 H L H H H L L H 169 L H H H H L L H 170 H L H L L L L H 171 H L L L L L L L 172 H H H L H L L H 173 H H H H H L L H 174 H H H H H H L H 175 H H H H H H L H 176 H H H H H L L H 177 H H H H H L H H 178 H H H H H L H H 179 H H H H H L H H 180 H H H H H L L H 181 H H H H H H H H 182 H H H H H H H H 183 L H H H H L H H 184 L H H L H L H H 185 L H L H H L L L 186 H H H H H L L H 187 H H H H H L L H 188 H H H H H L L H 189 H H H H H L L H 190 H H H H H L L H 191 H H H H H L L H 192 H H H H H L H H 193 H H H H H L H H 194 H H H H H L L H 195 H H H L H L L H 196 H H H L H L L L 197 H H H H H L L H 198 L L H L L L L L 199 L L H L L L L L 200 H H H H H L L H 201 H H H H H L L H 202 H H H H H L L H 203 H H H H H L L H 204 L H H L L L L H 205 L H H L H L L L 206 H H H H H L L H 207 H H H H H L H H 208 H H H H H L L H 209 H H H H H L L H 210 L H L L H L L H 211 H L H H H L L L 212 H L H H L L L L 213 H H H H H L L H 214 H L H H H L H L 215 H H H H H H H H 216 L H H H H L L H 217 L H H H H L L L 218 H L H L L L L L 219 L L L L L L H L 220 H H H H H L L H 221 L L H L L L L L 222 H H H H H L L H 223 H L H L L L H L 224 L H H H H L H H 225 L L H H H L H L 226 H H H H H L H H 227 L H H H H L L L 228 H H H H H L L H 229 H H H H H L L H 230 H H H H H L H H 231 H H H H H L L L 232 H H H H H L L L 233 H H H H H L L L 234 L H H H H L L L 235 H H H H H L L L 236 H H H H H L H H 237 L L H L L L L L 238 H H H H H L L H 239 H H H H H L L H 240 L H H H H L L H 241 L H L L H L L L 242 L H L L L L L L 243 L H H L H L L L 244 H H H H H L L H 245 H H H H H L L H 246 L L L L L L L H 247 L H L L L L L L 248 H H H H H L L H 249 L H H H H L L L 250 H H H H H L L H 251 H H H H H L L H 252 H H H H H L L H 253 L H H L H L L L 254 H H H H H L H H 255 H H H H H L H H 256 H H H H H L L H 257 L H L L L L L H 258 L L L L H L L L 259 L L H H H L L L 260 L L H L L L L L 261 H H H H H L L H 262 H H H H H L L H 263 H H H H H L L H 264 H H H L H L L H 265 L L H H H L L L 266 H H H H H L H H 267 H H H H H L L H 268 L L H H H L L L 269 H H H H H L L L 270 H H H H H L L H 271 H H H H H L H H 272 H H H H H L L H 273 H H H H H L L L 274 H H H H H L L L 275 H H H H H L L L 276 L L H H L L L L 277 H H H H H L H L 278 H H H H H L H L 279 H H H L H L L H 280 H L H L H L L H 281 L L H H L L L L 282 H H H H H L L H 283 H H H H H L L H 284 H H H H H L L H 285 H H H H H L L H 286 H H H H H L L H 287 H H H L H L L H 288 H H H L H L L H 289 L L H H H L L L 290 L L H H H H L L 291 L L H L L L L L 292 L H H H H L L L 293 H H H H H L L L 294 H L H H H L L L 295 L H H H H L H L 296 H H H H H L H H 297 L L L L H L L L 298 H H H L H L L H 299 H H H L H L L H 300 H H H H H L L H 301 H H H H H L L H 302 H H H H H L H H 303 L L H H H L L L 304 L L H H L L L L 305 L L H H H L L L 306 H H H H H L L H 307 H H H H H L L H 308 H H H H H L L H 309 H H H H H L L L 310 H H H H H L L H 311 H H H H H L L H 312 H H H H H L L H 313 H H H H H L L H 314 H H H H H L L H 315 H H H H H L L H 316 H H H H H L L H 317 L H H L H L L H 318 L H H H H H L H 319 H H H H H L L H 320 H H H H H L L H 321 L L L L L L L H 322 L H H H H L L L 323 H H H H H H H H 324 L L L L L L H H 325 L L H L L L L L 326 H H H H H L L H 327 H H H H H L L H 328 H H H H H L L H 329 H H H L L L L H 330 H H H H H L L H 331 H H H H H L H H 332 H H H H H L H H 333 H H H H H L H H 334 H H H H H L L H 335 H H H H H L H H 336 H H H H H H H H 337 H H H H H H H H 338 H H H H H L L H 339 H H H H H L L H 340 H H H H H L H H 341 H H H H H H L H 342 H H H H H L L H 343 H H H H H L H H 344 H H H H H L H H 345 H H H H H L H H 346 H H H H H L H H 347 H H H H H L H H 348 H H H L H L L L 349 H H H L H L H H 350 L H H H H L H H 351 H H H H H L L H 352 H H H H H L L H 353 H H H H H L L H 354 H H H H H L H H 355 H H H L H L L H 356 L H H H H L L L 357 H H H H H L L H 358 H H H L H L L H 359 H H H H H H H H 360 H H H H H L L H 361 H H H H H L L H 362 H H H H H L H H 363 H H H L H L L H 364 H H H H H L H H 365 H H H H H L H H 366 H H H H H L H H 367 L L H H L L L L 368 L nt H nt nt L H L 369 H H H H H L L H 370 H H H H H L L L 371 H H H H H L H H 372 L L L H L L H L 373 H H H L H L H H 374 L L L H H L H H 375 H H H H H L H H 376 L H L L H L H H 377 H H H H H H L H 378 H H H H H H L H 379 H H H L H L L H 380 H H H L H L L H 381 H H H H H H H H 382 H H L H H L L H 383 H H H H H L L H 384 H H H H H L L H 385 H H H H H H H H 386 H H H H H L L L 387 H H H H H L L L 388 H H H H H L L L 389 H H H H H L L H 390 H H H L H L L L 391 H H L L H H L L 392 H H H L L H L L 393 H H H L H H H H 394 H H H H H H H H 395 H H H H H L L H 396 H L L L L L L L 397 H H H H H L L H 398 H H H L H L L H 399 L H L L H L L L 400 H L H L L L L L 401 L L H L L L L L 402 H L H L L L L L 403 H H H L L L L L 404 H L H L L L L L 405 L L H H H L L L 406 L L H H L L L L 407 H H H H H L L H 408 H H H L H L L L 409 H H H H H L L L 410 H H H H H L H H 411 H H H L H L L L 412 H H H H H L H H 413 L H L H L L L H 414 H H H H H L L H 415 L nt L nt nt H L H 416 H H H H H L H H 417 H nt H nt nt H L L 418 H H H H H L L H 419 H nt H nt nt L L H 420 H nt H nt nt H L H 421 H H H H H L L H 422 H L H H H L L L 423 H H H H H L H H 424 H H H H H H H H 425 H H H H H L L H 426 H H H H H L L H 427 H H H L H L L H 428 H L H H H L L H 429 H H H L H L L H 430 H H H L H L L H 431 H H H L H L L H 432 H H H H L L L H 433 H H H H H L L H 434 H L L L L L L L 435 H H H L H L H H 436 H H H H H L H H 437 H H H H H L L H 438 H L H H H L L H 439 H H H H H L H H 440 H L H L L L H L 441 H H H L H L L H 442 H L L L L L L L 443 H H H H H L L H 444 H L H L H L L L 445 H H H H H L L H 446 H H H H H L L H 447 H H H H H L L L 448 H H H H H L L L 449 H H H H H L L H 450 H H H L H L L H 451 L L H H H L H L 452 H H H H H L L H 453 H H H L H L L H 454 L H H H H L H H 455 L L H L L L L L 456 H H H L H L L H 457 L H H L H L L H 458 H H H H H L L H 459 H H H L H L L H 460 H H H H H L H H 461 H H H H H L L H 462 H H H H H L L H 463 L L H H L L L H 464 H H H L H L L H 465 H H H L H L L H 466 H H H L H L L L 467 L H L L L L L L 468 H H H L H L L H 469 H H H H H L L H 470 L H H H H L H H 471 L L H L L L L L 472 H H H L H L H H 473 L H H L H L H L 474 L H L H H L L L 475 H H H H H L H H 476 H H H H H L H H 477 H H H L H L L L 478 H H H H H L L H 479 L H H H H L H H 480 L L H L L L L L 481 L H L H H L L L 482 H H H H H L L H 483 L H H H H L L H 484 H H H L H L L L 485 L L H H H L L L 486 H H H H H L H H 487 L L L L L L H L 488 H H H H H L H H 489 L L H L H L L L 490 H H H H H L H H 491 L H L L H L H L 492 L H H L H L L L 493 H H H H H L H L 494 H L H H H L H H 495 H H H L H L H L 496 H H H L H L H L 497 H H H L H L H H 498 H H H H H L H H 499 H H H L H L H H 500 H H H L H L H L 501 H H H L H L H H 502 H H H L H L H H 503 H H H H H L H H 504 H H H L H L H H 505 H H H H H L H L 506 H H H H H L H H 507 H nt H nt nt L H H 508 L L H L H L L H 509 L H H H H L H H 510 L H H H H L L H 511 L L L H L L L L 512 H H H H H L L H 513 L L H L H L L L 514 H H H H H L L H 515 H H H H H L H H

INDUSTRIAL APPLICABILITY

(1477) The pyridone compounds of the present invention are novel compounds and can treat or prevent plant diseases, thus being valuable as agricultural chemicals, for example, an agricultural and horticultural pest control agent, in particular, an agricultural and horticultural fungicide.

(1478) The entire contents of Japanese Patent Application No. 2017-78492 (filing date: Apr. 11, 2017) and Japanese Patent Application No. 2017-199795 (filing date: Oct. 13, 2017) are incorporated herein by reference.

(1479) All publications, patent applications and technical standards mentioned in the present specification are herein incorporated by reference to the same extent as if each individual publication, patent application or technical standard was specifically and individually indicated to be incorporated by reference.